taurine profile

ID Source	ID
PubMed CID	1123
CHEMBL ID	239243
CHEBI ID	15891
SCHEMBL ID	23068
MeSH ID	M0021065

Synonym
AB00443712-07
gtpl2379
CHEBI:15891 ,
beta-aminoethylsulfonic acid
2-aminoethyl sulfonate
ethanesulfonic acid, 2-amino-
NSC32428 ,
.beta.-aminoethylsulfonic acid
aminoethanesulfonic acid
o-due
wln: z2swq
nsc-32428
NCI60_002814
EU-0101134
taurine, >=99%
D00047
taurine (tn)
taurine (jp17/usp/inn)
aminoethylsulfonic acid (jan)
tocris-0209
lopac-t-0625
NCGC00015997-01
NCGC00024497-01
LOPAC0_001134
2-aminoethylsulfonic acid
MLS001332383
MLS001332384
1-aminoethane-2-sulfonic acid
2-sulfoethylamine
taukard
fema no. 3813
ccris 4721
ai3-18307
ethanesulfonic acid, 2-amino- (9ci)
taurine (8ci)
l-taurine
NCGC00024497-02
nci-c60606
nsc 32428
taurinum [latin]
einecs 203-483-8
taurine [inn]
taurina [spanish]
taufon
C00245
107-35-7
TAURINE ,
2-aminoethanesulfonic acid
aminoethylsulfonic acid
tauphon
taurine, cell culture tested, meets usp testing specifications
taurine, >=98%, fg
smr000326743
taurineold
DB01956
MLS000859681
NCGC00024497-05
NCGC00024497-03
NCGC00024497-04
taurine, bioultra, >=99.5% (t)
NCGC00015997-04
T 0625
HMS2093L13
A0295
NCGC00015997-07
taurate
CHEMBL239243
BMSE000120
NCGC00015997-06
HMS3263D09
unii-1eqv5mly3d
taurine [usp:inn:ban]
ec 203-483-8
taurinum
1eqv5mly3d ,
hsdb 8167
taurina
BMSE000805
BMSE000863
NCGC00260069-01
tox21_202520
AKOS005208848
nsc-759150
pharmakon1600-01505463
nsc759150
cas-107-35-7
tox21_110277
dtxcid301304
dtxsid3021304 ,
CCG-205208
HMS2233D19
NCGC00015997-02
NCGC00015997-05
NCGC00015997-08
NCGC00015997-03
bdbm50357220
FT-0611241
AM20080018
LP01134
S2008
HMS3370J18
aminoethylsulfonic acid [jan]
taurine [usp monograph]
taurine [mart.]
taurine [fhfi]
taurine [vandf]
taurine [who-dd]
taurine [jan]
taurine [inci]
taurine [usp-rs]
taurine [mi]
HY-B0351
2-aminoethane-1-sulfonic acid
SCHEMBL23068
tox21_110277_1
NCGC00015997-10
NCGC00261819-01
tox21_501134
2aminoethanesulfonic acid
2-aminoethane sulfonic acid
AB00443712_09
AB00443712_10
mfcd00008197
J-508042
F2191-0280
taurine, >=99.0% (t)
sr-01000076144
SR-01000076144-1
taurine, united states pharmacopeia (usp) reference standard
taurine, saj first grade, >=98.5%
taurine, vetec(tm) reagent grade, >=99%
taurine, pharmaceutical secondary standard; certified reference material
SR-01000076144-3
SR-01000076144-5
taurine, certified reference material, tracecert(r)
SBI-0051101.P002
2-aminoethanesulfonicacid
aminoethylsulfonate
beta-aminoethylsulfonate
b-aminoethylsulfonic acid
1-aminoethane-2-sulfonate
b-aminoethylsulfonate
2-aminoethylsulfonate
rkl10149
taurine,(s)
AS-13587
Q207051
EN300-28228
STL197941
SDCCGSBI-0051101.P003
NCGC00015997-20
D78121
2-aminoethanesulfonic acid.
T-130
taurine; 2-aminoethanesulfonic acid
taurine (usp-rs)
taurinum (latin)
taurine (usp:inn:ban)
taurine (usp monograph)
taurine (mart.)
Z248489432

Research Excerpts

Overview

Excerpt	Reference
"Taurine is a non-proteinogenic sulfonic acid found in high concentrations inside vertebrate cardiomyocytes and its movement across the sarcolemmal membrane is critical for cell volume regulation. "	( Gates, MA; Lamarre, SG; MacCormack, TJ; Morash, AJ, 2022)
"Taurine is an amino acid that has pleiotropic protective properties on some diseases."	( Jia, S; Ma, J; Yang, R; Yang, Z, 2022)
"Taurine is an intracellular free amino acid that has anti-inflammatory and antioxidant effects."	( Deng, S; Hao, Y; Li, R; Ma, Y; Qin, Q; Ran, C; Zhang, J; Zhang, Y; Zhu, L, 2022)
"Taurine is an important amino acid required for brain development."	( Cai, G; Fan, Z; Han, J; Li, X; Li, Y; Luo, D; Wang, R; Wu, S; Zhang, H; Zhang, L; Zhu, Y; Zhuo, L, 2023)
"Homotaurine is a potential therapeutic compound for treatment of Alzheimer's disease (AD), but its efficacy is still under investigation. "	( Banaj, N; Bossù, P; Golesorkhtafti, S; Lembo, M; Messina, B; Sireno, L; Spalletta, G; Toppi, E, 2022)
"Taurine is an essential amino acid. "	( Barnes, S; Cheng, H; Newman, SD; O'Donnell, BF; Raymond, D; Schnakenberg Martin, AM; Wilson, L, 2022)
"Taurine is an amino sulfonic acid that is implicated in numerous physiological functions, including the regulation of oxidative stress, which plays an important role in coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), together with other pathophysiological processes. "	( Bernal, ME; Bourgonje, AR; Hillebrands, JL; Offringa, AK; van Eijk, LE; van Goor, H, 2022)
"Taurine is an essential nutrient for felines including lions. "	( Akiba, Y; Honda, A; Kawase, K; Kobayashi, S; Kohari, D; Miyakawa, Y; Miyazaki, T, 2022)
"Taurine is a semi-essential amino acid in mammals and has been shown to be a potent endogenous antioxidant."	( Li, S; Piao, F; Wang, D; Zhang, C; Zhang, M, 2022)
"Taurine is a non-essential amino acid that has received much attention."	( Bkaily, G; Jacques, D; Jazzar, A; Khalil, A; Najibeddine, H; Normand, A; Simon, Y, 2022)
"Taurine is a naturally occurring essential β-amino acid reported to elicit antipsychotic property in first episode psychosis in clinical setting, thus require preclinical investigation."	( Adebayo, OG; Ben-Azu, B; Chijioke, BS; Edje, KE; Eduviere, AT; Esuku, DT; Japhet, K; Jarikre, TA; Moke, EG; Odili, OS; Omogbiya, IA; Omondiabge, OP; Oyovbaire, A; Oyovwi, MO; Ozah, EO, 2022)
"Taurine (TAU) is an abundant amino acid with substantial anti-inflammatory and antioxidative properties."	( Abdoli, N; Azarpira, N; Heidari, R; Lu, Y; Ma, Y; Manthari, RK; Mazloomi, S; Mehrabani, PS; Mingyu, Y; Mobasheri, A; Mousavifaraz, A; Nadgaran, A; Niknahad, H; Nikoozadeh, A; Ommati, MM; Rezaei, M; Sadeghian, I; Tang, Z; Xin, H; Xu, D, 2022)
"Taurine (TAU) is an amino acid with potent antioxidant and anti-inflammatory properties in animals and humans."	( Ali, S; Ashraf, MA; Hafeez, A; Rasheed, R; Rizwan, M, 2022)
"Taurine is an essential amino acid with various biological functions such as anti-inflammatory and anti-oxidation."	( Chen, X; He, W; Huang, K; Liu, K; Liu, S; Mao, X; Qu, J; Yue, D; Zhang, P, 2023)
"Taurine (TUR) is a sulfur-containing free β-amino acid with antioxidant and therapeutic value against several diseases."	( Althagafy, HS; Atwa, AM; Hassanein, EHM; Kotb El-Sayed, MI; Kozman, MR; Soubh, AA, 2022)
"Taurine is an amino acid that has several physiological functions. "	( He, F; Kobayashi, H; Ma, N; Murata, M; Nishimura, K; Oikawa, S; Okano, M; Tawara, I, 2023)
"Taurine is a β-amino acid known to regulate cardiac function in other animal models but its role in fish has not been well characterized."	( Buldo, EC; Cockshutt, A; Dixon, TM; El, N; Lamarre, SG; MacCormack, TJ; McGaw, SP; Morash, AJ; Otley, NA; Pabody, CM; Parker, KS; Rhyno, EM; Savoie, M, 2023)
"Taurine is an end-product of cysteine metabolism, whereas cysteine dioxygenase (CDO) and cysteine sulfinate decarboxylase (CSAD) are key enzymes regulating taurine synthesis. "	( Cui, S; Fan, J; Liu, H; Qiu, G; Zhang, D, 2023)
"Taurine (Tau) is an osmosensitive amino acid, whose release reflects increased cell volume."	( Albrecht, J; Czarnecka, AM; Czuczwar, SJ; Kołodziej, M; Pawlik, M; Podgajna, M; Skowrońska, K; Węgrzynowicz, M, 2023)
"Taurine is a crucial amino acid in the human body."	( Bian, Y; Dai, J; Fu, Z; Hu, J; Li, C; Lin, S; Ma, Y; Meng, L; Wang, J; Wu, Y; Yin, D; Zhang, X; Zhao, D, 2023)
"Taurine is a recently recognized plant growth regulator under abiotic stress. "	( Ali, S; Ashraf, MA; Hussain, I; Ibrahim, SM; Rasheed, R; Rizwan, M, 2023)
"Taurine is an important osmoregulator with a crucial role in osmoregulation in marine bivalves."	( Donghong, N; Min, D; Yifeng, L; Yihua, C; Zhiguo, D, 2024)
"Taurine is a sulfur-containing amino acid which has strong activities in enhancing immunity. "	( Fang, H; Jin, B; Li, M; Li, W; Meng, F; Piao, F, 2019)
"Taurine is an abundant sulfur-containing amino acid in myeloid cells. "	( Kang, IS; Kim, C, 2019)
"Taurine is a free amino acid and exhibits various biological functions such as brain development, retinal photoreceptor activity, reproduction, normal growth development and antioxidant activity. "	( Choi, MJ; Jung, YM, 2019)
"Taurine is a β-amino acid found most broadly distributed in human body, abundant in animal foods, and has an antioxidative function. "	( Choi, MJ; Jeong, JS, 2019)
"Taurine appears to be an attractive candidate for use as a radioprotector and as a radiation mitigator, but its protection mechanism against radiation-induced cell damage is still unclear until now."	( Gu, Y; Isogai, T; Kato, T; Ma, N; Yamashita, T, 2019)
"Taurine is a well-known antioxidant."	( Dong, G; Li, S; Wang, J; Wang, X; Wei, BK, 2019)
"Taurine is an important amino acid for the growth and development of the central nervous system and plays an important role in the development of the nervous system. "	( Cheng, Y; Guo, Y; Hao, X; Li, Y; Li, Z; Niu, X; Qin, C; Shang, X; Shao, J; Wang, R, 2019)
"Taurine is a nonessential amino acid that has received much attention. "	( Al-Khoury, J; Bkaily, G; Jacques, D; Jazzar, A; Normand, A; Simon, Y, 2020)
"Taurine is a semiessential amino acid found at high concentrations in mammalian plasma and cells, where it regulates cellular functions such as ion flux, controls cell volume and serves as a substrate for conjugated bile acids (BAs). "	( Carneiro, EM; Davel, AP; Guizoni, DM; Vettorazzi, JF, 2020)
"Taurine (TAU) is a β-amino sulfonic acid with pleiotropic roles in the brain, including the neuromodulatory activity via GABAergic and glycinergic agonism. "	( Canzian, J; Duarte, T; Fontana, BD; Mezzomo, NJ; Müller, TE; Parker, MO; Rosemberg, DB; Ziani, PR, 2020)
"Taurine is a ubiquitous sulphur-containing amino acid present in foods such as seafood."	( Burgueño, AL; Mensegue, MF; Tellechea, ML, 2020)
"Taurine (Tau) is a β-sulphonated amino acid postulated to improve glucose homeostasis in insulin resistance and diabetes. "	( Król, E; Kupsz, J; Okulicz, M, 2020)
"Taurine is an antioxidant that is abundant in some common energy drinks. "	( Bertolone, L; Busch, MP; D'Alessandro, A; Dumont, LJ; Fu, X; Hay, AM; Kanias, T; Kleinman, S; Morrison, EJ; Nemkov, T; Roy, MK; Stefanoni, D; Stone, M; Zimring, JC, 2020)
"Taurine is an amino acid usually added to energy drinks. "	( Almeida, RF; Bandiera, S; de Paula, LF; Gomez, R; Hansen, AW; Izolan, LDR; Nietiedt, NA; Pulcinelli, RR, 2020)
"Taurine is an abundant intracellular beta-amino acid majorly synthesized in the liver and transported through plasma. "	( Behera, A; Kumar, LK; Onteru, SK; Singh, D; Sravanthi, K; Vedamurthy, GV, 2021)
"Taurine is a free amino acid rich in neutrophils, and neutrophils play an important role in the forefront defense against infection. "	( Kang, IS; Kim, C; Kim, DG; Kwon, YM, 2020)
"Taurine is a non-protein amino acid that is expressed in the majority of animal tissues. "	( Abraham, JR; Apostolopoulos, V; Gadanec, LK; McSweeney, KR; Qaradakhi, T; Zulli, A, 2020)
"Taurine (Tau) is an abundant amino acid in polymorphonuclear leukocytes that react with hypochlorous acid to form taurine chloramine (TauCl) under inflammatory conditions. "	( Dal-Pizzol, F; Dall'igna, DM; Luz, JMD; Michels, M; Vuolo, F, 2020)
"Taurine is an abundant amino acid with multiple physiological functions, including osmoregulation, pH regulation, antioxidative protection, and neuromodulation."	( Haavik, J; Kursula, P; Loris, R; Luan, W; Mahootchi, E; Muruganandam, G; Raasakka, A, 2021)
"Taurine is an organic amino acid and a major constituent of bile. "	( Geng, CJ; Li, Q; Luo, H; Miao, SM; Wang, LH, 2021)
"Taurine is a sulfur-containing amino acid that plays an important role in glucose homeostasis. "	( An, Z; Hu, T; Liu, L; Liu, PJ; Liu, Y; Ma, L; Xia, LY; Yao, AM, 2021)
"Taurine is a compatible osmolyte that confers stability to proteins. "	( Ito, T; Maeyama, S; Murakami, S; Schaffer, SW; Tsubotani, K, 2021)
"Taurine (TAU) is an amino acid with antioxidant property and beneficial impacts on the male reproductive system."	( Khorsandi, L; Saki, G; Valizadeh, A; Yahyavy, S, 2021)
"Taurine is a fundamental mediator of homeostasis that exerts multiple roles to confer protection against oxidant stress. "	( Adamaki, M; Baliou, S; Christodoulou, I; Ioannou, P; Kyriakopoulos, AM; Panayiotidis, MI; Pappa, A; Spandidos, DA; Zoumpourlis, V, 2021)
"Taurine is an important antioxidant in lens tissue."	( Kerry, Z; Ozsarlak-Sozer, G; Sevin, G; Sozer, N, 2021)
"Taurine is a naturally occurring sulfur-containing amino acid that is found abundantly in excitatory tissues, such as the heart, brain, retina and skeletal muscles. "	( Jong, CJ; Sandal, P; Schaffer, SW, 2021)
"Taurine is an abundant amino acid in the brain that serves the central nervous system (CNS)."	( Deasy, K; Du, E; Hu, X; Mochizuki, T; Roy, S; Wang, P; Zhang, Y, 2017)
"Taurine is an important osmolyte in teleost hearts, but its role in stress tolerance, cardiac metabolism, and contractility has not been assessed."	( Henry, EF; MacCormack, TJ, 2018)
"Taurine is a ubiquitous sulfur-containing amino acid found in high concentration in most tissues. "	( Ito, T; Jong, CJ; Prentice, H; Schaffer, SW; Wu, JY, 2017)
"Taurine is a highly abundant "amino acid" in the brain. "	( Barcellos, LJG; Fontana, BD; Kalueff, AV; Mezzomo, NJ; Rosemberg, DB, 2017)
"Taurine is an essential amino acid in humans that proved efficacy as a non-pharmacological therapy in a plethora of diseases; however, its impact on NAFLD remains elusive."	( Abd Elwahab, AH; Ramadan, BK; Schaalan, MF; Tolba, AM, 2017)
"Taurine is an abundant beta-amino acid found in high concentration in mammalian tissues. "	( Ito, T; Murakami, S; Nakajima, D; Okazaki, K; Schaffer, S; Shibata, D, 2018)
"Taurine is a conditionally essential amino acid present in the body in free form. "	( Basak, P; Ghosh, S; Kundu, M; Sarkar, P; Sil, PC, 2017)
"Taurine is a partial agonist with an efficacy significantly lower than that of glycine."	( Kirson, D; Mihic, SJ; Todorovic, J, 2018)
"Taurine is a nonprotein sulfur containing amino acid as well as a well-known antioxidant and has valuable clinical applications in the detoxification of xenobiotics."	( Banerjee, B; Choudhury, SM; Das, T; Ghosh, R; Jana, K, 2018)
"Taurine (TAU) is an amino sulfonic acid which acts an endogenous inhibitory neuromodulator."	( Barbosa, NV; Canzian, J; Dos Santos, MM; Fontana, BD; Loro, VL; Mello, CF; Mezzomo, NJ; Müller, TE; Rosemberg, DB; Ziani, PR, 2019)
"Taurine (TAU) is a sulfur-containing beta amino acid that is not involved in protein composition and anabolism, conditionally essential in mammals provided through diet. "	( Favero, G; Lavazza, A; Monsalve, M; Rezzani, R; Rodella, LF; Stacchiotti, A, 2018)
"Taurine is a sulfur-containing-β-amino acid that is widely distributed in mammalian tissues."	( Ito, T; Kawasaki, A; Murakami, S; Ono, A; Takenaga, T, 2018)
"Taurine is a β-amino acid with antioxidant properties."	( Gao, F; He, X; Jiang, Y; Li, J; Lu, Z; Ma, B; Zhang, L; Zhou, G, 2019)
"Taurine is an organic compound that can act as a neuroprotectant."	( Hashemi, M; Karbalay-Doust, S; Karimi, F; Noorafshan, A, 2018)
"Taurine (TAU) is a β-amino sulfonic acid with pleiotropic roles in the brain."	( Fontana, BD; Mezzomo, NJ; Müller, TE; Parker, MO; Quadros, VA; Rico, EP; Rosemberg, DB; Stefanello, FV, 2018)
"Taurine is a sulfur-containing amino acid with vital biological functions."	( Anandakumar, P; Sakthisekaran, D; Vanitha, MK, 2018)
"Taurine is a nonproteinogenic ß-aminosulfonic acid. "	( Huebbe, P; Rimbach, G; Seidel, U, 2019)
"Taurine is a non‑proteogenic and essential amino acid in animals."	( Li, S; Liu, H; Niu, X; Zheng, S, 2018)
"Taurine is an amino acid abundantly present in heart and skeletal muscle. "	( Bove, M; Camerino, GM; Capogrosso, RF; Conte, E; De Bellis, M; De Luca, A; Mantuano, P; Mele, A; Morgese, MG; Pierno, S; Rana, F; Rolland, JF; Sanarica, F; Trabace, L, 2019)
"Taurine is an amino acid with significant neuroprotective properties."	( Abdoli, N; Ghanbarinejad, V; Heidari, R; Niknahad, H; Ommati, MM, 2019)
"Taurine is a biologically and physiologically valuable food additive. "	( Han, SO; Hyeon, JE; Joo, YC; Ko, YJ; Musaad, AS; Shin, SK; You, SK, 2018)
"Taurine is a dispensable amino acid that has been linked to DCM in dogs."	( Abood, SK; Aldrich, G; Columbus, DA; Ekenstedt, KJ; Larsen, JA; Mansilla, WD; Marinangeli, CPF; Shoveller, AK; Weber, L, 2019)
"Taurine (Tau) is a kind of semi-essential β amino acid, and beneficial for β cell function."	( Gao, N; Jia, X; Jiang, L; Liu, S; Liu, X; Pei, P; Qiu, T; Sun, X; Tao, Y; Wang, N; Wang, Z; Wei, S; Yang, G; Yang, L; Yao, X, 2019)
"Taurine is a β-amino acid present in high concentrations in different areas of the mammalian central nervous system (CNS). "	( Gulias-Cañizo, R; Ochoa-de la Paz, L; Quiroz-Mercado, H; Zenteno, E, 2019)
"Taurine is a sulfur-containing amino acid and known as semi-essential in mammals and is produced chiefly by the liver and kidney. "	( Azam, S; Choi, DK; Haque, ME; Jakaria, M; Jo, SH; Kim, IS; Uddin, MS, 2019)
"Taurine is an indispensable amino acid for many fish species and taurine supplementation is needed when plant-based diets are used as the primary protein source for these species. "	( Dong, J; Feng, J; Shen, G; Wang, S; Wang, X; Xia, F; Xu, J; Ye, J, 2019)
"Taurine is a key functional amino acid with many functions in the nervous system. "	( Chen, C; Han, H; He, J; Lu, G; Xia, S; Xie, Z, 2019)
"Taurine is an important endogenous agonist of glycine receptors (GlyR). "	( Bukanova, YV; Kondratenko, RV; Skrebitsky, VG; Solntseva, EI, 2019)
"Taurine is a low-molecular weight organic compound in living organisms."	( Apaydin, FG; Kalender, S; Kalender, Y, 2019)
"Taurine is a semi-essential sulfonic acid found at high concentrations in plasma and mammalian tissues which regulates osmolarity, ion channel activity and glucose homeostasis. "	( Gisselmann, G; Hatt, H; Kletke, O; May, A; Sergeeva, OA, 2013)
"Hypotaurine is an antioxidant with a protective effect on sperm functions."	( Artonne, C; Brugnon, F; Farigoule, M; Janny, L; Ouchchane, L; Pons-Rejraji, H, 2013)
"Taurine is an endogenous ligand acting on glycine receptors in many brain regions, including the hippocampus, prefrontal cortex, and nucleus accumbens (nAcc). "	( Cornelison, GL; Kirson, D; Mihic, SJ; Philpo, AE; Todorovic, J, 2013)
"Taurine is an endogenous brain substance with robust neuromodulatory and possible neuroprotective properties. "	( Agovic, MS; Banerjee, SP; Chan, CY; Friedman, E; Shah, SM; Sun, HS, 2014)
"Taurine is a semi-essential amino acid in mammals and has been shown to be a potent endogenous antioxidant."	( Chang, CC; Chang, CY; Kang, CK; Lee, TH; Shen, CY; Sher, YP; Sheu, WH, 2014)
"Taurine is a sulfur-containing amino acid that exerts protective effects on vascular function and structure in several models of cardiovascular diseases through its antioxidant and anti-inflammatory properties. "	( Batista, TM; Carneiro, EM; Clerici, SP; Davel, AP; Delbin, MA; Maia, AR; Victorio, JA, 2014)
"Taurine is a potent free radical scavenger that attenuates the damage caused by excessive oxygen free radicals."	( He, M; Liao, Z; Liu, D; Tang, L; Yi, B; Yin, D; Zhang, Z, 2014)
"Taurine is an ubiquitary expressed aminosulfonic acid known to play an important role in the development and maintenance of the nervous system. "	( Hagen, R; Jablonka, S; Jürgens, L; Mlynski, R; Radeloff, A; Rak, K; Schendzielorz, P; Scherzad, A; Völker, J, 2014)
"Taurine is a beta-amino acid found in very high concentration in the heart. "	( Azuma, J; Ito, T; Jong, CJ; Pastukh, V; Ramila, KC; Schaffer, SW, 2015)
"Taurine is a small organic osmolyte which participates in cell volume regulation. "	( Karjalainen, HM; Lammi, MJ; Leskelä, SS; Qu, C; Rilla, K, 2015)
"Taurine is a sulfur-containing amino acid present in high concentrations in mammalian tissues, and has been implicated in several processes involving brain development and neurotransmission. "	( Hu, P; Wang, Q; Wu, WJ; Xie, DH; Zhu, GH, 2015)
"Taurine is a sulfur-containing amino acid that is present in mammalian tissues in millimolar concentrations. "	( Murakami, S, 2015)
"Hypotaurine is a precursor of taurine and an antioxidant, and is concentrated in fetal plasma compared to maternal plasma. "	( Duereh, M; Higuchi, K; Nakashima, E; Nishimura, T; Sugita, Y; Tomi, M; Yoshida, Y, 2015)
"Taurine is a free amino acid found in numerous diets, with anti-inflammatory properties."	( Gebara, E; Sultan, S; Toni, N; Udry, F, 2015)
"Homotaurine is a natural compound of red algae, which has been demonstrated to have a neuroprotective effect and has been evaluated as a possible therapeutic agent for Alzheimer's disease. "	( De Nigris, F; Fasano, A; Ricciardi, L; Specchia, A, 2015)
"Taurine is an abundant amino acid that is widely distributed in human and animal tissues. "	( Demirkilic, U; Doganci, S; Karabacak, K; Kaya, E; Kurtoglu, M; Seyrek, M; Ulusoy, KG; Yildirim, V; Yildiz, O, 2015)
"Homotaurine is a natural aminosulfonate compound endowed with neuromodulatory effects, while the dipeptide L-carnosine is known for its antioxidant properties."	( Adornetto, A; Bagetta, G; Cavaliere, F; Corasaniti, MT; Morrone, LA; Nucci, C; Rusciano, D; Russo, R; Varano, GP, 2015)
"Taurine is an organic acid that has a role in the regulation of oxidative stress and promoting mitochondrial normal functions, and N-Acetyl cysteine (NAC) is a well-known anti-oxidant and glutathione precursor."	( Albers, DS; Alkholifi, FK, 2015)
"Taurine is a natural amino acid present as free form in many mammalian tissues and in particular in skeletal muscle. "	( Camerino, DC; De Luca, A; Pierno, S, 2015)
"Taurine is an essential amino-sulfonic acid having a fundamental function in the brain, participating in both cell volume regulation and neurotransmission. "	( Bhattarai, JP; Cho, DH; Chun, SW; Han, SK; Park, SJ, 2015)
"Taurine is a β-amino acid found in high concentrations in excitable tissues, including the heart. "	( Ito, T; Jong, CJ; Schaffer, SW; Shimada-Takaura, K; Takahashi, K, 2016)
"Taurine (TAU) is a sulfur-containing amino acid that is involved in a diverse array of biological and physiological functions, including bile salt conjugation, osmoregulation, membrane stabilization, calcium modulation, anti-oxidation, and immunomodulation. "	( Aranovich, I; Ben Shahar, Y; Berkowitz, D; Bitterman, A; Bitterman, N; Chepurov, D; Coran, AG; Pollak, Y; Sukhotnik, I, 2016)
"Taurine (TAU) is an amino sulfonic acid with pleiotropic actions on brain function."	( Blaser, RE; Filho, GL; Fontana, BD; Giuliani, GS; Meinerz, DL; Mezzomo, NJ; Quadros, VA; Rosa, LV; Rosemberg, DB; Silveira, A, 2016)
"Taurine (TAU) is an amino sulfonic acid with several functions in central nervous system. "	( Giuliani, GS; Mezzomo, NJ; Quadros, VA; Rosemberg, DB; Silveira, A, 2016)
"Taurine promises to be a potential prevention for epidural fibrosis after laminectomy."	( Cao, X; Chen, H; Ge, D; Ge, Y; Que, J; Sui, T; Tang, J; Yang, L, 2016)
"Taurine is an abundant amino acid in the nervous system, which has been proved to possess antioxidation, osmoregulation and membrane stabilization. "	( Hao, YJ; Li, YX; Ma, PS; Niu, Y; Sun, T; Wu, W; Yu, JQ; Zhou, R; Zhu, XY, 2016)
"Taurine is a semi essential amino acid with bioprotective properties."	( Akande, MG; Shittu, M; Uchendu, C; Yaqub, LS, 2016)
"Taurine is an inhibitory neuromodulatory amino acid in the central nervous system that activates the GABA- and glycine-insensitive chloride channel and inhibits the N-methyl-D-aspartate receptor. "	( Allott, KA; McGorry, PD; Moral, J; Murphy, BP; O'Donnell, CP; O'Regan, MK; Papas, A; Pham, T; Phassouliotis, C; Proffitt, TM; Simpson, R; Yuen, HP, 2016)
"Taurine is a free intracellular β-amino acid with antioxidant and neuroprotective properties."	( Abolaji, AO; Adedara, IA; Farombi, EO; Idris, UF; Ojuade, TD; Olabiyi, BF; Onibiyo, EM, 2017)
"Taurine is a non-essential amino acid expressed in high concentration in several mammalian tissues and particularly in skeletal muscle where it is involved in the modulation of intracellular calcium concentration and ion channel regulation and where it also acts as an antioxidant and anti-inflammatory factor."	( Scicchitano, BM; Sica, G, 2018)
"Taurine is a partial agonist at the glycine receptor (GlyR), a member of the cys-loop ligand-gated ion channel superfamily."	( Allen, HM; Bayly, MD; Kirson, D; Mihic, SJ; Todorovic, J; Welsh, BT, 2017)
"Taurine is an amino acid found abundantly in brain, retina, heart, and reproductive organ cells, as well as in meat and seafood. "	( Caine, JJ; Geracioti, TD, 2016)
"Taurine is an organic compound used in energy drinks and food that can cause many forms of hypersensitivity reactions, and one of these is erythema exsudativum multiforme."	( Begolli Gerqari, AM; Begolli, IM; Begolli, M; Daka, A; Ferizi, M; Halimi, S; Hapciu, S; Hysen Gerqari, I, 2016)
"Taurine is an amino acid found abundantly in the heart in very high concentrations. "	( Ahmadian, M; Ashourpore, E; Dabidi Roshan, V, 2017)
"Taurine is a conditionally-essential amino acid that is found in high concentrations in the CNS and is essential for growth and survival of neurons. "	( Einat, H; Whirley, BK, 2008)
"Taurine is a conditionally essential amino acid for human that is involved in the control of glucose homeostasis; however, the mechanisms by which the amino acid affects blood glucose levels are unknown. "	( Araujo, E; Bedoya, FJ; Beltrá, M; Berná, G; Carneiro, EM; Latorraca, MQ; Martín, F; Navarro, M; Oliveras, MJ; Soria, B; Velloso, LA, 2009)
"Taurine is a well documented antioxidant agent."	( Chuang, LY; Guh, JY; Hsu, MS; Huang, JS; Yang, YL, 2008)
"Taurine is an essential amino acid in some mammals and is conditionally essential in humans. "	( Anderson, CM; Ganapathy, V; Howard, A; Thwaites, DT; Walters, JR, 2009)
"Taurine is a semi-essential sulphur containing amino acid derived from methionine and cysteine metabolism. "	( Boukarrou, L; El Idrissi, A; L'Amoreaux, W, 2009)
"Taurine is an abundant free amino acid in inflammatory cells, where it is thought to be cytoprotective."	( Kim, AK; Yu, J, 2009)
"Taurine is a naturally occurring free amino acid that has been shown to have neurotrophic and neuroprotective properties in the retina."	( Chen, F; Chen, K; Liu, F; Mi, M; Wang, J; Xu, H; Zeng, K; Zhang, Q, 2009)
"Taurine is a semi-essential amino acid and is successful in preserving neutrophil bactericidal function in urine."	( Bouchier-Hayes, DJ; Casey, RG; Condron, C; Creagh, T; Kehoe, S; Toomey, D, 2010)
"Taurine is a potent free radical scavenger that attenuates a variety of renal diseases that are the consequence of excessive oxygen free radical damage."	( Jeon, SH; Kang, HS; Kim, GB; Kim, IS; Kim, JS; Kim, SJ; Lee, MY; Park, HM; Rahman, MM; Woo, JN, 2010)
"Taurine is a semi-essential amino acid and has many biological properties. "	( Dong, XF; Tong, JM; Wang, FR; Xie, ZG; Zhang, Q; Zhang, XM, 2010)
"Taurine is a free amino acid present in high concentrations in a variety of organs of mammalians. "	( Giraldo, GS; Pan, C; Prentice, H; Wu, JY, 2010)
"Taurine is a chemically simple compound, but it has profound effects on cells."	( Azuma, J; Jong, CJ; Ramila, KC; Schaffer, SW, 2010)
"Taurine is a small water-soluble molecule which is notoriously difficult to analyze due to its polarity and functionality."	( Antheaume, I; Besnard, J; Robins, RJ; Tea, I, 2010)
"Taurine is an organic acid, which has a very important function in the human body. "	( Akdemir, O; Arslan, Z; Hede, Y; Lineaweaver, WC; Songur, E; Zhang, F, 2011)
"Taurine is a sulfur-containing β-amino acid that is found in milimolar concentrations in most mammalian tissues and plasma. "	( Balabanli, B; Bircan, FS; Ozan, G; Turkozkan, N, 2012)
"Hypotaurine is an intermediate in taurine biosynthesis from cysteine in astrocytes. "	( Hara, K; Haranishi, Y; Kataoka, K; Nakamura, M; Sata, T; Terada, T, 2012)
"Taurine is a conditionally essential amino acid in humans that may be a promising therapy for treating this disease."	( da Rosa, DP; da Silveira, TR; Escobar, TD; Fracasso, LB; Hammes, TO; Hartmann, CR; Marroni, NP; Pedroso, GL; Porawski, M, 2012)
"Taurine is a semi-essential amino acid widely distributed in the body and we take in it from a wide range of nutritive-tonic drinks to improve health. "	( Arko, M; Ito, K; Kawaguchi, T; Kikusui, T; Kuwahara, M; Tsubone, H, 2012)
"Taurine is a free β-amino acid and plays important physiological roles including protective effect of cardiovascular events."	( Feng, X; Gu, L; Hu, YR; Li, JM; Liao, XB; Shang, BP; Sheng, ZF; Tang, H; Xie, H; Yuan, LQ; Zhang, W; Zhang, ZY; Zhou, XM, 2012)
"Taurine is an agent for treating the heavy metal intoxication and presence of metals such as zinc, copper, and iron may have a role in heavy metal toxicity, a study was undertaken to investigate the effect of taurine on the toxicity of zinc in male Wistar rats. "	( Hsieh, YL; Hwang, DF; Lee, YT; Yeh, YH, 2011)
"Taurine (TA) is an amino acid found in mammalian tissues that protects the cell against DNA damage."	( Aydin, E; Turkez, H, 2012)
"Taurine acts as a partial agonist at the glycine receptor (GlyR) in some brain regions such as the hippocampus, striatum, and nucleus accumbens. "	( Kirson, D; Mihic, SJ; Todorovic, J, 2012)
"Taurine is a quite safe antioxidant and nutrient extensively used in food addition and clinical treatment."	( Ji, H; Luo, J; Zhang, M; Zhao, G; Zhao, X, 2012)
"Taurine (TAU) is an amino sulfonic acid that plays protective roles against neurochemical impairments induced by ethanol (EtOH). "	( Blaser, RE; Braga, MM; Calcagnotto, ME; Campos, MM; Córdova, SD; de Oliveira, DL; Dias, RD; Leite, CE; Loss, CM; Mussulini, BH; Rico, EP; Rosemberg, DB; Souza, DO, 2012)
"Taurine is a direct LXR-α ligand, represses cholesterol accumulation, and modulates the expression of genes involved in reverse cholesterol transport in macrophages, without inducing hepatic lipogenesis. "	( Choi, DW; Hoang, MH; Hwang, KY; Jia, Y; Jun, HJ; Lee, BY; Lee, JH; Lee, SJ; Um, SJ; You, SG, 2012)
"Taurine is a sulfur-containing amino acid present in high concentrations in mammalian tissues. "	( Goh, EL; Low, G; Marcy, G; Rosales, FJ; Ryu, JR; Shivaraj, MC; Zhao, X, 2012)
"Taurine is an abundant β-amino acid that regulates several events that dramatically influence the development of ischemia-reperfusion injury. "	( Azuma, J; Ito, T; Jong, CJ; Schaffer, SW, 2014)
"Taurine is an abundant, free amino acid found in mammalian cells that contributes to many physiologic functions from that of a simple cell osmolyte to a programmer of adult health and disease. "	( Roysommuti, S; Wyss, JM, 2014)
"Taurine is an organic osmolyte involved in cell volume regulation, and provides a substrate for the formation of bile salts. "	( Ripps, H; Shen, W, 2012)
"Taurine is an abundant β-amino acid that concentrates in the mitochondria, where it participates in the conjugation of tRNAs for leucine, lysine, glutamate and glutamine. "	( Azuma, J; Ito, T; Jong, CJ; Schaffer, SW, 2014)
"Taurine serves as a substrate in the formation of 5-taurinomethyluridine-tRNA(Leu(UUR)); therefore, taurine deficiency should mimic 5-taurinomethyluridine-tRNA(Leu(UUR)) deficiency."	( Azuma, J; Ito, T; Jong, CJ; Schaffer, SW; Warner, D, 2013)
"Taurine is a nonessential amino acid and has a variety of physiological and pharmacological effects. "	( Kim, AK; Kim, T, 2013)
"Taurine is an antioxidant."	( Li, Y; Liu, X; Piao, F, 2013)
"Taurine is an inhibitory neurotransmitter and is one of the most abundant amino acids present in the mammalian nervous system. "	( Chen, PC; Gharibani, PM; Ma, Z; Menzie, J; Modi, J; Pan, C; Prentice, H; Tao, R; Wu, JY, 2013)
"Taurine is a free amino acid which is present at high concentrations in a range of organs including the brain, heart, and retina in mammalian systems."	( Chen, PC; Gharibani, PM; Pan, C; Prentice, H; Wu, JY, 2013)
"Taurine is a potent γ-aminobutyric acid (GABA) agonist and alters cellular events via GABA(A) receptors."	( Cuttitta, CM; Guariglia, SR; Idrissi, AE; L'amoreaux, WJ, 2013)
"Taurine is a nonessential amino acid that is of medical interest for the nutrition of infants. "	( Goicoechea, C; Martín, MI; Sánchez, E; Serrano, JS; Serrano, MI; Serrano-Martino, MC, 2002)
"Taurine is a unique amino acid with antioxidant and osmolytic properties. "	( Boelens, PG; de Thouars, HN; Haarman, HJ; Houdijk, AP; Teerlink, T; van Engeland, MI; van Leeuwen, PA, 2003)
"Taurine is an amino acid. "	( Sener, RN, 2003)
"Taurine (Tau) is an amino acid that is thought to mimic GABA function because of its agonistic properties towards GABA(A) receptors, and to contribute to neuroprotection and osmoregulation."	( Albrecht, J; Zielińska, M, 2002)
"Taurine is an inhibitory amino acid acting as an osmoregulator and neuroromodulator in the brain, with neuroprotective properties. "	( Oja, SS; Saransaari, P, 2003)
"Taurine is a semi-essential amino acid and is not incorporated into proteins. "	( Park, E; Schuller-Levis, GB, 2003)
"Taurine (TAU) is a free amino acid that is particularly abundant in the olfactory bulb. "	( Chaput, MA; Delaleu, JC; Duchamp-Viret, P; Palouzier-Paulignan, B, 2004)
"Taurine is a sulfur containing beta-amino acid rich in human body, and our previous experiments showed that it can inhibit the deposition of the extracellular matrix in the damaged liver."	( Chen, YX; Li, S; Xie, WF; Zhang, XR, 2004)
"Taurine is an important organic osmolyte in mammalian cells, and taurine release via a volume-sensitive taurine efflux pathway is increased and the active taurine uptake via the taurine specific taurine transporter TauT decreased following osmotic cell swelling."	( Lambert, IH, 2004)
"Taurine is a semiessential amino acid that is not incorporated into proteins. "	( Park, E; Schuller-Levis, GB, 2004)
"Taurine is a semiessential amino acid, and its deficiency is involved in retinal and cardiac degenerations. "	( Bennardini, F; Di Leo, MA; Franconi, F; Ghirlanda, G, 2004)
"Taurine is a free amino acid found in high millimolar concentrations in the retina, and age-related deficiency in retinal levels of taurine may contribute to the retinal degeneration associated with age."	( Lombardini, JB; Militante, J, 2004)
"Taurine is an abundant free amino acid that interacts with the potent oxidant hypochlorous acid to form the less toxic and more stable oxidant taurine monochloramine (TauNHCl). "	( Emerson, DK; Knudson, CM; McCormick, ML; Schmidt, JA, 2005)
"Taurine is a sulfur-containing amino acid thought to be an osmoregulator, neurotransmitter or neuromodulator in the brain. "	( Molchanova, S; Oja, SS; Saransaari, P, 2004)
"Taurine is an amino acid able to react with hypochlorous acid, produced endogenously by neutrophils, resulting in the more stable and less toxic taurine chloramine (Tau-Cl). "	( Tarkowski, A; Verdrengh, M, 2005)
"Taurine is a naturally occurring beta-amino acid present in the mammalian brain."	( Brito-Moreira, J; De Felice, FG; Ferreira, ST; Paula-Lima, AC, 2005)
"Taurine is an abundant free amino acid in inflammatory cells that protects cells from inflammatory damages. "	( Kim, C; Kim, JW, 2005)
"Taurine is a semi-essential beta-amino acid that was demonstrated to have both antioxidant and GABA-A agonistic activity."	( Abdel-Naim, AB; Arafa, HM; Khalifa, AE; Tadros, MG, 2005)
"Taurine is an abundant organic osmolyte with antioxidant and immunomodulatory properties. "	( Amiry-Moghaddam, M; Beer, S; Borsch, E; Buchczyk, D; Dienes, HP; Donner, M; Flögel, U; Gabrielsen, M; Häussinger, D; Heller-Stilb, B; Kappert, G; Marschall, HU; Mönnighoff, I; Ottersen, OP; Pfeffer, K; Reinehr, R; Soboll, S; Warskulat, U, 2006)
"Taurine is a semi-essential sulphur amino acid derived from methionine and cysteine metabolism. "	( Franconi, F; Ghirlanda, G; Loizzo, A; Seghieri, G, 2006)
"Taurine is an inhibitory amino-acid which has been proposed as a nociceptive process neuromodulator. "	( Angel, RD; Coffeen, U; López-Avila, A; Manuel Ortega-Legaspi, J; Pellicer, F, 2007)
"Taurine is a sulfur amino acid. "	( Gupta, RC; Seki, Y; Yosida, J, 2006)
"Taurine is an important endogenous amino acid for neural development and for many physiological functions, but little is known about its functional role in the central auditory system. "	( Chen, L; Tang, ZQ; Wang, W; Xu, H; Xu, TL, 2006)
"Taurine is an endogenous antioxidant and a membrane-stabilizing, intracellular, free beta-amino acid."	( Demirogullari, B; Guz, G; Karasu, C; Lortlar, N; Nurlu, N; Omeroglu, S; Oz, E; Sert, S; Ulusu, NN, 2007)
"Taurine is a semi-essential amino acid that is endothelial protective and restrains excess leucocyte activity by the formation of less toxic inflammatory mediators."	( Bouchier-Hayes, DJ; Casey, RG; Gang, C; Joyce, M, 2007)
"Taurine is a semi-essential amino acid that has previously been shown to have endothelial protective effects."	( Hu, CP; Huang, H; Jia, SJ; Jiang, DJ; Jiang, JL; Li, YJ; Tan, B, 2007)
"Taurine is a sulphur-containing amino acid abundant in the nervous system. "	( Djatchkova, IM; Oja, SS; Pelto-Huikko, M; Saransaari, P; Taranukhin, AG; Taranukhina, EY, 2008)
"Taurine is an inhibitory neurotransmitter or neuromodulator that reduces blood pressure when systemically or centrally administered. "	( Koga, Y; Takasugi, Y; Yoshioka, M, 2007)
"Taurine is an abundant amino acid in the brain that shares pharmacological effects and similar potency with ethanol. "	( Ginsburg, BC; Lamb, RJ, 2008)
"Taurine is an abundant aminoacid present in brain. "	( Avila, J; Hernández, F; Moreno, FJ; Santa-María, I, 2007)
"Taurine is an endogenous amino acid that can activate glycine and/or gamma-aminobutyric acid type A (GABA(A)) receptors in the central nervous system. "	( Chen, L; Lu, YG; Tang, ZQ, 2008)
"Taurine is a free beta-amino acid and plays an important physiological role in mammals."	( Hu, ZW; Li, JM; Liao, XB; Liu, W; Lu, Y; Tan, ZP; Yang, JF; Yuan, LQ; Zhou, XM, 2008)
"Taurine is a sulfur amino acid (2-amino ethane sulfonic acid) and has been claimed for a number of beneficial actions ranging from anti-epilepsy to anti-hypertension. "	( Gupta, H; Kim, SJ; Lee, W; Ramesh, C, 2007)
"Homotaurine is a powerful GABA agonist that exerts a central action upon parenteral administration."	( Black, JA; Fariello, RG; Golden, GT, 1981)
"Taurine is a useful model substrate because it is not catabolized in Myxicola and its net efflux is sensitive to Na."	( Horn, LW, 1981)
"Taurine (Tau) is an exceptionally abundant free amino acid in the cytosol of inflammatory cells and especially in neutrophils. "	( Bereta, J; Grabowska, A; Marcinkiewicz, J; Stelmaszynska, T, 1995)
"Taurine acts as a trap for toxic hypochlorous acid (HOCl) and forms the less reactive metabolite, N-chlorotaurine (5-6)."	( Park, E; Quinn, MR; Schuller-Levis, G; Wright, C, 1994)
"Taurine is a beta-sulfonic amino acid that serves as a nutrient important for developing brain and retina and as an osmolyte in the medullary collecting duct. "	( Chesney, RW; Jones, DP; Miller, LA, 1995)
"Taurine is an inhibitory amino acid that hyperpolarizes magnocellular neurosecretory neurons. "	( Decavel, C; Hatton, GI, 1995)
"1. Taurine is a ubiquitous, free amino acid found in mammalian systems. "	( Seabra, V; Timbrell, JA; Waterfield, CJ, 1995)
"Taurine is an endogenous amino acid that can occur in nerve terminals in the central nervous system and that can produce inhibitory neuronal responses. "	( Brodin, L; Cullheim, S; Grillner, S; Ottersen, OP; Shupliakov, O; Srinivasan, M; Storm-Mathisen, J, 1994)
"Taurine is an important modulator of neuronal activity in the immature brain. "	( Oja, SS; Saransaari, P, 1994)
"Taurine is a non-protein sulfur amino acid widely distributed in mammalian tissues, with poorly understood functions. "	( Angelico, M; Bologna, E; Gentile, S; Terracina, D, 1994)
"Taurine was found to be a component of the < 1 kDa fraction and to stimulate rod development when added to retinal cultures."	( Altshuler, D; Cepko, C; Lo Turco, JJ; Rush, J, 1993)
"Hypotaurine is a precursor of the synthesis of taurine and may act as an antioxidant."	( Dybdahl, A; Gribbestad, IS; Midelfart, A, 1996)
"Taurine is a sulfonic beta-amino acid which occurs in the highest concentration in the brain, the retina and in the myocardium. "	( Ciechanowska, B, 1997)
"Taurine is a conditionally-essential amino acid which is not utilized in protein synthesis, but rather is found free or in simple peptides. "	( Birdsall, TC, 1998)
"Taurine is a nonessential amino acid that plays a critical role in development. "	( Fernández-Villalba, E; Guerri, C; Martín-Algarra, RV; Plá Delfina, JM; Polache, A, 1998)
"Taurine is an essential amino acid during fetal life and appears to be vital for the growth of the fetus and for the development of the CNS. "	( Jansson, T; Norberg, S; Powell, TL, 1998)
"Taurine is a beta-aminosulfonic acid and is a ubiquitous amino acid whose role in the cochlea is not well established. "	( Angelini, E; Aran, JM; Ferrary, E; Teixeira, M, 1998)
"Taurine is an inhibitory amino acid in the CNS. "	( Beery, E; Belfer, I; Davidson, E; Ratner, A; Seltzer, Z; Shir, Y, 1998)
"Taurine is a very important organic osmolyte in most adult cells. "	( Azuma, J; Ballard-Croft, C; Jenkins, TE; Kakhniashvili, DG; Schaffer, SW; Takahashi, K, 1998)
"Taurine is a sulfur amino acid that is present in high concentration in mammalian tissues and previously has been reported to decline in a number of tissues with advancing age. "	( Dawson, R; Eppler, B; Liu, S; Patterson, T, 1999)
"Taurine is a free sulfur-containing amino acid that is found in abundance in mammalian tissues and fluids. "	( Dawson, R; Eppler, B, 1999)
"Taurine is a sulphur-containing beta-amino acid found in high (millimolar) concentrations in excitable tissues such as brain and heart. "	( O'Byrne, MB; Tipton, KF, 2000)
"Taurine is an amino acid mainly known for its involvement in cell volume regulation, as it is one of the major inorganic osmolytes used by cells to compensate for changes in extracellular osmolarity."	( Deleuze, C; Desarménien, MG; Hussy, N; Moos, FC, 2000)
"Taurine is a sulphonic aminoacid present in high amounts in various tissues including cardiac and skeletal muscles showing different properties such as antioxidative, antimyotonic and anti-schaemic effects. "	( Barbieri, M; Camerino, DC; Tricarico, D, 2000)
"Taurine is an important osmolyte involved in cell volume regulation. "	( Bröer, S; Lang, F; Matskevich, I; Paulmichl, M; Stegen, C; Wagner, CA, 2000)
"Taurine acts as an antioxidant protecting neurons from free radical-mediated cellular damage. "	( Brown, WD; Cahill, DW; Rivas-Arancibia, S; Rodríguez, AI; Sanberg, PR; Willing, AE; Zigova, T, 2001)
"Taurine is thought to be an osmolyte in the kidney medulla. "	( Bitoun, M; Levillain, O; Tappaz, M, 2001)
"Taurine (TAU) is a ubiquitous sulfur-containing amino acid that has been proposed to be an antioxidant. "	( Dawson, R; Eppler, B, 2001)
"Taurine chloramine is a long-lived molecule with immunomodulatory properties."	( Dornisch, K; Elstner, EF; Reim, M; Schempp, H, 2001)
"Taurine is an amino acid known to possess trophic properties in the central nervous system. "	( Cubillos, S; Fazzino, F; Jaimes, I; Lima, L; Obregon, F, 2001)
"Taurine (TAU) is a sulfur-containing amino acid that has been shown to decrease during aging and is believed to be important for cytoprotection. "	( Dawson, R; Eppler, B, 2002)
"Taurine is an inhibitor of hydroxyl radical and superoxide radical. "	( Chen, C; Chen, D; Dong, B; Lu, D; Zhang, W, 2002)
"Taurine is an osmolyte found in high concentration in the kidney. "	( Mozaffari, MS; Schaffer, SW, 2002)
"Taurine is a free amino acid found in high millimolar concentrations in mammalian tissue and is particularly abundant in the retina. "	( Lombardini, JB; Militante, JD, 2002)
"Taurine is a free amino acid found in high concentrations in tissues containing catecholamines. "	( Biasetti, M; Dawson, R, 2002)
"Taurine is an amino acid that is widely distributed in the fluids and tissues of man. "	( Gaull, GE; Rassin, DK, 1979)
"Taurine is a modifier of calcium fluxes in the heart, as are beta-adrenergic agonists."	( Chubb, J; Huxtable, R, 1977)
"Taurine is a ubiquitous amino sulfonic acid in mammals, present in high concentrations in tissues, including those exposed to elevated levels of oxidants. "	( Schuller-Levis, GB; Sturman, JA, 1992)
"Taurine appears to be a key component of the brain cytosol system in the fetus."	( Hida, K; Kwee, IL; Nakada, T, 1992)
"Taurine is a structurally simple amino acid, and has been reported to have several putative roles, such as neurotransmitter, neuromodulator, neurogrowth factor and to function in membrane stabilization."	( Ashihara, M; Nagatsu, I; Nishimura, T; Sakai, M; Takuya, O, 1992)
"Taurine is a cerebral osmolyte whose intracellular content changes in parallel with plasma osmolality. "	( Futterweit, S; Sturman, JA; Trachtman, H, 1992)
"Taurine is an amino acid that is essential for retinal integrity and function. "	( Gabrielian, K; Ogden, TE; Ryan, SJ; Wang, HM, 1992)
"Taurine is an amino sulfonic acid maintained at relatively high concentrations in skate (Raja erinacea) hepatocytes (65 mmol/l intracellular water). "	( Ballatori, N; Boyer, JL, 1992)
"Taurine is an organic osmolyte in brain cells. "	( del Pizzo, R; Futterweit, S; Trachtman, H, 1992)
"Taurine is a conditionally essential amino acid that possibly improves the micellar phase of fat digestion."	( Lacaille, F; Lamarre, A; Lepage, G; Ronco, N; Roy, CC; Smith, LJ, 1991)
"Taurine is a cerebral osmoprotective molecule during chronic hypernatremic dehydration. "	( del Pizzo, R; Sturman, JA; Trachtman, H, 1990)
"Taurine is a neuroinhibitory amino acid that is taken up, stored, and released from primary cultures of astrocytes and astroglial cells."	( Madelian, V; Shain, W; Silliman, S, 1988)
"Taurine is a sulfonic amino acid with inhibitory effects in the central nervous system. "	( Blom, H; Engelsen, BA; Nyland, H, 1989)
"Taurine is an amino acid that plays important roles in maintaining both the structural integrity and function of the retina. "	( Chou, TC; Liebowitz, SM; Lombardini, JB, 1989)
"Taurine is a ubiquitous dietary constituent of most mammals and is present in especially high concentrations in the tissues of developing mammals. "	( Sturman, JA, 1988)
"Taurine is an important age- and compartment-specific part of the pool of free amino acids in all human tissues and fluids examined. "	( Jürgens, P, 1988)

Effects

Excerpt	Reference
"Taurine has a certain protective effect against male reproductive toxicity caused by formaldehyde."	( Geng, T; Liu, B; Sun, C; Sun, F; Tian, Y; Xiao, YH, 2020)
"Taurine has a potent protective effect against ischemic reperfusion injury."	( Cynober, L; De Bandt, JP; Ginguay, A, 2016)
"Taurine has a number of physiological functions, e.g., in cell volume regulation and inhibitory neuromodulation. "	( Oja, SS; Saransaari, P, 2007)
"Taurine has a variety of biological actions, such as ion movement, calcium handling and cytoprotection in the cardiac and skeletal muscles."	( Azuma, J; Fujio, Y; Ito, T; Kimura, Y; Oishi, S; Schaffer, SW; Takai, M; Uozumi, Y, 2010)
"Taurine has an important role in numerous physiological processes, including many aspects of fetal development such as development of the pancreas and brain, and requirements increase during pregnancy. "	( Bloomfield, FH; Derraik, JG; Harding, JE; Jaquiery, AL; Oliver, MH; Thorstensen, EB, 2012)
"Taurine (TAU) has a lot of the biological, physiological, and pharmocological functions including anti-inflammatory and anti-oxidative stress. "	( Ishikura, K; Ito, M; Maeda, S; Matsuzaki, Y; Miyazaki, T; Nagayama, H; Ohmori, H; Ra, SG; Suzuki, T, 2013)
"Taurine has an ameliorating effect on atherosclerosis together with a decreasing effect on the cholesterol and triglyceride levels in rabbits fed on an HC diet."	( Aykaç-Toker, G; Balkan, J; Cevikbaş, U; Hatipoğlu, A; Kanbağli, O; Kücük, M; Uysal, M, 2002)
"Taurine has a variety of actions in the body such as cardiotonic, host-defensive, radioprotective and glucose-regulatory effects. "	( Kim, SJ; Zhang, CG, 2007)
"Taurine has an antioxidant capacity and its level in diabetic cataractous lens is markedly decreased."	( H Kwon, Y; Kim, H; Son, HY, 2007)
"Taurine in diabetes has an age old story; taurine is involved in the development and protection of insulin apparatus."	( Gupta, RC; Kim, SJ; Lee, HW, 2007)
"Taurine in diabetes has an age old story; taurine is involved in the development and protection of insulin apparatus."	( Gupta, H; Kim, SJ; Lee, W; Ramesh, C, 2007)
"Taurine efflux has a Q(10) of 1.8.10."	( Horn, LW, 1981)
"Hypotaurine has a protective role against peroxidative damage."	( Guérin, P; Guillaud, J; Ménézo, Y, 1995)
"Taurine has an important role in fat absorption in pre-term and possibly term infants and in children with cystic fibrosis."	( Budreau, AM; Chesney, RW; Christensen, M; Han, X; Helms, RA; Sturman, JA, 1998)
"Taurine has an inhibitory role on H(2)O(2)-induced bovine lens epithelial cell apoptosis and can delay and ameliorate the occurrence and development of cataract."	( Chen, C; Chen, F, 2000)
"Thus taurine, which has an anticonvulsant action appears to partially correct the amino acid imbalance in epileptics."	( Delsedime, M; Durelli, L; Monaco, F; Mutani, R, 1975)
"Taurine (Tau) has modulatory effects on inflammatory and oxidative stress biomarkers; however, the results of clinical studies are not comprehensive enough to determine the effect of different durations and doses of Tau supplementation on inflammatory and oxidative stress biomarkers. "	( Faghfouri, AH; Faghfuri, E; Fathollahi, P; Ostadrahimi, A; Papi, S; Seyyed Shoura, SM; Shadbad, MA, 2022)
"Taurine (Tau) has many profound physiological functions, but its role and molecular mechanism in muscle cells are still not fully understood. "	( Gao, X; Hao, Q; Li, M; Wang, L; Wang, Z; Zhang, M, 2022)
"Taurine (TAU) has the potential to inhibit growth in various cancer cells."	( Chantree, P; Sangpairoj, K; Surarak, T, 2021)
"Taurine (Tau) has been used against hepatotoxicity caused by different environmental toxins."	( Cui, S; Ma, K; Qiu, G; Zheng, J; Zhou, Y, 2023)
"Taurine has the function of immune regulation, relieving acute and chronic inflammation caused by various agents, and maintaining cell homeostasis. "	( Bian, Y; Dai, J; Feng, Y; Fu, Y; Fu, Z; Hu, J; Li, C; Lin, S; Ma, Y; Wang, J; Wu, Y; Zhang, X; Zhao, D, 2022)
"Taurine has the advantages of being safe, highly efficient, chemically stabile, and biologically active, together with having versatile functions. "	( Fu, Y; Hu, JM; Li, C; Lin, SM; Liu, M; Lv, QF; Ma, YD; Wang, JJ; Wu, GF; Yang, JC; Zhao, DD, 2022)
"Taurine has been reported to improve the action of insulin in normal, pre-, and diabetic conditions. "	( da Silva Junior, JA; Ribeiro, RA, 2022)
"Taurine has been investigated as a possible strategy for the treatment of obesity. "	( Abud, GF; Batitucci, G; De Carvalho, FG; de Freitas, EC, 2022)
"Taurine has been reported to play an important role in the development of the brain in newborns and in reducing the damage caused by cerebral ischemia."	( Ishida, T; Kawanokuchi, J; Ma, N; Nagaoka, N; Takagi, K; Yamamoto, T, 2022)
"Taurine has been proved to be synthesized and abundant in male reproductive organs."	( Chen, C; Dong, W; Guo, X; Li, Y; Peng, Q; Shang, J; Wu, S; Xie, Z, 2023)
"Taurine has been approved as a drug covered by public insurance for prevention of stroke-like episodes since 2019."	( Sunada, Y, 2023)
"Taurine has pivotal roles in anti-oxidation, membrane stabilization, osmoregulation, anti-inflammation, and other process."	( Fukumura, M; Gondo, Y; Satsu, H; Shimanaka, H; Shimizu, M; Watari, K, 2019)
"Taurine has been reported to play a key role in the growth and development of children's brains and nerves. "	( Chang, KJ; Kim, SH; Park, SH; Shin, JW, 2019)
"Taurine has been found to ameliorate the diabetic neuropathy and control apoptosis in various tissues."	( Li, K; Piao, F; Shahbaz, M; Shi, X; Suleman, R; Taj, A; Wu, P; Zhang, M, 2019)
"Taurine intake has escalated over the last decade due to increased consumption of taurine-containing energy drinks and dietary supplements."	( Adermark, L; Andrén, A; Ericson, M; Söderpalm, B; Ulenius, L, 2020)
"Taurine has been shown to attenuate apoptosis by inhibiting calpain activity."	( Hu, J; Li, W; Lin, S; Lyu, Q; Wu, G; Yang, J; Yang, Q, 2020)
"Taurine has been shown to have positive effects on bone mass, which are thought to be due in part to its cytoprotective effects on osteoblasts and here we show that taurine also protects osteocytes against cell death due to reactive oxygen species. "	( Bonewald, LF; Kimble, M; Kitase, Y; O'Connell, TM; Prideaux, M, 2020)
"Taurine has been found in only one macromolecular complex as a post-transcriptional modification to mitochondrial tRNA."	( Bane, SL; Cologna, SM; Mukherjee, K; Olson, MT; Pergande, MR; Sackett, DL; Yergey, AL, 2020)
"Taurine has been reported to have neuroprotective properties against dementia, including AD."	( Choi, JY; Han, SJ; Jeong, YJ; Kang, KJ; Lee, HJ; Lee, KC; Lee, YJ; Nam, KR; Oh, SJ, 2020)
"Taurine has a certain protective effect against male reproductive toxicity caused by formaldehyde."	( Geng, T; Liu, B; Sun, C; Sun, F; Tian, Y; Xiao, YH, 2020)
"Taurine has been considered as an essential nutrient for many aquaculture species. "	( Dai, T; Ding, ZN; Dong, JY; Feng, JH; Shen, GP; Xia, F; Xu, JJ; Ye, JD, 2021)
"Taurine has become a popular supplement among athletes attempting to improve performance. "	( Doyle, JA; Kurtz, JA; Otis, JS; VanDusseldorp, TA, 2021)
"Taurine has been reported to have immune-modulatory effects."	( Cheraghian, B; Hosseini, SA; Namjoonia, M; Soltani, F; Vahdat, M, 2021)
"Taurine has been chosen for the present study because of its positive known effects on cardiac injuries."	( Abdollahi, M; Armandeh, M; Azarmi, Y; Baeeri, M; Bameri, B; Eghbal, MA; Gholami, M; Haghi-Aminjan, H; Hassani, S; Hooshangi Shayesteh, MR; Rahimifard, M; Samadi, M; Sattari, M, 2021)
"Taurine has been reported to influence osteogenic differentiation, but the role of taurine on cartilaginous differentiation using human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) remains unclear. "	( Fan, W; Huang, H; Li, Z; Liu, X; Sun, X; Wang, X; Wei, H; Yao, X; Zhou, H; Zhu, J, 2017)
"Taurine has been widely evaluated as a potential therapeutic agent in chronic inflammatory disorders and various infections. "	( Jeong, HJ; Kim, HM; Nam, SY, 2017)
"Taurine has been demonstrated to exert protective effects on the brain development and can improve learning ability and memory."	( Feng, Y; Hu, JM; Lin, SM; Ren, S; Tang, RY; Wu, GF; Xu, C; Yang, JC; Yang, QH; Zhou, JQ, 2017)
"Taurine has already been demonstrated to protect cells effectively from oxidant-induced injury."	( Du, RR; Fang, Q; Hu, JH; Li, H; Liu, Q; Wang, LQ; Yang, GS; Zhang, XG, 2017)
"Taurine has been reported high amounts in marine animals to maintain osmotic balance between osmoformers and sea water. "	( Li, Q; Meng, Q; Xu, C; Yue, C; Zhao, X, 2017)
"Taurine and alcohol has been popularly ingested through energy drinks. "	( Alvarenga, RL; Cagy, M; da Costa, BM; Gongora, M; Paulucio, D; Pompeu, FAMS; Ribeiro, P; Santos, CG; Velasques, B, 2017)
"Taurine has been observed to be effective in treatments against diabetic hepatotoxicity, vascular problems and heart injury in diabetes."	( Aadil, RM; Ahmed, Z; Li, K; Piao, F; Shahbaz, M; Suleman, R; Wu, P; Zhang, M, 2018)
"Taurine has been widely researched as a growth-promoting additive or as an antioxidant in aquatic animals because of its multiple functions, however, few studies have explored its effects on crustacean in spite of the occurrence of serious diseases. "	( Cheng, R; Dong, J; Li, L; Li, X; Wu, G; Yang, Y; Zhang, R; Zhao, Y; Zhu, X, 2018)
"Taurine has important physiological roles as well as a wide range of pharmacological effects. "	( Kai, H; Matsuyama, S; Moriuchi, M; Nakano, Y; Nohara, H; Piruzyan, M; Shuto, T; Suico, MA; Tsurekawa, Y, 2018)
"Taurine (TAU) has been shown to have neuroprotective properties, thus we examined anti-apoptotic effect of TAU against retinal damage after NMDA exposure."	( Agarwal, P; Agarwal, R; Bakar, NS; Iezhitsa, I; Ismail, NM; Lambuk, L, 2019)
"Taurine has also been shown to reduce lenticular oxidative stress."	( Abdul Rahman, TH; Agarwal, P; Agarwal, R; Ahmad Fisol, NF; Awaludin, NA; Bakar, NS; Iezhitsa, I; Mohamed Ahmed Salama, MS; Mohd Ismail, N; Ozerov, A; Spasov, A, 2013)
"Taurine has also attracted attention because it has beneficial actions in CHF, in part by its demonstrated inhibition of the harmful actions of the neurohumoral factors."	( Azuma, J; Ito, T; Schaffer, S, 2014)
"Taurine has been found to reduce oxidative stress during exercise and also act as an antihypertensive agent."	( Luckose, F; Pandey, MC; Radhakrishna, K, 2015)
"Taurine deficiency has been suggested to contribute to the pathogenesis and complications of advanced hepatic diseases. "	( Fujitani, S; Hagiwara, A; Ishizaki, S; Satsu, H; Shimizu, M; Sonaka, I; Takehana, K, 2014)
"Taurine (Tau) has been shown to possess cancer therapeutic effect through induction of apoptosis, while the underlying molecular mechanism of its anti-cancer effect is not well understood. "	( Tu, S; Wan, F; Wang, Y; Xu, B; Zhang, X, 2014)
"Taurine has been reported to influence bone metabolism, but the role of taurine on osteogenic differentiation of human mesenchymal stem cells (hMSCs) remains unclear. "	( Cui, L; Wu, T; Xu, D; Xu, L; Zhang, X; Zhou, C, 2014)
"Taurine has little effect on stimulating the proliferation of intestinal crypt cells, except for 5 g/kg of taurine supplementation on d 14 (P < 0.05)."	( Guo, Y; Huang, C; Yuan, J, 2014)
"Taurine has multiple physiological activities and it is decreased by chemotherapy. "	( Asvadi, I; Esfahani, A; Islambulchilar, M; Sanaat, Z; Sattari, M, 2015)
"Taurine has anti-inflammatory and antioxidant characteristics. "	( Akdemir, O; Binboga, E; Cavusoglu, T; Lineaweaver, WC; Pekedis, M; Uyanikgil, Y; Yagci, T; Zhang, F, 2015)
"Taurine has a potent protective effect against ischemic reperfusion injury."	( Cynober, L; De Bandt, JP; Ginguay, A, 2016)
"Taurine has various physiological functions and hepatoprotective properties as well as anti-inflammatory and immunomodulatory activity."	( Huang, J; Ni, XQ; Qi, YF; Yu, YR; Zhu, YH, 2016)
"Taurine has anti-oxidant action, and taurine supplementation may be able to attenuate the increase in oxidative stress after exercise."	( Akazawa, N; Choi, Y; Maeda, S; Ohmori, H; Ra, SG, 2016)
"Taurine (TAU) has been shown to improve exercise time to exhaustion and 3-km running performance; however, no studies have considered the effect of acute TAU ingestion on short duration cycling time trial (TT) performance. "	( Bridge, CA; McNaughton, LR; Sparks, SA; Ward, R, 2016)
"Taurine has been shown to be a potent antioxidant."	( Gao, C; Guan, H; Hu, S; Li, G; Li, S; Piao, F; Qian, Z; Sun, Y; Yang, Y, 2017)
"Taurine has been reported to exert cardioprotective effects via various mechanisms."	( Li, W; Lu, X; Wang, J; Wang, Z; Zhang, Z; Zhao, L; Zhou, Y, 2017)
"Taurine has a number of physiological functions, e.g., in cell volume regulation and inhibitory neuromodulation. "	( Oja, SS; Saransaari, P, 2007)
"Taurine has lately attracted attention due to its suggested strong contribution to the health-promoting effects of seafood."	( Dragnes, BT; Elvevoll, EO; Ernstsen, MH; Larsen, R; Mæhre, H, 2009)
"Taurine has been shown to prevent cardiomyocyte apoptosis. "	( Arnold, JM; Babwah, AV; Li, Y; Pampillo, M; Peng, T, 2009)
"Hypotaurine (HT) has been proposed to reduce sulfide toxicity in some deep-sea invertebrates by scavenging free radicals produced from sulfide oxidation or by scavenging sulfide via the reaction of HT with sulfide, forming thiotaurine (ThT). "	( Julian, D; Ortega, JA; Ortega, JM, 2008)
"Taurine has potent protective function against glutamate-induced neuronal injury presumably through its function in regulation of intracellular free calcium level, [Ca2+]i. "	( Jin, Y; Lee, HH; Lee, YH; Lin, CH; Prentice, H; Sha, D; Wei, J; Wu, H; Wu, JY; Yang, LL, 2009)
"Taurine has several biological processes such as hypoglycemic action, antioxidation, and detoxification."	( Boukarrou, L; El Idrissi, A; L'Amoreaux, W, 2009)
"Taurine has been shown to protect organs from ischemia reperfusion or endotoxin by its anti-oxidant and anti-inflammatory activities."	( Chen, X; Jiang, H; Mao, Y; Qiao, H; Sun, X; Tong, L; Zhang, F; Zhao, H, 2010)
"Taurine has been shown to protect against lung injury induced by various oxidants including ozone, nitrogen dioxide, amiodarone, and paraquat and to protect against bleomycin-induced lung injury in combination with niacin. "	( Gordon, RE; Park, E; Park, SY; Schuller-Levis, G; Wang, C, 2009)
"Taurine has multiple functions in the central nervous system (CNS), serving as an osmoregulator, antioxidant, inhibitory neuromodulator, and regulator of intracellular Ca(2+) flux. "	( Gupta, RC; Hara, M; Nakajima, Y; Osuka, K; Seki, Y; Takayasu, M; Wakabayashi, T, 2010)
"Taurine has been reported to have beneficial effects on endotoxemia."	( He, P; Li, XD; Luo, M; Wan, XY; Wu, MC, 2010)
"Taurine has been documented to have protective effects on neuronal cells against ischemia in vivo and in vitro."	( Gao, X; Yang, X; Zhang, B, 2010)
"Taurine has a variety of biological actions, such as ion movement, calcium handling and cytoprotection in the cardiac and skeletal muscles."	( Azuma, J; Fujio, Y; Ito, T; Kimura, Y; Oishi, S; Schaffer, SW; Takai, M; Uozumi, Y, 2010)
"Taurine has been shown to affect coronary artery disease, blood pressure, plasma cholesterol and myocardial function in animal models of human disease. "	( Zulli, A, 2011)
"Taurine has chemical structure similar to an inhibitory neurotransmitter, γ-aminobutyric acid (GABA). "	( Chang, CC; Ho, JD; Huang, KH; Lu, RH; Tsai, LH, 2011)
"Taurine has positive effects on bone metabolism. "	( Chen, F; Deng, YW; Li, DZ; Li, J; Li, YW; Liu, WD; Lv, GH; Wang, B; Wang, ZG; Yin, BL; Zhang, LY; Zhou, YY, 2011)
"Taurine has been implicated in this process."	( Jin, CJ; Koh, JS; Lee, HJ; Lee, HK; Lee, SS; Lee, YY; Park, KS; Park, SH; Yi, KH, 2011)
"Taurine has an important role in numerous physiological processes, including many aspects of fetal development such as development of the pancreas and brain, and requirements increase during pregnancy. "	( Bloomfield, FH; Derraik, JG; Harding, JE; Jaquiery, AL; Oliver, MH; Thorstensen, EB, 2012)
"Taurine has thus a neuroprotective antiapoptotic action in the external granular layer of the cerebellum, preserving a number of neurons from ethanol-induced apoptosis."	( Oja, SS; Pelto-Huikko, M; Podkletnova, IM; Saransaari, P; Taranukhin, AG; Taranukhina, EY, 2012)
"Taurine has been shown to be elevated in plasma and lymphocytes of depressed patients, but the level normalises after successful drug therapy. "	( Gerdin, G; Ollinger, K; Samuelsson, M; Vrethem, M, 2012)
"Taurine has been shown to have potent anti-oxidant properties under various pathophysiological conditions. "	( Chen, G; Huang, XP; Jean-Charles, P; Li, Y; Nan, C; Tian, J; Weissbach, H, 2012)
"Taurine has been thought to protect neural cells against cell-damaging conditions to which the hippocampus is particularly vulnerable. "	( Oja, SS; Saransaari, P, 2013)
"Taurine has protective effects against xenobiotics-induced liver damages in the PC region, but not xenobiotics-induced PP region damages."	( Matsuzaki, Y; Miyazaki, T, 2014)
"Taurine metabolism has attracted much attention in fish nutrition due to the fact that as plant ingredients replace fishmeal, dietary taurine has declined."	( Espe, M; Holen, E, 2013)
"Taurine has several biological processes such as osmoregulation and antioxidation in retina."	( Kang, YS; Lee, NY, 2013)
"Taurine (TAU) has a lot of the biological, physiological, and pharmocological functions including anti-inflammatory and anti-oxidative stress. "	( Ishikura, K; Ito, M; Maeda, S; Matsuzaki, Y; Miyazaki, T; Nagayama, H; Ohmori, H; Ra, SG; Suzuki, T, 2013)
"Taurine has been shown to provide protection against neurological diseases, such as Huntington's disease, Alzheimer's disease, and stroke."	( Chen, PC; Gharibani, PM; Ma, Z; Menzie, J; Modi, J; Pan, C; Prentice, H; Tao, R; Wu, JY, 2013)
"Taurine has neuroprotective capabilities against glutamate-induced excitotoxicity through several identified mechanisms including opening of the Cl(-)channel associated with GABA(A)and glycine receptors, or a distinct Cl(-)channel. "	( Agovic, MS; Banerjee, SP; Chan, CY; Friedman, E; Ho, I; Shah, SM; Sun, HS, 2013)
"Taurine has been known to protect the cells against ER stress."	( Ji, HI; Kim, KS; Yang, HI, 2013)
"Taurine has been found in the central nervous system of rodents and humans, and among its potential therapeutic uses, it is interesting to remark its analgesic actions."	( Goicoechea, C; Martín, MI; Sánchez, E; Serrano, JS; Serrano, MI; Serrano-Martino, MC, 2002)
"Taurine has an ameliorating effect on atherosclerosis together with a decreasing effect on the cholesterol and triglyceride levels in rabbits fed on an HC diet."	( Aykaç-Toker, G; Balkan, J; Cevikbaş, U; Hatipoğlu, A; Kanbağli, O; Kücük, M; Uysal, M, 2002)
"Oral taurine treatment has been studied extensively as a hypotensive agent. "	( Lombardini, JB; Militante, JD, 2002)
"Taurine has been known to be related to certain modifications of the immune system."	( Baccichet, E; Carreira, I; Lima, L; Obregón, F; Peña, S; Urbina, M, 2003)
"Taurine has neuroinhibitory properties and may also have potential for neuroprotection in cerebral ischemia."	( Shuaib, A, 2003)
"Taurine has its own capacity to prevent the suppression of membrane-bound Na(+)/K(+)ATPase activity and prevent Ca(2+) overload."	( Anuradha, CV; Nandhini, TA, 2003)
"Taurine has been shown to be tissue-protective in many models of oxidant-induced injury."	( Park, E; Schuller-Levis, GB, 2003)
"Taurine has multiple biological and metabolic functions: this particular B-amino acid is an antioxidant, it conjugates biliary acids, detoxifies some xenobiotics and modulates intracellular calcium levels. "	( Bidri, M; Choay, P, 2003)
"Taurine has been shown to be an effective scavenger of hypochlorous acid (HOCl). "	( Li, JX; Li, ZQ; Pang, YZ; Tang, CS, 2004)
"Taurine has been shown to be tissue-protective in many models of oxidant-induced injury."	( Park, E; Schuller-Levis, GB, 2004)
"Taurine has been proposed as an inhibitory transmitter in the substantia nigra (SN), but the mechanisms involved in its release and uptake remain practically unexplored. "	( Alonso, TJ; Castro Fuentes, R; García Dopico, J; González Hernández, T; Perdomo Díaz, J; Rodríguez Díaz, M, 2004)
"Taurine has beneficial effects on lipid metabolism in experimental animals fed with high-cholesterol or high fat diets. "	( Bi, LF; Da, GL; Fang, JH; Kagamimori, S; Kuwamori, T; Su, XL; Zhang, M, 2004)
"Taurine chloramine has less impact than HOCL on MMP activation, and does not impair the activity of TIMP-1."	( McCarty, MF, 2004)
"Taurine has anti-atherosclerotic activity in animal models, possibly reflecting a role for macrophage-derived myeloperoxidase in the atherogenic process."	( McCarty, MF, 2004)
"Taurine has been found to inhibit ATP-sensitive K+ (KATP) channels in rat pancreatic beta-cells [Park et al., Biochem Pharmacol 2004;67:1089-1096] which could be due to its interaction with a benzamido-binding site on SUR1. "	( Bae, JH; Cho, CH; Han, J; Jang, BC; Kim, SP; Kim, SS; Lee, HY; Lim, JG; Park, JW; Park, MJ; Song, DK; Suh, SI; Yun, JE, 2004)
"Taurine has several biological processes such as hypoglycemic action, antioxidation, detoxification, etc. "	( Duyar, I; Kaplan, B; Karabay, G; Ozer, C; Sayan, H; Zağyapan, RD, 2004)
"Taurine or betaine have been reported to have antioxidative potential and inhibit Kupffer cell activation. "	( Aykaç-Toker, G; Balkan, J; Doğru-Abbasoğlu, S; Parldar, FH; Uysal, M, 2005)
"Taurine has been reported to enhance cholesterol 7alpha-hydroxylase (CYP7A1) mRNA expression in animal models. "	( Chen, W; Goda, T; Lam, NV; Nishimura, N; Suruga, K; Yokogoshi, H, 2006)
"Taurine has been proposed to play a role in calcium modulation. "	( Gao, WY; Liu, HY; Wen, W; Zhang, YM, 2006)
"Taurine has been thought to function as a regulator of neuronal activity, neuromodulator and osmoregulator. "	( Oja, SS; Saransaari, P, 2006)
"Taurine has been thought to be essential for the development and survival of neural cells and to protect them under cell-damaging conditions. "	( Oja, SS; Saransaari, P, 2007)
"Taurine has demonstrated promising actions in vitro, and as a result clinical trials have begun to investigate its effects on various diseases."	( Bouckenooghe, T; Remacle, C; Reusens, B, 2006)
"Taurine may have been released by the tissues as a protective mechanism against hypoxia-induced inflammation, or in an attempt to maintain osmotic balance."	( de Boo, HA; Harding, JE, 2007)
"Taurine has been shown to be tissue protective in many models of oxidant-induced injury. "	( Chen, K; Liu, J; Mi, M; Wei, N; Yu, X; Zhang, Q, 2007)
"Taurine has a variety of actions in the body such as cardiotonic, host-defensive, radioprotective and glucose-regulatory effects. "	( Kim, SJ; Zhang, CG, 2007)
"Taurine has an antioxidant capacity and its level in diabetic cataractous lens is markedly decreased."	( H Kwon, Y; Kim, H; Son, HY, 2007)
"Taurine has been reported to influence bone metabolism, and its specific transport system, the taurine transporter, is expressed in osteoblasts. "	( Hong, CU; Jeon, SH; Joe, SG; Kang, HS; Kim, GB; Kim, IS; Kim, JS; Kim, NS; Kim, SJ; Kim, SZ; Lee, MY, 2007)
"Taurine has been shown to protect liver grafts from ischemia/reperfusion injury after Tx."	( Büchler, MW; Dei-Anane, G; Gross, ML; Guan, X; Kern, M; Liang, R; Ludwig, J; Nickkholgh, A; Schemmer, P; Schmidt, J; Zeier, M, 2008)
"Taurine in diabetes has an age old story; taurine is involved in the development and protection of insulin apparatus."	( Gupta, RC; Kim, SJ; Lee, HW, 2007)
"Taurine in diabetes has an age old story; taurine is involved in the development and protection of insulin apparatus."	( Gupta, H; Kim, SJ; Lee, W; Ramesh, C, 2007)
"Taurine has been suggested to modulate nociceptive information at the spinal cord level. "	( Baba, H; Georgiev, SK; Ikoma, M; Ishii, H; Kohno, T; Petrenko, AB; Wu, J, 2008)
"Taurine also has little inhibitory effect (IC50 above 500 microM) on the binding of [3H]ethyl-beta-carboline-3-carboxylate."	( De Robertis, E; Medina, JH, 1984)
"Taurine has been reported to be a component of the capsular polysaccharide of the encapsulated M strain of Staphylococcus aureus. "	( Smiley, DW; Wilkinson, BJ, 1983)
"The taurine prepared has been identified by paper and thin-layer chromatography with a taurine pure sample."	( De Simone, F; Morrica, P; Ramundo, E, 1983)
"Taurine efflux has a Q(10) of 1.8.10."	( Horn, LW, 1981)
"Taurine and niacin have been previously found to block the accumulation of collagen in lung in the multidose bleomycin hamster model of pulmonary fibrosis. "	( Blaisdell, RJ; Giri, SN; Schiedt, MJ, 1994)
"Hypotaurine has a protective role against peroxidative damage."	( Guérin, P; Guillaud, J; Ménézo, Y, 1995)
"Hypotaurine has protective effects against peroxidative damage."	( Guérin, P; Ménézo, Y, 1995)
"Taurine has been assumed to function as an osmoregulator and neuromodulator in the brain. "	( Oja, SS; Saransaari, P, 1996)
"Taurine appears to have been virtually eliminated from Purkinje and granule cells, and concentrated in Golgi II cells and glia."	( Lu, P; Sturman, JA; Xu, W, 1996)
"Taurine has been postulated to function as a neurotransmitter or neuromodulator. "	( Itoh, T; Kamisaki, Y; Nakamoto, K; Wada, K, 1996)
"Taurine has been shown to act as an osmolyte during the regulatory volume decrease process in a variety of cell types. "	( Conejero, C, 1997)
"Taurine has been shown to be essential for neuronal development and survival in the central nervous system. "	( Oja, SS; Saransaari, P, 1997)
"1. Taurine has recently been known to protect against ischemia and heart failure. "	( Satoh, H; Sperelakis, N, 1998)
"Taurine has the ability to resist the action of oxygen-free radicals by protecting cytomembranes. "	( Cui, X; Hu, W; Song, L; Wang, D, 1998)
"Taurine has been shown to be essential in certain aspects of mammalian development, and in vitro studies in various species have demonstrated that low levels of taurine are associated with various pathological lesions, including cardiomyopathy, retinal degeneration, and growth retardation, especially if deficiency occurs during development."	( Birdsall, TC, 1998)
"Taurine has been proposed to have radical scavenging properties under certain experimental conditions."	( Isselhard, W; Minor, T; Niessen, F, 1998)
"Taurine has an important role in fat absorption in pre-term and possibly term infants and in children with cystic fibrosis."	( Budreau, AM; Chesney, RW; Christensen, M; Han, X; Helms, RA; Sturman, JA, 1998)
"Taurine has been proposed to have antiexcitotoxic and antihypoxic activity. "	( Cheng, JS; Huang, YL; Zhao, P, 1999)
"Taurine has previously been reported to decline in tissues during aging which could exacerbate an age-related increase in oxidative stress."	( Dawson, R; Eppler, B, 1999)
"Taurine has also been reported to activate aldehyde dehydrogenase and to inhibit the elevation of plasma acetaldehyde concentration after ethanol intake."	( Harada, H; Hayashi, T; Iwata, S; Kitazaki, K; Morimoto, K; Nonaka, H; Takeshita, T; Tsujino, T; Watari, Y; Yokoyama, M, 2000)
"Taurine has been shown to decrease this injury in vitro."	( Abdih, H; Barry, M; Bouchier-Hayes, D; Kearns, S; Kelly, CJ, 2000)
"Taurine has been implicated in the regulation of arginine vasopressin (AVP) secretion, and we have previously shown altered renal excretory function in the taurine-depleted rat. "	( Mozaffari, MS; Schaffer, D, 2001)
"Taurine has little effect on the binding of [(3)H]glutamate to the agonist binding site and of [(3)H]MDL 105,519 to the glycine binding site of the N-methyl-D-aspartic acid receptors, suggesting that taurine inhibits (45)Ca(2+) influx through other mechanisms, including its inhibitory effect on the reverse mode of the Na(+)/Ca(2+) exchangers (Wu et al."	( Carr, J; Chen, WQ; Faiman, MD; Hsu, CC; Jin, H; Lee, YJ; Nguyen, M; Schloss, JV; Wu, JY, 2001)
"Taurine has been suggested to have cytoprotective actions via a number of different mechanisms. "	( Dawson, R; Messina, SA, 2000)
"Taurine has been shown to be an effective scavenger of hypochlorous acid (HOCl). "	( Dawson, R; Kearns, S, 2000)
"Taurine has an inhibitory role on H(2)O(2)-induced bovine lens epithelial cell apoptosis and can delay and ameliorate the occurrence and development of cataract."	( Chen, C; Chen, F, 2000)
"Thus taurine, which has an anticonvulsant action appears to partially correct the amino acid imbalance in epileptics."	( Delsedime, M; Durelli, L; Monaco, F; Mutani, R, 1975)
"Taurine has been identified as a nonperturbing osmolyte in the renal medulla and Madin-Darby canine kidney (MDCK) cells."	( Handler, JS; Kwon, HM; Marumo, F; Preston, AS; Uchida, S; Yamauchi, A, 1992)
"Taurine has been proposed as an inhibitory neurotransmitter or neuromodulator in the vertebrate central nervous system. "	( Beitz, AJ; Lee, IS; Renno, WM, 1992)
"Taurine has been suggested to possess antioxidant and antiinflammatory properties, and we suggest that this uptake system may contribute to the defence of pulmonary tissue against oxidative stress."	( Cohen, GM; Lewis, CP; Smith, LL, 1990)
"Taurine deficiency has been implicated as a potential cause of dilated cardiomyopathy. "	( Gilmour, RF; Kallfelz, FA; King, JM; Moise, NS; Pacioretty, LM; Stipanuk, MH, 1991)
"Taurine has been shown to serve both as an osmoregulator and as an antioxidant."	( Cook, WR; Lowitt, S; Malone, JI, 1990)
"Taurine has been implicated as a possible cytosolic modulator of monovalent ion distribution, cytosolic "free" calcium activity, and neuronal excitability."	( Hastings, DF; Rohani, F; Welty, JD, 1985)
"Taurine has no effect on retinal ATPase activities or on phosphatase activity, thus suggesting that it directly affects a kinase system."	( Lombardini, JB, 1985)
"Taurine has recently been added to infant formulas (about 50 mg/L)."	( Chesney, RW, 1985)

Actions

Excerpt	Reference
"Taurine plays a role in several essential biological processes, including anti-oxidation, anti-inflammation, and osmoregulation."	( Fukumura, M; Satsu, H; Watari, K, 2022)
"Taurine plays an important role in neural growth and function from early to adult life, particularly in learning and memory via BDNF action. "	( Roysommuti, S; Wyss, JM, 2022)
"Taurine plays a considerable role in bone growth and development, and high-profile reports have demonstrated the importance of its metabolism for bone health."	( Gómez-Chávez, F; Gupta, RC; Pastrana-Carballo, JJ; Pérez-Hernández, E; Pérez-Hernández, N, 2022)
"Taurine plays a role in the maintenance of skeletal muscle functions and is associated with exercise capacity."	( Ma, Y; Maruta, H; Sun, B; Yamashita, H, 2023)
"Taurine plays an important role in the modulation of cardiovascular function by acting not only within the brain but also within peripheral tissues. "	( El Idrissi, A; Sidime, F, 2019)
"Taurine reportedly promotes the secretion of female reproductive hormones by stimulating hypothalamus-pituitary-gonadal axis function."	( Che, Y; Feng, Y; Hu, J; Lv, Q; Mu, T; Yang, J; Yang, Q, 2019)
"Taurine can suppress the creation of lipid hydroperoxide and decrease the level of total cholesterol and triglyceride in the blood. "	( Choi, MJ; Jun, H, 2019)
"Taurine displays anti-tumor activity in some kinds of human cancers. "	( He, F; Hiraku, Y; Ma, N; Midorikawa, K; Mo, Y; Murata, M; Oikawa, S; Takeuchi, K; Zhang, Z, 2019)
"Taurine plays an important role in improving immunity, regulating cell proliferation and differentiation, apoptosis and so on. "	( Han, L; Ji, M; Jing, L; Li, G; Li, L; Wu, X; Yang, J; Zhang, C, 2019)
"Taurine plays an important role in modulating glutamate and GABA neurotransmission and prevents excitotoxicity in vitro primarily through modulation of intracellular calcium homeostasis."	( El Idrissi, A, 2019)
"Taurine could inhibit hippocampus neuron apoptosis via NGF-Akt/Bad pathway."	( Che, X; Chen, X; Li, K; Li, Q; Li, S; Li, Y; Liu, X; Liu, Y; Luo, M; Ma, J; Piao, F; Shi, X; Wu, P; Zhang, C; Zhang, M, 2020)
"Taurine (TAU) plays important roles in the metabolism of bile acids, cholesterol and lipids. "	( Chi, S; Jia, L; Kim, SK; Liang, M; Liao, Z; Sun, B; Wei, Y; Xu, H; Zhang, Q, 2020)
"Taurine plays a pivotal role in regulating glucose and lipid metabolism, blood pressure homeostasis, and obesity largely due to its cytoprotective, antioxidant, and anti-inflammatory actions. "	( Guan, L; Miao, P, 2020)
"Taurine plays role in neural development and physiological functions such as endocrine regulation in the central nervous system (CNS), and it is one of the most abundant free amino acid there. "	( Jiang, P; Lan, Z; Li, K; Liu, C; Lu, W; Zhang, W, 2020)
"Taurine promotes for the balance of energy metabolism and the repair of inflammatory injury, preventing chronic diseases and complications."	( Chen, C; Lan, C; Lan, L; Li, X; Lu, C; Meng, L; Mo, L; Tang, S; Wang, Q; Wang, X; Wu, B; Zeng, X; Zhang, N, 2021)
"Taurine was found to inhibit the decrease of sucrose consumption and prevent the deficiency of spatial memory and anxiety in rats exposed to CUMS, suggesting a preventive effect of taurine on depression-like behavior."	( Feng, Y; Hu, JM; Lin, SM; Ren, S; Tang, RY; Wu, GF; Xu, C; Yang, JC; Yang, QH; Zhou, JQ, 2017)
"The taurine-induced increase ranged from 57 to 188% in the 3 brains examined."	( Hernández-Benítez, R; Lyman, WD; Pasantes-Morales, H; Ramos-Mandujano, G; Vangipuram, SD, 2013)
"Taurine plays an important role in brain and retinal development, and has an antiinflammatory and antioxidant function. "	( Cho, IS; Kascsak, RJ; Kim, BS; Park, E; Park, SY; Schuller-Levis, G; Spinner, DS, 2013)
"Taurine plays an important role as an antioxidant and is consequently expected to protect tissues from damage caused by reactive oxygen metabolites.The animals were randomized into four groups (n=6/group)."	( Abdel-Moneim, AM; Al Kahtani, MA; El-Sayed, WM, 2014)
"Taurine plays an important role in maintaining myocardial function. "	( Biourge, V; Fox, PR; Servet, E; Vollmar, AC, 2013)
"Taurine plays an important role in brain development, including neuronal proliferation, stem cell proliferation, and differentiation, via several mechanisms. "	( Gao, HY; Li, XW; Liu, J, 2017)
"Taurine could enhance CYP7A1 expression by inducing HNF4α and inhibiting MEK1/2 and p-c-Jun expressions to promote intracellular cholesterol metabolism."	( Cao, X; Chen, W; Gao, Y; Guo, J; Zhang, J, 2017)
"Taurine plays a protective role against free radicals and toxins in various cells and tissues. "	( Bouscarel, B; Honda, A; Ikegami, T; Matsuzaki, Y; Miyazaki, T, 2009)
"Taurine plays various important roles in a large number of physiological and pathological conditions in human body, such as the cytoprotective functions, antioxidant, anti-inflammatory and anti-apoptosis effects. "	( Diao, Y; Lv, D; Tian, X; Wang, S; Zhang, Z; Zhao, Z, 2009)
"Taurine can increase mRNA expression of PKA, CREB and GDNF in fetal rat brains of IUGR. "	( Chen, H; Li, J; Liu, J; Liu, L; Liu, N; Song, YZ, 2009)
"Taurine plays an important role in reducing physiological stress. "	( Do, CH; Kim, HM; Lee, DH, 2010)
"Taurine could lower blood glucose, TG, TC, BUN, Scr, NAG, U-PRO, the expression of laminin B1(LBN1) mRNA, and increase HDL-C of diabetic rats."	( Hu, J; Lin, S; Liu, M; Luan, X; Lv, Q; Wu, G; Yang, J; Zhao, H, 2010)
"Taurine could enhance the ability of oxidation resistance, improve blood rheology property in diabetic rats, at the same time it could be beneficial to prevent and cure the development of diabetic blood vessel complication."	( Dong, SY; Kong, XY; Men, XL; Zhang, FF; Zhang, YM; Zhao, LJ, 2010)
"Taurine plays multiple roles in the CNS including acting as a -neuro-modulator, an osmoregulator, a regulator of cytoplasmic calcium levels, a trophic factor in development, and a neuroprotectant. "	( Kumari, N; Prentice, H; Wu, JY, 2013)
"Taurine plays significant physiological roles, including those involved in neurotransmission. "	( Cuttitta, CM; Guariglia, SR; Idrissi, AE; L'amoreaux, WJ, 2013)
"Taurine plays an important role in the modulation of cardiovascular function by acting not only within the brain but also within peripheral tissues. "	( El Idrissi, A; Neuwirth, LS; Okeke, E; Sidime, F; Yan, X, 2013)
"Oral taurine appears to increase the effectiveness of oral iron in the treatment of IDA, and has no significant side-effects."	( Abu Shahla, AN; El-Agouza, IM; Sirdah, MM, 2002)
"Taurine did not increase intracellular uptake of RFP."	( Azuma, J; Fukuda, T; Fukuen, S; Kinoshita, K; Matsuda, H; Sumida, A; Takahashi, K; Yamamoto, I, 2002)
"Taurine plays an important role in a variety of physiological functions, pharmacological actions and pathological conditions. "	( Ding, X; Liu, Y; Mou, S, 2002)
"Taurine may inhibit neurotransmitter release and may result in normal intracellular osmolality."	( Shuaib, A, 2003)
"Taurine did not inhibit Kir6.2DeltaC36 currents, a truncated form of Kir6.2, expressed in Xenopus oocytes without SUR."	( Ashcroft, FM; Bae, JH; Baek, WK; Kim, SY; Kwon, TK; Lee, IK; Lim, JG; Park, EJ; Park, JW; Song, DK; Suh, SI, 2004)
"Taurine plays a role in neuronal development. "	( Diana, G; Fortuna, A; Franconi, F; Galietta, G; Loizzo, A; Seghieri, G; Trombetta, G; Valentini, G, 2004)
"Taurine did not cause any increase in enzyme activity."	( Aykac-Toker, G; Giris, M; Kocak-Toker, N; Tülübas, F; Uysal, M, 2005)
"Taurine was 38% lower in bodybuilders, though the difference was not significant."	( Boobis, LH; Fallowfield, JL; Harris, RC; Tallon, MJ; Wise, JA, 2005)
"Taurine caused an increase in [Mg(2+)]i by 0.72+/-0.04 mM in human osteoblast (HOB) cells."	( Hong, CU; Jeon, SH; Joe, SG; Kang, HS; Kim, GB; Kim, IS; Kim, JS; Kim, NS; Kim, SJ; Kim, SZ; Lee, MY, 2007)
"Taurine plays a role in neurologic development and neuromuscular function. "	( Atallah, JB; Barada, KA; Nassar, CF, 1997)
"Taurine was found to cause an increase in the affinity of the ATP substrate for the ATPase enzyme, contradicting the aforementioned effect of taurine to decrease the potency of ATP to induce calcium uptake."	( Lombardini, JB; Militante, JD, 1998)
"Taurine is known to increase ATP-dependent calcium ion (Ca2+) uptake in retinal membrane preparations and in isolated rod outer segments (ROS) under low calcium conditions (10 microM) (Pasantes-Morales and Ordóñez, 1982; Lombardini, 1991). "	( Lombardini, JB; Militante, JD, 1998)
"Taurine can inhibit the hypoxia-induced expression of ET-1 mRNA of PAEC and reduce the release of ET-1, AT-II and EDF from PAEC."	( Li, J; Sun, B; Yu, Z, 1997)
"Taurine inhibited the increase of Ca2+ inflow through L-type VDCC and normalized the decreased Vp induced by CVB3 infection. "	( Gu, QB; Guo, Q; Liu, GX; Liu, YH; Yang, YZ, 1998)
"Taurine may enhance the hepatic drug-metabolizing systems, leading to the stimulation of the ascorbic acid metabolism in rats fed diets containing PCB."	( Mochizuki, H; Oda, H; Yokogoshi, H, 2000)
"Taurine is known to lower blood pressure in essential hypertension and some experimental hypertensive models. "	( Harada, H; Hayashi, T; Iwata, S; Kitazaki, K; Morimoto, K; Nonaka, H; Takeshita, T; Tsujino, T; Watari, Y; Yokoyama, M, 2000)
"Taurine is known to inhibit the phosphorylation of PDH in vitro, and in taurine-depleted rats PDH phosphorylation is known to increase."	( Lombardini, JB; Militante, JD; Schaffer, SW, 2000)
"Milk taurine plays a critical role in neonatal development. "	( Bryson, JM; Hurley, WL; Jackson, SC; Wang, H, 2001)
"Hypotaurine could inhibit peroxynitrite formation from both SIN-1 (decrease 75%) and SNP (decrease 50%) at 10 mM."	( Dawson, R; Mehta, TR, 2001)
"Taurine may increase the size of depolarisation-induced force responses by augmenting SR Ca(2+) accumulation and release."	( Bakker, AJ; Berg, HM, 2002)
"Both taurine and GABA produce an increased conductance of pre- and postsynaptic membranes through changes in the permeability of chloride ions."	( Chanelet, J; Hue, B; Pelhate, M, 1979)
"Taurine was noted to increase from 1.1 mM in preterm infants to 2.3 mM in term infants and did not decrease significantly in adult brain."	( Bossi, E; Burri, R; Herschkowitz, N; Hüppi, PS; Lazeyras, F; Posse, S, 1991)
"This taurine increase was highly reversible."	( Ambrosio, E; Herranz, AS; Herreras, O; Martin del Rio, R; Menéndez, N; Orensanz, LM; Solis, JM, 1990)
"The taurine increase evoked by low Na+ is not caused by cellular swelling as it was unaffected by hyperosmolar medium."	( Lehmann, A; Sandberg, M, 1990)
"The taurine intake would increase serum low density lipoprotein cholesterol and biliary cholesterol levels when excessive cholesterol is administered simultaneously."	( Fujii, Y; Hori, S; Koizumi, M; Kotake, H; Namai, K; Oikawa, S; Sakuma, E; Suzuki, N; Tanno, N; Toyota, T, 1989)
"Taurine was found to inhibit beta-alanine uptake into neurons and astrocytes in a competitive manner, with Ki values of 217 microM in neurons and 24 microM in astrocytes."	( Allen, IC; Griffiths, R; Larsson, OM; Schousboe, A, 1986)
"Taurine was able to inhibit spiperone binding to striatal membranes in a uncompetitive manner and thus interfere with the function of dopaminergic receptors."	( Kontro, P, 1987)
"Taurine plays an important role in cell volume regulation in both vertebrates and invertebrates. "	( Fincham, DA; Wolowyk, MW; Young, JD, 1987)
"Taurine plays an important metabolical role and has a specific transport system during fetal life."	( Moriyama, IS, 1986)

Treatment

Excerpt	Reference
"In taurine-treated rats, superoxide dismutase activity was significantly (p < 0.05) higher than in AD rats."	( Abdulkadir, TS; Ayo, JO; Dawud, FA; Isa, AS, 2021)
"The taurine pretreatment group contained significantly reduced W/D, MPO activity, and the number of inflammatory cells in BALF induced by LPS."	( Bian, Y; Dai, J; Feng, Y; Fu, Y; Fu, Z; Hu, J; Li, C; Lin, S; Ma, Y; Wang, J; Wu, Y; Zhang, X; Zhao, D, 2022)
"Taurine treatment significantly restored the HOT to WT levels of anxiety-like behavior in the elevated plus maze."	( Chadman, KK; Elidrissi, A; Park, E; Schuller-Levis, G, 2019)
"Taurine treatment led to dose-dependent increases in SOD3 at both protein and mRNA levels in HMC-1 cells."	( Feng, Y; Li, F; Lu, Y; Wu, W; Xie, D; Zhou, J, 2020)
"Taurine (0.24 mM) treatment largely rescued the cell number decreased by gossypol, attenuated gossypol-induced cell apoptosis."	( Gao, X; Li, M; Li, P; Wang, Y; Yu, M, 2020)
"All taurine pretreatments prevented MK-801-induced increase in shoal area, while 400 mg/L taurine prevented the MK-801-induced alterations in neuroendocrine responses."	( Canzian, J; Franscescon, F; Michelotti, P; Müller, TE; Rosemberg, DB; Souza, TP; Stefanello, FV, 2021)
"Taurine treatment alleviated hepatocyte damage and oxidative stress."	( Chen, R; Chen, S; Peng, Z; Wan, J; Wu, B; Zhu, W, 2017)
"Taurine pretreatment significantly attenuated renal dysfunction and histologic damage, such as renal tubule dilation and loss of brush borders."	( Akdogan, G; Arslan, S; Camsari, T; Cavdar, Z; Celik, A; Ergur, UB; Guneli, E; Ozbal, S; Terzioglu, G; Ural, C; Yildiz, S, 2017)
"Taurine pretreatment also reduced the elevated expression levels of LPS‑induced cyclooxygenase‑2, nuclear factor κB and extracellular regulated protein kinase."	( Li, F; Liu, Y; Wang, Y; Wu, J; Yu, H; Zhang, L, 2017)
"Taurine treatment normalized the expression levels of γ-glutamyl ligase C/M, GS, OPLAH, and glyoxalase-1, and reversed HCU-induced deficits in protein glutathionylation by acting to double GSH levels relative to controls."	( Aivazidis, S; Allen, RH; Harris, PS; Jiang, H; Kim, E; Maclean, KN; Petersen, DR; Roede, JR; Shearn, CT; Stabler, SP, 2018)
"Taurine treatment performed well against oxidative stress in brain, increased the secretion of required hormones and protected against neuropathy, retinopathy and nephropathy in diabetes compared with the control."	( Aadil, RM; Ahmed, Z; Li, K; Piao, F; Shahbaz, M; Suleman, R; Wu, P; Zhang, M, 2018)
"Taurine treatment of mdx mice only altered ncRNA levels when administered from 18 days to 6 weeks of age, but a deficiency in tRNA levels was rectified earlier in mdx skeletal muscles treated from 14 days to 3 weeks."	( Butchart, LC; Filipovska, A; Grounds, MD; Rossetti, G; Terrill, JR; White, R, 2018)
"taurine. Treatments were administered 20 min post-injury and daily for 7 days."	( Brooks, WM; Christian, S; Gupte, R; Habiger, J; Harris, JL; Keselman, P, 2019)
"Taurine treatment reverted all the above changes induced by DMBA and inhibited the development of rat breast carcinoma through its ability to induce apoptosis."	( Anandakumar, P; Sakthisekaran, D; Vanitha, MK, 2018)
"Taurine treatment led to increased milk protein and fat synthesis, mTOR phosphorylation, and SREBP-1c protein expression, in a dose-dependent manner, with an apparent maximum at 0.24 mM."	( Gao, X; Liu, Y; Wang, Y; Wang, Z; Yu, M; Yu, Y, 2019)
"Taurine treatment significantly improved LV systolic and diastolic function, and there were persistent increases in activities of Akt/PKB and SOD, and the level of HO-1 protein."	( Li, W; Lu, XH; Wang, GG; Xu, L; Zhao, X, 2013)
"Taurine treatment ameliorates myocardial function and heart oxidant status, while increasing myocardial Akt/PKB phosphorylation, and HO-1 levels have beneficial effects on diabetic cardiomyopathy."	( Li, W; Lu, XH; Wang, GG; Xu, L; Zhao, X, 2013)
"Taurine treatment improves NO-mediated relaxations of corpus cavernosum in diabetic rats probably by inhibiting NADPH oxidase/Rho kinase pathways."	( Bayram, Z; Celik-Ozenci, C; Dalaklioglu, S; Kuscu, N; Nacitarhan, C; Ozdem, SS, 2014)
"Taurine post-treatment at i.p."	( Abdel-Moneim, AM, 2013)
"Taurine treatment elevated NOx levels significantly (p<0.01) in taurine and LPS + taurine group compared to control group, while it reduced NOx levels compared to LPS group."	( Agilli, M; Ark, M; Pasaoglu, OT; Polat, B; Turkozkan, N; Yaman, H, 2014)
"Taurine treatment rescued cognitive deficits in APP/PS1 mice up to the age-matching wild-type mice in Y-maze and passive avoidance tests without modifying the behaviours of cognitively normal mice."	( Cho, SM; Cho, Y; Kang, BR; Kim, HV; Kim, HY; Kim, JW; Kim, JY; Kim, Y; Lee, S; Woo, J; Yoon, JH, 2014)
"Hypotaurine treatment of TR-TBT 18d-1 cells increased antioxidant capacity against hydroxyl radical and peroxyl radical."	( Duereh, M; Higuchi, K; Nakashima, E; Nishimura, T; Sugita, Y; Tomi, M; Yoshida, Y, 2015)
"Taurine treatment produced a concentration-dependent reduction in rotenone-induced cell death."	( Albers, DS; Alkholifi, FK, 2015)
"Taurine treatment also reduced protein thiol oxidation and was overall more effective, as OTC treatment reduced body and muscle weight, suggesting some adverse effects of this drug."	( Arthur, PG; Graves, JA; Grounds, MD; Pinniger, GJ; Terrill, JR, 2016)
"Taurine treatment limited mitochondrial superoxide generation, supporting a role for taurine in maintaining complex I activity."	( Alexeyev, M; Jong, CJ; Mehdi, AB; Schaffer, SW; Shetewy, A; Shimada-Takaura, K; Takahashi, K; Warner, D, 2016)
"Taurine treatment (100 mg/kg body weight) appreciably counteracted all the above changes induced by DMBA."	( Anandakumar, P; Baskaran, K; Ilakkia, A; Periyasamy, K; Revathi Mani, B; Sakthisekaran, D; Saravanan, D; Selvaraj, S; Vanitha, MK; Venkateswari, R, 2016)
"Taurine pre-treatment dampened upregulation to some extent."	( Liu, M; Lu, J; Miao, J; Xu, Y; Yin, Y; Zheng, L, 2016)
"Taurine treatment markedly reduced laminectomy-induced epidural fibrosis in rat models. "	( Cao, X; Chen, H; Ge, D; Ge, Y; Que, J; Sui, T; Tang, J; Yang, L, 2016)
"Taurine pretreatment dose-dependently inhibited isoflurane-induced increase in expression of ER stress biomarkers except for P-EIF2α and ATF-4, and reversed isoflurane-induced changes in apoptosis-related proteins."	( Hou, D; Hou, J; Li, D; Li, H; Zhang, Y, 2016)
"Taurine treatment (250, 500, and 1000mg/kg) decreased mitochondrial swelling, ROS, and LPO."	( Abasvali, M; Abdoli, N; Asadi, B; Azarpira, N; Heidari, R; Jafari, F; Jamshidzadeh, A; Khodaei, F; Latifpour, Z; Mardani, E; Najibi, A; Ommati, MM; Yeganeh, Y; Zarei, A; Zarei, M, 2017)
"Taurine treatment reduced fibrosis scores significantly as compared to placebo. "	( Comert, B; Mas, MR; Mas, N; Tasci, I; Tuncer, M, 2008)
"Taurine treatment prevented SNP-mediated cellular apoptosis in a concentration dependent manner."	( Kim, HW; Kim, SY; Park, T, 2009)
"Taurine treatment of RGC-5 cells suppressed the induction of the mitochondrial permeability transition (mPT) by reducing intracellular calcium levels and inhibiting the opening of mitochondrial permeability transition pores (mPTPs)."	( Chen, F; Chen, K; Liu, F; Mi, M; Wang, J; Xu, H; Zeng, K; Zhang, Q, 2009)
"Taurine treatment alleviated the oxidative injury of the kidney, improved SOD and GSH-Px activities, as well as the mitochondrial membrane injury, with lesser crystal depositions in the kidney."	( Deng, YL; Li, CY; Sun, BH, 2009)
"Taurine treatment suppressed these apoptotic actions, suggesting that its protective role in arsenic-induced cardiomyocyte apoptosis is mediated by attenuation of p38 and JNK MAPK signaling pathways."	( Das, J; Ghosh, J; Manna, P; Sil, PC, 2009)
"Taurine treatment alters the presence of calbindin-D28k, calretinin, and parvalbumin in the brain, mainly in the hippocampus."	( Auladell, C; Camins, A; de Lemos, L; Junyent, F; Pallàs, M; Romero, R; Utrera, J, 2010)
"Taurine treatment both pre and post (150 mg/kg body weight for 3 days, orally) to APAP exposure, however, significantly reduced APAP-induced nephrotoxicity through its antioxidant properties, urinary excretion of APAP and suppression of CYP2E1."	( Das, J; Ghosh, J; Manna, P; Sil, PC, 2010)
"Taurine pretreatment reduced UCB-mediated apoptotic cell death in primary cultured neurons in a concentration-dependent manner, which was associated with reversal of the increased intracellular free calcium ion levels caused by UCB."	( Gao, X; Yang, X; Zhang, B, 2010)
"Taurine treatment was effective in counteracting APAP-induced hepatic damages, oxidative stress and cellular necrosis."	( Das, J; Ghosh, J; Manna, P; Sil, PC, 2010)
"Taurine treatment increased the catalase, SOD and GSH-px activity in a dose-dependent manner."	( Chen, K; Mantian, M; Xu, H; Zeng, K; Zhang, Q; Zhou, Y; Zhu, J, 2010)
"Taurine-treated slices exposed to H2O2 showed no change in IOS; however, taurine efflux increased by 335+/-178%."	( Olson, JE; Tucker, B, 2010)
"For taurine treatment, mice were either fed taurine in drinking water (0.05%) or injected (43 mg/kg) 15 min prior to picrotoxin injection."	( El Idrissi, A; L'Amoreaux, WJ; Marsillo, A, 2010)
"Taurine treatment resulted in a significant increase in the number and size of islets. "	( El Idrissi, A; L'Amoreaux, W; Sidime, F; Yan, X, 2010)
"Taurine treatments also prevented the alterations promoted in superoxide dismutase and catalase activities by EtOH, suggesting a modulatory role in enzymatic antioxidant defenses."	( Bogo, MR; Bonan, CD; da Rocha, RF; Dias, RD; Klamt, F; Moreira, JC; Rico, EP; Rosemberg, DB; Souza, DO; Zanotto-Filho, A, 2010)
"Taurine and treatment groups were given a 200 mg/kg/day dose of Taurine by oral gavage besides rat feed."	( Arslan, S; Cingoz, F; Demirkilic, U; Doganci, S; Gamsizkan, M; Guler, A; Jahollari, A; Sahin, MA; Yaman, H; Yucel, O, 2011)
"Taurine treatment reduced the BSO-induced increase in LOX-1 expression at both the protein and mRNA levels (P < 0.05 and P < 0.01, respectively)."	( Gokce, G; Kerry, Z; Oktay, G; Oran, I; Ozkal, S; Ozsarlak-Sozer, G, 2011)
"Taurine treatment increased angiogenesis in vitro and in vivo, which was followed by activation of the phosphatidylinositol 3-kinase (PI3K)/Akt, MEK/ERK, and Src/FAK signaling pathways."	( Baek, YY; Cho, DH; Choe, J; Ha, KS; Jeoung, D; Kim, YM; Kwon, YG; Lee, H; Won, MH, 2012)
"Taurine treatment could, however, result to a decrease in the elevated blood glucose and proinflammatory cytokine levels, diabetes-evoked oxidative stress, lipid profiles and NFκB translocation."	( Das, J; Sil, PC; Vasan, V, 2012)
"Taurine treatment significantly reduced the number of activated caspase-3-immunoreactive and TUNEL-positive cells."	( Oja, SS; Pelto-Huikko, M; Podkletnova, IM; Saransaari, P; Taranukhin, AG; Taranukhina, EY, 2012)
"Taurine treatment inhibited pancreatic fibrosis and apoptosis of acinar cells induced by DBTC."	( Koide, N; Matsushita, K; Mizushima, T; Ochi, K; Sawa, K; Shirahige, A; Tanimoto, M; Tanioka, H, 2012)
"Taurine treatment seems to be a useful agent for CYP2E1-related liver diseases with predominant damages in the PC region."	( Matsuzaki, Y; Miyazaki, T, 2014)
"Taurine 100 mM treatment did not block the inhibition of differentiation of preadipcytes into adipocytes."	( Ji, HI; Kim, KS; Yang, HI, 2013)
"Taurine treatment was performed by adding 1% taurine (w/v) to the drinking water plus injection (400 mg/kg body weight) intraperitoneally 3 times/week for 28 d after ethanol cessation in chronically ethanol-treatad rats."	( Aykaç-Toker, G; Balkan, J; Kanbağli, O; Uysal, M, 2002)
"Oral taurine treatment has been studied extensively as a hypotensive agent. "	( Lombardini, JB; Militante, JD, 2002)
"Taurine treatment had no effect on levels of several other amino acids but preserved slice potassium content."	( Kreisman, NR; Olson, JE, 2003)
"Taurine treatment significantly prevented the reduction in activities of Na(+)/K(+)- and Ca(2+)-ATPases activities in high glucose-treated RBC."	( Anuradha, CV; Nandhini, TA, 2003)
"Taurine-treated groups received 2%, 4% and 8% taurine injections once daily for 12 weeks (5 ml/kg b.w.)."	( Chen, CZ; Dong, B; Luo, GA; Shi, YY; Song, XD; Yan, LS; Zhang, W, 2003)
"Taurine treatment also significantly decreased fat accumulation and blood levels of cholesterol and triglyceride, which might improve insulin resistance and utilization of fat and glucose."	( Harada, N; Kurroda, I; Manabe, S; Morishima, M; Nakaya, Y; Okada, K; Okamoto, M; Sakai, K; Takahashi, A, 2003)
"Taurine (20mM) treatment attenuated simulated ischemia-induced decline in the activity of Akt."	( Azuma, J; Fujio, Y; Ito, T; Matsuda, T; Schaffer, SW; Takahashi, K; Takatani, T; Uozumi, Y, 2004)
"Taurine treatment appeared to be more beneficial when the treatment was started earlier."	( Du, J; Huang, Z; Li, J; Tang, C; Wang, S; Zhang, B, 2004)
"Taurine treatment had no effect on mitochondrial membrane potential and cytochrome c release; however, it inhibited ischemia-induced cleavage of caspase-9 and -3."	( Azuma, J; Fujio, Y; Ito, T; Matsuda, T; Schaffer, SW; Shikata, E; Takahashi, K; Takatani, T; Uozumi, Y; Yamamoto, Y, 2004)
"Taurine treatment delayed the mean onset time of diabetes from 18 to 30 weeks in females, and from 30 to 38 weeks in males, while 20% of treated females remained free of diabetes after one year."	( Arany, E; Hill, DJ; Remacle, C; Reusens, B; Romanus, P; Strutt, B, 2004)
"When taurine (3 mM) was pretreated for 24 h, the glucose responses of Ad-UCP2 cells were remarkably restored."	( Dae-Kyu, S; Hyun-Young, L; In-Kyu, L; Kim, SY; Lee, HY; Lee, IK; Lee, SH; Sang-Hoon, L; So-Yeon, K; Song, DK, 2004)
"Taurine treatment to fructose rats attenuated the increased lipid peroxidation, enhanced the levels of antioxidants and improved insulin sensitivity."	( Anuradha, CV; Nandhini, AT; Ravichandran, MK; Thirunavukkarasu, V, 2005)
"In taurine-treated animals, at 2h reperfusion, the mean arterial blood pressure and heart rate were increased, by 6% and 10%."	( Li, Y; Pang, YZ; Tang, CS; Wang, JX; Zhang, J; Zhang, LK; Zhao, J, 2005)
"Taurine or betaine pretreatment in lipopolysaccharide-injected rats caused significant decreases in plasma transaminase activities and hepatic malondialdehyde and DC levels, and significant increases in glutathione and alpha-tocopherol (not betaine) levels without changing ascorbic acid levels and SOD and glutathione peroxidase activities in the liver."	( Aykaç-Toker, G; Balkan, J; Doğru-Abbasoğlu, S; Parldar, FH; Uysal, M, 2005)
"Taurine pretreatment also caused about 2-fold increase in GABA concentration compared to 3-NP-treated animals."	( Abdel-Naim, AB; Arafa, HM; Khalifa, AE; Tadros, MG, 2005)
"Taurine treatment also restored the glucose metabolizing enzyme activities in fructose-fed rats."	( Anuradha, CV; Nandhini, AT; Thirunavukkarasu, V, 2005)
"Taurine treatment improved the degree of oxidative stress and fibrosis in rat CP. "	( Akay, C; Comert, B; Deveci, S; Inal, V; Isik, AT; Mas, MR; Mas, N; Tasci, I; Yamanel, L, 2006)
"The taurine treatment significantly decreased elevation of silica type I collagen positive area percentage of lung by 2.39, 1.62, 7.13 at the 7th, 21st, 28th day respectively (P < 0.05 or P < 0.01), and type III collagen positive area percentage of lung by 2.62 at the 28th day (P < 0.05) compared with the silica treated group."	( Chang, AH; Du, HK; Liu, DW; Wang, SX; Xu, ZR, 2006)
"Taurine treatment resulted in a significant decrease in liver weight, liver index, serum transaminase activities, serum triglyceride, fasting plasma glucose, and oxidative stress; the mRNA expression of TNF-alpha, TGF-beta(1), and type I procollagen decreased, but the expression of adiponectin increased significantly, compared with that in the model group."	( Chen, SW; Chen, YX; Lin, Y; Shi, J; Xie, WF, 2006)
"Taurine post-treatment (67, 200 and 600mgkg(-1)) showed a dose-dependent neuroprotective effect."	( Fan, XJ; Jiang, ZL; Ke, KF; Li, X; Wang, GH; Zhang, L, 2007)
"In taurine treatment group, each patient took 2 g taurine 3 times a day for three months, and then stopped treatment for 1 month."	( Hu, YH; Huang, YW; Hwang, DF; Lin, CL; Liu, PE, 2008)
"Taurine treatment significantly decreased silica-elevated TNF-alpha positive area percent by 3.52 at 7 day (P < 0.05)."	( Du, H; Liu, D; Wang, S; Xu, Z, 2007)
"Taurine treatment was associated with amelioration in macroscopic and microscopic colitis scores, decreased colonic MPO activity and MDA levels and increased GSH levels in TNBS-induced colitis."	( Aliş, H; Aykaç-Toker, G; Depboylu, B; Doğru-Abbasoğlu, S; Erbil, Y; Giriş, M; Olgaç, V; Uysal, M, 2008)
"Taurine treatment caused significant increases in heart taurine levels of old rats."	( Dogru-Abbasoglu, S; Koçak-Toker, N; Mehmetçik, G; Ozdemirler, G; Parildar, H; Uysal, M, 2008)
"Taurine treatment normalized the slight increase in calcium binding associated with ischemia, but had no observable effect on recovery of mechanical function."	( Chovan, JP; Kramer, JH; Schaffer, SW, 1981)
"The taurine pretreatment had no effect on the metabolism of 14CCl4 in hepatic microsomes and antioxidant content in the liver, but significantly enhanced the CCl4-induced increase in hepatic Ca++ content."	( Kuriyama, K; Nakashima, T; Takino, T, 1983)
"Taurine pretreatment inhibited the induction of 'hyper'-locomotor activity."	( Barbeau, A; Fukuda, T; Izumi, K; Munekata, E; Nakanishi, T; Yamamoto, H; Yoshida, M, 1982)
"Taurine-treated rats did not exhibit attenuation of paw oedema using subcutaneous or intraperitoneal administration but intracerebroventricular administration produced a significant reduction at a dosage of 4.0 mumol."	( Bloomfield, FJ; Mahon, TM; Nowlan, P; Stapleton, PP, 1994)
"Taurine treated rats showed levels of MDA not different from untreated rats after RS; also no differences were observed concerning enzyme concentrations and ammonia levels."	( Isselhard, W; Minor, T; Niessen, F, 1998)
"The taurine-treated animals showed reduced MPO activity (35% lower) when compared with that of the vehicle-treated animals."	( Kang, HK; Kim, BK; Kim, WB; Ko, JI; Son, M, 1998)
"The taurine-treated animals significantly reduced MPO activity (35% lower) when compared with that of the vehicle-treated animals."	( Doh, HM; Kim, BK; Kim, WB; Ko, JI; Park, TS; Shim, MJ; Son, MW, 1998)
"Taurine treatment lowered serum LDL + VLDL cholesterol by 44% in mice fed a high-fat diet, while it elevated serum HDL cholesterol by 25%."	( Kondo-Ohta, Y; Murakami, S; Tomisawa, K, 1999)
"In taurine-treated lenses LDH leakage was significantly decreased, and lens clarity was maintained, similarly to that found previously for vitamin C and lipoic acid."	( Bhardwaj, R; Caulfeild, J; Kilic, F; Trevithick, JR, 1999)
"Taurine treatment reduced gentamicin-induced increases in serum creatinine, 24 h urine volume, BUN and tissue lactate and TBARS levels (0.57+/-0.02 vs 1.06+/-0.08 mg/dl, P<0.001; 9.00+/-1.46 vs 20.9+/-2.73 ml, P<0.001; 25.3+/-1.87 vs 54.1+/-6.99 mg/dl, P<0. "	( Bozkurt, A; Erdem, A; Erdem, SR; Gündoğan, NU; Kara, A; Kilinç, K; Usubütün, A, 2000)
"Taurine and niacin treatment significantly reduced the numbers of neutrophils, lymphocytes, and macrophages in the BL + TN group and caused significant reductions in BL-induced increases in the lung hydroxyproline content at 14 and 21 days in the BL + TN group."	( Giri, SN; Gurujeyalakshmi, G; Wang, Y, 2000)
"Taurine treatment in the absence of ATP was effective in decreasing Ca2+ uptake at the higher levels of CaCl2 (2.0 and 2.5 mM)."	( Lombardini, JB; Militante, JD, 2000)
"Taurine-treated islets showed significant reduction in lipid peroxidation (0.905 and 0.848 nM MDA/microg protein for 0.3 and 3.0 mM taurine, respectively, p < 0.05) compared with control (1.307 nM MDA/microg protein) islets."	( Bhonde, RR; Hardikar, AA; Hoet, JJ; Remacle, C; Reusens, B; Risbud, MV, 2001)
"Taurine treatment significantly decreased serum LDL and VLDL cholesterol, while it significantly increased serum HDL cholesterol."	( Kondo, Y; Murakami, S; Nagate, T, 2000)
"Taurine treatment decreased the area of Oil red-O positive lipid accumulation in the aortic valve by 31%."	( Kondo, Y; Murakami, S; Nagate, T; Oda, H, 2000)
"Taurine treatment protects the kidney of the UNX rat against an age-dependent decline in excretory efficiency."	( Mozaffari, MS; Schaffer, SW, 2002)
"Taurine-treated animals received 15 ml/kg/day of a 5% taurine solution by a gastric tube for 5 days before administering CCl(4) (2 ml/kg, intraperitoneally, in a single dose)."	( Akyol, G; Dinçer, S; Oz, E; Ozenirler, S; Ozoğul, C, 2002)
"Taurine treatment increases the rate of production of these compounds 40- and 25-fold respectively by stimulating the activity of N-acetyltransferase."	( Klein, DC; Weller, JL; Wheler, GH, 1979)
"Taurine-treated mice displayed lower motor excitation with the 1.0 g/kg dose of ethanol than the saline group treated with the same dose of ethanol."	( Amit, Z; Aragon, CM; Trudeau, LE, 1992)
"Taurine-treated nephrotic rats had a reduction in albuminuria, as assessed by the urinary albumin-to-creatinine ratio (26 +/- 4 vs."	( Del Pizzo, R; Futterweit, S; Levine, D; Rao, PS; Sturman, JA; Trachtman, H; Valderrama, E, 1992)
"Taurine treatment had a marked prophylactic effect on these maternal pathological changes during pregnancy, resulting in better growth in offsprings."	( Horie, R; Kitao, M; Shibukawa, T; Yamori, Y, 1990)
"Taurine-treated cultures in the presence of extracellular Ca2+ or A23187 were characterized by surfaces with numerous microvillar, spine-like projections."	( Caple, CG; Roisen, FJ; Spoerri, PE, 1990)
"Taurine treatment caused a significant persistent reduction in blood pressure by 4 weeks that was maximal at 16 weeks (146 +/- 6 [exp.] v 182 +/- 5 [control] mm Hg, P less than .01)."	( Del Pizzo, R; Rao, P; Rujikarn, N; Sturman, JA; Trachtman, H, 1989)
"The taurine-treated group was divided into three subgroups."	( Del Valle, JR; Gordon, RE; Heller, RF, 1989)
"Taurine pretreatment partially inhibited the excess accumulation of calcium in the myocardium that occurs upon calcium repletion, and microscopy revealed almost normal structure."	( Azuma, J; Kishimoto, S; Onishi, S; Sperelakis, N; Yamauchi-Takihara, K, 1988)
"taurine when the pretreatment interval was 4-5 days."	( Dlouha, H; Elkhawad, AO; McBroom, MJ, 1986)
"This taurine pretreatment produced a 4-fold increase in liver taurine content."	( Hobara, N; Nagashima, H; Watanabe, A, 1985)
"Treatment with taurine + CM increased (p < 0.05) acetylcholinesterase activity compared to controls."	( Abdulkadir, TS; Ayo, JO; Dawud, FA; Isa, AS, 2021)
"Treatment with taurine, Tau-CS-PT-NPs, and CS-PT-NPs partly reversed these effects."	( Abdel-Halim, M; Ahmed, O; Elamir, A; Farid, A, 2022)
"Cotreatment with taurine (100 mg/kg daily) or curcumin (100 mg/kg daily) alleviated the lipid peroxidation level and antioxidant enzyme activities and histological alterations brought about by BPA."	( Aslanturk, A; Uzunhisarcikli, M, 2020)
"Pretreatment with taurine increased the expression of phosphorylated extracellular regulated protein kinases (ERK) as well as the nuclear translocation of nuclear factor (erythroid 2-derived)-like 2 (Nrf2) in the CORT rich environment."	( Chen, G; Jia, N; Sun, Q; Yang, J, 2018)
"Pretreatment with taurine significantly decreased mRNA and protein expression of p47phox and p22phox in mammary tissues."	( Ma, Z; Miao, J; Zhang, J; Zheng, L, 2013)
"Treatment with taurine, prior to administration of KBrO3, resulted in significant attenuation in all these parameters but the administration of taurine alone had no effect."	( Ahmad, MK; Khan, AA; Mahmood, R, 2013)
"Pre-treatment with taurine (100 mg/kg/day) significantly reversed the decrease in testes weight, and the reduction in sperm count, motility, viability and daily sperm production in endosulfan (5 mg/kg/day)-treated rats."	( Aly, HA; Khafagy, RM, 2014)
"Pretreatment of taurine significantly attenuated Aβ1-42-induced neuronal death."	( Feng, G; Hu, H; Jia, N; Jin, H; Sun, Q; Wang, W, 2014)
"Pretreatment with taurine at 100 μM significantly attenuated the oxLDL-induced cytotoxicity."	( Chang, CC; Chang, CY; Kang, CK; Lee, TH; Shen, CY; Sher, YP; Sheu, WH, 2014)
"Treatment with taurine at 1 mM decreased the number of apoptotic RMPs and the activity of caspase-3 (P < 0.05)."	( Ming, J; Song, Y; Wang, J; Yang, N; Yang, Y; Yu, X; Zeng, K, 2014)
"Treatment with taurine mediated a reduction in oxidative stress in iron‑overloaded mice, attenuated liver lipid peroxidation, elevated antioxidant enzyme activities and maintained reduced glutathione levels."	( He, M; Liao, Z; Liu, D; Tang, L; Yi, B; Yin, D; Zhang, Z, 2014)
"Treatment with taurine, prior to administration of KBrO3, resulted in significant attenuation in all these parameters but the administration of taurine alone had no effect."	( Ahmad, MK; Ali, SN; Khan, AA; Mahmood, R, 2015)
"Pretreatment with taurine zinc (50, 100 or 200mg/kg) SDs dose-dependently protected rat gastric mucosa against cold-restraint stress (CRS)-induced gastric injury, and significantly attenuated increases in gastric mucosal H(+)K(+)-ATPase activity and lipid peroxidation and enhanced SOD activity."	( Mei, XT; Xu, DH; Yu, C; Zheng, YP, 2015)
"Treatment with taurine prevents gut mucosal damage and inhibits intestinal epithelial cell apoptosis following intestinal IR in a rat."	( Aranovich, I; Ben Shahar, Y; Berkowitz, D; Bitterman, A; Bitterman, N; Chepurov, D; Coran, AG; Pollak, Y; Sukhotnik, I, 2016)
"Treatment with taurine before Cd intoxication prevented the toxin-induced oxidative impairments in the erythrocytes of the experimental animals."	( Manna, P; Sil, PC; Sinha, M, 2008)
"Treatment with taurine prior to arsenic administration effectively ameliorated As-induced oxidative renal dysfunctions and apoptotic cell death."	( Manna, P; Roy, A; Sil, PC, 2009)
"The treatment of taurine (300mgkg(-1)d(-1)) and oat fiber (15gkg(-1)d(-1)) induced 21.5% and 18.4% reduction in endotoxin levels, respectively, when compared to the control group (P<0.05)."	( He, P; Li, XD; Luo, M; Wan, XY; Wu, MC, 2010)
"Treatment with taurine restored the reduced expression of Bcl-2 close to the control level without any obvious effect on Bax."	( Giraldo, GS; Pan, C; Prentice, H; Wu, JY, 2010)
"A treatment with taurine was found to significantly attenuate all these alterations, with the protection being, in all instances, greater when given before rather than after LPS."	( Bhavsar, TM; Lau-Cam, CA; Patel, SN, 2010)
"Treatment with taurine markedly reduced neurological deficits, lessened brain swelling, attenuated cell death, and decreased the infarct volume 72 h after ischemia."	( Gu, Y; Sun, M; Xu, C; Zhao, Y, 2012)
"Pretreatment with taurine attenuated inflammatory changes and significantly decreased mRNA expression of TLR-2 (8 h post S."	( Ma, Z; Miao, J; Zhang, J; Zheng, L; Zhu, W; Zou, S, 2011)
"Treatment with taurine showed also significant reduction in the frequency of chromosomal aberrations in both somatic and germ cells."	( Abd El-Rahim, AH; Alam, SS; Hafiz, NA, 2011)
"Pretreatment with taurine (150, 300 mg/kg) significantly prevented bufadienolide-induced cardiotoxicity and reduced the mortality in vivo."	( Ding, A; Duan, J; Jiang, J; Lv, G; Ma, H; Xu, H; You, F; Zhan, Z; Zhang, J; Zhou, J, 2012)
"Treatment with taurine 4 h or 8 h after ischemia significantly improved the neurologic function, and decreased the infarct volumes 24 h after ischemia."	( Gu, Y; Sun, M; Xu, C; Zhao, YM, 2012)
"Co-treatment of taurine strongly reversed the decline of antioxidase activities induced by METH."	( Bu, Q; Cen, X; Chen, B; Deng, Y; Hou, J; Hu, Z; Huang, Y; Li, H; Li, Y; Lu, W; Lv, L; Shao, X; Zhang, B; Zhao, J; Zhao, Y; Zhu, R, 2012)
"Treatment with taurine (1% w/v for three weeks) post-hyperglycemia, however, could restore all the alteration caused by ALX."	( Das, J; Rashid, K; Sil, PC, 2013)
"Treatment with taurine did not significantly alter levels of SST (p > 0.05) or GAD67 (p > 0.05)."	( Cuttitta, CM; Guariglia, SR; Idrissi, AE; L'amoreaux, WJ, 2013)
"Treatment with taurine prior to stimulation down-regulated FasL protein expression and partially inhibited apoptosis."	( Bouchier-Hayes, DJ; Condron, CE; Maher, SG; Toomey, DM, 2005)
"Treatment with taurine inhibited I/R-induced compartment syndrome by at least in part attenuating oxidative stress injury induced by I/R, suggesting clinical application of taurine might be a new strategy for the prevention and treatment of compartment syndrome."	( Li, Y; Pang, YZ; Tang, CS; Wang, JX; Zhang, J; Zhang, LK; Zhao, J, 2005)
"Treatment with taurine hardly influences on the increase in expression of nitric oxide synthase in rat lung induced by silica dust."	( Du, HK; Liu, DW; Wang, J; Wang, SX; Xu, ZR, 2005)
"Treatment with taurine can effectively attenuate type I and III collagen expression in the rat lung induced by silica particles at different time points in our study."	( Chang, AH; Du, HK; Liu, DW; Wang, SX; Xu, ZR, 2006)
"Treatment with taurine in vivo (60 or 180 mg/kg) significantly attenuated the inhibition of endothelium-dependent vasorelaxation and the reduced level of NO, and decreased the elevated levels of ADMA, MDA, and TNF-alpha."	( Hu, CP; Huang, H; Jia, SJ; Jiang, DJ; Jiang, JL; Li, YJ; Tan, B, 2007)
"Pre-treatment with taurine and vitamins E and C revealed that taurine prevents the effects of intrastriatal administration of GAA on the inhibition of complex II, complex II-III, and Na(+),K(+)-ATPase activities."	( Mattos, C; Ribeiro, CA; Scherer, EB; Wajner, M; Wannmacher, CM; Wyse, AT; Zugno, AI, 2007)
"Treatment with taurine can effectively attenuate the pathological expression of TNF-alpha protein of lung in rats induced by silica."	( Du, H; Liu, D; Wang, S; Xu, Z, 2007)
"Treatment with taurine (at a dose of 100 mg/kg body weight for 5 days) before cadmium intoxication prevented the toxin-induced oxidative impairments in renal tissues."	( Manna, P; Sil, PC; Sinha, M, 2009)
"Pre-treatment with taurine (1.6 micromol/g of body weight), or alpha-tocopherol plus ascorbic acid (40 and 100 microg/g body weight, respectively) prevented those effects of tryptophan, reinforcing the hypothesis that tryptophan induces oxidative stress in brain cortex of the rats."	( Amaral, MF; Dutra-Filho, CS; Feksa, LR; Feksa, PB; Koch, GD; Latini, A; Leipnitz, G; Rech, VC; Wajner, M; Wannmacher, CM, 2008)
"Pretreatment with taurine (200 mg/kg, i.p.) attenuated the rise in serum glucose levels at 0.5 hr after glucose administration."	( Kulakowski, EC; Maturo, J, 1984)
"Pretreatment with taurine (3% aqueous solution, p.o., for 3 days) facilitated lipid peroxide formation in the rat liver associated with carbon tetrachloride (CCl4:2 ml/kg, b.w., i.p.) administration. "	( Kuriyama, K; Nakashima, T; Takino, T, 1983)
"Pretreatment with taurine that had been injected IVT 10 min prior to every administration of DAME suppressed the development of tolerance to both the akinetic and analgetic effects of the peptide."	( Barbeau, A; Fukuda, T; Izumi, K; Koja, T; Shimizu, T; Yoshida, M, 1983)
"Pretreatment with taurine (9.5 X 10(-2) M) which was injected in a volume of 10 microliter intraventricularly 10 min prior to every administration of DAME suppressed the development of tolerance to both analgesia and akinesia effects of this peptide, whereas pretreatment with L-leucine at the same concentration did not."	( Barbeau, A; Fukuda, T; Izumi, K; Munekata, E; Nakanishi, T; Yamamoto, H; Yoshida, M, 1982)
"Pretreatment with taurine (scavenger of hypochlorous acid) or antineutrophil serum significantly attenuated gastric mucosal lesions induced by the above test agents."	( Asagoe, K; Dekigai, H; Kita, T; Kusaka, S; Murakami, M; Saita, H, 1995)
"Oral treatment with taurine (CAS 107-35-7) of rabbits with congestive heart failure (CHF) caused by impairment of aortic valve dose-dependently improved hemodynamic and contractile indices of the heart and prolonged the animals' life. "	( Elizarova, EP; Medvedeva, NV; Orlova, TR, 1993)
"Treatment with taurine was followed by a significant increase in serum prealbumin levels (P = .053), a trend toward a reduction in fat malabsorption, and no effect on the biochemical profile."	( Battezzati, PM; Bettinardi, N; Colombo, C; Giunta, A; Podda, M, 1996)
"Treatment with taurine significantly suppressed adriamycin-induced proteinuria, albuminuria, and urinary excretion of N-acetyl-beta-D-glucosaminidase."	( Arumugam, V; Karthikeyan, J; Venkatesan, N; Venkatesan, P, 1997)
"Treating with taurine reversed these depletions."	( Kennedy, DO; Matsui-Yuasa, I; Otani, S; Wu, C; Yano, Y, 1999)
"Treatment with taurine and niacin attenuated the BL-induced increases in proinflammatory cytokines such as IL-1alpha, TNF-alpha, IL-6, and TGF-beta in BALF and lung hydroxyproline content of the mice in BL + TN groups."	( Giri, SN; Gurujeyalakshmi, G; Wang, Y, 2000)
"Treatment with taurine alone did not change either SDL or EL."	( Hui, X; Vohra, BP, 2000)
"Treatment of taurine and niacin began 2 days before the first intratracheal instillation of saline or BL and thereafter daily throughout the study for taurine + niacin + saline and taurine + niacin + BL groups."	( Giri, SN; Hyde, DM; Wang, Q, 1992)
"Pretreatment with taurine inhibited the nociceptive-related writhing behavior produced by an intraperitoneal injection of acetic acid in mice but failed to alter the latency of response in the hot plate or tail flick assay.(ABSTRACT TRUNCATED AT 250 WORDS)"	( Larson, AA; Skilling, SR; Smullin, DH, 1990)
"Treatment with taurine seems to reduce lipoperoxidation and decrease cell damage at the time of reperfusion."	( Boveris, A; Covarrubias, J; Ferreira, R; Forcada, P; Llesuy, S; Milei, J, 1992)
"Pretreatment with taurine (0.5% in drinking water for 3 days) prevented both the drop in bile flow and the histological changes in the liver, suggesting that conjugation with taurine removed the cholestatic potential of sulfated lithocholate."	( Belli, DC; Fournier, LA; Giguère, R; Roy, CC; Tuchweber, B; Yousef, IM, 1991)
"Treatment with taurine (470 mg/kg/day, p.o.) strengthened the bactericidal capacity of neutrophils which was decreased by cholesterol diet feeding, as the capacity was stronger on the 40th day than that in animals fed laboratory chow."	( Horisaka, K; Koeda, T; Masuda, M, 1986)

Pathways (30)

taurine is involved in 30 pathway(s), involving a total of 426 unique proteins and 1452 unique compounds

Role	Description
human metabolite	Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
antioxidant	A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
mouse metabolite	Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
Saccharomyces cerevisiae metabolite	Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
Escherichia coli metabolite	Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
glycine receptor agonist	An agonist that binds to and activates glycine receptors
nutrient	A nutrient is a food component that an organism uses to survive and grow.
radical scavenger	A role played by a substance that can react readily with, and thereby eliminate, radicals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Class	Description
amino sulfonic acid	An organosulfonic acid containing one or more amino groups.
zwitterion	A neutral compound having formal unit electrical charges of opposite sign on non-adjacent atoms. Sometimes referred to as inner salts, dipolar ions (a misnomer).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathway	Proteins	Compounds
Taurine and Hypotaurine Metabolism	5	9
Bile Acid Biosynthesis	17	61
Congenital Bile Acid Synthesis Defect Type II	17	61
Congenital Bile Acid Synthesis Defect Type III	17	61
Familial Hypercholanemia (FHCA)	17	61
Zellweger Syndrome	17	61
Cerebrotendinous Xanthomatosis (CTX)	17	61
27-Hydroxylase Deficiency	17	61
Taurine Metabolism	4	12
Inner Membrane Transport	78	62
Sulfur Metabolism	28	33
Sulfur Metabolism (Butanesulfonate)	28	34
Sulfur Metabolism (Propanesulfonate)	28	34
Sulfur Metabolism (Ethanesulfonate)	28	34
Sulfur Metabolism (Isethionate)	28	34
Sulfur Metabolism (Methanesulfonate)	28	34
Taurine Metabolism I	4	12
Taurine and Hypotaurine Biosynthesis	1	5
Methionine and Cysteine metabolism ( Methionine and Cysteine metabolism )	23	42
Choloyl-CoA + Taurine = CoA + Taurocholic acid ( Methionine and Cysteine metabolism )	1	4
One-carbon donor	0	22
Differentiation pathway	0	12
Trans-sulfuration pathway	0	14
Trans-sulfuration, one-carbon metabolism and related pathways	0	53
Pluripotent stem cell differentiation pathway	0	11
Biochemical pathways: part I	0	466
One-carbon metabolism and related pathways	0	38
Methionine metabolism leading to sulfur amino acids and related disorders	9	19
Cysteine and methionine catabolism	14	36
Amino acid conjugation	0	5

Protein	Taxonomy	Measurement	Average (µ)	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	Homo sapiens (human)	Potency	7.0795	0.0032	45.4673	12,589.2998	AID2517
Chain A, Cruzipain	Trypanosoma cruzi	Potency	39.8107	0.0020	14.6779	39.8107	AID1476
Luciferase	Photinus pyralis (common eastern firefly)	Potency	41.4924	0.0072	15.7588	89.3584	AID1224835
pregnane X receptor	Rattus norvegicus (Norway rat)	Potency	25.1189	0.0251	27.9203	501.1870	AID651751
RAR-related orphan receptor gamma	Mus musculus (house mouse)	Potency	3.7578	0.0060	38.0041	19,952.5996	AID1159521
GALC protein	Homo sapiens (human)	Potency	0.5623	28.1838	28.1838	28.1838	AID1159614
GLI family zinc finger 3	Homo sapiens (human)	Potency	8.8030	0.0007	14.5928	83.7951	AID1259369; AID1259392
AR protein	Homo sapiens (human)	Potency	23.2920	0.0002	21.2231	8,912.5098	AID743035; AID743063
nuclear receptor subfamily 1, group I, member 3	Homo sapiens (human)	Potency	17.3107	0.0010	22.6508	76.6163	AID1224838; AID1224839; AID1224893
regulator of G-protein signaling 4	Homo sapiens (human)	Potency	0.1865	0.5318	15.4358	37.6858	AID504845
EWS/FLI fusion protein	Homo sapiens (human)	Potency	0.9350	0.0013	10.1577	42.8575	AID1259256
glucocorticoid receptor [Homo sapiens]	Homo sapiens (human)	Potency	15.0890	0.0002	14.3764	60.0339	AID720691
retinoic acid nuclear receptor alpha variant 1	Homo sapiens (human)	Potency	28.3716	0.0030	41.6115	22,387.1992	AID1159553
estrogen-related nuclear receptor alpha	Homo sapiens (human)	Potency	26.2127	0.0015	30.6073	15,848.9004	AID1224821; AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptor	Homo sapiens (human)	Potency	31.8334	0.0054	28.0263	1,258.9301	AID1346982
estrogen nuclear receptor alpha	Homo sapiens (human)	Potency	35.7177	0.0002	29.3054	16,493.5996	AID743079
glucocerebrosidase	Homo sapiens (human)	Potency	35.4813	0.0126	8.1569	44.6684	AID2101
peroxisome proliferator-activated receptor delta	Homo sapiens (human)	Potency	44.6684	0.0010	24.5048	61.6448	AID588535
arylsulfatase A	Homo sapiens (human)	Potency	0.0107	1.0691	13.9551	37.9330	AID720538
IDH1	Homo sapiens (human)	Potency	20.5962	0.0052	10.8652	35.4813	AID686970
euchromatic histone-lysine N-methyltransferase 2	Homo sapiens (human)	Potency	39.8107	0.0355	20.9770	89.1251	AID504332
aryl hydrocarbon receptor	Homo sapiens (human)	Potency	30.1025	0.0007	23.0674	1,258.9301	AID743085; AID743122
thyroid stimulating hormone receptor	Homo sapiens (human)	Potency	33.7756	0.0016	28.0151	77.1139	AID1224843; AID1259385
activating transcription factor 6	Homo sapiens (human)	Potency	0.0007	0.1434	27.6121	59.8106	AID1159516
v-jun sarcoma virus 17 oncogene homolog (avian)	Homo sapiens (human)	Potency	13.2849	0.0578	21.1097	61.2679	AID1159528
Histone H2A.x	Cricetulus griseus (Chinese hamster)	Potency	31.7236	0.0391	47.5451	146.8240	AID1224845; AID1224896
Bloom syndrome protein isoform 1	Homo sapiens (human)	Potency	0.0126	0.5406	17.6392	96.1227	AID2364; AID2528
cytochrome P450 2C19 precursor	Homo sapiens (human)	Potency	39.8107	0.0025	5.8400	31.6228	AID899
nuclear factor erythroid 2-related factor 2 isoform 1	Homo sapiens (human)	Potency	11.8566	0.0006	27.2152	1,122.0200	AID651741; AID743202; AID743219
DNA polymerase kappa isoform 1	Homo sapiens (human)	Potency	0.8913	0.0316	22.3146	100.0000	AID588579
lamin isoform A-delta10	Homo sapiens (human)	Potency	22.3872	0.8913	12.0676	28.1838	AID1487
Cellular tumor antigen p53	Homo sapiens (human)	Potency	28.3716	0.0023	19.5956	74.0614	AID651631
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)	IC50 (µMol)	10.0000	10.0000	182.0000	354.0000	AID1794824
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Process	via Protein(s)	Taxonomy
negative regulation of cell population proliferation	Cellular tumor antigen p53	Homo sapiens (human)
regulation of cell cycle	Cellular tumor antigen p53	Homo sapiens (human)
regulation of cell cycle G2/M phase transition	Cellular tumor antigen p53	Homo sapiens (human)
DNA damage response	Cellular tumor antigen p53	Homo sapiens (human)
ER overload response	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to glucose starvation	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
regulation of apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of miRNA transcription	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Cellular tumor antigen p53	Homo sapiens (human)
mitophagy	Cellular tumor antigen p53	Homo sapiens (human)
in utero embryonic development	Cellular tumor antigen p53	Homo sapiens (human)
somitogenesis	Cellular tumor antigen p53	Homo sapiens (human)
release of cytochrome c from mitochondria	Cellular tumor antigen p53	Homo sapiens (human)
hematopoietic progenitor cell differentiation	Cellular tumor antigen p53	Homo sapiens (human)
T cell proliferation involved in immune response	Cellular tumor antigen p53	Homo sapiens (human)
B cell lineage commitment	Cellular tumor antigen p53	Homo sapiens (human)
T cell lineage commitment	Cellular tumor antigen p53	Homo sapiens (human)
response to ischemia	Cellular tumor antigen p53	Homo sapiens (human)
nucleotide-excision repair	Cellular tumor antigen p53	Homo sapiens (human)
double-strand break repair	Cellular tumor antigen p53	Homo sapiens (human)
regulation of DNA-templated transcription	Cellular tumor antigen p53	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Cellular tumor antigen p53	Homo sapiens (human)
protein import into nucleus	Cellular tumor antigen p53	Homo sapiens (human)
autophagy	Cellular tumor antigen p53	Homo sapiens (human)
DNA damage response	Cellular tumor antigen p53	Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	Cellular tumor antigen p53	Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
transforming growth factor beta receptor signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
Ras protein signal transduction	Cellular tumor antigen p53	Homo sapiens (human)
gastrulation	Cellular tumor antigen p53	Homo sapiens (human)
neuroblast proliferation	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of neuroblast proliferation	Cellular tumor antigen p53	Homo sapiens (human)
protein localization	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of DNA replication	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of cell population proliferation	Cellular tumor antigen p53	Homo sapiens (human)
determination of adult lifespan	Cellular tumor antigen p53	Homo sapiens (human)
mRNA transcription	Cellular tumor antigen p53	Homo sapiens (human)
rRNA transcription	Cellular tumor antigen p53	Homo sapiens (human)
response to salt stress	Cellular tumor antigen p53	Homo sapiens (human)
response to inorganic substance	Cellular tumor antigen p53	Homo sapiens (human)
response to X-ray	Cellular tumor antigen p53	Homo sapiens (human)
response to gamma radiation	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of gene expression	Cellular tumor antigen p53	Homo sapiens (human)
cardiac muscle cell apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
glial cell proliferation	Cellular tumor antigen p53	Homo sapiens (human)
viral process	Cellular tumor antigen p53	Homo sapiens (human)
glucose catabolic process to lactate via pyruvate	Cellular tumor antigen p53	Homo sapiens (human)
cerebellum development	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of cell growth	Cellular tumor antigen p53	Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
mitotic G1 DNA damage checkpoint signaling	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of telomere maintenance via telomerase	Cellular tumor antigen p53	Homo sapiens (human)
T cell differentiation in thymus	Cellular tumor antigen p53	Homo sapiens (human)
tumor necrosis factor-mediated signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
regulation of tissue remodeling	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to UV	Cellular tumor antigen p53	Homo sapiens (human)
multicellular organism growth	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of mitochondrial membrane permeability	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to glucose starvation	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
entrainment of circadian clock by photoperiod	Cellular tumor antigen p53	Homo sapiens (human)
mitochondrial DNA repair	Cellular tumor antigen p53	Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of neuron apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
transcription initiation-coupled chromatin remodeling	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of proteolysis	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of DNA-templated transcription	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of DNA-templated transcription	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assembly	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Cellular tumor antigen p53	Homo sapiens (human)
response to antibiotic	Cellular tumor antigen p53	Homo sapiens (human)
fibroblast proliferation	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of fibroblast proliferation	Cellular tumor antigen p53	Homo sapiens (human)
circadian behavior	Cellular tumor antigen p53	Homo sapiens (human)
bone marrow development	Cellular tumor antigen p53	Homo sapiens (human)
embryonic organ development	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation	Cellular tumor antigen p53	Homo sapiens (human)
protein stabilization	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of helicase activity	Cellular tumor antigen p53	Homo sapiens (human)
protein tetramerization	Cellular tumor antigen p53	Homo sapiens (human)
chromosome organization	Cellular tumor antigen p53	Homo sapiens (human)
neuron apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
regulation of cell cycle	Cellular tumor antigen p53	Homo sapiens (human)
hematopoietic stem cell differentiation	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of glial cell proliferation	Cellular tumor antigen p53	Homo sapiens (human)
type II interferon-mediated signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
cardiac septum morphogenesis	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of programmed necrotic cell death	Cellular tumor antigen p53	Homo sapiens (human)
protein-containing complex assembly	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	Cellular tumor antigen p53	Homo sapiens (human)
thymocyte apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of thymocyte apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
necroptotic process	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to hypoxia	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to xenobiotic stimulus	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to ionizing radiation	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to gamma radiation	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to UV-C	Cellular tumor antigen p53	Homo sapiens (human)
stem cell proliferation	Cellular tumor antigen p53	Homo sapiens (human)
signal transduction by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
reactive oxygen species metabolic process	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to actinomycin D	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondria	Cellular tumor antigen p53	Homo sapiens (human)
cellular senescence	Cellular tumor antigen p53	Homo sapiens (human)
replicative senescence	Cellular tumor antigen p53	Homo sapiens (human)
oxidative stress-induced premature senescence	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
oligodendrocyte apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of execution phase of apoptosis	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of mitophagy	Cellular tumor antigen p53	Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of miRNA transcription	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of G1 to G0 transition	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of miRNA processing	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvate	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of pentose-phosphate shunt	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxia	Cellular tumor antigen p53	Homo sapiens (human)
regulation of fibroblast apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of reactive oxygen species metabolic process	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of reactive oxygen species metabolic process	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of stem cell proliferation	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of cellular senescence	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of cell differentiation	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
nitrogen compound transport	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
neurotransmitter transport	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
amino acid transport	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
taurine transmembrane transport	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
alanine transport	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
modulation of chemical synaptic transmission	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
gamma-aminobutyric acid import	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
amino acid import across plasma membrane	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
import across plasma membrane	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
transport across blood-brain barrier	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
sodium ion transmembrane transport	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
monoatomic ion transport	Proton-coupled amino acid transporter 1	Homo sapiens (human)
amino acid transport	Proton-coupled amino acid transporter 1	Homo sapiens (human)
taurine transmembrane transport	Proton-coupled amino acid transporter 1	Homo sapiens (human)
proline transport	Proton-coupled amino acid transporter 1	Homo sapiens (human)
alanine transport	Proton-coupled amino acid transporter 1	Homo sapiens (human)
amino acid import across plasma membrane	Proton-coupled amino acid transporter 1	Homo sapiens (human)
glycine transport	Proton-coupled amino acid transporter 1	Homo sapiens (human)
proline transmembrane transport	Proton-coupled amino acid transporter 1	Homo sapiens (human)
proton transmembrane transport	Proton-coupled amino acid transporter 1	Homo sapiens (human)
L-alanine transport	Proton-coupled amino acid transporter 1	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
transcription cis-regulatory region binding	Cellular tumor antigen p53	Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA binding	Cellular tumor antigen p53	Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specific	Cellular tumor antigen p53	Homo sapiens (human)
cis-regulatory region sequence-specific DNA binding	Cellular tumor antigen p53	Homo sapiens (human)
core promoter sequence-specific DNA binding	Cellular tumor antigen p53	Homo sapiens (human)
TFIID-class transcription factor complex binding	Cellular tumor antigen p53	Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specific	Cellular tumor antigen p53	Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specific	Cellular tumor antigen p53	Homo sapiens (human)
protease binding	Cellular tumor antigen p53	Homo sapiens (human)
p53 binding	Cellular tumor antigen p53	Homo sapiens (human)
DNA binding	Cellular tumor antigen p53	Homo sapiens (human)
chromatin binding	Cellular tumor antigen p53	Homo sapiens (human)
DNA-binding transcription factor activity	Cellular tumor antigen p53	Homo sapiens (human)
mRNA 3'-UTR binding	Cellular tumor antigen p53	Homo sapiens (human)
copper ion binding	Cellular tumor antigen p53	Homo sapiens (human)
protein binding	Cellular tumor antigen p53	Homo sapiens (human)
zinc ion binding	Cellular tumor antigen p53	Homo sapiens (human)
enzyme binding	Cellular tumor antigen p53	Homo sapiens (human)
receptor tyrosine kinase binding	Cellular tumor antigen p53	Homo sapiens (human)
ubiquitin protein ligase binding	Cellular tumor antigen p53	Homo sapiens (human)
histone deacetylase regulator activity	Cellular tumor antigen p53	Homo sapiens (human)
ATP-dependent DNA/DNA annealing activity	Cellular tumor antigen p53	Homo sapiens (human)
identical protein binding	Cellular tumor antigen p53	Homo sapiens (human)
histone deacetylase binding	Cellular tumor antigen p53	Homo sapiens (human)
protein heterodimerization activity	Cellular tumor antigen p53	Homo sapiens (human)
protein-folding chaperone binding	Cellular tumor antigen p53	Homo sapiens (human)
protein phosphatase 2A binding	Cellular tumor antigen p53	Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor binding	Cellular tumor antigen p53	Homo sapiens (human)
14-3-3 protein binding	Cellular tumor antigen p53	Homo sapiens (human)
MDM2/MDM4 family protein binding	Cellular tumor antigen p53	Homo sapiens (human)
disordered domain specific binding	Cellular tumor antigen p53	Homo sapiens (human)
general transcription initiation factor binding	Cellular tumor antigen p53	Homo sapiens (human)
molecular function activator activity	Cellular tumor antigen p53	Homo sapiens (human)
promoter-specific chromatin binding	Cellular tumor antigen p53	Homo sapiens (human)
amino acid:sodium symporter activity	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
gamma-aminobutyric acid:sodium:chloride symporter activity	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
taurine transmembrane transporter activity	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
taurine:sodium symporter activity	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
amino acid transmembrane transporter activity	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
gamma-aminobutyric acid transmembrane transporter activity	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
alanine transmembrane transporter activity	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
amino acid:proton symporter activity	Proton-coupled amino acid transporter 1	Homo sapiens (human)
proline:proton symporter activity	Proton-coupled amino acid transporter 1	Homo sapiens (human)
taurine transmembrane transporter activity	Proton-coupled amino acid transporter 1	Homo sapiens (human)
protein binding	Proton-coupled amino acid transporter 1	Homo sapiens (human)
amino acid transmembrane transporter activity	Proton-coupled amino acid transporter 1	Homo sapiens (human)
alanine transmembrane transporter activity	Proton-coupled amino acid transporter 1	Homo sapiens (human)
L-alanine transmembrane transporter activity	Proton-coupled amino acid transporter 1	Homo sapiens (human)
L-proline transmembrane transporter activity	Proton-coupled amino acid transporter 1	Homo sapiens (human)
glycine transmembrane transporter activity	Proton-coupled amino acid transporter 1	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
nuclear body	Cellular tumor antigen p53	Homo sapiens (human)
nucleus	Cellular tumor antigen p53	Homo sapiens (human)
nucleoplasm	Cellular tumor antigen p53	Homo sapiens (human)
replication fork	Cellular tumor antigen p53	Homo sapiens (human)
nucleolus	Cellular tumor antigen p53	Homo sapiens (human)
cytoplasm	Cellular tumor antigen p53	Homo sapiens (human)
mitochondrion	Cellular tumor antigen p53	Homo sapiens (human)
mitochondrial matrix	Cellular tumor antigen p53	Homo sapiens (human)
endoplasmic reticulum	Cellular tumor antigen p53	Homo sapiens (human)
centrosome	Cellular tumor antigen p53	Homo sapiens (human)
cytosol	Cellular tumor antigen p53	Homo sapiens (human)
nuclear matrix	Cellular tumor antigen p53	Homo sapiens (human)
PML body	Cellular tumor antigen p53	Homo sapiens (human)
transcription repressor complex	Cellular tumor antigen p53	Homo sapiens (human)
site of double-strand break	Cellular tumor antigen p53	Homo sapiens (human)
germ cell nucleus	Cellular tumor antigen p53	Homo sapiens (human)
chromatin	Cellular tumor antigen p53	Homo sapiens (human)
transcription regulator complex	Cellular tumor antigen p53	Homo sapiens (human)
protein-containing complex	Cellular tumor antigen p53	Homo sapiens (human)
plasma membrane protein complex	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
plasma membrane	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
membrane	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
basolateral plasma membrane	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
apical plasma membrane	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
dendrite	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
microvillus membrane	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
neuronal cell body	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
postsynaptic membrane	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
GABA-ergic synapse	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
cell projection	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
plasma membrane	Sodium- and chloride-dependent taurine transporter	Homo sapiens (human)
lysosomal membrane	Proton-coupled amino acid transporter 1	Homo sapiens (human)
endoplasmic reticulum	Proton-coupled amino acid transporter 1	Homo sapiens (human)
plasma membrane	Proton-coupled amino acid transporter 1	Homo sapiens (human)
apical plasma membrane	Proton-coupled amino acid transporter 1	Homo sapiens (human)
vacuolar membrane	Proton-coupled amino acid transporter 1	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Assay ID	Title	Year	Journal	Article
AID1347083	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588378	qHTS for Inhibitors of ATXN expression: Validation
AID504810	Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign	2010	Endocrinology, Jul, Volume: 151, Issue:7	A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347050	Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay	2019	Science translational medicine, 07-10, Volume: 11, Issue:500	Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347045	Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line	2019	Science translational medicine, 07-10, Volume: 11, Issue:500	Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347151	Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay	2020	Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49	Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID504836	Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation	2002	The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16	Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID504812	Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign	2010	Endocrinology, Jul, Volume: 151, Issue:7	A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1508630	Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay	2021	Cell reports, 04-27, Volume: 35, Issue:4	A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347410	qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library	2019	Cellular signalling, 08, Volume: 60	A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347057	CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation	2019	PloS one, , Volume: 14, Issue:7	Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347059	CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation	2019	PloS one, , Volume: 14, Issue:7	Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347049	Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen	2019	Science translational medicine, 07-10, Volume: 11, Issue:500	Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347405	qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection	2020	ACS chemical biology, 07-17, Volume: 15, Issue:7	High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347058	CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation	2019	PloS one, , Volume: 14, Issue:7	Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID588349	qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID1347097	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID504749	qHTS profiling for inhibitors of Plasmodium falciparum proliferation	2011	Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043	Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1347091	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008	Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening	2020	SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1	Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347104	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154	Primary screen GU AMC qHTS for Zika virus inhibitors	2020	Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49	Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347090	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346987	P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen	2019	Molecular pharmacology, 11, Volume: 96, Issue:5	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1745845	Primary qHTS for Inhibitors of ATXN expression
AID1347098	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346986	P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen	2019	Molecular pharmacology, 11, Volume: 96, Issue:5	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347089	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407	qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection	2020	ACS chemical biology, 07-17, Volume: 15, Issue:7	High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347424	RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)	2019	The Journal of biological chemistry, 11-15, Volume: 294, Issue:46	Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID651635	Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347425	Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)	2019	The Journal of biological chemistry, 11-15, Volume: 294, Issue:46	Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID588497	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set	2010	Current protocols in cytometry, Oct, Volume: Chapter 13	Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set	2006	Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5	Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set	2010	Assay and drug development technologies, Feb, Volume: 8, Issue:1	High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set	2010	Current protocols in cytometry, Oct, Volume: Chapter 13	Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set	2006	Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5	Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set	2010	Assay and drug development technologies, Feb, Volume: 8, Issue:1	High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set	2010	Current protocols in cytometry, Oct, Volume: Chapter 13	Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set	2006	Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5	Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set	2010	Assay and drug development technologies, Feb, Volume: 8, Issue:1	High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID309303	Cytotoxicity against rat L6 cells after 72 hrs	2007	Bioorganic & medicinal chemistry, Nov-01, Volume: 15, Issue:21	Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
AID309301	Antitrypanosomal activity against Trypanosoma cruzi after 72 hrs	2007	Bioorganic & medicinal chemistry, Nov-01, Volume: 15, Issue:21	Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
AID521220	Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay	2007	Nature chemical biology, May, Volume: 3, Issue:5	Chemical genetics reveals a complex functional ground state of neural stem cells.
AID630741	Inhibition of human PAT1-mediated L-[3H]proline uptake in human Caco2 cells after 10 mins by liquid scintillation counting	2011	Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21	Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1).
AID1174113	Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 7 days by microplate Alamar blue assay	2015	European journal of medicinal chemistry, Jan-07, Volume: 89	Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
AID500816	Inhibition of nitrogen-starved wild type sigma1278b yeast Gap1-mediated amino acid uptake at 5 mM after 60 secs relative to L-citrulline	2009	Nature chemical biology, Jan, Volume: 5, Issue:1	Transport and signaling via the amino acid binding site of the yeast Gap1 amino acid transceptor.
AID309299	Antimalarial activity against chloroquine-resistant, pyrimethamine-resistant Plasmodium falciparum K1 after 48 hrs	2007	Bioorganic & medicinal chemistry, Nov-01, Volume: 15, Issue:21	Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
AID309302	Antileishmanial activity against Leishmania donovani after 72 hrs by Alamar blue assay	2007	Bioorganic & medicinal chemistry, Nov-01, Volume: 15, Issue:21	Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
AID402367	In vivo antitumor activity against mouse P388 cells at 4 to 800 mg/ kg	2005	Journal of natural products, Jul, Volume: 68, Issue:7	Antineoplastic agents. 545. Isolation and structure of turbostatins 1-4 from the Asian marine mollusk Turbo stenogyrus.
AID309300	Antitrypanosomal activity against Trypanosoma brucei rhodesiense after 72 hrs by Alamar blue assay	2007	Bioorganic & medicinal chemistry, Nov-01, Volume: 15, Issue:21	Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
AID355114	Antineoplastic activity against mouse P388 cells at 100 mg/kg relative to control	1996	Journal of natural products, Aug, Volume: 59, Issue:8	Progress in the discovery of biosynthetic anticancer drugs.
AID309298	Inhibition of Plasmodium falciparum FabI	2007	Bioorganic & medicinal chemistry, Nov-01, Volume: 15, Issue:21	Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
AID1347411	qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary	2020	ACS chemical biology, 07-17, Volume: 15, Issue:7	High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1794808	Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).	2014	Journal of biomolecular screening, Jul, Volume: 19, Issue:6	A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808	Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607	Screen for inhibitors of RMI FANCM (MM2) intereaction	2016	Journal of biomolecular screening, Jul, Volume: 21, Issue:6	A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	2910 (29.98)	18.7374
1990's	1955 (20.14)	18.2507
2000's	2175 (22.40)	29.6817
2010's	2024 (20.85)	24.3611
2020's	644 (6.63)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	430 (4.17%)	5.53%
Reviews	761 (7.39%)	6.00%
Case Studies	77 (0.75%)	4.05%
Observational	11 (0.11%)	0.25%
Other	9,022 (87.58%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Description	Relationhip Strength	Studies	Trials	Classes	Roles
helenalin	[no description available]	medium	1	0	cyclic ketone; gamma-lactone; organic heterotricyclic compound; secondary alcohol; sesquiterpene lactone	anti-inflammatory agent; antineoplastic agent; metabolite; plant metabolite
dolastatin 10	[no description available]	medium	1	0	1,3-thiazoles; tetrapeptide	animal metabolite; antineoplastic agent; apoptosis inducer; marine metabolite; microtubule-destabilising agent
cephalostatin i	[no description available]	medium	1	0	oxo steroid	metabolite
gamma-aminobutyric acid	[no description available]	high	882	3	amino acid zwitterion; gamma-amino acid; monocarboxylic acid	human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule
gamma-aminobutyric acid	[no description available]	high	882	0	amino acid zwitterion; gamma-amino acid; monocarboxylic acid	human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule
acetamide	[no description available]	medium	1	0	acetamides; carboximidic acid; monocarboxylic acid amide; N-acylammonia
quinacrine	[no description available]	medium	5	0	acridines; aromatic ether; organochlorine compound; tertiary amino compound	antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
catechol	[no description available]	medium	1	0	catechols	allelochemical; genotoxin; plant metabolite
taxifolin	[no description available]	medium	1	0	3'-hydroxyflavanones; 4'-hydroxyflavanones; dihydroflavonols; pentahydroxyflavanone; secondary alpha-hydroxy ketone
phosphonoacetic acid	[no description available]	medium	1	0	monocarboxylic acid; phosphonic acids	antiviral agent; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor
3,4-dihydroxyphenylacetic acid	[no description available]	high	20	0	catechols; dihydroxyphenylacetic acid	human metabolite
aminocaproic acid	[no description available]	medium	3	0	amino acid zwitterion; epsilon-amino acid; omega-amino fatty acid	antifibrinolytic drug; hematologic agent; metabolite
diacetyl	[no description available]	medium	1	0	alpha-diketone	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
hydroquinone	[no description available]	medium	1	0	benzenediol; hydroquinones	antioxidant; carcinogenic agent; cofactor; Escherichia coli metabolite; human xenobiotic metabolite; mouse metabolite; skin lightening agent
melatonin	[no description available]	high	32	0	acetamides; tryptamines	anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger
n-acetylserotonin	[no description available]	medium	2	0	acetamides; N-acylserotonin; phenols	antioxidant; human metabolite; mouse metabolite; tropomyosin-related kinase B receptor agonist
pyrazinamide	[no description available]	medium	1	0	monocarboxylic acid amide; N-acylammonia; pyrazines	antitubercular agent; prodrug
quinolinic acid	[no description available]	high	8	0	pyridinedicarboxylic acid	Escherichia coli metabolite; human metabolite; mouse metabolite; NMDA receptor agonist
2-amino-5-phosphonovalerate	[no description available]	medium	17	0	non-proteinogenic alpha-amino acid	NMDA receptor antagonist
alpha-methyl-4-carboxyphenylglycine	[no description available]	medium	1	0
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid	[no description available]	medium	3	0
1-hydroxy-3-amino-2-pyrrolidone	[no description available]	medium	1	0
ibotenic acid	[no description available]	medium	7	0	non-proteinogenic alpha-amino acid	neurotoxin
n(8)-bromoacetyl-n(1)-3'-(4-indolyloxy)-2'-hydroxypropyl-1,8-diamino-4-menthane	[no description available]	medium	1	0
sk&f-38393	[no description available]	medium	2	0	benzazepine; catechols; secondary amino compound
vanilmandelic acid	[no description available]	medium	1	0	2-hydroxy monocarboxylic acid; aromatic ether; phenols	human metabolite
1,10-diaminodecane	[no description available]	medium	1	0
1,3-diethyl-8-phenylxanthine	[no description available]	medium	1	0
1,3-dipropyl-8-cyclopentylxanthine	[no description available]	medium	3	0	oxopurine	adenosine A1 receptor antagonist; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
1,3-dipropyl-8-(4-sulfophenyl)xanthine	[no description available]	medium	1	0
1,5-dihydroxyisoquinoline	[no description available]	medium	1	0	isoquinolinol	EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
pk 11195	[no description available]	medium	1	0	aromatic amide; isoquinolines; monocarboxylic acid amide; monochlorobenzenes	antineoplastic agent
1-(2-trifluoromethylphenyl)imidazole	[no description available]	medium	1	0	imidazoles
1-aminobenzotriazole	[no description available]	medium	1	0
1-methylimidazole	[no description available]	medium	1	0	imidazoles
edelfosine	[no description available]	medium	1	0	glycerophosphocholine
1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	[no description available]	medium	1	0	oxadiazoloquinoxaline	EC 4.6.1.2 (guanylate cyclase) inhibitor
2,2'-dipyridyl	[no description available]	medium	1	0	bipyridine	chelator; ferroptosis inhibitor
2-hydroxysaclofen	[no description available]	medium	3	0	organochlorine compound
3,4-dichloroisocoumarin	[no description available]	medium	1	0	isocoumarins; organochlorine compound	geroprotector; serine protease inhibitor
phaclofen	[no description available]	medium	5	0	organophosphate oxoanion; zwitterion
3-aminobenzamide	[no description available]	medium	2	0	benzamides; substituted aniline	EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
3-bromo-7-nitroindazole	[no description available]	medium	1	0
enprofylline	[no description available]	medium	1	0	oxopurine	anti-arrhythmia drug; anti-asthmatic drug; bronchodilator agent; non-steroidal anti-inflammatory drug
3-nitropropionic acid	[no description available]	medium	7	0	C-nitro compound	antimycobacterial drug; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mycotoxin; neurotoxin
4-amino-1,8-naphthalimide	[no description available]	medium	1	0	benzoisoquinoline; dicarboximide
4-aminopyridine	[no description available]	medium	13	0	aminopyridine; aromatic amine	avicide; orphan drug; potassium channel blocker
homovanillic acid	[no description available]	high	19	0	guaiacols; monocarboxylic acid	human metabolite; mouse metabolite
4-hydroxybenzoic acid hydrazide	[no description available]	medium	2	0	carbohydrazide; phenols
4-phenyl-3-furoxancarbonitrile	[no description available]	medium	1	0	1,2,5-oxadiazole; benzenes; N-oxide; nitrile	geroprotector; nitric oxide donor; platelet aggregation inhibitor; soluble guanylate cyclase activator; vasodilator agent
5,5-dimethyl-1-pyrroline-1-oxide	[no description available]	medium	2	0	1-pyrroline nitrones	neuroprotective agent; spin trapping reagent
phenytoin	[no description available]	medium	14	0	imidazolidine-2,4-dione	anticonvulsant; drug allergen; sodium channel blocker; teratogenic agent
5,7-dichlorokynurenic acid	[no description available]	medium	2	0	quinolines
5-(n,n-hexamethylene)amiloride	[no description available]	medium	1	0	aromatic amine; azepanes; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines	antineoplastic agent; apoptosis inducer; odorant receptor antagonist; sodium channel blocker
ethylisopropylamiloride	[no description available]	medium	2	0	aromatic amine; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines; tertiary amino compound	anti-arrhythmia drug; neuroprotective agent; sodium channel blocker
5-fluoroindole-2-carboxylic acid	[no description available]	medium	1	0	indolyl carboxylic acid
hydroxyindoleacetic acid	[no description available]	high	21	0	indole-3-acetic acids	drug metabolite; human metabolite; mouse metabolite
phenanthridone	[no description available]	medium	1	0	lactam; phenanthridines	EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; immunosuppressive agent; mutagen
6-chloromelatonin	[no description available]	medium	1	0	acetamides
6-hydroxymelatonin	[no description available]	medium	1	0	acetamides; tryptamines	metabolite; mouse metabolite
6-methoxytryptoline	[no description available]	medium	1	0
6-nitroso-1,2-benzopyrone	[no description available]	medium	1	0
7-chlorokynurenic acid	[no description available]	medium	4	0	organochlorine compound; quinolinemonocarboxylic acid	neuroprotective agent; NMDA receptor antagonist
7-nitroindazole	[no description available]	medium	2	0
8-(4-sulfophenyl)theophylline	[no description available]	medium	1	0
8-cyclopentyl-1,3-dimethylxanthine	[no description available]	medium	1	0	oxopurine
8-phenyltheophylline	[no description available]	medium	2	0
acetazolamide	[no description available]	medium	3	0	monocarboxylic acid amide; sulfonamide; thiadiazoles	anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor
acetohexamide	[no description available]	medium	1	0	acetophenones; N-sulfonylurea	hypoglycemic agent; insulin secretagogue
ag 127	[no description available]	medium	1	0	nitrophenol
rtki cpd	[no description available]	medium	1	0	aromatic ether; monochlorobenzenes; quinazolines	antineoplastic agent; antiviral agent; epidermal growth factor receptor antagonist; geroprotector
tyrphostin a23	[no description available]	medium	2	0	catechols
tyrphostin 25	[no description available]	medium	1	0	benzenetriol
tyrphostin a1	[no description available]	medium	1	0	methoxybenzenes	geroprotector
1-aminoindan-1,5-dicarboxylic acid	[no description available]	medium	1	0
albuterol	[no description available]	medium	4	0	phenols; phenylethanolamines; secondary amino compound	beta-adrenergic agonist; bronchodilator agent; environmental contaminant; xenobiotic
alpha-methyltyrosine methyl ester	[no description available]	medium	1	0
altretamine	[no description available]	medium	1	0	triamino-1,3,5-triazine
amfonelic acid	[no description available]	medium	1	0
amifostine anhydrous	[no description available]	high	2	0	diamine; organic thiophosphate	antioxidant; prodrug; radiation protective agent
theophylline	[no description available]	medium	7	0	dimethylxanthine	adenosine receptor antagonist; anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; drug metabolite; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; fungal metabolite; human blood serum metabolite; immunomodulator; muscle relaxant; vasodilator agent
amoxapine	[no description available]	medium	1	0	dibenzooxazepine	adrenergic uptake inhibitor; antidepressant; dopaminergic antagonist; geroprotector; serotonin uptake inhibitor
aniracetam	[no description available]	medium	1	0	N-acylpyrrolidine; pyrrolidin-2-ones
2-amino-4-phosphonobutyric acid	[no description available]	medium	2	0
aspirin	[no description available]	medium	16	0	benzoic acids; phenyl acetates; salicylates	anticoagulant; antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; EC 1.1.1.188 (prostaglandin-F synthase) inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; plant activator; platelet aggregation inhibitor; prostaglandin antagonist; teratogenic agent
atenolol	[no description available]	medium	3	0	ethanolamines; monocarboxylic acid amide; propanolamine	anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; sympatholytic agent; xenobiotic
alpha-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionate	[no description available]	medium	1	0	alpha-amino acid
aurintricarboxylic acid	[no description available]	medium	1	0	monohydroxybenzoic acid; quinomethanes; tricarboxylic acid	fluorochrome; histological dye; insulin-like growth factor receptor 1 antagonist
azathioprine	[no description available]	medium	2	0	aryl sulfide; C-nitro compound; imidazoles; thiopurine	antimetabolite; antineoplastic agent; carcinogenic agent; DNA synthesis inhibitor; hepatotoxic agent; immunosuppressive agent; prodrug
azelaic acid	[no description available]	medium	2	0	alpha,omega-dicarboxylic acid; dicarboxylic fatty acid	antibacterial agent; antineoplastic agent; dermatologic drug; plant metabolite
baclofen	[no description available]	medium	69	0	amino acid zwitterion; gamma-amino acid; monocarboxylic acid; monochlorobenzenes; primary amino compound	central nervous system depressant; GABA agonist; muscle relaxant
bay-k-8644	[no description available]	medium	2	0	(trifluoromethyl)benzenes; C-nitro compound; dihydropyridine; methyl ester
benzamide	[no description available]	medium	1	0	benzamides
bepridil	[no description available]	medium	2	0	pyrrolidines; tertiary amine	anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent
bml 190	[no description available]	medium	1	0	N-acylindole
brimonidine	[no description available]	medium	1	0	imidazoles; quinoxaline derivative; secondary amine	adrenergic agonist; alpha-adrenergic agonist; antihypertensive agent
bumetanide	[no description available]	medium	8	0	amino acid; benzoic acids; sulfonamide	diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
caffeine	[no description available]	high	115	29	purine alkaloid; trimethylxanthine	adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic
caffeine	[no description available]	high	115	0	purine alkaloid; trimethylxanthine	adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic
carbamazepine	[no description available]	medium	8	0	dibenzoazepine; ureas	analgesic; anticonvulsant; antimanic drug; drug allergen; EC 3.5.1.98 (histone deacetylase) inhibitor; environmental contaminant; glutamate transporter activator; mitogen; non-narcotic analgesic; sodium channel blocker; xenobiotic
carbamazepine	[no description available]	medium	8	1	dibenzoazepine; ureas	analgesic; anticonvulsant; antimanic drug; drug allergen; EC 3.5.1.98 (histone deacetylase) inhibitor; environmental contaminant; glutamate transporter activator; mitogen; non-narcotic analgesic; sodium channel blocker; xenobiotic
carbetapentane	[no description available]	medium	1	0	benzenes
carisoprodol	[no description available]	medium	1	0	carbamate ester	muscle relaxant
carmustine	[no description available]	medium	7	0	N-nitrosoureas; organochlorine compound	alkylating agent; antineoplastic agent
cgs 12066	[no description available]	medium	1	0	N-arylpiperazine; organofluorine compound; pyrroloquinoxaline	serotonergic agonist
cgs 15943	[no description available]	medium	1	0	aromatic amine; biaryl; furans; organochlorine compound; primary amino compound; quinazolines; triazoloquinazoline	adenosine A1 receptor antagonist; adenosine A2A receptor antagonist; antineoplastic agent; central nervous system stimulant
chlorambucil	[no description available]	medium	1	0	aromatic amine; monocarboxylic acid; nitrogen mustard; organochlorine compound; tertiary amino compound	alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent
chlormezanone	[no description available]	medium	1	0	1,3-thiazine; lactam; monochlorobenzenes; sulfone	antipsychotic agent; anxiolytic drug; muscle relaxant
chlorothiazide	[no description available]	medium	1	0	benzothiadiazine	antihypertensive agent; diuretic
chlorpropamide	[no description available]	medium	1	0	monochlorobenzenes; N-sulfonylurea	hypoglycemic agent; insulin secretagogue
chlorzoxazone	[no description available]	medium	1	0	1,3-benzoxazoles; heteroaryl hydroxy compound; organochlorine compound	muscle relaxant; sedative
cilostamide	[no description available]	medium	1	0	quinolines
cilostazol	[no description available]	medium	1	0	lactam; tetrazoles	anticoagulant; bronchodilator agent; EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor; fibrin modulating drug; neuroprotective agent; platelet aggregation inhibitor; vasodilator agent
cimetidine	[no description available]	medium	5	0	aliphatic sulfide; guanidines; imidazoles; nitrile	adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor
cimetidine	[no description available]	medium	5	1	aliphatic sulfide; guanidines; imidazoles; nitrile	adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor
cinoxacin	[no description available]	medium	1	0	cinnolines; oxacycle; oxo carboxylic acid	antibacterial drug; antiinfective agent
ciprofibrate	[no description available]	medium	1	0	cyclopropanes; monocarboxylic acid; organochlorine compound	antilipemic drug
clofibrate	[no description available]	medium	5	0	aromatic ether; ethyl ester; monochlorobenzenes	anticholesteremic drug; antilipemic drug; geroprotector; PPARalpha agonist
clofibrate	[no description available]	medium	5	1	aromatic ether; ethyl ester; monochlorobenzenes	anticholesteremic drug; antilipemic drug; geroprotector; PPARalpha agonist
clotrimazole	[no description available]	medium	1	0	conazole antifungal drug; imidazole antifungal drug; imidazoles; monochlorobenzenes	antiinfective agent; environmental contaminant; xenobiotic
cx546	[no description available]	medium	1	0
cyclothiazide	[no description available]	medium	2	0	benzothiadiazine	antihypertensive agent; diuretic
dephostatin	[no description available]	medium	1	0
nonivamide	[no description available]	medium	1	0	capsaicinoid; phenols	lachrymator
r 59022	[no description available]	medium	1	0	diarylmethane
diazoxide	[no description available]	medium	1	0	benzothiadiazine; organochlorine compound; sulfone	antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent
pentetic acid	[no description available]	medium	1	0	pentacarboxylic acid	copper chelator
diphenyleneiodonium	[no description available]	medium	3	0	organic cation
dipyridamole	[no description available]	medium	7	0	piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol	adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent
disopyramide	[no description available]	medium	1	0	monocarboxylic acid amide; pyridines; tertiary amino compound	anti-arrhythmia drug
disulfiram	[no description available]	medium	100	0	organic disulfide; organosulfur acaricide	angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor
disulfiram	[no description available]	medium	100	2	organic disulfide; organosulfur acaricide	angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor
2-amino-7-phosphonoheptanoic acid	[no description available]	medium	2	0
thiorphan	[no description available]	medium	1	0	N-acyl-amino acid
2,3-dimethoxy-1,4-naphthoquinone	[no description available]	medium	1	0	1,4-naphthoquinones
domperidone	[no description available]	medium	1	0	benzimidazoles; heteroarylpiperidine	antiemetic; dopaminergic antagonist
droperidol	[no description available]	medium	1	0	aromatic ketone; benzimidazoles; organofluorine compound	anaesthesia adjuvant; antiemetic; dopaminergic antagonist; first generation antipsychotic
ebselen	[no description available]	medium	1	0	benzoselenazole	anti-inflammatory drug; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 3.5.4.1 (cytosine deaminase) inhibitor; EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor; enzyme mimic; ferroptosis inhibitor; genotoxin; hepatoprotective agent; neuroprotective agent; radical scavenger
ellipticine	[no description available]	medium	1	0	indole alkaloid; organic heterotetracyclic compound; organonitrogen heterocyclic compound; polycyclic heteroarene	antineoplastic agent; plant metabolite
emodin	[no description available]	medium	3	0	trihydroxyanthraquinone	antineoplastic agent; laxative; plant metabolite; tyrosine kinase inhibitor
ethosuximide	[no description available]	medium	2	0	dicarboximide; pyrrolidinone	anticonvulsant; geroprotector; T-type calcium channel blocker
etodolac	[no description available]	medium	1	0	monocarboxylic acid; organic heterotricyclic compound	antipyretic; cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
felbamate	[no description available]	medium	1	0	carbamate ester	anticonvulsant; neuroprotective agent
felodipine	[no description available]	medium	1	0	dichlorobenzene; dihydropyridine; ethyl ester; methyl ester	anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent
fenofibrate	[no description available]	medium	1	0	aromatic ether; chlorobenzophenone; isopropyl ester; monochlorobenzenes	antilipemic drug; environmental contaminant; geroprotector; xenobiotic
flumazenil	[no description available]	medium	6	0	ethyl ester; imidazobenzodiazepine; organofluorine compound	antidote to benzodiazepine poisoning; GABA antagonist
fluorouracil	[no description available]	medium	15	0	nucleobase analogue; organofluorine compound	antimetabolite; antineoplastic agent; environmental contaminant; immunosuppressive agent; radiosensitizing agent; xenobiotic
fluorouracil	[no description available]	medium	15	2	nucleobase analogue; organofluorine compound	antimetabolite; antineoplastic agent; environmental contaminant; immunosuppressive agent; radiosensitizing agent; xenobiotic
fluspirilene	[no description available]	medium	1	0	diarylmethane
flutamide	[no description available]	medium	1	0	(trifluoromethyl)benzenes; monocarboxylic acid amide	androgen antagonist; antineoplastic agent
formoterol fumarate	[no description available]	medium	1	0	formamides; phenols; phenylethanolamines; secondary alcohol; secondary amino compound
fpl 64176	[no description available]	medium	1	0	carboxylic ester; pyrroles	calcium channel agonist
furafylline	[no description available]	medium	1	0	oxopurine
furosemide	[no description available]	medium	20	0	chlorobenzoic acid; furans; sulfonamide	environmental contaminant; loop diuretic; xenobiotic
fusaric acid	[no description available]	medium	1	0	aromatic carboxylic acid; pyridines
gabapentin	[no description available]	medium	4	0	gamma-amino acid	anticonvulsant; calcium channel blocker; environmental contaminant; xenobiotic
4-amino-5-hexynoic acid	[no description available]	medium	4	0
glipizide	[no description available]	medium	1	0	aromatic amide; monocarboxylic acid amide; N-sulfonylurea; pyrazines	EC 2.7.1.33 (pantothenate kinase) inhibitor; hypoglycemic agent; insulin secretagogue
glyburide	[no description available]	medium	10	0	monochlorobenzenes; N-sulfonylurea	anti-arrhythmia drug; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor; hypoglycemic agent
1-(5-isoquinolinesulfonyl)piperazine	[no description available]	medium	1	0	isoquinolines
haloperidol	[no description available]	medium	12	0	aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol	antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist
hemicholinium 3	[no description available]	medium	1	0	morpholines
4-fluorohexahydrosiladifenidol	[no description available]	medium	1	0
hydrochlorothiazide	[no description available]	medium	1	0	benzothiadiazine; organochlorine compound; sulfonamide	antihypertensive agent; diuretic; environmental contaminant; xenobiotic
hydroxyurea	[no description available]	high	2	0	one-carbon compound; ureas	antimetabolite; antimitotic; antineoplastic agent; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; genotoxin; immunomodulator; radical scavenger; teratogenic agent
ibudilast	[no description available]	medium	1	0	pyrazolopyridine
ibuprofen	[no description available]	high	7	0	monocarboxylic acid	antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; radical scavenger; xenobiotic
ic 261	[no description available]	medium	1	0	indoles
ifenprodil	[no description available]	medium	4	0	piperidines
indirubin-3'-monoxime	[no description available]	medium	1	0
indomethacin	[no description available]	medium	18	0	aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole	analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic
iodoacetamide	[no description available]	medium	1	0
1-methyl-3-isobutylxanthine	[no description available]	medium	7	0	3-isobutyl-1-methylxanthine
4-piperidinecarboxylic acid	[no description available]	medium	2	0
4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline	[no description available]	medium	1	0
jl 18	[no description available]	medium	1	0
nsc 664704	[no description available]	medium	1	0	indolobenzazepine; lactam; organobromine compound	cardioprotective agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor; geroprotector
ketoconazole	[no description available]	medium	3	0	dichlorobenzene; dioxolane; ether; imidazoles; N-acylpiperazine; N-arylpiperazine
ketoprofen	[no description available]	medium	1	0	benzophenones; oxo monocarboxylic acid	antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-steroidal anti-inflammatory drug; xenobiotic
kynurenic acid	[no description available]	high	17	0	monohydroxyquinoline; quinolinemonocarboxylic acid	G-protein-coupled receptor agonist; human metabolite; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist; Saccharomyces cerevisiae metabolite
2-amino-3-phosphonopropionic acid	[no description available]	medium	1	0	alanine derivative; non-proteinogenic alpha-amino acid; phosphonic acids	human metabolite; metabotropic glutamate receptor antagonist
lamotrigine	[no description available]	medium	5	0	1,2,4-triazines; dichlorobenzene; primary arylamine	anticonvulsant; antidepressant; antimanic drug; calcium channel blocker; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; excitatory amino acid antagonist; geroprotector; non-narcotic analgesic; xenobiotic
lamotrigine	[no description available]	medium	5	1	1,2,4-triazines; dichlorobenzene; primary arylamine	anticonvulsant; antidepressant; antimanic drug; calcium channel blocker; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; excitatory amino acid antagonist; geroprotector; non-narcotic analgesic; xenobiotic
lansoprazole	[no description available]	medium	1	0	benzimidazoles; pyridines; sulfoxide	anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
beta-lapachone	[no description available]	medium	1	0	benzochromenone; orthoquinones	anti-inflammatory agent; antineoplastic agent; plant metabolite
leflunomide	[no description available]	medium	1	0	(trifluoromethyl)benzenes; isoxazoles; monocarboxylic acid amide	antineoplastic agent; antiparasitic agent; EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; hepatotoxic agent; immunosuppressive agent; non-steroidal anti-inflammatory drug; prodrug; pyrimidine synthesis inhibitor; tyrosine kinase inhibitor
linopirdine	[no description available]	medium	1	0	indoles
loratadine	[no description available]	medium	1	0	benzocycloheptapyridine; ethyl ester; N-acylpiperidine; organochlorine compound; tertiary carboxamide	anti-allergic agent; cholinergic antagonist; geroprotector; H1-receptor antagonist
loxoprofen	[no description available]	medium	1	0	cyclopentanones; monocarboxylic acid	antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one	[no description available]	medium	2	0	chromones; morpholines; organochlorine compound	autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector
meclofenamate sodium anhydrous	[no description available]	medium	1	0	organic sodium salt
methiothepin	[no description available]	medium	1	0	aryl sulfide; dibenzothiepine; N-alkylpiperazine; tertiary amino compound	antipsychotic agent; dopaminergic antagonist; geroprotector; serotonergic antagonist
methoctramine	[no description available]	medium	1	0	aromatic ether; tetramine	muscarinic antagonist
nocodazole	[no description available]	medium	1	0	aromatic ketone; benzimidazoles; carbamate ester; thiophenes	antimitotic; antineoplastic agent; microtubule-destabilising agent; tubulin modulator
3-Hydroxy-alpha-methyl-DL-tyrosine	[no description available]	medium	1	0	benzenes; monocarboxylic acid
metolazone	[no description available]	medium	1	0	organochlorine compound; quinazolines; sulfonamide	antihypertensive agent; diuretic; ion transport inhibitor
milrinone	[no description available]	medium	1	0	bipyridines; nitrile; pyridone	cardiotonic drug; EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor; platelet aggregation inhibitor; vasodilator agent
minoxidil	[no description available]	medium	1	0	dialkylarylamine; tertiary amino compound
mitotane	[no description available]	medium	1	0	diarylmethane
mitoxantrone	[no description available]	medium	2	0	dihydroxyanthraquinone	analgesic; antineoplastic agent
ml 7	[no description available]	medium	1	0	N-sulfonyldiazepane; organoiodine compound	EC 2.7.11.18 (myosin-light-chain kinase) inhibitor
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide	[no description available]	medium	1	0	naphthalenes; organochlorine compound; primary amino compound; sulfonamide
n-bromoacetamide	[no description available]	medium	1	0
ethylmaleimide	[no description available]	medium	10	0	maleimides	anticoronaviral agent; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.1.1 (hexokinase) inhibitor
fg 7142	[no description available]	medium	1	0	beta-carbolines
fenamic acid	[no description available]	medium	3	0	aminobenzoic acid; secondary amino compound	membrane transport modulator
n 0840	[no description available]	medium	1	0
nialamide	[no description available]	medium	1	0	organonitrogen compound; organooxygen compound
niclosamide	[no description available]	medium	1	0	benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide	anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor
nifedipine	[no description available]	high	13	0	C-nitro compound; dihydropyridine; methyl ester	calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent
niflumic acid	[no description available]	medium	25	0	aromatic carboxylic acid; pyridines
nilutamide	[no description available]	medium	1	0	(trifluoromethyl)benzenes; C-nitro compound; imidazolidinone	androgen antagonist; antineoplastic agent
nimesulide	[no description available]	medium	1	0	aromatic ether; C-nitro compound; sulfonamide	cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug
nimodipine	[no description available]	medium	5	0	2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester	antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent
nipecotic acid	[no description available]	medium	14	0	beta-amino acid; piperidinemonocarboxylic acid
nitrendipine	[no description available]	medium	2	0	C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester	antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent
masoprocol	[no description available]	medium	1	0	catechols; lignan; tetrol	antioxidant; ferroptosis inhibitor; geroprotector; plant metabolite
5-nitro-2-(3-phenylpropylamino)benzoic acid	[no description available]	medium	26	0	nitrobenzoic acid
ns 2028	[no description available]	medium	1	0
ns 1619	[no description available]	medium	1	0	(trifluoromethyl)benzenes; benzimidazoles; phenols	potassium channel opener
o(6)-benzylguanine	[no description available]	medium	1	0
ofloxacin	[no description available]	medium	3	0	3-oxo monocarboxylic acid; N-arylpiperazine; N-methylpiperazine; organofluorine compound; oxazinoquinoline
olomoucine	[no description available]	medium	1	0	2,6-diaminopurines; ethanolamines	EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
oxaprozin	[no description available]	medium	1	0	1,3-oxazoles; monocarboxylic acid	analgesic; non-steroidal anti-inflammatory drug
oxatomide	[no description available]	medium	1	0	benzimidazoles; diarylmethane; N-alkylpiperazine	anti-allergic agent; anti-inflammatory agent; geroprotector; H1-receptor antagonist; serotonergic antagonist
oxiracetam	[no description available]	medium	1	0	organonitrogen compound; organooxygen compound
oxolinic acid	[no description available]	medium	1	0	aromatic carboxylic acid; organic heterotricyclic compound; oxacycle; quinolinemonocarboxylic acid; quinolone antibiotic	antibacterial drug; antifungal agent; antiinfective agent; antimicrobial agent; enzyme inhibitor
quinone	[no description available]	medium	1	0	1,4-benzoquinones	cofactor; human xenobiotic metabolite; mouse metabolite
fenclonine	[no description available]	medium	5	0	phenylalanine derivative
palmidrol	[no description available]	medium	3	0	endocannabinoid; N-(long-chain-acyl)ethanolamine; N-(saturated fatty acyl)ethanolamine	anti-inflammatory drug; anticonvulsant; antihypertensive agent; neuroprotective agent
1,7-dimethylxanthine	[no description available]	medium	1	0	dimethylxanthine	central nervous system stimulant; human blood serum metabolite; human xenobiotic metabolite; mouse metabolite
pd 98059	[no description available]	medium	6	0	aromatic amine; monomethoxyflavone	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector
pentamidine	[no description available]	medium	2	0	aromatic ether; carboxamidine; diether	anti-inflammatory agent; antifungal agent; calmodulin antagonist; chemokine receptor 5 antagonist; EC 2.3.1.48 (histone acetyltransferase) inhibitor; NMDA receptor antagonist; S100 calcium-binding protein B inhibitor; trypanocidal drug; xenobiotic
pentoxifylline	[no description available]	medium	6	0	oxopurine
perphenazine	[no description available]	medium	1	0	N-(2-hydroxyethyl)piperazine; N-alkylpiperazine; organochlorine compound; phenothiazines	antiemetic; dopaminergic antagonist; phenothiazine antipsychotic drug
phenyl biguanide	[no description available]	medium	1	0	guanidines	central nervous system drug
phenylbutazone	[no description available]	medium	2	0	pyrazolidines	antirheumatic drug; EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor; metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug
phloretin	[no description available]	medium	3	0	dihydrochalcones	antineoplastic agent; plant metabolite
picotamide	[no description available]	medium	1	0	benzamides
pinacidil	[no description available]	medium	1	0	pyridines
pindolol	[no description available]	medium	2	0	indoles; secondary amine	antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist; serotonergic antagonist; vasodilator agent
pindolol	[no description available]	medium	2	1	indoles; secondary amine	antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist; serotonergic antagonist; vasodilator agent
piperidine-4-sulfonic acid	[no description available]	medium	3	0
piracetam	[no description available]	medium	4	0	organonitrogen compound; organooxygen compound
pirenperone	[no description available]	medium	1	0	aromatic ketone
praziquantel	[no description available]	medium	1	0	isoquinolines
primidone	[no description available]	medium	1	0	pyrimidone	anticonvulsant; environmental contaminant; xenobiotic
proglumide	[no description available]	medium	1	0	benzamides; dicarboxylic acid monoamide; glutamine derivative; racemate	anti-ulcer drug; cholecystokinin antagonist; cholinergic antagonist; delta-opioid receptor agonist; drug metabolite; gastrointestinal drug; opioid analgesic; xenobiotic metabolite
propentofylline	[no description available]	medium	2	0	oxopurine
propofol	[no description available]	high	5	0	phenols	anticonvulsant; antiemetic; intravenous anaesthetic; radical scavenger; sedative
pf 5901	[no description available]	medium	2	0	quinolines
riluzole	[no description available]	medium	5	0	benzothiazoles
risperidone	[no description available]	medium	2	0	1,2-benzoxazoles; heteroarylpiperidine; organofluorine compound; pyridopyrimidine	alpha-adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; psychotropic drug; second generation antipsychotic; serotonergic antagonist
ritanserin	[no description available]	medium	3	0	organofluorine compound; piperidines; thiazolopyrimidine	antidepressant; antipsychotic agent; anxiolytic drug; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; serotonergic antagonist
4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone	[no description available]	medium	3	0	methoxybenzenes
rolipram	[no description available]	medium	2	0	pyrrolidin-2-ones	antidepressant; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
salmeterol xinafoate	[no description available]	medium	1	0	ether; phenols; primary alcohol; secondary alcohol; secondary amino compound
sb 202190	[no description available]	medium	2	0	imidazoles; organofluorine compound; phenols; pyridines	apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
sobuzoxane	[no description available]	medium	1	0	organic molecular entity
spiroxatrine	[no description available]	medium	1	0	imidazolidines
sq 22536	[no description available]	medium	1	0	nucleoside analogue; oxolanes	EC 4.6.1.1 (adenylate cyclase) inhibitor
sulfaphenazole	[no description available]	medium	1	0	primary amino compound; pyrazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial drug; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor; P450 inhibitor
sulpiride	[no description available]	medium	4	0	benzamides; N-alkylpyrrolidine; sulfonamide	antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist
t0156	[no description available]	medium	1	0	naphthyridine derivative
1,4-bis(2-(3,5-dichloropyridyloxy))benzene	[no description available]	medium	1	0
terfenadine	[no description available]	medium	1	0	diarylmethane
tetraisopropylpyrophosphamide	[no description available]	medium	1	0	phosphoramide
thalidomide	[no description available]	medium	2	0	phthalimides; piperidones
theobromine	[no description available]	medium	1	0	dimethylxanthine	adenosine receptor antagonist; bronchodilator agent; food component; human blood serum metabolite; mouse metabolite; plant metabolite; vasodilator agent
8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate	[no description available]	medium	2	0	trihydroxybenzoic acid
tolazamide	[no description available]	medium	1	0	N-sulfonylurea	hypoglycemic agent; potassium channel blocker
tolbutamide	[no description available]	high	3	0	N-sulfonylurea	human metabolite; hypoglycemic agent; insulin secretagogue; potassium channel blocker
(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid	[no description available]	medium	3	0
ici 136,753	[no description available]	medium	1	0	pyrazolopyridine
triamterene	[no description available]	medium	1	0	pteridines	diuretic; sodium channel blocker
trimethoprim	[no description available]	medium	1	0	aminopyrimidine; methoxybenzenes	antibacterial drug; diuretic; drug allergen; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; environmental contaminant; xenobiotic
tropicamide	[no description available]	medium	1	0	acetamides
tyrphostin a9	[no description available]	medium	1	0	alkylbenzene	geroprotector
vigabatrin	[no description available]	medium	21	0	gamma-amino acid	anticonvulsant; EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor
vigabatrin	[no description available]	medium	21	1	gamma-amino acid	anticonvulsant; EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor
8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine	[no description available]	medium	1	0
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole	[no description available]	medium	1	0	aromatic primary alcohol; furans; indazoles	antineoplastic agent; apoptosis inducer; platelet aggregation inhibitor; soluble guanylate cyclase activator; vasodilator agent
zardaverine	[no description available]	medium	1	0	organofluorine compound; pyridazinone	anti-asthmatic drug; bronchodilator agent; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; peripheral nervous system drug
cortisone acetate	[no description available]	medium	1	0	corticosteroid hormone
corticosterone	[no description available]	high	15	1	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
corticosterone	[no description available]	high	15	0	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
reserpine	[no description available]	medium	8	0	alkaloid ester; methyl ester; yohimban alkaloid	adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic
procaine hydrochloride	[no description available]	medium	1	0	organic molecular entity
isoproterenol hydrochloride	[no description available]	medium	1	0	catechols
histamine dihydrochloride	[no description available]	medium	1	0
carbachol	[no description available]	medium	8	0	ammonium salt; carbamate ester	cardiotonic drug; miotic; muscarinic agonist; nicotinic acetylcholine receptor agonist; non-narcotic analgesic
spironolactone	[no description available]	medium	2	0	3-oxo-Delta(4) steroid; oxaspiro compound; steroid lactone; thioester	aldosterone antagonist; antihypertensive agent; diuretic; environmental contaminant; xenobiotic
estrone	[no description available]	high	2	0	17-oxo steroid; 3-hydroxy steroid; phenolic steroid; phenols	antineoplastic agent; bone density conservation agent; estrogen; human metabolite; mouse metabolite
androsterone	[no description available]	medium	1	0	17-oxo steroid; 3alpha-hydroxy steroid; androstanoid; C19-steroid	androgen; anticonvulsant; human blood serum metabolite; human metabolite; human urinary metabolite; mouse metabolite; pheromone
promazine hydrochloride	[no description available]	medium	1	0	hydrochloride
pilocarpine hydrochloride	[no description available]	medium	1	0	hydrochloride
dimethylphenylpiperazinium iodide	[no description available]	medium	6	0	N-arylpiperazine; organic iodide salt; piperazinium salt; quaternary ammonium salt	nicotinic acetylcholine receptor agonist
pentylenetetrazole	[no description available]	medium	20	0	organic heterobicyclic compound; organonitrogen heterocyclic compound
racepinephrine hydrochloride	[no description available]	medium	1	0
(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride	[no description available]	medium	2	0
hexamethonium bromide	[no description available]	medium	1	0
cystamine dihydrochloride	[no description available]	medium	1	0
cantharidin	[no description available]	medium	1	0	cyclic dicarboxylic anhydride; monoterpenoid	EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; herbicide
tetraethylammonium chloride	[no description available]	medium	1	0	organic chloride salt; quaternary ammonium salt	potassium channel blocker
aspartic acid	[no description available]	high	496	4	aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; mouse metabolite; neurotransmitter
aspartic acid	[no description available]	high	496	0	aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; mouse metabolite; neurotransmitter
glutamine	[no description available]	high	323	5	amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid	EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
glutamine	[no description available]	high	323	0	amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid	EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
vincristine	[no description available]	medium	1	0	acetate ester; formamides; methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; tertiary alcohol; tertiary amino compound; vinca alkaloid	antineoplastic agent; drug; microtubule-destabilising agent; plant metabolite; tubulin modulator
physostigmine	[no description available]	medium	4	0	carbamate ester; indole alkaloid	antidote to curare poisoning; EC 3.1.1.8 (cholinesterase) inhibitor; miotic
apomorphine	[no description available]	medium	4	0	aporphine alkaloid	alpha-adrenergic drug; antidyskinesia agent; antiparkinson drug; dopamine agonist; emetic; serotonergic drug
promethazine hydrochloride	[no description available]	medium	1	0	hydrochloride	anti-allergic agent; anticoronaviral agent; antiemetic; antipruritic drug; geroprotector; H1-receptor antagonist; local anaesthetic; sedative
bromodeoxyuridine	[no description available]	medium	6	0	pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent
levodopa	[no description available]	high	8	0	amino acid zwitterion; dopa; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid	allelochemical; antidyskinesia agent; antiparkinson drug; dopaminergic agent; hapten; human metabolite; mouse metabolite; neurotoxin; plant growth retardant; plant metabolite; prodrug
methoxamine hydrochloride	[no description available]	medium	1	0	dimethoxybenzene
papaverine hydrochloride	[no description available]	medium	1	0
bretylium tosylate	[no description available]	medium	1	0	organosulfonate salt; quaternary ammonium salt	adrenergic antagonist; anti-arrhythmia drug; antihypertensive agent
berlition	[no description available]	medium	1	0	dithiolanes; heterocyclic fatty acid; lipoic acid; thia fatty acid	cofactor; nutraceutical; prosthetic group
methacholine chloride	[no description available]	medium	1	0	quaternary ammonium salt
androstenedione	[no description available]	medium	1	0	17-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid	androgen; Daphnia magna metabolite; human metabolite; mouse metabolite
colchicine	[no description available]	medium	15	0	alkaloid; colchicine	anti-inflammatory agent; gout suppressant; mutagen
yohimbine hydrochloride	[no description available]	medium	1	0
gallamine triethiodide	[no description available]	medium	3	0
cycloheximide	[no description available]	medium	18	0	antibiotic fungicide; cyclic ketone; dicarboximide; piperidine antibiotic; piperidones; secondary alcohol	anticoronaviral agent; bacterial metabolite; ferroptosis inhibitor; neuroprotective agent; protein synthesis inhibitor
egtazic acid	[no description available]	medium	23	0	diether; tertiary amino compound; tetracarboxylic acid	chelator
cycloserine	[no description available]	high	4	0	4-amino-1,2-oxazolidin-3-one; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic; zwitterion	antiinfective agent; antimetabolite; antitubercular agent; metabolite; NMDA receptor agonist
17-alpha-hydroxyprogesterone	[no description available]	medium	1	0	17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; tertiary alpha-hydroxy ketone	human metabolite; metabolite; mouse metabolite; progestin
quinacrine monohydrochloride	[no description available]	medium	1	0
chlorpromazine hydrochloride	[no description available]	medium	1	0	hydrochloride; phenothiazines	anticoronaviral agent; phenothiazine antipsychotic drug
cytarabine hydrochloride	[no description available]	medium	1	0
tryptophan	[no description available]	high	62	2	erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan	antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
tryptophan	[no description available]	high	62	0	erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan	antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
lidocaine hydrochloride	[no description available]	medium	1	0	hydrochloride	anti-arrhythmia drug; local anaesthetic
arginine	[no description available]	high	125	2	arginine; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid	biomarker; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical
arginine	[no description available]	high	125	0	arginine; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid	biomarker; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical
rotenone	[no description available]	medium	3	0	organic heteropentacyclic compound; rotenones	antineoplastic agent; metabolite; mitochondrial NADH:ubiquinone reductase inhibitor; phytogenic insecticide; piscicide; toxin
synephrine	[no description available]	medium	2	0	ethanolamines; phenethylamine alkaloid; phenols	alpha-adrenergic agonist; plant metabolite
pyridostigmine bromide	[no description available]	medium	1	0	pyridinium salt
imipramine hydrochloride	[no description available]	medium	1	0	hydrochloride	antidepressant
neostigmine bromide	[no description available]	medium	1	0	bromide salt
edrophonium chloride	[no description available]	medium	1	0	chloride salt; quaternary ammonium salt	antidote; diagnostic agent; EC 3.1.1.8 (cholinesterase) inhibitor
suramin sodium	[no description available]	medium	1	0	organic sodium salt	angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug
pyrazolanthrone	[no description available]	medium	2	0	anthrapyrazole; aromatic ketone; cyclic ketone	antineoplastic agent; c-Jun N-terminal kinase inhibitor; geroprotector
methapyrilene hydrochloride	[no description available]	medium	1	0	hydrochloride	anti-allergic agent; carcinogenic agent; H1-receptor antagonist; sedative
tetrracaine hydrochloride	[no description available]	medium	1	0	benzoate ester
chelidamic acid	[no description available]	medium	1	0
2-chloroadenosine	[no description available]	medium	2	0	purine nucleoside
diphenhydramine hydrochloride	[no description available]	medium	1	0	hydrochloride; organoammonium salt	anti-allergic agent; antiemetic; antiparkinson drug; antipruritic drug; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; sedative
cysteamine hydrochloride	[no description available]	medium	1	0
propantheline bromide	[no description available]	medium	1	0	xanthenes
hydralazine hydrochloride	[no description available]	medium	1	0	hydrochloride	antihypertensive agent; vasodilator agent
ethamivan	[no description available]	medium	1	0	methoxybenzenes; phenols
pargyline hydrochloride	[no description available]	medium	1	0
aminophylline	[no description available]	medium	1	0	mixture	bronchodilator agent; cardiotonic drug
azacitidine	[no description available]	medium	1	0	N-glycosyl-1,3,5-triazine; nucleoside analogue	antineoplastic agent
orphenadrine hydrochloride	[no description available]	medium	1	0	hydrochloride	antiparkinson drug; H1-receptor antagonist; muscarinic antagonist; muscle relaxant; NMDA receptor antagonist; parasympatholytic
betamethasone	[no description available]	medium	1	0	11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	anti-asthmatic agent; anti-inflammatory drug; immunosuppressive agent
benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide	[no description available]	medium	1	0
cyproterone acetate	[no description available]	medium	1	0	20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; chlorinated steroid; steroid ester	androgen antagonist; geroprotector; progestin
bicuculline	[no description available]	medium	94	0	benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines	agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin
kainic acid	[no description available]	medium	74	0	dicarboxylic acid; L-proline derivative; non-proteinogenic L-alpha-amino acid; pyrrolidinecarboxylic acid	antinematodal drug; excitatory amino acid agonist
podophyllotoxin	[no description available]	medium	2	0	furonaphthodioxole; lignan; organic heterotetracyclic compound	antimitotic; antineoplastic agent; keratolytic drug; microtubule-destabilising agent; plant metabolite; tubulin modulator
tetrahydrozoline hydrochloride	[no description available]	medium	1	0	hydrochloride	nasal decongestant; sympathomimetic agent; vasoconstrictor agent
dequalinium chloride	[no description available]	medium	1	0	organic chloride salt	antifungal agent; antineoplastic agent; antiseptic drug; mitochondrial NADH:ubiquinone reductase inhibitor
decamethonium dibromide	[no description available]	medium	1	0
amitriptyline hydrochloride	[no description available]	medium	1	0	organic tricyclic compound
naphazoline hydrochloride	[no description available]	medium	1	0	organic molecular entity
doxylamine succinate	[no description available]	medium	1	0	organic molecular entity
carbamylhydrazine monohydrochloride	[no description available]	medium	1	0	organic molecular entity
formestane	[no description available]	medium	1	0	17-oxo steroid; 3-oxo-Delta(4) steroid; enol; hydroxy steroid	antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor
debrisoquin sulfate	[no description available]	medium	1	0	organic sulfate salt
betaine hydrochloride	[no description available]	medium	1	0
bethanechol chloride	[no description available]	medium	1	0	carbamate ester; chloride salt; quaternary ammonium salt	muscarinic agonist
acetylcysteine	[no description available]	high	55	3	acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid	antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary
acetylcysteine	[no description available]	high	55	0	acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid	antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary
Mecamylamine hydrochloride	[no description available]	medium	1	0	monoterpenoid
vinblastine	[no description available]	medium	1	0
cyproheptadine hydrochloride (anhydrous)	[no description available]	medium	1	0	hydrochloride
5 alpha-androstane-3 alpha,17 beta-diol	[no description available]	medium	1	0	androstane-3alpha,17beta-diol	Daphnia magna metabolite; human metabolite
pimozide	[no description available]	medium	4	0	benzimidazoles; heteroarylpiperidine; organofluorine compound	antidyskinesia agent; dopaminergic antagonist; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist
azetidyl-2-carboxylic acid	[no description available]	medium	2	0	azetidine-2-carboxylic acid
muscarine	[no description available]	medium	1	0
antazoline hydrochloride	[no description available]	medium	1	0
doxifluridine	[no description available]	medium	1	0	organofluorine compound; pyrimidine 5'-deoxyribonucleoside	antimetabolite; antineoplastic agent; prodrug
meclofenoxate hydrochloride	[no description available]	medium	1	0
clonidine hydrochloride	[no description available]	medium	1	0	dichlorobenzene
beclomethasone	[no description available]	medium	1	0	11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; chlorinated steroid; corticosteroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	anti-asthmatic drug; anti-inflammatory drug
buthionine sulfoximine	[no description available]	medium	8	0	diastereoisomeric mixture; homocysteines; non-proteinogenic alpha-amino acid; sulfoximide	EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor; ferroptosis inducer
mexiletine hydrochloride	[no description available]	medium	1	0	hydrochloride	anti-arrhythmia drug
cyclophosphamide	[no description available]	medium	1	0	hydrate	alkylating agent; antineoplastic agent; carcinogenic agent; immunosuppressive agent
suxamethonium chloride	[no description available]	medium	1	0	chloride salt	muscle relaxant
cyclobenzaprine hydrochloride	[no description available]	medium	1	0	hydrochloride	antidepressant; muscle relaxant
n-methylaspartate	[no description available]	medium	73	0	amino dicarboxylic acid; D-alpha-amino acid; D-aspartic acid derivative; secondary amino compound	neurotransmitter agent
3-deazaadenosine	[no description available]	medium	1	0
metoclopramide hydrochloride	[no description available]	medium	1	0
isoetharine mesylate	[no description available]	medium	1	0
zalcitabine	[no description available]	medium	1	0	pyrimidine 2',3'-dideoxyribonucleoside	antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor
propionylpromazine hydrochloride	[no description available]	medium	1	0
camptothecin	[no description available]	medium	1	0	delta-lactone; pyranoindolizinoquinoline; quinoline alkaloid; tertiary alcohol	antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; genotoxin; plant metabolite
nsc-145,668	[no description available]	medium	1	0	hydrochloride	antimetabolite; antineoplastic agent
clodronic acid	[no description available]	medium	1	0	1,1-bis(phosphonic acid); one-carbon compound; organochlorine compound	antineoplastic agent; bone density conservation agent
benserazide hydrochloride	[no description available]	medium	1	0	hydrochloride	antiparkinson drug; dopaminergic agent; EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor
pancuronium bromide	[no description available]	medium	1	0	bromide salt	cholinergic antagonist; muscle relaxant; nicotinic antagonist
tetradecanoylphorbol acetate	[no description available]	medium	35	0	acetate ester; diester; phorbol ester; tertiary alpha-hydroxy ketone; tetradecanoate ester	antineoplastic agent; apoptosis inducer; carcinogenic agent; mitogen; plant metabolite; protein kinase C agonist; reactive oxygen species generator
danazol	[no description available]	medium	1	0	17beta-hydroxy steroid; terminal acetylenic compound	anti-estrogen; estrogen antagonist; geroprotector
metergoline	[no description available]	medium	1	0	carbamate ester; ergoline alkaloid	dopamine agonist; geroprotector; serotonergic antagonist
lisuride	[no description available]	medium	2	0	monocarboxylic acid amide	antidyskinesia agent; antiparkinson drug; dopamine agonist; serotonergic agonist
disopyramide phosphate	[no description available]	medium	1	0	organoammonium phosphate
bromocriptine	[no description available]	medium	3	0	indole alkaloid	antidyskinesia agent; antiparkinson drug; dopamine agonist; hormone antagonist
ergocristine	[no description available]	medium	1	0	ergot alkaloid
triamcinolone	[no description available]	medium	2	0	11beta-hydroxy steroid; 16alpha-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	anti-allergic agent; anti-inflammatory drug
zidovudine	[no description available]	medium	2	0	azide; pyrimidine 2',3'-dideoxyribonucleoside	antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor
paclitaxel	[no description available]	high	4	0	taxane diterpenoid; tetracyclic diterpenoid	antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent
buspirone hydrochloride	[no description available]	medium	1	0	hydrochloride	anxiolytic drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; sedative; serotonergic agonist
etoposide	[no description available]	medium	3	0	beta-D-glucoside; furonaphthodioxole; organic heterotetracyclic compound	antineoplastic agent; DNA synthesis inhibitor
propafenone hydrochloride	[no description available]	medium	1	0	hydrochloride	anti-arrhythmia drug
etazolate hydrochloride	[no description available]	medium	1	0
butaclamol	[no description available]	medium	1	0	amino alcohol; organic heteropentacyclic compound; tertiary alcohol; tertiary amino compound	dopaminergic antagonist
ribavirin	[no description available]	medium	2	0	1-ribosyltriazole; aromatic amide; monocarboxylic acid amide; primary carboxamide	anticoronaviral agent; antiinfective agent; antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
carbidopa	[no description available]	medium	1	0	catechols; hydrate; hydrazines; monocarboxylic acid	antidyskinesia agent; antiparkinson drug; dopaminergic agent; EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor
cephradine	[no description available]	medium	1	0	beta-lactam antibiotic allergen; cephalosporin	antibacterial drug
methyldopa	[no description available]	medium	2	0	L-tyrosine derivative; non-proteinogenic L-alpha-amino acid	alpha-adrenergic agonist; antihypertensive agent; hapten; peripheral nervous system drug; sympatholytic agent
lonidamine	[no description available]	medium	1	0	dichlorobenzene; indazoles; monocarboxylic acid	antineoplastic agent; antispermatogenic agent; EC 2.7.1.1 (hexokinase) inhibitor; geroprotector
dexibuprofen	[no description available]	medium	1	0	ibuprofen	non-narcotic analgesic; non-steroidal anti-inflammatory drug
quisqualic acid	[no description available]	medium	18	0	non-proteinogenic alpha-amino acid
pirfenidone	[no description available]	medium	2	0	pyridone	antipyretic; non-narcotic analgesic; non-steroidal anti-inflammatory drug
flecainide acetate	[no description available]	medium	1	0	acetate salt	anti-arrhythmia drug
nicardipine hydrochloride	[no description available]	medium	1	0	dihydropyridine	geroprotector
idarubicin	[no description available]	medium	1	0	anthracycline antibiotic; deoxy hexoside; monosaccharide derivative
captopril	[no description available]	medium	8	0	alkanethiol; L-proline derivative; N-acylpyrrolidine; pyrrolidinemonocarboxylic acid	antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
terazosin hydrochloride anhydrous	[no description available]	medium	1	0
pergolide mesylate	[no description available]	medium	1	0	methanesulfonate salt	antiparkinson drug; dopamine agonist; geroprotector
ranitidine hydrochloride	[no description available]	medium	1	0
colforsin	[no description available]	medium	21	0	acetate ester; cyclic ketone; labdane diterpenoid; organic heterotricyclic compound; tertiary alpha-hydroxy ketone; triol	adenylate cyclase agonist; anti-HIV agent; antihypertensive agent; plant metabolite; platelet aggregation inhibitor; protein kinase A agonist
colforsin	[no description available]	medium	21	1	acetate ester; cyclic ketone; labdane diterpenoid; organic heterotricyclic compound; tertiary alpha-hydroxy ketone; triol	adenylate cyclase agonist; anti-HIV agent; antihypertensive agent; plant metabolite; platelet aggregation inhibitor; protein kinase A agonist
cefaclor anhydrous	[no description available]	medium	1	0	cephalosporin	antibacterial drug; drug allergen
alo 2145	[no description available]	medium	1	0	hydrochloride	alpha-adrenergic agonist; antiglaucoma drug
enoximone	[no description available]	medium	1	0	aromatic ketone
atomoxetine	[no description available]	medium	1	0	aromatic ether; secondary amino compound; toluenes	adrenergic uptake inhibitor; antidepressant; environmental contaminant; xenobiotic
raloxifene hydrochloride	[no description available]	medium	2	0	hydrochloride	bone density conservation agent; estrogen antagonist; estrogen receptor modulator
mifepristone	[no description available]	medium	3	0	3-oxo-Delta(4) steroid; acetylenic compound; tertiary amino compound	abortifacient; contraceptive drug; hormone antagonist; synthetic oral contraceptive
quinpirole hydrochloride	[no description available]	medium	1	0
imazodan	[no description available]	medium	1	0
mibefradil dihydrochloride	[no description available]	medium	1	0
aptiganel hydrochloride	[no description available]	medium	1	0
adenosine	[no description available]	high	29	0	adenosines; purines D-ribonucleoside	analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent
phenelzine sulfate	[no description available]	medium	1	0	organic molecular entity
fluoxetine hydrochloride	[no description available]	medium	1	0	hydrochloride; N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
propranolol hydrochloride	[no description available]	medium	1	0	hydrochloride
bupropion hydrochloride	[no description available]	medium	1	0	aromatic ketone
diltiazem hydrochloride	[no description available]	medium	1	0	hydrochloride	antihypertensive agent; calcium channel blocker; vasodilator agent
trazodone hydrochloride	[no description available]	medium	5	0	hydrochloride	adrenergic antagonist; antidepressant; H1-receptor antagonist; sedative; serotonin uptake inhibitor
trazodone hydrochloride	[no description available]	medium	5	1	hydrochloride	adrenergic antagonist; antidepressant; H1-receptor antagonist; sedative; serotonin uptake inhibitor
verapamil hydrochloride	[no description available]	medium	1	0
doxazosin mesylate	[no description available]	medium	1	0	methanesulfonate salt	geroprotector
amantadine hydrochloride	[no description available]	medium	1	0	hydrochloride	antiviral agent; dopamine agonist; NMDA receptor antagonist
mevastatin	[no description available]	medium	1	0	2-pyranones; carboxylic ester; hexahydronaphthalenes; polyketide; statin (naturally occurring)	antifungal agent; apoptosis inducer; EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor; fungal metabolite; Penicillium metabolite
chloroquine diphosphate	[no description available]	medium	1	0
dobutamine hydrochloride	[no description available]	medium	1	0	hydrochloride	beta-adrenergic agonist; cardiotonic drug; sympathomimetic agent
desipramine hydrochloride	[no description available]	medium	1	0	hydrochloride	drug allergen
dopamine hydrochloride	[no description available]	medium	1	0	catecholamine
proadifen hydrochloride	[no description available]	medium	1	0
4-nitrobenzylthioinosine	[no description available]	medium	3	0	purine nucleoside
metrifudil	[no description available]	medium	1	0
rutecarpine	[no description available]	medium	1	0	beta-carbolines
trihexyphenidyl hydrochloride	[no description available]	medium	1	0	aralkylamine
thioridazine hydrochloride	[no description available]	medium	1	0	hydrochloride	first generation antipsychotic; geroprotector
procainamide hydrochloride	[no description available]	medium	1	0	hydrochloride	anti-arrhythmia drug
siquil	[no description available]	medium	1	0	hydrochloride	anticoronaviral agent
sotalol hydrochloride	[no description available]	medium	1	0	hydrochloride	anti-arrhythmia drug; beta-adrenergic antagonist
oxymetazoline hydrochloride	[no description available]	medium	1	0	hydrochloride	alpha-adrenergic agonist; nasal decongestant; sympathomimetic agent; vasoconstrictor agent
alprenolol hydrochloride	[no description available]	medium	1	0	hydrochloride
2-methoxyestradiol	[no description available]	medium	1	0	17beta-hydroxy steroid; 3-hydroxy steroid	angiogenesis modulating agent; antimitotic; antineoplastic agent; human metabolite; metabolite; mouse metabolite
fluphenazine hydrochloride	[no description available]	medium	1	0	phenothiazines	anticoronaviral agent
tryptamine monohydrochloride	[no description available]	medium	1	0
clomipramine hydrochloride	[no description available]	medium	1	0	hydrochloride	anticoronaviral agent; antidepressant; serotonergic antagonist; serotonergic drug
amiloride hydrochloride	[no description available]	medium	1	0	hydrate	diuretic; sodium channel blocker
prazosin hydrochloride	[no description available]	medium	1	0	hydrochloride
mianserin hydrochloride	[no description available]	medium	1	0	hydrochloride	geroprotector
lomefloxacin hydrochloride	[no description available]	medium	1	0	hydrochloride	antimicrobial agent; antitubercular agent; photosensitizing agent
fenspiride hydrochloride	[no description available]	medium	1	0
nilverm	[no description available]	medium	1	0	organic molecular entity
sanguinarine chloride	[no description available]	medium	1	0
ropinirole hydrochloride	[no description available]	medium	1	0	indoles
plasmenylserine	[no description available]	medium	1	0	O-phosphoserine	EC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor; EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor; EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
5-aminovaleric acid hydrochloride	[no description available]	medium	1	0
n-acetyltryptamine	[no description available]	medium	2	0	acetamides; indoles
D-serine	[no description available]	medium	2	0	D-alpha-amino acid; serine zwitterion; serine	Escherichia coli metabolite; human metabolite; NMDA receptor agonist
dihydroergotamine mesylate	[no description available]	medium	1	0	methanesulfonate salt	non-narcotic analgesic; serotonergic agonist; vasoconstrictor agent
ranolazine hydrochloride	[no description available]	medium	1	0
loxapine succinate	[no description available]	medium	1	0	succinate salt	geroprotector
guanfacine hydrochloride	[no description available]	medium	1	0	acetamides	geroprotector
pirenzepine dihydrochloride	[no description available]	medium	1	0	hydrochloride
labetalol hydrochloride	[no description available]	medium	1	0	salicylamides
acecainide hydrochloride	[no description available]	medium	1	0
loperamide hydrochloride	[no description available]	medium	1	0	hydrochloride	anticoronaviral agent; antidiarrhoeal drug; mu-opioid receptor agonist
maprotiline hydrochloride	[no description available]	medium	1	0	anthracenes
protoporphyrin ix, disodium salt	[no description available]	medium	1	0
siguazodan	[no description available]	medium	1	0	pyridazinone
3-octadecanamido-2-ethoxypropylphosphocholine	[no description available]	medium	1	0
chelerythrine chloride	[no description available]	medium	1	0
tosyllysine chloromethyl ketone	[no description available]	medium	1	0
5-(n-methyl-n-isobutyl)amiloride	[no description available]	medium	2	0
1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride	[no description available]	medium	1	0	hydrochloride	EC 2.7.11.13 (protein kinase C) inhibitor
amperozide hydrochloride	[no description available]	medium	1	0	hydrochloride	anxiolytic drug; dopamine uptake inhibitor; geroprotector; second generation antipsychotic; serotonergic antagonist
pyrrolidine dithiocarbamic acid	[no description available]	medium	1	0
agroclavine	[no description available]	medium	1	0	ergot alkaloid
s-methylisothiourea sulfate	[no description available]	medium	1	0
p-Aminobenzamidine dihydrochloride	[no description available]	medium	1	0	organic molecular entity
benzamidine hydrochloride	[no description available]	medium	1	0
ketorolac tromethamine	[no description available]	medium	2	0	organoammonium salt	analgesic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor
methionine sulfoximine	[no description available]	medium	1	0	L-alpha-amino acid zwitterion; L-methionine derivative; methionine sulfoximine; non-proteinogenic L-alpha-amino acid	EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor; geroprotector
tretazicar	[no description available]	medium	1	0
carbetapentane citrate	[no description available]	medium	1	0	carbonyl compound
phentolamine mesylate	[no description available]	medium	1	0
mephentermine	[no description available]	medium	1	0	2-aminooctadecane-1,3-diol	EC 2.7.11.13 (protein kinase C) inhibitor; human metabolite; mouse metabolite
oxybutynin hydrochloride	[no description available]	medium	1	0	hydrochloride
nimustine	[no description available]	medium	1	0	hydrochloride	antineoplastic agent
cordium	[no description available]	medium	1	0	hydrate; hydrochloride
L-2-aminoadipic acid	[no description available]	medium	1	0	2-aminoadipic acid	Escherichia coli metabolite; human metabolite
prilocaine hydrochloride	[no description available]	medium	1	0	hydrochloride	local anaesthetic
mor-14	[no description available]	medium	1	0	hydroxypiperidine; piperidine alkaloid; tertiary amino compound	anti-HIV agent; cardioprotective agent; EC 3.2.1.20 (alpha-glucosidase) inhibitor; plant metabolite
brexanolone	[no description available]	medium	1	0	3-hydroxy-5alpha-pregnan-20-one	antidepressant; GABA modulator; human metabolite; intravenous anaesthetic; sedative
phenylisopropyladenosine	[no description available]	medium	1	0	aromatic amine; benzenes; hydrocarbyladenosine; purine nucleoside; secondary amino compound	adenosine A1 receptor agonist; neuroprotective agent
hexamethonium chloride	[no description available]	medium	1	0
6-(4-nitrobenzylthio)guanosine	[no description available]	medium	1	0
3-aminopropylphosphonic acid	[no description available]	medium	2	0	phosphonic acids; primary amino compound; zwitterion	GABAB receptor agonist
5'-n-methylcarboxamideadenosine	[no description available]	medium	1	0
3,7-dimethyl-1-propargylxanthine	[no description available]	medium	1	0
zpck	[no description available]	medium	1	0
n(6)-phenyladenosine	[no description available]	medium	1	0	purine nucleoside
tetrahydrodeoxycorticosterone	[no description available]	medium	4	0	21-hydroxy steroid
n-methyladenosine	[no description available]	medium	1	0	methyladenosine
mizoribine	[no description available]	medium	1	0	imidazoles	anticoronaviral agent
1-amino-1,3-dicarboxycyclopentane	[no description available]	medium	3	0
u 73122	[no description available]	medium	5	0	aromatic ether; aza-steroid; maleimides	EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
alphaxalone	[no description available]	medium	4	0	corticosteroid hormone
s-nitrosoglutathione	[no description available]	medium	2	0	glutathione derivative; nitrosothio compound	bronchodilator agent; nitric oxide donor; platelet aggregation inhibitor; signalling molecule
cp-55,940	[no description available]	medium	1	0
vanoxerine	[no description available]	medium	1	0	hydrochloride	dopamine uptake inhibitor
methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate	[no description available]	medium	1	0	beta-carbolines
u 69593	[no description available]	medium	1	0	monocarboxylic acid amide; N-alkylpyrrolidine; organic heterobicyclic compound; oxaspiro compound	anti-inflammatory agent; diuretic; kappa-opioid receptor agonist
cv 3988	[no description available]	medium	1	0
beta-carboline-3-carboxylic acid methyl ester	[no description available]	medium	1	0	beta-carbolines
methoctramine	[no description available]	medium	1	0	hydrochloride	muscarinic antagonist
hypotaurine	[no description available]	high	269	0	aminosulfinic acid; zwitterion	human metabolite; metabolite; mouse metabolite
hypotaurine	[no description available]	high	269	1	aminosulfinic acid; zwitterion	human metabolite; metabolite; mouse metabolite
dihydrokainate	[no description available]	medium	6	0	dicarboxylic acid
gabazine	[no description available]	medium	1	0
cl 218872	[no description available]	medium	1	0	pyridazines; ring assembly
betaxolol hydrochloride	[no description available]	medium	1	0	hydrochloride	antihypertensive agent; beta-adrenergic antagonist
catechin	[no description available]	medium	1	0	hydrate	geroprotector
1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine	[no description available]	medium	1	0	hydrobromide	serotonergic antagonist
s-methylthiocitrulline	[no description available]	medium	1	0	imidothiocarbamic ester; L-arginine derivative; L-ornithine derivative; non-proteinogenic L-alpha-amino acid	EC 1.14.13.39 (nitric oxide synthase) inhibitor; neuroprotective agent
dihydrocapsaicin	[no description available]	medium	1	0	capsaicinoid
ml 9	[no description available]	medium	1	0
parthenolide	[no description available]	medium	1	0	germacranolide
3',4'-dichlorobenzamil	[no description available]	medium	2	0	guanidines; pyrazines
1-(carboxymethylthio)tetradecane	[no description available]	medium	1	0	straight-chain fatty acid
2-iodomelatonin	[no description available]	medium	1	0	acetamides
arcaine, sulfate	[no description available]	medium	1	0
gr 113808	[no description available]	medium	1	0	indolyl carboxylate ester; piperidines; sulfonamide	serotonergic antagonist
gallopamil hydrochloride	[no description available]	medium	1	0
gamma-glutamylaminomethylsulfonic acid	[no description available]	medium	2	0
buthionine sulfoximine	[no description available]	medium	1	0	2-amino-4-(S-butylsulfonimidoyl)butanoic acid	EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor; ferroptosis inducer
sb 204070a	[no description available]	medium	1	0
1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine	[no description available]	medium	1	0	(trifluoromethyl)benzenes; N-alkylpiperazine; N-arylpiperazine; primary arylamine; substituted aniline	geroprotector; serotonergic agonist
l 655240	[no description available]	medium	1	0	methylindole
san 58035	[no description available]	medium	1	0
nnc 711	[no description available]	medium	2	0
4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide	[no description available]	medium	1	0	diarylmethane
e 64	[no description available]	medium	1	0	dicarboxylic acid monoamide; epoxy monocarboxylic acid; guanidines; L-leucine derivative; zwitterion	antimalarial; antiparasitic agent; protease inhibitor
azetidine-2,4-dicarboxylic acid	[no description available]	medium	1	0
pre 084	[no description available]	medium	1	0	morpholines
methotrexate	[no description available]	medium	9	0	dicarboxylic acid; monocarboxylic acid amide; pteridines	abortifacient; antimetabolite; antineoplastic agent; antirheumatic drug; dermatologic drug; DNA synthesis inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; immunosuppressive agent
1-(2-allylphenoxy)-3-((8-bromoacetylamino-4-menthane-1-yl)amino)-1-propanol	[no description available]	medium	1	0
sr 2640	[no description available]	medium	1	0	quinolines
ici 204448	[no description available]	medium	1	0
4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride	[no description available]	medium	1	0
n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide	[no description available]	medium	1	0	phenylindole
3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan	[no description available]	medium	1	0
8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine	[no description available]	medium	1	0
l 741626	[no description available]	medium	1	0	piperidines
nisoxetine hydrochloride	[no description available]	medium	1	0
ng-nitroarginine methyl ester	[no description available]	medium	1	0	hydrochloride	EC 1.14.13.39 (nitric oxide synthase) inhibitor
tilarginine acetate	[no description available]	medium	1	0
alpha-guanidinoglutaric acid	[no description available]	medium	1	0	L-glutamic acid derivative
3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(+-)-isomer	[no description available]	medium	1	0
imidazole-4-acetic acid hydrochloride	[no description available]	medium	1	0
nsc-141549	[no description available]	medium	1	0
2-chloro-2-deoxyglucose	[no description available]	medium	1	0
idazoxan hydrochloride	[no description available]	medium	1	0
isoguvacine hydrochloride	[no description available]	medium	1	0
8-methoxymethyl-3-isobutyl-1-methylxanthine	[no description available]	medium	1	0	oxopurine
cyc 202	[no description available]	medium	1	0	2,6-diaminopurines	antiviral drug; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
Serotonin hydrochloride	[no description available]	medium	1	0	tryptamines
n-phthaloylglutamic acid	[no description available]	medium	1	0	L-glutamic acid derivative; phthalimides
1,3-dipropyl-7-methylxanthine	[no description available]	medium	1	0
ag 3-5	[no description available]	medium	1	0	C-nitro compound
n-n-propylnorapomorphine	[no description available]	medium	1	0	aporphine alkaloid
urapidil monohydrochloride	[no description available]	medium	1	0
aminopterin	[no description available]	medium	2	0	dicarboxylic acid	EC 1.5.1.3 (dihydrofolate reductase) inhibitor; mutagen
azepexole, dihydrochloride	[no description available]	medium	1	0
2,5-dimethoxy-4-iodoamphetamine hydrochloride	[no description available]	medium	1	0
abt 980	[no description available]	medium	1	0
sk&f 75670	[no description available]	medium	1	0
esatenolol	[no description available]	medium	1	0	atenolol	beta-adrenergic antagonist
nbi 27914	[no description available]	medium	1	0	dialkylarylamine; tertiary amino compound
sb 216763	[no description available]	medium	1	0	indoles; maleimides
(R)-atenolol	[no description available]	medium	1	0	atenolol
memantine hydrochloride	[no description available]	medium	1	0	hydrochloride	antidepressant; antiparkinson drug; dopaminergic agent; neuroprotective agent; NMDA receptor antagonist
pefabloc	[no description available]	medium	1	0
pongidae	[no description available]	medium	1	0
succinylproline	[no description available]	medium	1	0	N-acyl-amino acid
sb 205384	[no description available]	medium	1	0	thienopyridine
hydrastine	[no description available]	medium	1	0	isoquinolines	metabolite
gabaculine hydrochloride	[no description available]	medium	1	0
etiron monohydrobromide	[no description available]	medium	1	0
bmy 7378	[no description available]	medium	1	0
vesamicol	[no description available]	medium	1	0
cortisone	[no description available]	high	6	0	11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	human metabolite; mouse metabolite
vincristine sulfate	[no description available]	medium	1	0	organic sulfate salt	antineoplastic agent; geroprotector
n-methylserotonin oxalate salt	[no description available]	medium	1	0
nsc 95397	[no description available]	medium	1	0	1,4-naphthoquinones
wortmannin	[no description available]	medium	5	0	acetate ester; cyclic ketone; delta-lactone; organic heteropentacyclic compound	anticoronaviral agent; antineoplastic agent; autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector; Penicillium metabolite; radiosensitizing agent
lithium chloride	[no description available]	medium	2	0	inorganic chloride; lithium salt	antimanic drug; geroprotector
canavanine	[no description available]	medium	3	0	amino acid zwitterion; non-proteinogenic L-alpha-amino acid	phytogenic insecticide; plant metabolite
5-hydroxytryptophan	[no description available]	medium	1	0	5-hydroxytryptophan; amino acid zwitterion; hydroxy-L-tryptophan; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite; plant metabolite
ouabain	[no description available]	medium	62	0	11alpha-hydroxy steroid; 14beta-hydroxy steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; cardenolide glycoside; steroid hormone	anti-arrhythmia drug; cardiotonic drug; EC 2.3.3.1 [citrate (Si)-synthase] inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; ion transport inhibitor; plant metabolite
tosylphenylalanyl chloromethyl ketone	[no description available]	medium	1	0	alpha-chloroketone; sulfonamide	alkylating agent; serine proteinase inhibitor
monoiodotyrosine	[no description available]	medium	1	0	amino acid zwitterion; L-tyrosine derivative; monoiodotyrosine; non-proteinogenic L-alpha-amino acid	EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor; human metabolite; mouse metabolite
nitroarginine	[no description available]	medium	6	0	guanidines; L-arginine derivative; N-nitro compound; non-proteinogenic L-alpha-amino acid
willardiine	[no description available]	medium	1	0	amino acid zwitterion; L-alanine derivative; non-proteinogenic L-alpha-amino acid
cortodoxone	[no description available]	medium	1	0	deoxycortisol; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	human metabolite; mouse metabolite
amiodarone hydrochloride	[no description available]	medium	1	0	aromatic ketone
dicyclomine hydrochloride	[no description available]	medium	1	0	hydrochloride	antispasmodic drug; muscarinic antagonist
metyrosine	[no description available]	medium	1	0	L-tyrosine derivative; non-proteinogenic L-alpha-amino acid	antihypertensive agent; EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor
nortriptyline hydrochloride	[no description available]	medium	1	0	organic tricyclic compound	geroprotector
paromomycin sulfate	[no description available]	medium	1	0
Dubinidine	[no description available]	medium	1	0	organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle
cyclopamine	[no description available]	medium	2	0	piperidines	glioma-associated oncogene inhibitor
s-(4-azidophenacyl)glutathione	[no description available]	medium	1	0	peptide
hydroxylamine hydrochloride	[no description available]	medium	1	0	organic molecular entity
sb 228357	[no description available]	medium	1	0	indolyl carboxylic acid
3,5-dihydroxyphenylglycine	[no description available]	medium	1	0	amino acid zwitterion; non-proteinogenic L-alpha-amino acid; resorcinols
actinonin	[no description available]	medium	1	0
vinpocetine	[no description available]	medium	1	0	alkaloid	geroprotector
dihydroergocristine monomesylate	[no description available]	medium	1	0	methanesulfonate salt	alpha-adrenergic antagonist; geroprotector; vasodilator agent
tretinoin	[no description available]	high	11	0	retinoic acid; vitamin A	anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule
resveratrol	[no description available]	high	7	0	resveratrol	antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger
oleic acid	[no description available]	high	9	0	octadec-9-enoic acid	antioxidant; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; mouse metabolite; plant metabolite; solvent
thapsigargin	[no description available]	medium	6	0	butyrate ester; organic heterotricyclic compound; sesquiterpene lactone	calcium channel blocker; EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
brivudine	[no description available]	medium	1	0
5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol	[no description available]	medium	1	0	carbotetracyclic compound; polyphenol	estrogen receptor agonist; estrogen receptor antagonist; geroprotector; neuroprotective agent
2-amino-3-(5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl)propionic acid	[no description available]	medium	1	0
adenosine-5'-(n-ethylcarboxamide)	[no description available]	medium	3	0	adenosines; monocarboxylic acid amide	adenosine A1 receptor agonist; adenosine A2A receptor agonist; antineoplastic agent; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent
L-cycloserine	[no description available]	medium	2	0	4-amino-1,2-oxazolidin-3-one	anti-HIV agent; anticonvulsant; EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor
1,4-dideoxy-1,4-imino-d-arabinitol	[no description available]	medium	1	0
purvalanol a	[no description available]	medium	1	0	purvalanol
melphalan	[no description available]	medium	2	0	L-phenylalanine derivative; nitrogen mustard; non-proteinogenic L-alpha-amino acid; organochlorine compound	alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent
isoliquiritigenin	[no description available]	medium	1	0	chalcones	antineoplastic agent; biological pigment; EC 1.14.18.1 (tyrosinase) inhibitor; GABA modulator; geroprotector; metabolite; NMDA receptor antagonist
rauwolscine	[no description available]	medium	1	0	methyl 17-hydroxy-20xi-yohimban-16-carboxylate
gw9662	[no description available]	medium	1	0	benzamides
calmidazolium	[no description available]	medium	1	0	organic chloride salt	apoptosis inducer; calmodulin antagonist
tropisetron hydrochloride	[no description available]	medium	1	0
Reactive blue 2	[no description available]	medium	1	0	anthraquinone
5,6-dichloro-1-ethyl-1,3-dihydro-2h-benzimidazol-2-one	[no description available]	medium	1	0	dichlorobenzene
quinidine sulfate	[no description available]	medium	1	0
ipratropium bromide anhydrous	[no description available]	medium	1	0
methamilane methiodide	[no description available]	medium	1	0
pilocarpine nitrate	[no description available]	medium	1	0
r 59949	[no description available]	medium	1	0	diarylmethane
n(6)-cyclopentyladenosine	[no description available]	medium	2	0
methylatropine nitrate	[no description available]	medium	1	0
sb 366791	[no description available]	medium	1	0
ag-213	[no description available]	medium	1	0
3,3',4,5'-tetrahydroxystilbene	[no description available]	medium	3	0	catechols; polyphenol; resorcinols; stilbenol	antineoplastic agent; apoptosis inducer; geroprotector; hypoglycemic agent; plant metabolite; protein kinase inhibitor; tyrosine kinase inhibitor
bemesetron	[no description available]	medium	1	0
(S)-(-)-pindolol	[no description available]	medium	1	0	pindolol
levosulpiride	[no description available]	medium	1	0	sulpiride	antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist
caffeic acid	[no description available]	medium	1	0	caffeic acid	geroprotector; mouse metabolite
4-fluorophenyl-L-alanine	[no description available]	medium	1	0	4-fluorophenylalanine; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid
urocanic acid	[no description available]	high	2	0	urocanic acid	human metabolite
cotinine	[no description available]	medium	1	0	N-alkylpyrrolidine; pyridines; pyrrolidin-2-ones; pyrrolidine alkaloid	antidepressant; biomarker; human xenobiotic metabolite; plant metabolite
cinnarizine	[no description available]	medium	1	0	diarylmethane; N-alkylpiperazine; olefinic compound	anti-allergic agent; antiemetic; calcium channel blocker; geroprotector; H1-receptor antagonist; histamine antagonist; muscarinic antagonist
sulindac	[no description available]	medium	2	0	monocarboxylic acid; organofluorine compound; sulfoxide	analgesic; antineoplastic agent; antipyretic; apoptosis inducer; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug; tocolytic agent
cysteine sulfinic acid	[no description available]	medium	1	0	organosulfinic acid; S-substituted L-cysteine	Escherichia coli metabolite; human metabolite; metabotropic glutamate receptor agonist; mouse metabolite
d-ap7	[no description available]	medium	1	0
(1R,2S)-tranylcypromine hydrochloride	[no description available]	medium	1	0	hydrochloride
tacrine hydrochloride	[no description available]	medium	1	0
4-bromotetramisole, oxalate (1:1), salt(s)-isomer	[no description available]	medium	1	0
3-hydroxybenzylhydrazine hydrochloride	[no description available]	medium	1	0
1-(3-chlorophenyl)biguanide hydrochloride	[no description available]	medium	1	0
4-chlorophenylalanine methyl ester, hydrochloride, (dl)-isomer	[no description available]	medium	1	0
capsazepine	[no description available]	medium	1	0	benzazepine; catechols; monochlorobenzenes; thioureas	capsaicin receptor antagonist
diphenyleneiodium chloride	[no description available]	medium	1	0	organic chloride salt	EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor; G-protein-coupled receptor agonist
azetidine-2,4-dicarboxylic acid, (cis)-isomer	[no description available]	medium	1	0
tamoxifen citrate	[no description available]	medium	1	0	citrate salt	angiogenesis inhibitor; anticoronaviral agent
pimagedine hydrochloride	[no description available]	medium	1	0
Betaine Aldehyde Chloride	[no description available]	medium	1	0	quaternary ammonium salt
eskazine	[no description available]	medium	1	0
monastrol	[no description available]	medium	1	0	enoate ester; ethyl ester; phenols; racemate; thioureas	antileishmanial agent; antimitotic; antineoplastic agent; EC 3.5.1.5 (urease) inhibitor
u 0126	[no description available]	medium	3	0	aryl sulfide; dinitrile; enamine; substituted aniline	antineoplastic agent; antioxidant; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; osteogenesis regulator; vasoconstrictor agent
4-diphenylacetoxy-n-methylpiperidine methiodide	[no description available]	medium	1	0	iodide salt; quaternary ammonium salt	cholinergic antagonist; muscarinic antagonist
1-(4-hydroxybenzyl)imidazole-2-thiol	[no description available]	medium	1	0
2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide	[no description available]	medium	1	0
bp 897	[no description available]	medium	1	0	naphthalenecarboxamide
trequinsin hydrochloride	[no description available]	medium	1	0
neboglamine	[no description available]	medium	1	0
benzatropine methanesulfonate	[no description available]	medium	1	0
sb 203186	[no description available]	medium	1	0	indolyl carboxylic acid
n-(1-methyl-5-indolyl)-n'-(3-methyl-5-isothiazolyl)urea	[no description available]	medium	1	0	1,2-thiazoles; indoles; ureas	receptor modulator; serotonergic antagonist
gw 7647	[no description available]	medium	1	0	aryl sulfide; monocarboxylic acid; ureas	PPARalpha agonist
ro 41-0960	[no description available]	medium	1	0
cgp 13501	[no description available]	medium	1	0	alkylbenzene
n-(2-(4-(4-chlorophenyl)piperazin-1-yl)ethyl)-3-methoxybenzamide	[no description available]	medium	1	0
brl 15572	[no description available]	medium	1	0	monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; secondary alcohol	geroprotector; serotonergic antagonist
mrs 1523	[no description available]	medium	1	0
or486	[no description available]	medium	1	0
fg 9041	[no description available]	medium	5	0	quinoxaline derivative
iik7	[no description available]	medium	1	0
sb 415286	[no description available]	medium	1	0	C-nitro compound; maleimides; monochlorobenzenes; phenols; secondary amino compound; substituted aniline	antioxidant; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent
dm 235	[no description available]	medium	1	0
jhw 015	[no description available]	medium	1	0	indolecarboxamide
bw 723c86	[no description available]	medium	1	0	tryptamines
sc 560	[no description available]	medium	1	0	aromatic ether; monochlorobenzenes; organofluorine compound; pyrazoles	angiogenesis modulating agent; antineoplastic agent; apoptosis inducer; cyclooxygenase 1 inhibitor; non-steroidal anti-inflammatory drug
sc-19220	[no description available]	medium	1	0	aromatic ether
le 300	[no description available]	medium	1	0	indoles
ly 367265	[no description available]	medium	1	0	dihydropyridine; fluoroindole; tertiary amino compound; thiadiazoloquinoline	antidepressant; geroprotector; serotonergic antagonist; serotonin uptake inhibitor
diclofenac sodium	[no description available]	medium	1	0	organic sodium salt
cgp 7930	[no description available]	medium	1	0	alkylbenzene
1,3,5-tris(4-hydroxyphenyl)-4-propyl-1h-pyrazole	[no description available]	medium	1	0	phenols; pyrazoles	estrogen receptor agonist
sib 1757	[no description available]	medium	1	0
sphingosine	[no description available]	high	3	0	sphing-4-enine	human metabolite; mouse metabolite
apigenin	[no description available]	medium	1	0	trihydroxyflavone	antineoplastic agent; metabolite
luteolin	[no description available]	high	2	0	3'-hydroxyflavonoid; tetrahydroxyflavone	angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; c-Jun N-terminal kinase inhibitor; EC 2.3.1.85 (fatty acid synthase) inhibitor; immunomodulator; nephroprotective agent; plant metabolite; radical scavenger; vascular endothelial growth factor receptor antagonist
daphnetin	[no description available]	medium	1	0	hydroxycoumarin
genistein	[no description available]	medium	10	0	7-hydroxyisoflavones	antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor
pulmicort	[no description available]	medium	1	0	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; cyclic acetal; glucocorticoid; primary alpha-hydroxy ketone	anti-inflammatory drug; bronchodilator agent; drug allergen
timolol maleate	[no description available]	medium	1	0	maleate salt	anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist
brompheniramine maleate	[no description available]	medium	1	0	maleate salt	anti-allergic agent
chlorpheniramine maleate	[no description available]	medium	1	0	organic molecular entity
clemastine fumarate	[no description available]	medium	1	0	fumarate salt	anti-allergic agent; antipruritic drug; H1-receptor antagonist; muscarinic antagonist
methylergonovine maleate	[no description available]	medium	1	0	ergoline alkaloid	geroprotector
astaxanthine	[no description available]	medium	1	0	carotenol; carotenone	animal metabolite; anticoagulant; antioxidant; food colouring; plant metabolite
harman	[no description available]	medium	1	0	harmala alkaloid; indole alkaloid fundamental parent; indole alkaloid	anti-HIV agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; plant metabolite
morin	[no description available]	medium	1	0	7-hydroxyflavonol; pentahydroxyflavone	angiogenesis modulating agent; anti-inflammatory agent; antibacterial agent; antihypertensive agent; antineoplastic agent; antioxidant; EC 5.99.1.2 (DNA topoisomerase) inhibitor; hepatoprotective agent; metabolite; neuroprotective agent
myricetin	[no description available]	medium	1	0	7-hydroxyflavonol; hexahydroxyflavone	antineoplastic agent; antioxidant; cyclooxygenase 1 inhibitor; food component; geroprotector; hypoglycemic agent; plant metabolite
daidzein	[no description available]	medium	1	0	7-hydroxyisoflavones	antineoplastic agent; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; phytoestrogen; plant metabolite
caffeic acid phenethyl ester	[no description available]	medium	1	0	alkyl caffeate ester	anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; antiviral agent; immunomodulator; metabolite; neuroprotective agent
rottlerin	[no description available]	medium	1	0	aromatic ketone; benzenetriol; chromenol; enone; methyl ketone	anti-allergic agent; antihypertensive agent; antineoplastic agent; apoptosis inducer; K-ATP channel agonist; metabolite
flupenthixol	[no description available]	medium	1	0	flupenthixol	dopaminergic antagonist
n-oleoyldopamine	[no description available]	medium	1	0	catechols; fatty amide; N-(fatty acyl)-dopamine; secondary carboxamide	TRPV1 agonist
pheniramine maleate	[no description available]	medium	1	0	organic molecular entity
tranilast	[no description available]	medium	1	0	amidobenzoic acid; cinnamamides; dimethoxybenzene; secondary carboxamide	anti-allergic agent; anti-asthmatic drug; antineoplastic agent; aryl hydrocarbon receptor agonist; calcium channel blocker; hepatoprotective agent; nephroprotective agent
trimipramine maleate	[no description available]	medium	1	0	maleate salt	antidepressant
isotretinoin	[no description available]	medium	3	0	retinoic acid	antineoplastic agent; keratolytic drug; teratogenic agent
xylometazoline hydrochloride	[no description available]	medium	1	0
flunarizine hydrochloride	[no description available]	medium	1	0	diarylmethane
ketotifen fumarate	[no description available]	medium	1	0	organoammonium salt	anti-asthmatic drug; H1-receptor antagonist
cis-flupenthixol dihydrochloride	[no description available]	medium	1	0	hydrochloride	geroprotector
n-arachidonylglycine	[no description available]	medium	2	0	fatty amide; N-acylglycine
n-oleoylethanolamine	[no description available]	medium	1	0	endocannabinoid; N-(long-chain-acyl)ethanolamine; N-acylethanolamine 18:1	EC 3.5.1.23 (ceramidase) inhibitor; geroprotector; PPARalpha agonist
cyclosporine	[no description available]	medium	1	0	homodetic cyclic peptide	anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite
phenoxybenzamine hydrochloride	[no description available]	medium	1	0	organic molecular entity
phenylephrine hydrochloride	[no description available]	medium	1	0	hydrochloride
mepyramine maleate	[no description available]	medium	1	0
brefeldin a	[no description available]	medium	2	0	macrolide antibiotic	Penicillium metabolite
fenretinide	[no description available]	medium	1	0	monocarboxylic acid amide; retinoid	antineoplastic agent; antioxidant
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid	[no description available]	medium	1	0	benzoic acids; naphthalenes; retinoid	antineoplastic agent; retinoic acid receptor agonist; teratogenic agent
l-2-(carboxypropyl)glycine	[no description available]	medium	1	0
4-aminocrotonic acid	[no description available]	medium	5	0
denopamine	[no description available]	medium	1	0	dimethoxybenzene
l 655,708	[no description available]	medium	1	0
ro 41-1049	[no description available]	medium	1	0
sb 200646a	[no description available]	medium	1	0
seglitide	[no description available]	medium	1	0
sib 1893	[no description available]	medium	1	0
su 6656	[no description available]	medium	1	0
tyrphostin ag 555	[no description available]	medium	1	0
tyrphostin ag-494	[no description available]	medium	1	0
tyrphostin b44	[no description available]	medium	1	0
ag-490	[no description available]	medium	1	0	catechols; enamide; monocarboxylic acid amide; nitrile; secondary carboxamide	anti-inflammatory agent; antioxidant; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector; STAT3 inhibitor
ag 112	[no description available]	medium	1	0
ag 183	[no description available]	medium	2	0
semaxinib	[no description available]	medium	1	0	olefinic compound; oxindoles; pyrroles	angiogenesis modulating agent; antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; vascular endothelial growth factor receptor antagonist
8-(3-chlorostyryl)caffeine	[no description available]	medium	1	0	monochlorobenzenes; trimethylxanthine	adenosine A2A receptor antagonist; EC 1.4.3.4 (monoamine oxidase) inhibitor
bay 11-7085	[no description available]	medium	1	0	benzenes; nitrile; sulfone	anti-inflammatory agent; antibacterial agent; antineoplastic agent; apoptosis inducer; autophagy inducer; EC 2.7.11.10 (IkappaB kinase) inhibitor; ferroptosis inducer; NF-kappaB inhibitor
molsidomine	[no description available]	high	1	0	ethyl ester; morpholines; oxadiazole; zwitterion	antioxidant; apoptosis inhibitor; cardioprotective agent; nitric oxide donor; vasodilator agent
diamide	[no description available]	medium	6	0	1,1'-azobis(N,N-dimethylformamide)
nomifensine maleate	[no description available]	medium	1	0
nalbuphine hydrochloride	[no description available]	medium	1	0	hydrochloride
isoalloxazine	[no description available]	medium	1	0	benzo[g]pteridine-2,4-dione
vinblastine sulfate	[no description available]	medium	1	0
n-methylscopolamine bromide	[no description available]	medium	1	0
dextromethorphan hydrobromide	[no description available]	medium	1	0	hydrate; hydrobromide
naloxone hydrochloride	[no description available]	medium	1	0	hydrochloride	antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist
s-trans,trans-farnesylthiosalicylic acid	[no description available]	medium	1	0	sesquiterpenoid
sulindac sulfone	[no description available]	medium	1	0	monocarboxylic acid; organofluorine compound; sulfone	apoptosis inducer; cyclooxygenase 2 inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor
naltrexone hydrochloride	[no description available]	medium	1	0	hydrochloride	antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist
guanabenz acetate	[no description available]	medium	1	0	dichlorobenzene	geroprotector
nylidrin hydrochloride	[no description available]	medium	1	0	alkylbenzene
triprolidine hydrochloride anhydrous	[no description available]	medium	1	0	hydrochloride	H1-receptor antagonist
famotidine	[no description available]	medium	1	0	1,3-thiazoles; guanidines; sulfonamide	anti-ulcer drug; H2-receptor antagonist; P450 inhibitor
fenoterol	[no description available]	medium	1	0	hydrobromide	beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent
tiapridex	[no description available]	medium	1	0	benzamides
quipazine maleate	[no description available]	medium	1	0
n-(2-aminoethyl)-4-chlorobenzamide hydrochloride	[no description available]	medium	1	0
tulobuterol hydrochloride	[no description available]	medium	1	0	organic molecular entity
hp 029	[no description available]	medium	1	0
n,n,n-trimethyl-1-(4-stilbenoxy)-2-propylammonium iodide	[no description available]	medium	1	0
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one	[no description available]	medium	3	0	naphthalenes
nf023	[no description available]	medium	1	0
nf 449	[no description available]	medium	1	0
7-chloro-4-hydroxy-2-phenyl-1,8-naphthyridine	[no description available]	medium	1	0
gr 46611	[no description available]	medium	1	0
diacetylmonoxime	[no description available]	medium	1	0
homatropine hydrobromide, (endo-(+-)-isomer)	[no description available]	medium	1	0
vancomycin hydrochloride	[no description available]	medium	1	0
moxisylyte hydrochloride	[no description available]	medium	1	0	monoterpenoid
dizocilpine maleate	[no description available]	medium	32	0	maleate salt; tetracyclic antidepressant	anaesthetic; anticonvulsant; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist
beta-aminopropionitrile fumarate	[no description available]	medium	2	0
flupirtine	[no description available]	medium	1	0
zimelidine hydrochloride	[no description available]	medium	1	0
pregna-4,17-diene-3,16-dione, (17z)-isomer	[no description available]	medium	1	0
su 4312	[no description available]	medium	1	0
gw 1929	[no description available]	medium	1	0	benzophenones
protriptyline hydrochloride	[no description available]	medium	1	0	hydrochloride	antidepressant
n(4)-chloroacetylcytosine arabinoside	[no description available]	medium	1	0
n-(3-(cyclohexylidene-(1h-imidazol-4-ylmethyl))phenyl)ethanesulfonamide	[no description available]	medium	1	0
n-(4-amino-2-chlorophenyl)phthalimide	[no description available]	medium	1	0
cb 34	[no description available]	medium	1	0
b 43	[no description available]	medium	1	0	aromatic amine; aromatic ether; cyclopentanes; primary amino compound; pyrrolopyrimidine	EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector
(8R)-7-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,13,14-triol	[no description available]	medium	1	0	aporphine alkaloid
(8R)-7-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,13,14-triol	[no description available]	medium	1	0	aporphine alkaloid
3-(6-chloro-3-pyridazinyl)-3,8-diazabicyclo(3.2.1)octane	[no description available]	medium	1	0
2-(3,3-diphenylpropylamino)acetamide	[no description available]	medium	1	0	diarylmethane
4-(2-(phenylsulfonylamino)ethylthio)-2,6-difluorophenoxyacetamide	[no description available]	medium	1	0
gw2974	[no description available]	medium	1	0	pyridopyrimidine
l 162313	[no description available]	medium	1	0
l-165041	[no description available]	medium	1	0	aromatic ketone
mrs 1754	[no description available]	medium	1	0	oxopurine
s-nitroso-n-acetylpenicillamine	[no description available]	medium	6	0	nitroso compound; nitrosothio compound	nitric oxide donor; vasodilator agent
pd 404182	[no description available]	medium	1	0
sb 222200	[no description available]	medium	1	0	quinolines
dantrolene sodium	[no description available]	medium	1	0
cr 2945	[no description available]	medium	1	0
sb 218795	[no description available]	medium	1	0	quinolines
dihydroceramide	[no description available]	medium	1	0	N-acylsphinganine
epinephrine bitartrate	[no description available]	medium	1	0
bicuculline methobromide	[no description available]	medium	2	0
butylscopolammonium bromide	[no description available]	medium	1	0
butaclamol hydrochloride	[no description available]	medium	1	0
a 38503	[no description available]	medium	1	0
8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide	[no description available]	medium	1	0
sk&f 89976-a	[no description available]	medium	1	0
cv 1808	[no description available]	medium	1	0	purine nucleoside
fluvoxamine maleate	[no description available]	medium	1	0	(trifluoromethyl)benzenes
naloxone benzoylhydrazone	[no description available]	medium	1	0
2-methyl-6-(phenylethynyl)pyridine hydrochloride	[no description available]	medium	1	0	hydrochloride	anxiolytic drug; metabotropic glutamate receptor antagonist
amiprilose	[no description available]	medium	1	0
(R)-fluoxetine hydrochloride	[no description available]	medium	1	0	hydrochloride	antidepressant; serotonin uptake inhibitor
desmethylselegiline hydrochloride	[no description available]	medium	1	0
3-morpholino-sydnonimine monohydrochloride	[no description available]	medium	1	0
t 1032	[no description available]	medium	1	0
qx-314 bromide	[no description available]	medium	1	0
(S)-fluoxetine hydrochloride	[no description available]	medium	1	0	hydrochloride	antidepressant; serotonin uptake inhibitor
sr 59230a	[no description available]	medium	1	0
u 74389g	[no description available]	medium	1	0
1-(2-methoxyphenyl)piperazine hydrochloride	[no description available]	medium	1	0
y 27632, dihydrochloride, (4(r)-trans)-isomer	[no description available]	medium	1	0
noscapine hydrochloride	[no description available]	medium	1	0
a 77636	[no description available]	medium	1	0	hydrochloride	antiparkinson drug; dopamine agonist
cgp 20712a	[no description available]	medium	1	0
levodopa methyl ester hydrochloride	[no description available]	medium	1	0
benalfocin hydrochloride	[no description available]	medium	1	0
lu 19005	[no description available]	medium	1	0
benoxathian hydrochloride	[no description available]	medium	1	0
((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1h-inden-5-yl)oxy)acetic acid, (+)-isomer	[no description available]	medium	1	0
n-cyclopropyl adenosine-5'-carboxamide	[no description available]	medium	1	0
cefotaxime sodium	[no description available]	medium	1	0	organic sodium salt
calpain inhibitor iii	[no description available]	medium	1	0
GR 127935 hydrochloride	[no description available]	medium	1	0	hydrochloride	serotonergic antagonist
mrs 1845	[no description available]	medium	1	0
1-aminocyclopropane-1-carboxylic acid hydrochloride	[no description available]	medium	1	0
alaproclate hydrochloride	[no description available]	medium	1	0
ubenimex	[no description available]	medium	1	0	peptide
3-chloroalanine hydrochloride, (l-ala)-isomer	[no description available]	medium	1	0
dsp 4 hydrochloride	[no description available]	medium	1	0
calcimycin	[no description available]	medium	28	0	benzoxazole
(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzodioxan hydrochloride	[no description available]	medium	1	0	hydrochloride	alpha-adrenergic antagonist
2-cyclooctyl-2-hydroxyethylamine hydrochloride	[no description available]	medium	1	0
cirazoline monohydrochloride	[no description available]	medium	1	0
adtn	[no description available]	medium	1	0
apocodeine hydrochloride, (r)-isomer	[no description available]	medium	1	0
Dihydro-beta-erythroidine hydrobromide	[no description available]	medium	1	0	indoles
lilly 78335	[no description available]	medium	1	0
efaroxan hydrochloride	[no description available]	medium	1	0
fenoldopam hydrobromide	[no description available]	medium	1	0
1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride	[no description available]	medium	1	0	hydrochloride	dopamine uptake inhibitor
guvacine hydrochloride	[no description available]	medium	1	0
7-hydroxy-2-n,n-dipropylaminotetralin hydrobromide	[no description available]	medium	1	0
8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide, (r)-isomer,	[no description available]	medium	1	0	organic molecular entity
1-(2-(4-(4-fluoro-benzoyl)-piperidin-1-yl)-ethyl)-3,3-dimethyl-1,2-dihydro-indol-2-one	[no description available]	medium	1	0	hydrochloride	receptor modulator; serotonergic antagonist
4-iodoclonidine	[no description available]	medium	1	0
4-methylpyrazole monohydrochloride	[no description available]	medium	1	0
tele-methylhistamine	[no description available]	medium	1	0
alpha-methyltyrosine methyl ester, monohydrochloride	[no description available]	medium	1	0
octoclothepine maleate	[no description available]	medium	1	0
2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin hydrochloride	[no description available]	medium	1	0
du 24565	[no description available]	medium	1	0
2-methoxyidazoxan hydrochloride	[no description available]	medium	1	0
ro 25-6981	[no description available]	medium	1	0
sk&f 77434	[no description available]	medium	1	0	hydrobromide	dopamine agonist; prodrug
3-[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-yl]-1,1-diethylurea	[no description available]	medium	1	0	organic heterotetracyclic compound; organonitrogen heterocyclic compound
demethylcantharidin	[no description available]	medium	1	0
atropine sulfate	[no description available]	medium	1	0
1-deoxynojirimycin hydrochloride	[no description available]	medium	1	0
win 62577	[no description available]	medium	1	0
quinine sulfate	[no description available]	medium	1	0	hydrate
quercetin	[no description available]	medium	1	0
rv 538, (r-(r,r))-isomer	[no description available]	medium	1	0
3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1s-cis)-isomer	[no description available]	medium	1	0
valproate sodium	[no description available]	medium	1	0	organic sodium salt	geroprotector
u 63557a	[no description available]	medium	1	0
taurocholic acid, monosodium salt	[no description available]	medium	1	0	bile salt
cefmetazole sodium	[no description available]	medium	1	0	organic sodium salt	antimicrobial agent
fusidate sodium	[no description available]	medium	1	0
cephapirin sodium	[no description available]	medium	1	0	cephalosporin; organic sodium salt	antibacterial drug
sodium cephalothin	[no description available]	medium	1	0	organic sodium salt
cefazolin sodium	[no description available]	medium	1	0	organic sodium salt
5-hydroxydecanoic acid, monosodium salt	[no description available]	medium	1	0
ro13-9904	[no description available]	medium	1	0
phenytoin sodium	[no description available]	medium	1	0
cr 1409	[no description available]	medium	1	0
cortisol succinate, sodium salt	[no description available]	medium	1	0	organic molecular entity
piroxicam	[no description available]	medium	1	0	benzothiazine; monocarboxylic acid amide; pyridines	analgesic; antirheumatic drug; cyclooxygenase 1 inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug
lfm a13	[no description available]	medium	1	0	aromatic amide; dibromobenzene; enamide; enol; nitrile; secondary carboxamide	antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 2.7.11.21 (polo kinase) inhibitor; geroprotector; platelet aggregation inhibitor
l 701324	[no description available]	medium	1	0	quinolines
hispidin	[no description available]	medium	1	0	2-pyranones; catechols	antioxidant; EC 2.7.11.13 (protein kinase C) inhibitor; fungal metabolite
minocycline hydrochloride	[no description available]	medium	1	0
demeclocycline hydrochloride	[no description available]	medium	1	0
acyclovir	[no description available]	medium	2	0	2-aminopurines; oxopurine	antimetabolite; antiviral drug
sepiapterin	[no description available]	medium	1	0	sepiapterin
isoxanthopterin	[no description available]	medium	1	0	dihydroxypteridine
clozapine	[no description available]	medium	3	0	benzodiazepine; N-arylpiperazine; N-methylpiperazine; organochlorine compound	adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; GABA antagonist; histamine antagonist; muscarinic antagonist; second generation antipsychotic; serotonergic antagonist; xenobiotic
ganciclovir	[no description available]	medium	2	0	2-aminopurines; oxopurine	antiinfective agent; antiviral drug
zaprinast	[no description available]	medium	1	0	triazolopyrimidines
allopurinol	[no description available]	high	13	0	nucleobase analogue; organic heterobicyclic compound	antimetabolite; EC 1.17.3.2 (xanthine oxidase) inhibitor; gout suppressant; radical scavenger
thiolactomycin	[no description available]	medium	1	0
2,4-diaminohypoxanthine	[no description available]	medium	1	0	hydroxypyrimidine
quazinone	[no description available]	medium	1	0
8-bromocyclic gmp, sodium salt	[no description available]	medium	1	0	organic sodium salt	muscle relaxant; protein kinase G agonist
ag-879	[no description available]	medium	1	0
miltefosine	[no description available]	medium	1	0	phosphocholines; phospholipid	anti-inflammatory agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antiprotozoal drug; apoptosis inducer; immunomodulator; protein kinase inhibitor
triclosan	[no description available]	medium	3	0	aromatic ether; dichlorobenzene; monochlorobenzenes; phenols	antibacterial agent; antimalarial; drug allergen; EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; fungicide; persistent organic pollutant; xenobiotic
melarsoprol	[no description available]	medium	1	0	triazines
benzonidazole	[no description available]	medium	1	0	C-nitro compound; imidazoles; monocarboxylic acid amide	antiprotozoal drug
4,5-dibromo-2-pyrrolic acid	[no description available]	medium	1	0
oroidin	[no description available]	medium	1	0	pyrroles; secondary carboxamide	metabolite
pipecolic acid	[no description available]	medium	7	0	piperidinemonocarboxylic acid
serine	[no description available]	high	139	2	L-alpha-amino acid; proteinogenic amino acid; serine family amino acid; serine zwitterion; serine	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
serine	[no description available]	high	139	0	L-alpha-amino acid; proteinogenic amino acid; serine family amino acid; serine zwitterion; serine	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
lysine	[no description available]	high	79	2	aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid	algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
lysine	[no description available]	high	79	0	aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid	algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
tyrosine	[no description available]	medium	87	0	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine	EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical
tyrosine	[no description available]	medium	87	2	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine	EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical
phenylalanine	[no description available]	high	53	1	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid	algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
phenylalanine	[no description available]	high	53	0	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid	algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
histidine	[no description available]	high	68	1	amino acid zwitterion; histidine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
histidine	[no description available]	high	68	0	amino acid zwitterion; histidine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
threonine	[no description available]	high	55	1	amino acid zwitterion; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid; threonine	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
threonine	[no description available]	high	55	0	amino acid zwitterion; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid; threonine	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
citrulline	[no description available]	high	24	1	amino acid zwitterion; citrulline	Daphnia magna metabolite; EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; protective agent; Saccharomyces cerevisiae metabolite
citrulline	[no description available]	high	24	0	amino acid zwitterion; citrulline	Daphnia magna metabolite; EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; protective agent; Saccharomyces cerevisiae metabolite
glycyl-glycyl-glycine	[no description available]	medium	1	0	tripeptide zwitterion; tripeptide
glycylglycine	[no description available]	high	4	0	dipeptide zwitterion; dipeptide	human metabolite
glutamic acid	[no description available]	high	544	7	glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical
glutamic acid	[no description available]	high	544	0	glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical
leucyltyrosine	[no description available]	medium	1	0	dipeptide	metabolite
leucyl-glycyl-glycine	[no description available]	medium	1	0	tripeptide	metabolite
leucylleucine	[no description available]	medium	1	0	dipeptide; L-aminoacyl-L-amino acid zwitterion	human metabolite; Mycoplasma genitalium metabolite
leucyl-alanine	[no description available]	medium	1	0	dipeptide	metabolite
leucyl-leucyl-leucine	[no description available]	medium	1	0	tripeptide	metabolite
glycyltryptophan	[no description available]	medium	1	0	dipeptide	metabolite
glycylleucine	[no description available]	medium	1	0	dipeptide zwitterion; dipeptide	metabolite
glycyl-l-phenylalanine	[no description available]	medium	2	0	dipeptide zwitterion; dipeptide	human metabolite; metabolite
aspartyl-phenylalanine	[no description available]	medium	1	0	dipeptide	human blood serum metabolite; human xenobiotic metabolite
glycylsarcosine	[no description available]	medium	3	0	dipeptide zwitterion; dipeptide
leucylleucine	[no description available]	medium	1	0	peptide
glycyl-leucyl-tyrosine	[no description available]	medium	1	0	oligopeptide
glycyl-glycyl-proline	[no description available]	medium	1	0	tripeptide zwitterion; tripeptide
glycylaspartic acid	[no description available]	medium	2	0	dipeptide	metabolite
glycyl-histidyl-glycine	[no description available]	medium	1	0	oligopeptide
n-glycylglutamic acid	[no description available]	medium	1	0	dipeptide	metabolite
histidylglycine	[no description available]	medium	1	0	dipeptide	metabolite
valylvaline	[no description available]	medium	1	0	dipeptide	Mycoplasma genitalium metabolite
alpha-methylphenylalanine	[no description available]	medium	1	0	benzenes; monocarboxylic acid
prolinamide	[no description available]	medium	1	0	amino acid amide; L-proline derivative; pyrrolidinecarboxamide
tyrosyl-glycyl-glycine	[no description available]	medium	1	0	tripeptide zwitterion; tripeptide	metabolite
proline	[no description available]	high	62	1	amino acid zwitterion; glutamine family amino acid; L-alpha-amino acid; proline; proteinogenic amino acid	algal metabolite; compatible osmolytes; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
proline	[no description available]	high	62	0	amino acid zwitterion; glutamine family amino acid; L-alpha-amino acid; proline; proteinogenic amino acid	algal metabolite; compatible osmolytes; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
arginylarginine 2-naphthylamide	[no description available]	medium	1	0
histidylphenylalanine	[no description available]	medium	1	0	dipeptide
glycyl-glycyl-valine	[no description available]	medium	1	0	oligopeptide
glycyl-glycyl-sarcosine	[no description available]	medium	1	0
cysteinylglycine	[no description available]	medium	8	0	dipeptide zwitterion; dipeptide	Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
glutamyl-glutamic acid	[no description available]	medium	1	0	dipeptide	Mycoplasma genitalium metabolite
n-acetyltryptophan	[no description available]	medium	1	0	L-tryptophan derivative; N-acetyl-L-amino acid	metabolite
n-glycylalanine	[no description available]	medium	1	0	dipeptide	metabolite
glycylvaline	[no description available]	medium	1	0	dipeptide	human metabolite
epsilon-tert-butyloxycarbonyl-lysine	[no description available]	medium	1	0
glycylproline	[no description available]	medium	1	0	dipeptide zwitterion; dipeptide	metabolite
tryptophanol	[no description available]	medium	1	0
phenylalanylglycine	[no description available]	medium	1	0	dipeptide	metabolite
glycyl-alanyl-phenylalanine	[no description available]	medium	1	0	oligopeptide
methionylglycine	[no description available]	medium	1	0	dipeptide	metabolite
histidylhistidine	[no description available]	medium	1	0	dipeptide	Mycoplasma genitalium metabolite
valylleucine	[no description available]	medium	1	0	dipeptide	metabolite
alanylglycine	[no description available]	medium	1	0	dipeptide zwitterion; dipeptide	metabolite
alpha-glutamyltryptophan	[no description available]	medium	1	0	dipeptide	metabolite
methionylglutamic acid	[no description available]	medium	1	0	dipeptide	metabolite
phenylalanyl-valine	[no description available]	medium	1	0	dipeptide	metabolite
homocarnosine	[no description available]	medium	1	0	dipeptide zwitterion; dipeptide; homocarnosine; L-histidine derivative; N-acyl-L-alpha-amino acid anion; N-acyl-L-alpha-amino acid	human metabolite
clove	[no description available]	medium	1	0
beta-alanine	[no description available]	high	247	1	amino acid zwitterion; beta-amino acid	agonist; fundamental metabolite; human metabolite; inhibitor; neurotransmitter
beta-alanine	[no description available]	high	247	0	amino acid zwitterion; beta-amino acid	agonist; fundamental metabolite; human metabolite; inhibitor; neurotransmitter
betaine	[no description available]	medium	111	0	amino-acid betaine; glycine derivative	fundamental metabolite
betaine	[no description available]	medium	111	2	amino-acid betaine; glycine derivative	fundamental metabolite
creatine	[no description available]	high	108	4	glycine derivative; guanidines; zwitterion	geroprotector; human metabolite; mouse metabolite; neuroprotective agent; nutraceutical
creatine	[no description available]	high	108	0	glycine derivative; guanidines; zwitterion	geroprotector; human metabolite; mouse metabolite; neuroprotective agent; nutraceutical
glycine	[no description available]	medium	957	0	alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid	EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical
glycine	[no description available]	medium	957	6	alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid	EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical
glycocyamine	[no description available]	high	12	0	guanidinoacetic acids; zwitterion	bacterial metabolite; human metabolite; mouse metabolite; nutraceutical; rat metabolite
picolinic acid	[no description available]	medium	2	0	pyridinemonocarboxylic acid	human metabolite; MALDI matrix material
sarcosine	[no description available]	high	19	2	N-alkylglycine zwitterion; N-alkylglycine; N-methyl-amino acid; N-methylglycines	Escherichia coli metabolite; glycine receptor agonist; glycine transporter 1 inhibitor; human metabolite; mouse metabolite
sarcosine	[no description available]	high	19	0	N-alkylglycine zwitterion; N-alkylglycine; N-methyl-amino acid; N-methylglycines	Escherichia coli metabolite; glycine receptor agonist; glycine transporter 1 inhibitor; human metabolite; mouse metabolite
tramiprosate	[no description available]	medium	162	0	amino sulfonic acid; zwitterion	algal metabolite; anti-inflammatory agent; anticonvulsant; GABA agonist; nootropic agent
tramiprosate	[no description available]	medium	162	10	amino sulfonic acid; zwitterion	algal metabolite; anti-inflammatory agent; anticonvulsant; GABA agonist; nootropic agent
isoguvacine	[no description available]	medium	9	0	tetrahydropyridine
hydroxyproline	[no description available]	high	31	0	4-hydroxyproline; L-alpha-amino acid zwitterion	human metabolite; mouse metabolite; plant metabolite
cysteine	[no description available]	medium	1	0	cysteine zwitterion; cysteine; L-alpha-amino acid; proteinogenic amino acid; serine family amino acid	EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; flour treatment agent; human metabolite
alanine	[no description available]	medium	338	0	alanine zwitterion; alanine; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid	EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor; fundamental metabolite
alanine	[no description available]	medium	338	4	alanine zwitterion; alanine; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid	EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor; fundamental metabolite
leucine	[no description available]	high	98	1	amino acid zwitterion; L-alpha-amino acid; leucine; proteinogenic amino acid; pyruvate family amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
leucine	[no description available]	high	98	0	amino acid zwitterion; L-alpha-amino acid; leucine; proteinogenic amino acid; pyruvate family amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
2-aminoisobutyric acid	[no description available]	medium	7	0	2,2-dialkylglycine zwitterion; 2,2-dialkylglycine
isoleucine	[no description available]	high	36	0	aspartate family amino acid; isoleucine; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
3-aminobenzoic acid	[no description available]	medium	2	0	aminobenzoic acid
piperidine	[no description available]	medium	2	0	azacycloalkane; piperidines; saturated organic heteromonocyclic parent; secondary amine	base; catalyst; human metabolite; non-polar solvent; plant metabolite; protic solvent; reagent
D-proline	[no description available]	medium	1	0	D-alpha-amino acid zwitterion; D-alpha-amino acid; proline	mouse metabolite
4-hydroxybutyric acid	[no description available]	medium	2	0	4-hydroxy monocarboxylic acid; hydroxybutyric acid	general anaesthetic; GHB receptor agonist; neurotoxin; sedative
thiazolidines	[no description available]	medium	9	0	thiazolidine
pyrrolidine	[no description available]	medium	2	0	azacycloalkane; pyrrolidines; saturated organic heteromonocyclic parent
norvaline	[no description available]	medium	1	0	2-aminopentanoic acid; L-alpha-amino acid zwitterion	bacterial metabolite; hypoglycemic agent; neuroprotective agent
guanidinopropionic acid	[no description available]	medium	4	0	guanidines; zwitterion	hypoglycemic agent
D-alanine	[no description available]	medium	1	0	alanine zwitterion; alanine; D-alpha-amino acid	EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor; Escherichia coli metabolite; human metabolite
D-valine	[no description available]	medium	1	0	D-alpha-amino acid zwitterion; D-alpha-amino acid; valine
2-(methylamino)isobutyric acid	[no description available]	medium	3	0	alanine derivative; alpha-amino acid zwitterion; non-proteinogenic alpha-amino acid; secondary amino compound	human urinary metabolite
thiazolidine-4-carboxylic acid, (r)-isomer	[no description available]	medium	1	0	thiazolidinemonocarboxylic acid; thioproline	geroprotector; metabolite
prolinol	[no description available]	medium	1	0
n-methylalanine	[no description available]	medium	2	0	amino acid zwitterion; methyl-L-alanine
isoniazid	[no description available]	medium	13	0	carbohydrazide	antitubercular agent; drug allergen
kojic acid	[no description available]	medium	1	0	4-pyranones; enol; primary alcohol	Aspergillus metabolite; EC 1.10.3.1 (catechol oxidase) inhibitor; EC 1.10.3.2 (laccase) inhibitor; EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor; EC 1.14.18.1 (tyrosinase) inhibitor; EC 1.4.3.3 (D-amino-acid oxidase) inhibitor; NF-kappaB inhibitor; skin lightening agent
5-nitroquinoline	[no description available]	medium	1	0
ethambutol	[no description available]	medium	2	0	ethanolamines; ethylenediamine derivative	antitubercular agent; environmental contaminant; xenobiotic
streptomycin	[no description available]	medium	2	0	antibiotic antifungal drug; antibiotic fungicide; streptomycins	antibacterial drug; antifungal agrochemical; antimicrobial agent; antimicrobial drug; bacterial metabolite; protein synthesis inhibitor
questin	[no description available]	medium	1	0	dihydroxyanthraquinone
3-acetyl-7-methoxycoumarin	[no description available]	medium	1	0	coumarins
amphotericin b	[no description available]	medium	2	0	antibiotic antifungal drug; macrolide antibiotic; polyene antibiotic	antiamoebic agent; antiprotozoal drug; bacterial metabolite
nidulin	[no description available]	medium	1	0
neoechinulin a	[no description available]	medium	1	0
asperflavin	[no description available]	medium	1	0
asperparaline a	[no description available]	medium	1	0	alkaloid; azaspiro compound; dicarboximide	Aspergillus metabolite
rifampin	[no description available]	high	4	0	cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion	angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor
flavin-adenine dinucleotide	[no description available]	medium	2	0	flavin adenine dinucleotide; vitamin B2	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; prosthetic group
fenthion	[no description available]	medium	1	0	organic thiophosphate	acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide
nadp	[no description available]	medium	33	0
tamoxifen	[no description available]	medium	23	0	stilbenoid; tertiary amino compound	angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator
taurolidine	[no description available]	medium	294	44	thiadiazinane
citric acid, anhydrous	[no description available]	medium	41	5	tricarboxylic acid	antimicrobial agent; chelator; food acidity regulator; fundamental metabolite
aluminum chloride	[no description available]	medium	7	0	aluminium coordination entity	Lewis acid
aluminum phosphide	[no description available]	medium	2	0
chlorine	[no description available]	medium	26	0	diatomic chlorine; gas molecular entity	bleaching agent
n-chlorotaurine	[no description available]	medium	217	11
hypochlorous acid	[no description available]	medium	86	0	chlorine oxoacid; reactive oxygen species	EC 2.5.1.18 (glutathione transferase) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; human metabolite
transforming growth factor beta	[no description available]	medium	25	0
pectins	[no description available]	medium	6	0	D-galactopyranuronic acid
acetic acid	[no description available]	medium	7	1	monocarboxylic acid	antimicrobial food preservative; Daphnia magna metabolite; food acidity regulator; protic solvent
chitosan	[no description available]	medium	9	0
paraquat	[no description available]	medium	11	0	organic cation	geroprotector; herbicide
mocetinostat	[no description available]	medium	103	1	aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline	antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent
isethionic acid	[no description available]	medium	31	0	alkanesulfonic acid	human metabolite
hydrogen sulfide	[no description available]	medium	31	0	gas molecular entity; hydracid; mononuclear parent hydride; sulfur hydride	Escherichia coli metabolite; genotoxin; metabolite; signalling molecule; toxin; vasodilator agent
sulfites	[no description available]	medium	28	0	divalent inorganic anion; sulfur oxide; sulfur oxoanion
etiocholanolone	[no description available]	medium	1	0	17-oxo steroid; 3alpha-hydroxy steroid; androstanoid	human metabolite; mouse metabolite
pregnanolone	[no description available]	medium	3	0	3-hydroxy-5beta-pregnan-20-one; 3alpha-hydroxy steroid	human metabolite; intravenous anaesthetic; sedative
temozolomide	[no description available]	medium	1	0	imidazotetrazine; monocarboxylic acid amide; triazene derivative	alkylating agent; antineoplastic agent; prodrug
sodium chlorate	[no description available]	medium	1	0	chlorate salt; inorganic sodium salt	herbicide
chlorates	[no description available]	medium	2	0	chlorine oxoanion; monovalent inorganic anion
acamprosate	[no description available]	medium	573	103	acetamides; organosulfonic acid	environmental contaminant; neurotransmitter agent; xenobiotic
bupivacaine	[no description available]	medium	2	0	aromatic amide; piperidinecarboxamide; tertiary amino compound
choline	[no description available]	medium	112	4	cholines	allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter; nutrient; plant metabolite; Saccharomyces cerevisiae metabolite
carnitine	[no description available]	medium	76	3	amino-acid betaine	human metabolite; mouse metabolite
boron	[no description available]	medium	2	0	boron group element atom; metalloid atom; nonmetal atom	micronutrient
chromium	[no description available]	medium	15	0	chromium group element atom; metal allergen	micronutrient
acetovanillone	[no description available]	medium	3	0	acetophenones; aromatic ketone; methyl ketone	antirheumatic drug; EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug; plant metabolite
3-hydroxybutyric acid	[no description available]	medium	5	1	(omega-1)-hydroxy fatty acid; 3-hydroxy monocarboxylic acid; hydroxybutyric acid	human metabolite
cadmium	[no description available]	medium	21	0	cadmium molecular entity; zinc group element atom
chloramphenicol	[no description available]	medium	2	0	C-nitro compound; carboxamide; diol; organochlorine compound	antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor
xanthenes	[no description available]	medium	5	0	xanthene
angiotensin ii	[no description available]	medium	25	0	amino acid zwitterion; angiotensin II	human metabolite
beta-escin	[no description available]	medium	7	1
gallic acid	[no description available]	medium	3	0	trihydroxybenzoic acid	antineoplastic agent; antioxidant; apoptosis inducer; astringent; cyclooxygenase 2 inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; geroprotector; human xenobiotic metabolite; plant metabolite
lactic acid	[no description available]	medium	79	4	2-hydroxy monocarboxylic acid	algal metabolite; Daphnia magna metabolite
valine	[no description available]	medium	53	2	L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid; valine	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
chenodeoxycholic acid	[no description available]	medium	88	1	bile acid; C24-steroid; dihydroxy-5beta-cholanic acid	human metabolite; mouse metabolite
cysteic acid	[no description available]	medium	47	0	alanine derivative; amino sulfonic acid; carboxyalkanesulfonic acid; cysteine derivative; non-proteinogenic alpha-amino acid	animal metabolite
phosphorylcholine	[no description available]	medium	11	0	phosphocholines	allergen; epitope; hapten; human metabolite; mouse metabolite
inositol	[no description available]	medium	147	3	cyclitol; hexol
2-(n-cyclohexylamino)ethanesulfonic acid	[no description available]	medium	20	0	alkanesulfonic acid; secondary aliphatic amine	Good's buffer substance
phosphatidylcholines	[no description available]	medium	40	1	1,2-diacyl-sn-glycero-3-phosphocholine
methionine	[no description available]	medium	264	10	aspartate family amino acid; L-alpha-amino acid; methionine zwitterion; methionine; proteinogenic amino acid	antidote to paracetamol poisoning; human metabolite; micronutrient; mouse metabolite; nutraceutical
cysteine	[no description available]	medium	336	7	cysteinium	fundamental metabolite
cystathionine	[no description available]	medium	37	2	cysteine derivative
sulfur	[no description available]	medium	92	0	chalcogen; nonmetal atom	macronutrient
naltrexone	[no description available]	medium	247	43	cyclopropanes; morphinane-like compound; organic heteropentacyclic compound	antidote to opioid poisoning; central nervous system depressant; environmental contaminant; mu-opioid receptor antagonist; xenobiotic
pyridoxamine dihydrochloride	[no description available]	medium	1	0	hydrochloride; vitamin B6	Escherichia coli metabolite; human metabolite; iron chelator; mouse metabolite; nephroprotective agent; plant metabolite; Saccharomyces cerevisiae metabolite
pyridoxamine dihydrochloride	[no description available]	medium	1	1	hydrochloride; vitamin B6	Escherichia coli metabolite; human metabolite; iron chelator; mouse metabolite; nephroprotective agent; plant metabolite; Saccharomyces cerevisiae metabolite
pyridoxamine	[no description available]	medium	3	1	aminoalkylpyridine; hydroxymethylpyridine; monohydroxypyridine; vitamin B6	Escherichia coli metabolite; human metabolite; iron chelator; mouse metabolite; nephroprotective agent; plant metabolite; Saccharomyces cerevisiae metabolite
n-(2-acetamido)-2-aminoethanesulfonic acid	[no description available]	medium	18	0	1,1-diunsubstituted alkanesulfonate; ACES; amino sulfonic acid
niacinamide	[no description available]	medium	13	0	pyridine alkaloid; pyridinecarboxamide; vitamin B3	anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor
fluoxetine	[no description available]	medium	6	1	(trifluoromethyl)benzenes; aromatic ether; secondary amino compound
ellagic acid	[no description available]	medium	3	0	catechols; cyclic ketone; lactone; organic heterotetracyclic compound; polyphenol	antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor; EC 2.4.1.1 (glycogen phosphorylase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor; EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor; EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; food additive; fungal metabolite; geroprotector; plant metabolite; skin lightening agent
triticonazole	[no description available]	medium	1	0
triazoles	[no description available]	medium	3	0	1,2,3-triazole
cyclopentane	[no description available]	medium	12	0	cycloalkane; cyclopentanes; volatile organic compound	non-polar solvent
tanshinone	[no description available]	medium	1	0	abietane diterpenoid	anticoronaviral agent
pyruvic acid	[no description available]	medium	21	1	2-oxo monocarboxylic acid	cofactor; fundamental metabolite
ethyl pyruvate	[no description available]	medium	1	0	oxo carboxylic acid
2,3-diphosphoglycerate	[no description available]	medium	2	0	bisphosphoglyceric acid; tetronic acid derivative	human metabolite
adenine	[no description available]	medium	10	0	6-aminopurines; purine nucleobase	Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
aflatoxin b1	[no description available]	medium	3	0	aflatoxin; aromatic ether; aromatic ketone	carcinogenic agent; human metabolite
1-naphthylisothiocyanate	[no description available]	medium	5	0	isothiocyanate	insecticide
malondialdehyde	[no description available]	medium	139	5	dialdehyde	biomarker
thiosulfates	[no description available]	medium	12	0	divalent inorganic anion; sulfur oxide; sulfur oxoanion	human metabolite
methanol	[no description available]	medium	6	0	alkyl alcohol; one-carbon compound; primary alcohol; volatile organic compound	amphiprotic solvent; Escherichia coli metabolite; fuel; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite
retinaldehyde	[no description available]	medium	4	0	retinal; vitamin A	gap junctional intercellular communication inhibitor; human metabolite; mouse metabolite
n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine	[no description available]	medium	3	0	N-substituted diamine; pyridines; tertiary amino compound	apoptosis inducer; chelator; copper chelator
erythrosine	[no description available]	medium	5	0
pyrrolidonecarboxylic acid	[no description available]	medium	13	0	5-oxoproline; L-proline derivative; non-proteinogenic L-alpha-amino acid	algal metabolite
coenzyme a	[no description available]	medium	15	0	adenosine 3',5'-bisphosphate	coenzyme; Escherichia coli metabolite; mouse metabolite
n-bromotaurine	[no description available]	medium	26	1
cytochrome c-t	[no description available]	medium	18	0
uric acid	[no description available]	medium	22	5	uric acid	Escherichia coli metabolite; human metabolite; mouse metabolite
metformin	[no description available]	medium	8	0	guanidines	environmental contaminant; geroprotector; hypoglycemic agent; xenobiotic
taurochenodeoxycholic acid	[no description available]	medium	21	0	bile acid taurine conjugate	human metabolite; mouse metabolite
ursodoxicoltaurine	[no description available]	medium	11	0	bile acid taurine conjugate	anti-inflammatory agent; apoptosis inhibitor; bone density conservation agent; cardioprotective agent; human metabolite; neuroprotective agent
pyrethrins	[no description available]	medium	5	0
cyhalothrin	[no description available]	medium	2	0	aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound	agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide
methomyl	[no description available]	medium	1	0	aliphatic sulfide; carbamate ester	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; insecticide; nematicide; xenobiotic
azoxymethane	[no description available]	medium	2	0
aminomethanesulfonic acid	[no description available]	medium	3	0
cystamine	[no description available]	medium	23	0	organic disulfide; primary amino compound	EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor
thiotaurine	[no description available]	medium	28	0
interleukin-8	[no description available]	medium	13	0
manganese	[no description available]	medium	18	1	elemental manganese; manganese group element atom	Escherichia coli metabolite; micronutrient
asparagine	[no description available]	medium	33	2	amino acid zwitterion; asparagine; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
imiquimod	[no description available]	medium	1	0	imidazoquinoline	antineoplastic agent; interferon inducer
ketamine	[no description available]	medium	11	0	cyclohexanones; monochlorobenzenes; secondary amino compound	analgesic; environmental contaminant; intravenous anaesthetic; neurotoxin; NMDA receptor antagonist; xenobiotic
racemethionine	[no description available]	medium	4	0	alpha-amino acid; amino acid zwitterion; sulfur-containing amino acid	algal metabolite; Daphnia magna metabolite; Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
benzo(a)pyrene	[no description available]	medium	3	0	ortho- and peri-fused polycyclic arene	carcinogenic agent; mouse metabolite
niacin	[no description available]	medium	23	0	pyridine alkaloid; pyridinemonocarboxylic acid; vitamin B3	antidote; antilipemic drug; EC 3.5.1.19 (nicotinamidase) inhibitor; Escherichia coli metabolite; human urinary metabolite; metabolite; mouse metabolite; plant metabolite; vasodilator agent
diphenoxylate	[no description available]	medium	1	0	ethyl ester; nitrile; piperidinecarboxylate ester; tertiary amine	antidiarrhoeal drug
quercetin	[no description available]	medium	7	0	7-hydroxyflavonol; pentahydroxyflavone	antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger
ascorbic acid	[no description available]	medium	70	0	ascorbic acid; vitamin C	coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent
phosphorus	[no description available]	medium	11	0	monoatomic phosphorus; nonmetal atom; pnictogen	macronutrient
pyruvaldehyde	[no description available]	medium	6	1	2-oxo aldehyde; propanals	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
urea	[no description available]	medium	78	0	isourea; monocarboxylic acid amide; one-carbon compound	Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
butyric acid	[no description available]	medium	3	0	fatty acid 4:0; straight-chain saturated fatty acid	human urinary metabolite; Mycoplasma genitalium metabolite
d-alpha tocopherol	[no description available]	medium	73	1	alpha-tocopherol	algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite
adenosine monophosphate	[no description available]	medium	18	0	adenosine 5'-phosphate; purine ribonucleoside 5'-monophosphate	adenosine A1 receptor agonist; cofactor; EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.11 (fructose-bisphosphatase) inhibitor; fundamental metabolite; micronutrient; nutraceutical
anserine	[no description available]	high	12	0	beta-alanine derivative; dipeptide; zwitterion	animal metabolite; mouse metabolite
uridine monophosphate	[no description available]	medium	1	0	pyrimidine ribonucleoside 5'-monophosphate; uridine 5'-phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
carnosine	[no description available]	medium	49	2	amino acid zwitterion; dipeptide	anticonvulsant; antineoplastic agent; antioxidant; Daphnia magna metabolite; geroprotector; human metabolite; mouse metabolite; neuroprotective agent
mannose	[no description available]	medium	2	0	D-aldohexose; D-mannose; mannopyranose	metabolite
succinic acid	[no description available]	medium	19	0	alpha,omega-dicarboxylic acid; C4-dicarboxylic acid	anti-ulcer drug; fundamental metabolite; micronutrient; nutraceutical; radiation protective agent
putrescine	[no description available]	medium	10	0	alkane-alpha,omega-diamine	antioxidant; fundamental metabolite
acetylgalactosamine	[no description available]	medium	1	0	N-acetyl-D-hexosamine; N-acetylgalactosamine	Escherichia coli metabolite; human metabolite; mouse metabolite
1-anilino-8-naphthalenesulfonate	[no description available]	medium	14	0	aminonaphthalene; naphthalenesulfonic acid	fluorescent probe
ammonium hydroxide	[no description available]	medium	63	0	azane; gas molecular entity; mononuclear parent hydride	EC 3.5.1.4 (amidase) inhibitor; metabolite; mouse metabolite; neurotoxin; NMR chemical shift reference compound; nucleophilic reagent; refrigerant
kynurenine	[no description available]	medium	9	1	aromatic ketone; non-proteinogenic alpha-amino acid; substituted aniline	human metabolite
n-pentanoic acid	[no description available]	medium	1	0	short-chain fatty acid; straight-chain saturated fatty acid	plant metabolite
propionic acid	[no description available]	medium	2	0	saturated fatty acid; short-chain fatty acid	antifungal drug
hexanoic acid	[no description available]	medium	2	0	medium-chain fatty acid; straight-chain saturated fatty acid	human metabolite; plant metabolite
ochratoxin a	[no description available]	medium	3	0	isochromanes; monocarboxylic acid amide; N-acyl-L-phenylalanine; organochlorine compound; phenylalanine derivative	Aspergillus metabolite; calcium channel blocker; carcinogenic agent; mycotoxin; nephrotoxin; Penicillium metabolite; teratogenic agent
thiram	[no description available]	medium	1	0	organic disulfide	antibacterial drug; antifungal agrochemical; antiseptic drug
cholic acid	[no description available]	medium	39	1	12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; bile acid; C24-steroid; trihydroxy-5beta-cholanic acid	human metabolite; mouse metabolite
carbon tetrachloride	[no description available]	medium	25	0	chlorocarbon; chloromethanes	hepatotoxic agent; refrigerant
arachidonic acid	[no description available]	medium	25	1	icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid	Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite
lead	[no description available]	medium	14	0	carbon group element atom; elemental lead; metal atom	neurotoxin
aluminum	[no description available]	medium	9	0	boron group element atom; elemental aluminium; metal atom
deferiprone	[no description available]	medium	1	0	4-pyridones	iron chelator; protective agent
linoleic acid	[no description available]	medium	5	0	octadecadienoic acid; omega-6 fatty acid	algal metabolite; Daphnia galeata metabolite; plant metabolite
sodium oxybate	[no description available]	medium	5	0
sodium salicylate	[no description available]	medium	1	0	organic molecular entity
morphine	[no description available]	medium	26	0	morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound	anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic
icaritin	[no description available]	medium	1	0
homocysteine	[no description available]	medium	75	2	amino acid zwitterion; homocysteine; serine family amino acid	fundamental metabolite; mouse metabolite
edetic acid	[no description available]	medium	18	0	ethylenediamine derivative; polyamino carboxylic acid; tetracarboxylic acid	anticoagulant; antidote; chelator; copper chelator; geroprotector
methionine sulfoximine	[no description available]	medium	4	0	methionine derivative; non-proteinogenic alpha-amino acid; sulfoximide
pilocarpine	[no description available]	medium	5	0	pilocarpine	antiglaucoma drug
muramidase	[no description available]	medium	10	0
deoxynivalenol	[no description available]	medium	1	0	cyclic ketone; enone; primary alcohol; secondary alpha-hydroxy ketone; trichothecene; triol	mycotoxin
glycocholic acid	[no description available]	medium	37	0	bile acid glycine conjugate	human metabolite
caseins	[no description available]	medium	41	0
ethinyl estradiol	[no description available]	medium	2	0	17-hydroxy steroid; 3-hydroxy steroid; terminal acetylenic compound	xenoestrogen
natriuretic peptide, brain	[no description available]	medium	4	1	polypeptide
diquat	[no description available]	medium	1	0	organic cation	defoliant; herbicide
bortezomib	[no description available]	medium	1	0	amino acid amide; L-phenylalanine derivative; pyrazines	antineoplastic agent; antiprotozoal drug; protease inhibitor; proteasome inhibitor
phosphinothricin	[no description available]	medium	1	0	organic anion
selenium	[no description available]	medium	27	1	chalcogen; nonmetal atom	micronutrient
mercury	[no description available]	medium	6	0	elemental mercury; zinc group element atom	neurotoxin
sulfoacetaldehyde	[no description available]	medium	18	0	alpha-CH2-containing aldehyde; organosulfonic acid
silver	[no description available]	medium	5	0	copper group element atom; elemental silver	Escherichia coli metabolite
ginsenosides	[no description available]	medium	5	0
isoquercitrin	[no description available]	medium	1	0
n-acetylaspartic acid	[no description available]	medium	56	0	N-acetyl-L-amino acid; N-acyl-L-aspartic acid	antioxidant; human metabolite; mouse metabolite; nutraceutical; rat metabolite
n-acetylaspartic acid	[no description available]	medium	56	1	N-acetyl-L-amino acid; N-acyl-L-aspartic acid	antioxidant; human metabolite; mouse metabolite; nutraceutical; rat metabolite
vitamin b 12	[no description available]	medium	28	0
folic acid	[no description available]	medium	19	1	folic acids; N-acyl-amino acid	human metabolite; mouse metabolite; nutrient
nandrolone decanoate	[no description available]	medium	4	0	steroid ester
galactosamine	[no description available]	medium	3	0	D-galactosamine; primary amino compound	toxin
lovastatin	[no description available]	medium	3	0	delta-lactone; fatty acid ester; hexahydronaphthalenes; polyketide; statin (naturally occurring)	anticholesteremic drug; antineoplastic agent; Aspergillus metabolite; prodrug
dehydroepiandrosterone sulfate	[no description available]	medium	1	0	17-oxo steroid; steroid sulfate	EC 2.7.1.33 (pantothenate kinase) inhibitor; human metabolite; mouse metabolite
loperamide	[no description available]	medium	1	0	monocarboxylic acid amide; monochlorobenzenes; piperidines; tertiary alcohol	anticoronaviral agent; antidiarrhoeal drug; mu-opioid receptor agonist
pd 150606	[no description available]	medium	1	0	cinnamic acids; organoiodine compound; thioenol	apoptosis inhibitor; calpain inhibitor
calpain	[no description available]	medium	17	0
ornidazole	[no description available]	medium	1	0	C-nitro compound; imidazoles; organochlorine compound; secondary alcohol	antiamoebic agent; antibacterial drug; antiinfective agent; antiprotozoal drug; antitrichomonal drug; epitope
arsenic	[no description available]	medium	30	0	metalloid atom; pnictogen	micronutrient
decabromobiphenyl ether	[no description available]	medium	4	0	polybromodiphenyl ether	neurotoxin
dinoprostone	[no description available]	medium	21	0	prostaglandins E	human metabolite; mouse metabolite; oxytocic
ribose	[no description available]	medium	9	0	D-ribose; ribopyranose
methylnitrosourea	[no description available]	medium	4	0	N-nitrosoureas	alkylating agent; carcinogenic agent; mutagen; teratogenic agent
imidazole	[no description available]	medium	3	0	imidazole
6 beta-hydroxycortisol	[no description available]	medium	2	0	11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; 6beta-hydroxy steroid; C21-steroid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	human metabolite; mammalian metabolite; probe
sorafenib	[no description available]	medium	1	0	(trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; phenylureas; pyridinecarboxamide	angiogenesis inhibitor; anticoronaviral agent; antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; ferroptosis inducer; tyrosine kinase inhibitor
3-(2,2,2-trimethylhydrazine)propionate	[no description available]	medium	1	0	ammonium betaine	cardioprotective agent; EC 1.14.11.1 (gamma-butyrobetaine dioxygenase) inhibitor; neuroprotective agent
raffinose	[no description available]	medium	9	0	raffinose family oligosaccharide; trisaccharide	mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
sucrose	[no description available]	medium	28	1	glycosyl glycoside	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; sweetening agent
trehalose	[no description available]	medium	13	0	trehalose	Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
tromethamine	[no description available]	medium	9	0	primary amino compound; triol	buffer
gold	[no description available]	medium	10	0	copper group element atom; elemental gold
n-vinyl-2-pyrrolidinone	[no description available]	medium	9	1	pyrrolidin-2-ones
octanoic acid	[no description available]	medium	1	0	medium-chain fatty acid; straight-chain saturated fatty acid	antibacterial agent; Escherichia coli metabolite; human metabolite
caprylates	[no description available]	medium	2	0	fatty acid anion 8:0; straight-chain saturated fatty acid anion	human metabolite; Saccharomyces cerevisiae metabolite
D-fructopyranose	[no description available]	medium	53	1	cyclic hemiketal; D-fructose; fructopyranose	sweetening agent
glucagon-like peptide 1	[no description available]	medium	4	1
glucagon	[no description available]	medium	12	1	peptide hormone
trimethyloxamine	[no description available]	medium	16	0	tertiary amine oxide	Escherichia coli metabolite; metabolite; osmolyte
propoxur	[no description available]	medium	2	0	aromatic ether; carbamate ester	acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
dimethylamine	[no description available]	medium	6	0	methylamines; secondary aliphatic amine	metabolite
bisphenol a	[no description available]	medium	6	0	bisphenol	endocrine disruptor; environmental contaminant; xenobiotic; xenoestrogen
curcumin	[no description available]	medium	15	0	aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol	anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger
bilirubin	[no description available]	medium	73	1	biladienes; dicarboxylic acid	antioxidant; human metabolite; mouse metabolite
bilirubin ditaurine	[no description available]	medium	18	0
chromium	[no description available]	medium	4	0	chromium cation; monoatomic hexacation
trichostatin a	[no description available]	medium	1	0	antibiotic antifungal agent; hydroxamic acid; trichostatin	bacterial metabolite; EC 3.5.1.98 (histone deacetylase) inhibitor; geroprotector
dexmedetomidine	[no description available]	medium	2	0	medetomidine	alpha-adrenergic agonist; analgesic; non-narcotic analgesic; sedative
hypoxanthine	[no description available]	medium	9	0	nucleobase analogue; oxopurine; purine nucleobase	fundamental metabolite
minocycline	[no description available]	medium	4	0
methylene blue	[no description available]	medium	8	0	organic chloride salt	acid-base indicator; antidepressant; antimalarial; antimicrobial agent; antioxidant; cardioprotective agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 4.6.1.2 (guanylate cyclase) inhibitor; fluorochrome; histological dye; neuroprotective agent; physical tracer
5-hydroxy-1-methylhydantoin	[no description available]	medium	1	0
hydantoins	[no description available]	medium	3	0	imidazolidine-2,4-dione
arabitol	[no description available]	medium	1	0	arabinitol
xylitol	[no description available]	medium	4	0
pseudouridine	[no description available]	medium	1	0	pseudouridines	fundamental metabolite
threonic acid	[no description available]	medium	1	0	threonic acid
homarine	[no description available]	medium	4	0	non-proteinogenic alpha-amino acid
3-methyladenine	[no description available]	medium	3	0
endothelin-1	[no description available]	medium	5	0
acetyltaurine	[no description available]	medium	17	1	acetamides; organosulfonic acid	human blood serum metabolite; human urinary metabolite
nad	[no description available]	medium	19	0	organophosphate oxoanion	cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite
edaravone	[no description available]	medium	10	0	pyrazolone	antioxidant; radical scavenger
guanine	[no description available]	medium	6	1	2-aminopurines; oxopurine; purine nucleobase	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
orotic acid	[no description available]	medium	2	1	pyrimidinemonocarboxylic acid	Escherichia coli metabolite; metabolite; mouse metabolite
8-hydroxyguanine	[no description available]	medium	1	1	oxopurine
acetyl coenzyme a	[no description available]	medium	5	0	acyl-CoA	acyl donor; coenzyme; effector; fundamental metabolite
riboflavin	[no description available]	medium	8	0	flavin; vitamin B2	anti-inflammatory agent; antioxidant; cofactor; Escherichia coli metabolite; food colouring; fundamental metabolite; human urinary metabolite; mouse metabolite; photosensitizing agent; plant metabolite
isoproterenol	[no description available]	medium	46	0	catechols; secondary alcohol; secondary amino compound	beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; sympathomimetic agent
atrial natriuretic factor	[no description available]	medium	8	0	polypeptide
calpastatin	[no description available]	medium	6	0	polypeptide	EC 3.4.22.52 (calpain-1) inhibitor; EC 3.4.22.53 (calpain-2) inhibitor
lactoferrin	[no description available]	medium	2	0
acetaldehyde	[no description available]	medium	29	0	aldehyde	carcinogenic agent; EC 3.5.1.4 (amidase) inhibitor; electron acceptor; Escherichia coli metabolite; human metabolite; mouse metabolite; mutagen; oxidising agent; Saccharomyces cerevisiae metabolite; teratogenic agent
acridine orange	[no description available]	medium	2	0	aminoacridines; aromatic amine; tertiary amino compound	fluorochrome; histological dye
coenzyme q10	[no description available]	medium	15	0	ubiquinones	antioxidant; ferroptosis inhibitor; human metabolite
coenzyme q10	[no description available]	medium	15	3	ubiquinones	antioxidant; ferroptosis inhibitor; human metabolite
ubiquinone	[no description available]	medium	18	3
ginsenoside rf	[no description available]	medium	1	0	12beta-hydroxy steroid; 20-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid	antineoplastic agent; apoptosis inducer; plant metabolite
deoxycholic acid	[no description available]	medium	77	2	bile acid; C24-steroid; dihydroxy-5beta-cholanic acid	human blood serum metabolite
leptin	[no description available]	medium	14	3
purine	[no description available]	medium	2	0	purine
thiamine	[no description available]	medium	15	1	primary alcohol; vitamin B1	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
sodium hydroxide	[no description available]	medium	1	0	alkali metal hydroxide
isocaproic acid	[no description available]	medium	1	0	branched-chain saturated fatty acid; medium-chain fatty acid; methyl-branched fatty acid	human metabolite
pentosidine	[no description available]	medium	2	1	imidazopyridine; non-proteinogenic L-alpha-amino acid	biomarker; cross-linking reagent
gossypol	[no description available]	medium	1	0
donepezil	[no description available]	medium	3	0	aromatic ether; indanones; piperidines; racemate	EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; nootropic agent
cocaine	[no description available]	medium	15	1	benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid	adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic
carbamide peroxide	[no description available]	medium	1	0	mixture	disinfectant; oxidising agent; reagent
salicylic acid	[no description available]	medium	2	0	monohydroxybenzoic acid	algal metabolite; antifungal agent; antiinfective agent; EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor; keratolytic drug; plant hormone; plant metabolite
glycolic acid	[no description available]	medium	1	0	2-hydroxy monocarboxylic acid; primary alcohol	keratolytic drug; metabolite
cytidine diphosphate choline	[no description available]	medium	5	1	nucleotide-(amino alcohol)s; phosphocholines	human metabolite; mouse metabolite; neuroprotective agent; psychotropic drug; Saccharomyces cerevisiae metabolite
chlorpromazine	[no description available]	medium	11	0	organochlorine compound; phenothiazines; tertiary amine	anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug
indapamide	[no description available]	medium	1	0	indoles; organochlorine compound; sulfonamide	antihypertensive agent; diuretic
perindopril	[no description available]	medium	1	0	alpha-amino acid ester; dicarboxylic acid monoester; ethyl ester; organic heterobicyclic compound	antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
pyridoxal phosphate	[no description available]	medium	22	0	methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6 phosphate	coenzyme; cofactor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
cysteine sulfinic acid	[no description available]	medium	46	1
maneb	[no description available]	medium	3	0
formaldehyde	[no description available]	medium	7	0	aldehyde; one-carbon compound	allergen; carcinogenic agent; disinfectant; EC 3.5.1.4 (amidase) inhibitor; environmental contaminant; Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
isoflurane	[no description available]	medium	6	0	organofluorine compound	inhalation anaesthetic
phosphocreatine	[no description available]	medium	27	1	phosphagen; phosphoamino acid	human metabolite; mouse metabolite
penicillamine	[no description available]	medium	23	0	non-proteinogenic alpha-amino acid; penicillamine	antirheumatic drug; chelator; copper chelator; drug allergen
2,3-dihydroxypropane-1-sulfonate	[no description available]	medium	1	0	alkanesulfonate oxoanion
deoxyglucose	[no description available]	medium	8	0
1,5-anhydroglucitol	[no description available]	medium	1	0	anhydro sugar	human metabolite
galactose	[no description available]	medium	19	0	D-galactose; galactopyranose	Escherichia coli metabolite; mouse metabolite
fucose	[no description available]	medium	2	0	fucopyranose; L-fucose	Escherichia coli metabolite; mouse metabolite
sorbitol	[no description available]	medium	34	0	glucitol	cathartic; Escherichia coli metabolite; food humectant; human metabolite; laxative; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite; sweetening agent
glycerol	[no description available]	medium	19	2	alditol; triol	algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent
s-adenosylmethionine	[no description available]	medium	16	0	organic cation; sulfonium compound	coenzyme; cofactor; human metabolite; micronutrient; Mycoplasma genitalium metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
idebenone	[no description available]	medium	1	0	1,4-benzoquinones; primary alcohol	antioxidant; ferroptosis inhibitor
oxidopamine	[no description available]	medium	7	0	benzenetriol; catecholamine; primary amino compound	drug metabolite; human metabolite; neurotoxin
vitamin k semiquinone radical	[no description available]	medium	3	0
methyl-thiohydantoin-tryptophan	[no description available]	medium	1	0	organonitrogen compound; organooxygen compound
valproic acid	[no description available]	medium	12	0	branched-chain fatty acid; branched-chain saturated fatty acid	anticonvulsant; antimanic drug; EC 3.5.1.98 (histone deacetylase) inhibitor; GABA agent; neuroprotective agent; psychotropic drug; teratogenic agent
diminazene aceturate	[no description available]	medium	1	0	N-acetylglycinate salt	antiparasitic agent; trypanocidal drug
diminazene	[no description available]	medium	1	0	carboxamidine; triazene derivative	antiparasitic agent; trypanocidal drug
angiotensin i	[no description available]	medium	2	0	angiotensin; peptide zwitterion	human metabolite; neurotransmitter agent
angiotensin ii, des-phe(8)-	[no description available]	medium	2	0	amino acid zwitterion; angiotensin	vasodilator agent
beta-hydroxyisovaleric acid	[no description available]	medium	3	0	3-hydroxy monocarboxylic acid	human metabolite
3-aminoisobutyric acid	[no description available]	medium	4	0	amino acid zwitterion; beta-amino acid	metabolite
valerates	[no description available]	medium	7	0	short-chain fatty acid anion; straight-chain saturated fatty acid anion	plant metabolite
thioacetamide	[no description available]	medium	11	0	thiocarboxamide	hepatotoxic agent
diethylhexyl phthalate	[no description available]	medium	2	0	diester; phthalate ester	androstane receptor agonist; apoptosis inhibitor; plasticiser
phthalic acid	[no description available]	medium	1	0	benzenedicarboxylic acid	human xenobiotic metabolite
quinoline	[no description available]	medium	1	0	azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; quinolines
amikacin	[no description available]	medium	1	0	alpha-D-glucoside; amino cyclitol glycoside; aminoglycoside; carboxamide	antibacterial drug; antimicrobial agent; nephrotoxin
sb 203580	[no description available]	medium	3	0	imidazoles; monofluorobenzenes; pyridines; sulfoxide	EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector; Hsp90 inhibitor; neuroprotective agent
paroxetine	[no description available]	medium	1	0	aromatic ether; benzodioxoles; organofluorine compound; piperidines	antidepressant; anxiolytic drug; hepatotoxic agent; P450 inhibitor; serotonin uptake inhibitor
baicalin	[no description available]	medium	1	0	dihydroxyflavone; glucosiduronic acid; glycosyloxyflavone; monosaccharide derivative	antiatherosclerotic agent; antibacterial agent; anticoronaviral agent; antineoplastic agent; antioxidant; cardioprotective agent; EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; ferroptosis inhibitor; neuroprotective agent; non-steroidal anti-inflammatory drug; plant metabolite; prodrug
diethyl sulfate	[no description available]	medium	2	0	alkyl sulfate	alkylating agent; apoptosis inducer; carcinogenic agent; mutagen
ethyl glucuronide	[no description available]	medium	3	0	beta-D-glucosiduronic acid	human urinary metabolite
phosphatidylethanol	[no description available]	medium	1	0
n-acetylhistidine	[no description available]	medium	1	0	L-histidine derivative; N-acetyl-L-amino acid; N-acetylhistidine	animal metabolite
taurocholic acid	[no description available]	high	103	1	amino sulfonic acid; bile acid taurine conjugate	human metabolite
hydrogen	[no description available]	medium	19	0	elemental hydrogen; elemental molecule; gas molecular entity	antioxidant; electron donor; food packaging gas; fuel; human metabolite
naltrexazone	[no description available]	medium	1	0
ruthenium	[no description available]	medium	2	0	iron group element atom; platinum group metal atom
ryanodine	[no description available]	medium	3	0
nalmefene	[no description available]	medium	19	0	morphinane alkaloid
topiramate	[no description available]	medium	28	1	cyclic ketal; ketohexose derivative; sulfamate ester	anticonvulsant; sodium channel blocker
varenicline	[no description available]	medium	2	0
mesna	[no description available]	medium	1	0	organosulfonic acid
chlorine	[no description available]	medium	224	0	halide anion; monoatomic chlorine	cofactor; Escherichia coli metabolite; human metabolite
s-adenosylmethionine	[no description available]	medium	2	0	sulfonium betaine	human metabolite
sodium fluoride	[no description available]	medium	5	0	fluoride salt	mutagen
sodium nitrite	[no description available]	medium	4	0	inorganic sodium salt; nitrite salt	antidote to cyanide poisoning; antihypertensive agent; antimicrobial food preservative; food antioxidant; poison
ovalbumin	[no description available]	medium	4	0
histamine	[no description available]	medium	21	0	aralkylamino compound; imidazoles	human metabolite; mouse metabolite; neurotransmitter
mitotempo	[no description available]	medium	2	0
piperidines	[no description available]	medium	25	0
tetrabutylammonium	[no description available]	medium	1	0	quaternary ammonium ion
atropine	[no description available]	medium	18	0
dimethylsulfonioacetate	[no description available]	medium	1	0	sulfonium betaine
ditiocarb	[no description available]	medium	3	0	dithiocarbamic acids	chelator; copper chelator
s-methyl n,n-diethylthiolcarbamate sulfoxide	[no description available]	medium	2	0
arsenic trioxide	[no description available]	medium	11	0
bromide	[no description available]	medium	12	0	halide anion; monoatomic bromine
bromamine	[no description available]	medium	5	0
carbonates	[no description available]	medium	6	1	carbon oxoanion
xylose	[no description available]	medium	7	0	D-xylose
deoxyguanosine	[no description available]	medium	9	0	purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
8-hydroxy-2'-deoxyguanosine	[no description available]	medium	7	0	guanosines	biomarker
perfluorooctane sulfonic acid	[no description available]	medium	1	0	perfluoroalkanesulfonic acid	antilipemic drug; persistent organic pollutant
2,2'-azobis(2-amidinopropane)	[no description available]	medium	7	0	monoazo compound
ursodeoxycholic acid	[no description available]	medium	68	8	bile acid; C24-steroid; dihydroxy-5beta-cholanic acid	human metabolite; mouse metabolite
vanadates	[no description available]	medium	4	0	trivalent inorganic anion; vanadium oxoanion	EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
ferryl iron	[no description available]	medium	3	0
malathion	[no description available]	medium	1	0	diester; ethyl ester; organic thiophosphate
nickel	[no description available]	medium	4	0	metal allergen; nickel group element atom	epitope; micronutrient
icodextrin	[no description available]	medium	2	0
ng-nitroarginine methyl ester	[no description available]	medium	11	0	alpha-amino acid ester; L-arginine derivative; methyl ester; N-nitro compound	EC 1.14.13.39 (nitric oxide synthase) inhibitor
cystine	[no description available]	medium	84	4
calcium citrate	[no description available]	medium	1	0	organic calcium salt	flavouring agent; food additive; food preservative; nutraceutical
chlorhexidine	[no description available]	medium	19	2	biguanides; monochlorobenzenes	antibacterial agent; antiinfective agent
povidone-iodine	[no description available]	medium	14	0
octenidine	[no description available]	medium	1	0	dihydropyridine
carbon monoxide	[no description available]	medium	8	0	carbon oxide; gas molecular entity; one-carbon compound	biomarker; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; human metabolite; ligand; metabolite; mitochondrial respiratory-chain inhibitor; mouse metabolite; neurotoxin; neurotransmitter; P450 inhibitor; probe; signalling molecule; vasodilator agent
citalopram	[no description available]	medium	5	1	2-benzofurans; cyclic ether; nitrile; organofluorine compound; tertiary amino compound
pyrene	[no description available]	medium	1	0	ortho- and peri-fused polycyclic arene	fluorescent probe; persistent organic pollutant
glyoxylic acid	[no description available]	medium	1	0	2-oxo monocarboxylic acid; aldehydic acid	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
thiobarbituric acid	[no description available]	medium	1	0	barbiturates	allergen; reagent
barbituric acid	[no description available]	medium	1	0	barbiturates	allergen; xenobiotic
uridine	[no description available]	medium	12	0	uridines	drug metabolite; fundamental metabolite; human metabolite
5-taurinomethyluridine	[no description available]	medium	5	0
phytoestrogens	[no description available]	medium	1	0
glucose, (beta-d)-isomer	[no description available]	medium	13	0	D-glucopyranose	epitope; mouse metabolite
glycogen	[no description available]	medium	24	0
alpha-synuclein	[no description available]	medium	3	0
diphenhydramine	[no description available]	medium	2	0	ether; tertiary amino compound	anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative
rhodamine 6g	[no description available]	medium	1	0
diazepam	[no description available]	medium	27	0	1,4-benzodiazepinone; organochlorine compound	anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic
maltitol	[no description available]	medium	1	0	alpha-D-glucoside; glycosyl alditol	laxative; metabolite; sweetening agent
ciprofloxacin	[no description available]	medium	4	0	aminoquinoline; cyclopropanes; fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone; zwitterion	antibacterial drug; antiinfective agent; antimicrobial agent; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; environmental contaminant; topoisomerase IV inhibitor; xenobiotic
diethylenetriamine	[no description available]	medium	2	0	polyazaalkane; triamine
acebutolol	[no description available]	medium	1	0	alpha-D-glucosyl-(1->4)-D-mannopyranose
puromycin aminonucleoside	[no description available]	medium	4	0	3'-deoxyribonucleoside; adenosines
cholecalciferol	[no description available]	medium	8	0	D3 vitamins; hydroxy seco-steroid; seco-cholestane; secondary alcohol; steroid hormone	geroprotector; human metabolite
vitamin b 6	[no description available]	medium	4	0
peptones	[no description available]	medium	4	0
acetaminophen	[no description available]	medium	14	0	acetamides; phenols	antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; cyclooxygenase 3 inhibitor; environmental contaminant; ferroptosis inducer; geroprotector; hepatotoxic agent; human blood serum metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
levamisole	[no description available]	medium	2	0	6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole	antinematodal drug; antirheumatic drug; EC 3.1.3.1 (alkaline phosphatase) inhibitor; immunological adjuvant; immunomodulator
alpha-cyclodextrin	[no description available]	medium	1	0	cyclodextrin
5-hydroxyhexanoic acid	[no description available]	medium	1	0	(omega-1)-hydroxy fatty acid; medium-chain fatty acid	human urinary metabolite
allura red ac dye	[no description available]	medium	1	0
3-nitrotyrosine	[no description available]	medium	10	0	2-nitrophenols; C-nitro compound; nitrotyrosine; non-proteinogenic alpha-amino acid
9,10-dimethyl-1,2-benzanthracene	[no description available]	medium	3	0	ortho-fused polycyclic arene; tetraphenes	carcinogenic agent
ethylmalonic acid	[no description available]	medium	1	0	dicarboxylic acid; dicarboxylic fatty acid	human metabolite
aconitine	[no description available]	medium	2	0
guanidinoethane sulfonate	[no description available]	medium	113	0	guanidines; organosulfonic acid; zwitterion
zinc sulfate	[no description available]	medium	5	0	metal sulfate; zinc molecular entity	fertilizer
biotin	[no description available]	medium	4	0	biotins; vitamin B7	coenzyme; cofactor; Escherichia coli metabolite; fundamental metabolite; human metabolite; mouse metabolite; nutraceutical; prosthetic group; Saccharomyces cerevisiae metabolite
pyrroles	[no description available]	medium	5	0	pyrrole; secondary amine
cyclin d1	[no description available]	medium	3	0
fipronil	[no description available]	medium	1	0	(trifluoromethyl)benzenes; dichlorobenzene; nitrile; primary amino compound; pyrazoles; sulfoxide
acrylamide	[no description available]	medium	1	0	acrylamides; N-acylammonia; primary carboxamide	alkylating agent; carcinogenic agent; Maillard reaction product; mutagen; neurotoxin
mk 2206	[no description available]	medium	1	0	organic heterotricyclic compound	EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
cyclosporine	[no description available]	medium	15	0
colistin	[no description available]	medium	1	0
memantine	[no description available]	medium	11	0	adamantanes; primary aliphatic amine	antidepressant; antiparkinson drug; dopaminergic agent; neuroprotective agent; NMDA receptor antagonist
gliotoxin	[no description available]	medium	2	0	dipeptide; organic disulfide; organic heterotetracyclic compound; pyrazinoindole	antifungal agent; EC 2.5.1.58 (protein farnesyltransferase) inhibitor; immunosuppressive agent; mycotoxin; proteasome inhibitor
pentobarbital	[no description available]	medium	23	0	barbiturates	GABAA receptor agonist
muscimol	[no description available]	medium	64	0	alkaloid; isoxazoles; primary amino compound	fungal metabolite; GABA agonist; oneirogen; psychotropic drug
spermine	[no description available]	medium	8	0	polyazaalkane; tetramine	antioxidant; fundamental metabolite; immunosuppressive agent
probucol	[no description available]	medium	2	0	dithioketal; polyphenol	anti-inflammatory drug; anticholesteremic drug; antilipemic drug; antioxidant; cardiovascular drug
inosine	[no description available]	medium	6	0	inosines; purines D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
cholecystokinin	[no description available]	medium	9	0
phosphorylethanolamine	[no description available]	medium	37	0	phosphoethanolamine; primary amino compound	algal metabolite; human metabolite; mouse metabolite
glycerophosphoethanolamine	[no description available]	medium	4	0	phosphoethanolamine; sn-glycerol 3-phosphates
acetylcarnitine	[no description available]	medium	3	0	O-acylcarnitine	human metabolite
gentamicin	[no description available]	medium	16	4
vancomycin	[no description available]	medium	5	0	glycopeptide	antibacterial drug; antimicrobial agent; bacterial metabolite
methyl-4-tyramine	[no description available]	medium	1	0	tyramines	mouse metabolite
tyramine	[no description available]	medium	5	0	monoamine molecular messenger; primary amino compound; tyramines	EC 3.1.1.8 (cholinesterase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter
5-methoxytryptophan	[no description available]	medium	1	0	L-alpha-amino acid zwitterion; L-tryptophan derivative	metabolite
mercaptoethanol	[no description available]	medium	7	0	alkanethiol; primary alcohol	geroprotector
sodium bisulfide	[no description available]	medium	5	0
ganoderic acid	[no description available]	medium	1	0
malic acid	[no description available]	medium	1	0	2-hydroxydicarboxylic acid; C4-dicarboxylic acid	food acidity regulator; fundamental metabolite
obeticholic acid	[no description available]	medium	1	0	3alpha-hydroxy steroid; 7alpha-hydroxy steroid; dihydroxy-5beta-cholanic acid	farnesoid X receptor agonist; hepatoprotective agent
catechin	[no description available]	medium	11	1	catechin	antioxidant; plant metabolite
epigallocatechin gallate	[no description available]	medium	8	0	flavans; gallate ester; polyphenol	antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite
epigallocatechin gallate	[no description available]	medium	8	1	flavans; gallate ester; polyphenol	antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite
cefazolin	[no description available]	medium	2	1	beta-lactam antibiotic allergen; cephalosporin; tetrazoles; thiadiazoles	antibacterial drug
n-acetylalanine	[no description available]	medium	1	0	L-alanine derivative; N-acetyl-L-amino acid	human metabolite; Saccharomyces cerevisiae metabolite
3-aminobutyric acid	[no description available]	medium	2	0	amino acid zwitterion; beta-amino acid; monocarboxylic acid	metabolite
quinic acid	[no description available]	medium	1	0
alpha-glycerophosphoric acid	[no description available]	medium	3	0	glycerol monophosphate	algal metabolite; human metabolite
mitomycin	[no description available]	medium	8	0	mitomycin	alkylating agent; antineoplastic agent
o-phthalaldehyde	[no description available]	medium	14	0	benzaldehydes; dialdehyde	epitope
ethanethiol	[no description available]	medium	1	0	alkanethiol	rodenticide
alprostadil	[no description available]	medium	3	0	prostaglandins E	anticoagulant; human metabolite; platelet aggregation inhibitor; vasodilator agent
lithium	[no description available]	medium	22	1	alkali metal atom
amyloid beta-peptides	[no description available]	medium	5	1
guanosine	[no description available]	medium	5	0	guanosines; purines D-ribonucleoside	fundamental metabolite
8-hydroxyguanosine	[no description available]	medium	2	0	purine nucleoside
5-bromosalicylaldehyde	[no description available]	medium	2	0
deferoxamine	[no description available]	medium	5	0	acyclic desferrioxamine	bacterial metabolite; ferroptosis inhibitor; iron chelator; siderophore
methane	[no description available]	medium	8	0	alkane; gas molecular entity; mononuclear parent hydride; one-carbon compound	bacterial metabolite; fossil fuel; greenhouse gas
ici 204,219	[no description available]	medium	1	0	carbamate ester; indoles; N-sulfonylcarboxamide	anti-asthmatic agent; leukotriene antagonist
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid	[no description available]	medium	75	0
peptide yy	[no description available]	medium	1	0
cremophor el	[no description available]	medium	1	0
3,3',5,5'-tetramethylbenzidine	[no description available]	medium	4	0
dimethyl sulfoxide	[no description available]	medium	14	0	sulfoxide; volatile organic compound	alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger
fluorine	[no description available]	medium	2	0	diatomic fluorine; gas molecular entity	NMR chemical shift reference compound
hypobromous acid	[no description available]	medium	7	0	bromine oxoacid
bromates	[no description available]	medium	10	0	bromine oxoanion; monovalent inorganic anion
nvc-422	[no description available]	medium	12	1
phenyl acetate	[no description available]	medium	46	0	benzenes; phenyl acetates
c-peptide	[no description available]	medium	6	0
sildenafil citrate	[no description available]	medium	1	0	citrate salt	EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent
amphetamine	[no description available]	medium	8	0	primary amine
thiazoles	[no description available]	medium	19	0	1,3-thiazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
eglumetad	[no description available]	medium	1	0	L-alpha-amino acid
zolpidem	[no description available]	medium	1	0	imidazopyridine	central nervous system depressant; GABA agonist; sedative
glutathione disulfide	[no description available]	medium	21	0	glutathione derivative; organic disulfide	Escherichia coli metabolite; mouse metabolite
phytic acid	[no description available]	medium	2	0	inositol phosphate
thioctic acid	[no description available]	medium	19	2	dithiolanes; heterocyclic fatty acid; thia fatty acid	fundamental metabolite; geroprotector
zirconium	[no description available]	medium	1	0	titanium group element atom
ractopamine	[no description available]	medium	1	0	benzyl alcohols; polyphenol; secondary alcohol; secondary amino compound
1,10-phenanthroline	[no description available]	medium	2	0	phenanthroline	EC 2.7.1.1 (hexokinase) inhibitor; EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
salicylaldehyde	[no description available]	medium	2	0	hydroxybenzaldehyde	nematicide; plant metabolite
1,7-phenanthroline	[no description available]	medium	4	0	phenanthroline
hydroxyl radical	[no description available]	medium	15	0	oxygen hydride; oxygen radical; reactive oxygen species
hydrazine	[no description available]	medium	10	0	azane; hydrazines	EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
dorzolamide	[no description available]	medium	1	0	sulfonamide; thiophenes	antiglaucoma drug; antihypertensive agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor
timolol	[no description available]	medium	5	0	timolol	anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist
latanoprost	[no description available]	medium	1	0	isopropyl ester; prostaglandins Falpha; triol	antiglaucoma drug; antihypertensive agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor; prodrug
thiophenes	[no description available]	medium	3	0	mancude organic heteromonocyclic parent; monocyclic heteroarene; thiophenes; volatile organic compound	non-polar solvent
dorzolamide-timolol combination	[no description available]	medium	1	0
2-oxothiazolidine-4-carboxylic acid	[no description available]	medium	6	0
isofloridoside	[no description available]	medium	1	0	alpha-D-galactoside; galactosylglycerol
potassium bromate	[no description available]	medium	3	0	bromate salt; potassium salt	flour treatment agent
gw 4064	[no description available]	medium	2	0	stilbenoid
isoxazoles	[no description available]	medium	13	0	isoxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
deuterium	[no description available]	medium	5	0	dihydrogen
phenylacetylglycine	[no description available]	medium	3	0	monocarboxylic acid amide; monocarboxylic acid; N-acylglycine	human metabolite; mouse metabolite
4-cresol sulfate	[no description available]	medium	1	0	aryl sulfate	gut flora metabolite; human metabolite; uremic toxin
potassium chloride	[no description available]	medium	62	1	inorganic chloride; inorganic potassium salt; potassium salt	fertilizer
guanosine monophosphate	[no description available]	medium	2	0	guanosine 5'-phosphate; purine ribonucleoside 5'-monophosphate	biomarker; Escherichia coli metabolite; metabolite; mouse metabolite
inosinic acid	[no description available]	medium	4	0	inosine phosphate; purine ribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
sodium glutamate	[no description available]	medium	8	0	monosodium glutamate	flavouring agent
6-cyano-7-nitroquinoxaline-2,3-dione	[no description available]	medium	8	0	quinoxaline derivative
6-methyl-2-(phenylethynyl)pyridine	[no description available]	medium	4	0	acetylenic compound; methylpyridines	anxiolytic drug; metabotropic glutamate receptor antagonist
ectoine	[no description available]	medium	1	0	1,4,5,6-tetrahydropyrimidines; carboxamidine; monocarboxylic acid; zwitterion	osmolyte
trazodone	[no description available]	medium	5	1	monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazolopyridine	adrenergic antagonist; antidepressant; anxiolytic drug; H1-receptor antagonist; sedative; serotonin uptake inhibitor
galantamine	[no description available]	medium	1	0	benzazepine alkaloid fundamental parent; benzazepine alkaloid; organic heterotetracyclic compound; tertiary amino compound	antidote to curare poisoning; cholinergic drug; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; plant metabolite
methylamine	[no description available]	medium	2	0	methylamines; one-carbon compound; primary aliphatic amine	mouse metabolite
sodium benzoate	[no description available]	medium	1	0	organic sodium salt	algal metabolite; antimicrobial food preservative; drug allergen; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; human xenobiotic metabolite; plant metabolite
olanzapine	[no description available]	medium	1	0	benzodiazepine; N-arylpiperazine; N-methylpiperazine	antiemetic; dopaminergic antagonist; histamine antagonist; muscarinic antagonist; second generation antipsychotic; serotonergic antagonist; serotonin uptake inhibitor
antipyrine	[no description available]	medium	11	0	pyrazolone	antipyretic; cyclooxygenase 3 inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
thiouridine	[no description available]	medium	2	0	nucleoside analogue; thiouridine	affinity label; antimetabolite
2-thiouridine	[no description available]	medium	2	0	nucleoside analogue; thiouridine
glycosides	[no description available]	medium	3	0
sodium taurodeoxycholate	[no description available]	medium	9	0	bile acid taurine conjugate	human metabolite
glycodeoxycholic acid	[no description available]	medium	5	0	bile acid glycine conjugate	human metabolite
acetosulfame	[no description available]	medium	1	0	organic heteromonocyclic compound; organonitrogen heterocyclic compound; oxacycle; sulfamate ester	environmental contaminant; sweetening agent; xenobiotic
endosulfan	[no description available]	medium	1	0	cyclic sulfite ester; cyclodiene organochlorine insecticide	acaricide; agrochemical; GABA-gated chloride channel antagonist; persistent organic pollutant
glucosamine	[no description available]	medium	7	0	D-glucosamine	Escherichia coli metabolite; geroprotector; mouse metabolite
fenclozic acid	[no description available]	medium	2	0
titanium	[no description available]	medium	3	1	titanium group element atom
picrotoxin	[no description available]	medium	75	0
strychnine	[no description available]	medium	122	0	monoterpenoid indole alkaloid; organic heteroheptacyclic compound	avicide; cholinergic antagonist; glycine receptor antagonist; neurotransmitter agent; rodenticide
chlorpyrifos	[no description available]	medium	3	0	chloropyridine; organic thiophosphate	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; insecticide; xenobiotic
carboplatin	[no description available]	medium	2	0
sodium hypochlorite	[no description available]	medium	9	0	inorganic sodium salt	bleaching agent; disinfectant
aminosalicylic acid	[no description available]	medium	1	0	aminobenzoic acid; phenols	antitubercular agent
prothionamide	[no description available]	medium	1	0	pyridines
amplex red	[no description available]	medium	1	0
benzotriazole	[no description available]	medium	1	0	benzotriazoles	environmental contaminant; xenobiotic
nephrin	[no description available]	medium	1	0
sodium selenite	[no description available]	medium	3	0	inorganic sodium salt; selenite salt	nutraceutical
mercuric chloride	[no description available]	medium	7	0	mercury coordination entity	sensitiser
hippuric acid	[no description available]	medium	13	0	N-acylglycine	human blood serum metabolite; uremic toxin
xanthurenic acid	[no description available]	medium	2	0	dihydroxyquinoline; quinolinemonocarboxylic acid	animal metabolite; iron chelator; metabotropic glutamate receptor agonist; vesicular glutamate transport inhibitor
guanidinosuccinic acid	[no description available]	medium	1	0	L-alpha-amino acid anion
indoleacetic acid	[no description available]	medium	1	0	indole-3-acetic acids; monocarboxylic acid	auxin; human metabolite; mouse metabolite; plant hormone; plant metabolite
indican	[no description available]	medium	2	0	beta-D-glucoside; exopolysaccharide; indolyl carbohydrate
fructosamine	[no description available]	medium	4	0
fadrozole	[no description available]	medium	1	0	imidazopyridine
exenatide	[no description available]	medium	2	0
activins	[no description available]	medium	1	0
incretins	[no description available]	medium	1	0
n-arachidonoyl l-serine	[no description available]	medium	1	0	N-(fatty acyl)-L-alpha-amino acid	cannabinoid receptor agonist; mammalian metabolite; neuroprotective agent; pro-angiogenic agent; vasodilator agent
2,2-dimethyl-beta-alanine	[no description available]	medium	5	0
fumaric acid	[no description available]	medium	1	0	butenedioic acid	food acidity regulator; fundamental metabolite; geroprotector
fumarates	[no description available]	medium	3	0	butenedioate; C4-dicarboxylate	human metabolite; metabolite; Saccharomyces cerevisiae metabolite
aminolevulinic acid	[no description available]	medium	5	0	4-oxo monocarboxylic acid; amino acid zwitterion; delta-amino acid	antineoplastic agent; dermatologic drug; Escherichia coli metabolite; human metabolite; mouse metabolite; photosensitizing agent; plant metabolite; prodrug; Saccharomyces cerevisiae metabolite
protoporphyrin ix	[no description available]	medium	1	0
epidermal growth factor	[no description available]	medium	4	0
chloramine-t	[no description available]	medium	6	1	organic sodium salt	allergen; antifouling biocide; disinfectant
4-aminophenol	[no description available]	medium	1	0	aminophenol	allergen; metabolite
intrinsic factor	[no description available]	medium	1	0
anpirtoline	[no description available]	medium	1	0	aryl sulfide
2-piperidone	[no description available]	medium	1	0	delta-lactam; piperidones	EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor
eperisone	[no description available]	medium	1	0	aromatic ketone; piperidines
quinidine	[no description available]	medium	7	0	cinchona alkaloid	alpha-adrenergic antagonist; anti-arrhythmia drug; antimalarial; drug allergen; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; muscarinic antagonist; P450 inhibitor; potassium channel blocker; sodium channel blocker
3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate	[no description available]	medium	1	0	purine ribonucleoside triphosphate
propane	[no description available]	medium	2	0	alkane; gas molecular entity	food propellant
dalteparin	[no description available]	medium	1	0
eprodisate	[no description available]	medium	1	0
ornithine	[no description available]	medium	33	1	non-proteinogenic L-alpha-amino acid; ornithine	algal metabolite; hepatoprotective agent; mouse metabolite
dimethylglycine	[no description available]	medium	6	0	amino acid zwitterion; N-methyl-amino acid; N-methylglycines	Daphnia magna metabolite; human metabolite; mouse metabolite
dimethylglycine	[no description available]	medium	6	2	amino acid zwitterion; N-methyl-amino acid; N-methylglycines	Daphnia magna metabolite; human metabolite; mouse metabolite
trimethylamine	[no description available]	medium	4	0	methylamines; tertiary amine	Escherichia coli metabolite; human xenobiotic metabolite
trimethylamine	[no description available]	medium	4	1	methylamines; tertiary amine	Escherichia coli metabolite; human xenobiotic metabolite
glycerylphosphorylcholine	[no description available]	medium	23	2	glycerophosphocholine
dithiothreitol	[no description available]	medium	12	0	1,4-dimercaptobutane-2,3-diol; butanediols; dithiol; glycol; thiol	chelator; human metabolite; reducing agent
bezafibrate	[no description available]	medium	1	1	aromatic ether; monocarboxylic acid amide; monocarboxylic acid; monochlorobenzenes	antilipemic drug; environmental contaminant; geroprotector; xenobiotic
xanthine	[no description available]	medium	3	0	xanthine	Saccharomyces cerevisiae metabolite
s-sulphocysteine	[no description available]	medium	7	0	organic thiosulfate; S-substituted L-cysteine	human metabolite; plant metabolite
alpha-hydroxy-gamma-methylmercaptobutyric acid	[no description available]	medium	3	1	thia fatty acid
furan	[no description available]	medium	1	0	furans; mancude organic heteromonocyclic parent; monocyclic heteroarene	carcinogenic agent; hepatotoxic agent; Maillard reaction product
toosendanin	[no description available]	medium	1	0
2-bromoethanesulfonic acid	[no description available]	medium	1	0
nitrogen dioxide	[no description available]	medium	5	0	nitrogen oxide
tyrosine	[no description available]	medium	1	0	alpha-amino-acid radical
tetramethylpyrazine	[no description available]	medium	2	0	alkaloid; pyrazines	antineoplastic agent; apoptosis inhibitor; bacterial metabolite; neuroprotective agent; platelet aggregation inhibitor; vasodilator agent
pyrazines	[no description available]	medium	2	0	diazine; pyrazines	Daphnia magna metabolite
piplartine	[no description available]	medium	1	0	cinnamamides; dicarboximide
acetylglucosamine	[no description available]	medium	2	0	N-acetyl-D-glucosamine	epitope
glucuronic acid	[no description available]	medium	5	0	D-glucuronic acid	algal metabolite
retinol	[no description available]	medium	24	1	retinol; vitamin A	human metabolite; mouse metabolite; plant metabolite
methadone	[no description available]	medium	5	0	benzenes; diarylmethane; ketone; tertiary amino compound
buprenorphine	[no description available]	medium	7	0	morphinane alkaloid	delta-opioid receptor antagonist; kappa-opioid receptor antagonist; mu-opioid receptor agonist; opioid analgesic
myelin basic protein	[no description available]	medium	1	0
nicotine	[no description available]	medium	10	0	3-(1-methylpyrrolidin-2-yl)pyridine	anxiolytic drug; biomarker; immunomodulator; mitogen; neurotoxin; nicotinic acetylcholine receptor agonist; peripheral nervous system drug; phytogenic insecticide; plant metabolite; psychotropic drug; teratogenic agent; xenobiotic
bupropion	[no description available]	medium	3	0	aromatic ketone; monochlorobenzenes; secondary amino compound	antidepressant; environmental contaminant; xenobiotic
kaempferol 3-o-rhamnoside	[no description available]	medium	1	0	glycosyloxyflavone; monosaccharide derivative; trihydroxyflavone	anti-inflammatory agent; antibacterial agent; plant metabolite
lespenefril	[no description available]	medium	1	0	alpha-L-rhamnoside; dihydroxyflavone; glycosyloxyflavone; monosaccharide derivative; polyphenol	anti-inflammatory agent; antidepressant; antineoplastic agent; apoptosis inducer; bone density conservation agent; hypoglycemic agent; immunomodulator; plant metabolite
procyanidin	[no description available]	medium	2	0	proanthocyanidin
3-hydroxyflavone	[no description available]	medium	3	0	flavonols; monohydroxyflavone
procaine	[no description available]	medium	4	1	benzoate ester; substituted aniline; tertiary amino compound	central nervous system depressant; drug allergen; local anaesthetic; peripheral nervous system drug
glyceryl 2-arachidonate	[no description available]	medium	1	0	2-acylglycerol 20:4; endocannabinoid	human metabolite
pf 3845	[no description available]	medium	2	0	piperidines
phentolamine	[no description available]	medium	7	0	imidazoles; phenols; substituted aniline; tertiary amino compound	alpha-adrenergic antagonist; vasodilator agent
propranolol	[no description available]	medium	24	0	naphthalenes; propanolamine; secondary amine	anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic
verapamil	[no description available]	medium	26	0	aromatic ether; nitrile; polyether; tertiary amino compound
tetrodotoxin	[no description available]	medium	40	0	azatetracycloalkane; oxatetracycloalkane; quinazoline alkaloid	animal metabolite; bacterial metabolite; marine metabolite; neurotoxin; voltage-gated sodium channel blocker
mangiferin	[no description available]	medium	1	0	C-glycosyl compound; xanthones	anti-inflammatory agent; antioxidant; hypoglycemic agent; plant metabolite
fluorescein-5-isothiocyanate	[no description available]	medium	2	0	fluorescein isothiocyanate
berberine	[no description available]	medium	1	0	alkaloid antibiotic; berberine alkaloid; botanical anti-fungal agent; organic heteropentacyclic compound	antilipemic drug; antineoplastic agent; antioxidant; EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor; EC 1.21.3.3 (reticuline oxidase) inhibitor; EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.11.10 (IkappaB kinase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; hypoglycemic agent; metabolite; potassium channel blocker
chloramine	[no description available]	medium	28	0	halide
indazoles	[no description available]	medium	2	0	indazole
fibrinogen	[no description available]	medium	1	0	iditol	fungal metabolite
eslicarbazepine	[no description available]	medium	1	0	dibenzooxazepine
latrunculin a	[no description available]	medium	1	0	cyclic hemiketal; macrolide; oxabicycloalkane; thiazolidinone	actin polymerisation inhibitor; metabolite; toxin
eslicarbazepine acetate	[no description available]	medium	1	0	acetate ester; carboxamide; dibenzoazepine; ureas	anticonvulsant; drug allergen
simvastatin	[no description available]	medium	3	2	delta-lactone; fatty acid ester; hexahydronaphthalenes; statin (semi-synthetic)	EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor; EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor; ferroptosis inducer; geroprotector; prodrug
ezetimibe	[no description available]	medium	2	2	azetidines; beta-lactam; organofluorine compound	anticholesteremic drug; antilipemic drug; antimetabolite
allantoin	[no description available]	medium	5	2	imidazolidine-2,4-dione; ureas	Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite; vulnerary
tetralysine	[no description available]	medium	1	0
capsaicin	[no description available]	medium	7	1	capsaicinoid	non-narcotic analgesic; TRPV1 agonist; voltage-gated sodium channel blocker
ozone	[no description available]	medium	9	0	elemental molecule; gas molecular entity; reactive oxygen species; triatomic oxygen	antiseptic drug; disinfectant; electrophilic reagent; greenhouse gas; mutagen; oxidising agent; tracer
nandrolone	[no description available]	medium	3	0	17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; anabolic androgenic steroid	human metabolite
diethylnitrosamine	[no description available]	medium	5	0	nitrosamine	carcinogenic agent; hepatotoxic agent; mutagen
3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde	[no description available]	medium	1	0	benzoic acids; quinolines	fluorochrome
sertraline	[no description available]	medium	1	0	dichlorobenzene; secondary amino compound; tetralins	antidepressant; serotonin uptake inhibitor
dehydroepiandrosterone	[no description available]	medium	2	0	17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid	androgen; human metabolite; mouse metabolite
nickel chloride	[no description available]	medium	2	0	nickel coordination entity	calcium channel blocker; hapten
isocitric acid	[no description available]	medium	1	0	secondary alcohol; tricarboxylic acid	fundamental metabolite
formic acid	[no description available]	medium	5	0	monocarboxylic acid	antibacterial agent; astringent; metabolite; protic solvent; solvent
propargylglycine	[no description available]	medium	8	0
cysteamine	[no description available]	medium	27	0	amine; thiol	geroprotector; human metabolite; mouse metabolite; radiation protective agent
tris(pyrazolyl)borate	[no description available]	medium	1	0
celestine blue	[no description available]	medium	1	0
benzimidazole	[no description available]	medium	1	0	benzimidazole; polycyclic heteroarene
alloxan	[no description available]	medium	7	0	pyrimidone	hyperglycemic agent; metabolite
nitrites	[no description available]	medium	17	0	monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species	human metabolite
2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid	[no description available]	medium	3	0
1,1-diphenyl-2-picrylhydrazyl	[no description available]	medium	3	0
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	[no description available]	medium	3	0	chromanol; monocarboxylic acid; phenols	antioxidant; ferroptosis inhibitor; neuroprotective agent; radical scavenger; Wnt signalling inhibitor
alendronate	[no description available]	medium	4	0	1,1-bis(phosphonic acid); primary amino compound	bone density conservation agent; EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
formazans	[no description available]	medium	1	0
ro 25-6981	[no description available]	medium	1	0	benzenes; phenols; piperidines; secondary alcohol; tertiary amino compound	anticonvulsant; antidepressant; neuroprotective agent; NMDA receptor antagonist
buprenorphine, naloxone drug combination	[no description available]	medium	1	0
deoxycytidine	[no description available]	medium	2	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
gemcitabine	[no description available]	medium	2	0	organofluorine compound; pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent; antiviral drug; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; environmental contaminant; immunosuppressive agent; photosensitizing agent; prodrug; radiosensitizing agent; xenobiotic
quetiapine fumarate	[no description available]	medium	1	0	fumarate salt
terephthalic acid	[no description available]	medium	2	0	benzenedicarboxylic acid
pyridoxine	[no description available]	medium	50	0	hydroxymethylpyridine; methylpyridines; monohydroxypyridine; vitamin B6	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
metadoxine	[no description available]	medium	2	0
s-adenosylhomocysteine	[no description available]	medium	5	0	adenosines; amino acid zwitterion; homocysteine derivative; homocysteines; organic sulfide	cofactor; EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor; EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor; epitope; fundamental metabolite
gamma-glutamylcysteine	[no description available]	medium	3	0	gamma-glutamylcysteine	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
spermidine	[no description available]	medium	6	0	polyazaalkane; triamine	autophagy inducer; fundamental metabolite; geroprotector
lathosterol	[no description available]	medium	1	0	3beta-sterol; C27-steroid; cholestanoid; Delta(7)-sterol	human metabolite; mouse metabolite
(3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid	[no description available]	medium	1	0	(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
enalapril	[no description available]	medium	5	0	dicarboxylic acid monoester; dipeptide	antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; geroprotector; prodrug
quinuclidines	[no description available]	medium	4	0	quinuclidines; saturated organic heterobicyclic parent
peroxynitrous acid	[no description available]	medium	13	0	nitrogen oxoacid
singlet oxygen	[no description available]	medium	6	0	chalcogen; monoatomic oxygen; nonmetal atom	macronutrient
4-(2-aminoethyl)benzenesulfonylfluoride	[no description available]	medium	1	0
4-chloro-7-nitrobenzofurazan	[no description available]	medium	5	0	benzoxadiazole; C-nitro compound; organochlorine compound	EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.6.1.3 (adenosinetriphosphatase) inhibitor; fluorescent probe; fluorochrome
amiloride	[no description available]	medium	16	0	aromatic amine; guanidines; organochlorine compound; pyrazines	diuretic; sodium channel blocker
ammonium chloride	[no description available]	medium	26	1	ammonium salt; inorganic chloride	ferroptosis inhibitor
lumirubin	[no description available]	medium	1	0
xanthobilirubic acid	[no description available]	medium	1	0
biliverdine	[no description available]	medium	7	0
acrylonitrile	[no description available]	medium	2	0	aliphatic nitrile; volatile organic compound	antifungal agent; carcinogenic agent; fungal metabolite; mutagen; polar aprotic solvent
chlorophyll a	[no description available]	medium	1	0	chlorophyll; methyl ester	cofactor
ketanserin	[no description available]	medium	3	0	aromatic ketone; organofluorine compound; piperidines; quinazolines	alpha-adrenergic antagonist; antihypertensive agent; cardiovascular drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; serotonergic antagonist
dobutamine	[no description available]	medium	4	0	catecholamine; secondary amine	beta-adrenergic agonist; cardiotonic drug; sympathomimetic agent
pimobendan	[no description available]	medium	2	0	benzimidazoles; pyridazinone	cardiotonic drug; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent
sr 95531	[no description available]	medium	5	0	methoxybenzenes
8-bromo-2'-deoxyguanosine	[no description available]	medium	1	0	guanosines; organobromine compound
4-butyrolactone	[no description available]	medium	1	0	butan-4-olide	metabolite; neurotoxin
5-hydroxy-6,8,11,14-eicosatetraenoic acid	[no description available]	medium	1	0	HETE	human metabolite; mouse metabolite
protolichesterinic acid	[no description available]	medium	1	0
pyridoxamine phosphate	[no description available]	medium	1	0	aminoalkylpyridine; methylpyridines; monohydroxypyridine; vitamin B6 phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
pantoyltaurine	[no description available]	medium	9	0
gaboxadol	[no description available]	medium	9	0	oxazole
guvacine	[no description available]	medium	1	0	alpha,beta-unsaturated monocarboxylic acid; beta-amino acid; pyridine alkaloid; secondary amino compound; tetrahydropyridine	GABA reuptake inhibitor; plant metabolite
ergothioneine	[no description available]	medium	1	0	1,3-dihydroimidazole-2-thiones; amino-acid betaine; L-histidine derivative; sulfur-containing amino acid	antioxidant; chelator; fungal metabolite; plant metabolite; xenobiotic metabolite
cardiovascular agents	[no description available]	medium	8	0
sivelestat	[no description available]	medium	1	0	N-acylglycine; pivalate ester
celastrol	[no description available]	medium	1	0	monocarboxylic acid; pentacyclic triterpenoid	anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite
neuropeptide y	[no description available]	medium	5	0
stilbenes	[no description available]	medium	13	0	stilbene
bromochloroacetic acid	[no description available]	medium	2	0	2-bromocarboxylic acid; monocarboxylic acid; organochlorine compound
methylprednisolone	[no description available]	medium	4	0	6-methylprednisolone; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	adrenergic agent; anti-inflammatory drug; antiemetic; environmental contaminant; neuroprotective agent; xenobiotic
bexarotene	[no description available]	medium	1	0	benzoic acids; naphthalenes; retinoid	antineoplastic agent
butyl methacrylate	[no description available]	medium	1	0	enoate ester
adenosine diphosphate	[no description available]	medium	17	1	adenosine 5'-phosphate; purine ribonucleoside 5'-diphosphate	fundamental metabolite; human metabolite
isoflurophate	[no description available]	medium	1	0	dialkyl phosphate
pioglitazone	[no description available]	medium	1	0	aromatic ether; pyridines; thiazolidinediones	antidepressant; cardioprotective agent; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; geroprotector; hypoglycemic agent; insulin-sensitizing drug; PPARgamma agonist; xenobiotic
8,9-dihydrobarettin	[no description available]	medium	1	0
barettin	[no description available]	medium	1	0	organic molecular entity
midazolam	[no description available]	medium	1	0	imidazobenzodiazepine; monofluorobenzenes; organochlorine compound	anticonvulsant; antineoplastic agent; anxiolytic drug; apoptosis inducer; central nervous system depressant; GABAA receptor agonist; general anaesthetic; muscle relaxant; sedative
nitrates	[no description available]	medium	12	0	monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species
3-methoxytyramine	[no description available]	medium	2	0	monomethoxybenzene; phenols; phenylethylamine; primary amino compound	biomarker; human blood serum metabolite; human urinary metabolite
rosiglitazone	[no description available]	medium	1	0	aminopyridine; thiazolidinediones	EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; insulin-sensitizing drug
sodium citrate, anhydrous	[no description available]	medium	2	0	organic sodium salt	anticoagulant; flavouring agent
nitroglycerin	[no description available]	medium	4	0	nitroglycerol	explosive; muscle relaxant; nitric oxide donor; prodrug; tocolytic agent; vasodilator agent; xenobiotic
ondansetron	[no description available]	medium	5	0	carbazoles
fluorides	[no description available]	medium	8	1	halide anion; monoatomic fluorine
hydroxycitric acid	[no description available]	medium	1	0	carbonyl compound
n,n-dimethylarginine	[no description available]	medium	3	0	dimethylarginine; guanidines; L-arginine derivative; non-proteinogenic L-alpha-amino acid	EC 1.14.13.39 (nitric oxide synthase) inhibitor
symmetric dimethylarginine	[no description available]	medium	2	0	amino acid zwitterion; dimethylarginine; guanidines; L-arginine derivative; non-proteinogenic L-alpha-amino acid	EC 1.14.13.39 (nitric oxide synthase) inhibitor
n(g),n(g')-dimethyl-l-arginine	[no description available]	medium	3	0	alpha-amino acid
ammonium acetate	[no description available]	medium	3	0	acetate salt; ammonium salt	buffer; food acidity regulator
hydroxylamine	[no description available]	medium	4	0	hydroxylamines	algal metabolite; bacterial xenobiotic metabolite; EC 1.1.3.13 (alcohol oxidase) inhibitor; EC 4.2.1.22 (cystathionine beta-synthase) inhibitor; EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor; nitric oxide donor; nucleophilic reagent
metallothionein	[no description available]	medium	7	0
thyroxine	[no description available]	medium	10	0	2-halophenol; iodophenol; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid; thyroxine zwitterion; thyroxine	antithyroid drug; human metabolite; mouse metabolite; thyroid hormone
triiodothyronine	[no description available]	medium	16	0	2-halophenol; amino acid zwitterion; iodophenol; iodothyronine	human metabolite; mouse metabolite; thyroid hormone
naloxone	[no description available]	medium	21	1	morphinane alkaloid; organic heteropentacyclic compound; tertiary alcohol	antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist
probenecid	[no description available]	medium	6	0	benzoic acids; sulfonamide	uricosuric drug
penicillin g	[no description available]	medium	9	0	penicillin allergen; penicillin	antibacterial drug; drug allergen; epitope
5-s-cysteinyldopamine	[no description available]	medium	1	0	S-conjugate
carbenoxolone sodium	[no description available]	medium	2	0	triterpenoid
cytidine	[no description available]	medium	1	0	cytidines	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
cytosine	[no description available]	medium	2	0	aminopyrimidine; pyrimidine nucleobase; pyrimidone	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
octadecylsilane	[no description available]	medium	1	0
2,5-hexanedione	[no description available]	medium	1	0	diketone; methyl ketone	human xenobiotic metabolite; neurotoxin
ethanolamine	[no description available]	medium	9	0	ethanolamines; primary alcohol; primary amine	Escherichia coli metabolite; human metabolite; mouse metabolite
phenanthrene	[no description available]	medium	1	0	ortho-fused polycyclic arene; ortho-fused tricyclic hydrocarbon; phenanthrenes	environmental contaminant; mouse metabolite
phenanthrenes	[no description available]	medium	1	0
cadmium chloride	[no description available]	medium	17	0	cadmium coordination entity
acrolein	[no description available]	medium	1	0	enal	herbicide; human xenobiotic metabolite; toxin
cinnamaldehyde	[no description available]	medium	1	0	3-phenylprop-2-enal; cinnamaldehydes	antifungal agent; EC 4.3.1.24 (phenylalanine ammonia-lyase) inhibitor; flavouring agent; hypoglycemic agent; plant metabolite; sensitiser; vasodilator agent
3-methylhistidine	[no description available]	high	4	0	L-histidine derivative; non-proteinogenic L-alpha-amino acid; zwitterion	human metabolite; Saccharomyces cerevisiae metabolite
3-methylhistidine	[no description available]	high	4	1	L-histidine derivative; non-proteinogenic L-alpha-amino acid; zwitterion	human metabolite; Saccharomyces cerevisiae metabolite
homocystine	[no description available]	medium	6	1	amino acid zwitterion; homocystines	human metabolite
glycoursodeoxycholic acid	[no description available]	medium	5	0	bile acid glycine conjugate; N-acylglycine	human blood serum metabolite; neuroprotective agent
beta-n-methylamino-l-alanine	[no description available]	medium	1	0	diamino acid; L-alanine derivative; non-proteinogenic L-alpha-amino acid; secondary amino compound	bacterial metabolite; neurotoxin
imidazoleacetic acid	[no description available]	medium	4	0	imidazoles; monocarboxylic acid	metabolite; mouse metabolite
casein kinase ii	[no description available]	medium	3	0
clindamycin	[no description available]	medium	2	1
fomepizole	[no description available]	medium	1	0	pyrazoles	antidote; EC 1.1.1.1 (alcohol dehydrogenase) inhibitor; protective agent
methylcellulose	[no description available]	medium	2	0
brine	[no description available]	medium	1	0
tetraethylammonium	[no description available]	medium	7	0	quaternary ammonium ion
phenylephrine	[no description available]	medium	16	0	phenols; phenylethanolamines; secondary amino compound	alpha-adrenergic agonist; cardiotonic drug; mydriatic agent; nasal decongestant; protective agent; sympathomimetic agent; vasoconstrictor agent
iberiotoxin	[no description available]	medium	3	0
2-(n-morpholino)ethanesulfonic acid	[no description available]	medium	1	0	MES; organosulfonic acid; zwitterion
tetramethylammonium	[no description available]	medium	3	0	quaternary ammonium ion
chlormethiazole	[no description available]	medium	1	0	thiazoles
sodium sulfite	[no description available]	medium	1	0	inorganic sodium salt; sulfite salt	food preservative; reducing agent
sodium bisulfite	[no description available]	medium	1	0	inorganic sodium salt; sulfite salt	allergen; food antioxidant; food colour retention agent; mutagen; reducing agent
neurotensin	[no description available]	medium	5	0	peptide hormone	human metabolite; mitogen; neurotransmitter; vulnerary
sr 48692	[no description available]	medium	1	0	N-acyl-amino acid
hyodeoxycholic acid	[no description available]	medium	4	0	5beta-cholanic acids; 6alpha,20xi-murideoxycholic acid; bile acid; C24-steroid	human metabolite; mouse metabolite
muricholic acid	[no description available]	medium	3	0	3alpha-hydroxy steroid; 6-hydroxy steroid; 7-hydroxy steroid; bile acid; C24-steroid; trihydroxy-5beta-cholanic acid
opc 12759	[no description available]	medium	5	0	secondary carboxamide
sodium dodecyl sulfate	[no description available]	medium	15	0	organic sodium salt	detergent; protein denaturant
carbostyril	[no description available]	medium	5	0	monohydroxyquinoline; quinolone	bacterial xenobiotic metabolite
dihydropyridines	[no description available]	medium	4	0
ios 11212	[no description available]	medium	2	0
glutapyrone	[no description available]	medium	1	0
gw-5074	[no description available]	medium	1	0
fmrfamide	[no description available]	medium	1	0
4-hydroxyphenylacetic acid	[no description available]	medium	1	0	monocarboxylic acid; phenols	fungal metabolite; human metabolite; mouse metabolite; plant metabolite
1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea	[no description available]	medium	63	7
lomustine	[no description available]	medium	5	0	N-nitrosoureas; organochlorine compound	alkylating agent; antineoplastic agent
hepes	[no description available]	medium	12	0	HEPES; organosulfonic acid
oxotremorine m	[no description available]	medium	1	0	quaternary ammonium ion	muscarinic agonist
guanidine	[no description available]	medium	6	0	carboxamidine; guanidines; one-carbon compound
oxotremorine	[no description available]	medium	3	0	N-alkylpyrrolidine
sphingosine 1-phosphate	[no description available]	medium	2	0	sphingoid 1-phosphate	mouse metabolite; signalling molecule; sphingosine-1-phosphate receptor agonist; T-cell proliferation inhibitor; vasodilator agent
propylthiouracil	[no description available]	medium	5	0	pyrimidinethione	antidote to paracetamol poisoning; antimetabolite; antioxidant; antithyroid drug; carcinogenic agent; EC 1.14.13.39 (nitric oxide synthase) inhibitor; hormone antagonist
diclofenac	[no description available]	medium	2	0	amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound	antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
mannitol	[no description available]	medium	21	0	mannitol	allergen; antiglaucoma drug; compatible osmolytes; Escherichia coli metabolite; food anticaking agent; food bulking agent; food humectant; food stabiliser; food thickening agent; hapten; metabolite; osmotic diuretic; sweetening agent
2-aminobicyclo(2,2,1)heptane-2-carboxylic acid	[no description available]	medium	1	0	monoterpenoid
saxitoxin	[no description available]	medium	1	0	alkaloid; carbamate ester; guanidines; ketone hydrate; paralytic shellfish toxin; pyrrolopurine	cyanotoxin; marine metabolite; neurotoxin; sodium channel blocker; toxin
dapi	[no description available]	medium	2	1	indoles	fluorochrome
leukotriene c4	[no description available]	medium	1	0	leukotriene	bronchoconstrictor agent; human metabolite; mouse metabolite
pyridoxal	[no description available]	medium	5	0	hydroxymethylpyridine; methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
labetalol	[no description available]	medium	1	0	benzamides; benzenes; phenols; primary carboxamide; salicylamides; secondary alcohol; secondary amino compound
toluene	[no description available]	medium	5	0	methylbenzene; toluenes; volatile organic compound	cholinergic antagonist; fuel additive; neurotoxin; non-polar solvent
11-cis-retinal	[no description available]	medium	11	0	retinal	chromophore; human metabolite; mouse metabolite
idazoxan	[no description available]	medium	1	0	benzodioxine; imidazolines	alpha-adrenergic antagonist
bicuculline methiodide	[no description available]	medium	3	0
6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide	[no description available]	medium	23	0
4-amino-3-phenylbutyric acid	[no description available]	medium	2	0	organonitrogen compound; organooxygen compound
oxazepam	[no description available]	medium	2	0	1,4-benzodiazepinone; organochlorine compound	anxiolytic drug; environmental contaminant; xenobiotic
oligonucleotides	[no description available]	medium	1	0
methiocarb	[no description available]	medium	2	0	aryl sulfide; carbamate ester; methyl sulfide	acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide; molluscicide; xenobiotic
anisomycin	[no description available]	medium	1	0	monohydroxypyrrolidine; organonitrogen heterocyclic antibiotic	anticoronaviral agent; antimicrobial agent; antineoplastic agent; antiparasitic agent; bacterial metabolite; DNA synthesis inhibitor; protein synthesis inhibitor
warfarin	[no description available]	medium	2	0	benzenes; hydroxycoumarin; methyl ketone
coumarin	[no description available]	medium	1	0	coumarins	fluorescent dye; human metabolite; plant metabolite
sodium arsenite	[no description available]	medium	7	0	arsenic molecular entity; inorganic sodium salt	antibacterial agent; antifungal agent; antineoplastic agent; carcinogenic agent; herbicide; insecticide; rodenticide
benzylamine	[no description available]	medium	1	0	aralkylamine; primary amine	allergen; EC 3.5.5.1 (nitrilase) inhibitor; plant metabolite
omeprazole	[no description available]	medium	1	0	aromatic ether; benzimidazoles; pyridines; sulfoxide
ytterbium	[no description available]	medium	1	0	f-block element atom; lanthanoid atom
beta-lactams	[no description available]	medium	1	0	beta-lactam antibiotic allergen; beta-lactam
beta-sultam	[no description available]	medium	2	0
mesalamine	[no description available]	medium	4	0	amino acid; aromatic amine; monocarboxylic acid; monohydroxybenzoic acid; phenols	non-steroidal anti-inflammatory drug
prednisolone	[no description available]	medium	4	0	11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	adrenergic agent; anti-inflammatory drug; antineoplastic agent; drug metabolite; environmental contaminant; immunosuppressive agent; xenobiotic
trypan blue	[no description available]	medium	2	0
lauric acid	[no description available]	medium	5	0	medium-chain fatty acid; straight-chain saturated fatty acid	algal metabolite; antibacterial agent; plant metabolite
vitamin k 3	[no description available]	medium	1	0	1,4-naphthoquinones; vitamin K	angiogenesis inhibitor; antineoplastic agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; human urinary metabolite; nutraceutical
thiazolyl blue	[no description available]	medium	5	0	organic bromide salt	colorimetric reagent; dye
palmitic acid	[no description available]	medium	4	0	long-chain fatty acid; straight-chain saturated fatty acid	algal metabolite; Daphnia magna metabolite; EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor; plant metabolite
acetoacetic acid	[no description available]	medium	1	0	3-oxo fatty acid; ketone body	metabolite
acetone	[no description available]	medium	3	0	ketone body; methyl ketone; propanones; volatile organic compound	EC 3.5.1.4 (amidase) inhibitor; human metabolite; polar aprotic solvent
2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine	[no description available]	medium	1	0	adenosines; dicarboxylic acid monoamide; monocarboxylic acid	adenosine A2A receptor agonist; anti-inflammatory agent
cyclic gmp	[no description available]	medium	25	0	3',5'-cyclic purine nucleotide; guanyl ribonucleotide	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
monoisoamyl-2,3-dimercaptosuccinate	[no description available]	medium	2	0
succimer	[no description available]	medium	4	0	dicarboxylic acid; dithiol; sulfur-containing carboxylic acid	chelator
barium	[no description available]	medium	11	0	alkaline earth metal atom; elemental barium
d-aspartic acid	[no description available]	medium	3	0	aspartic acid; D-alpha-amino acid	mouse metabolite
beta-endorphin	[no description available]	medium	7	1
lysophosphatidic acid	[no description available]	medium	2	0	1-acyl-sn-glycerol 3-phosphate
8-bromo cyclic adenosine monophosphate	[no description available]	medium	4	0	3',5'-cyclic purine nucleotide; adenyl ribonucleotide; organobromine compound	antidepressant; protein kinase agonist
n,n-dichlorotaurine	[no description available]	medium	6	0
chlorodimedone	[no description available]	medium	2	0
tiletamine hydrochloride	[no description available]	medium	2	0
beta-glycerophosphoric acid	[no description available]	medium	3	0	glycerol monophosphate	Escherichia coli metabolite; plant metabolite
tacrolimus	[no description available]	medium	2	0	macrolide lactam	bacterial metabolite; immunosuppressive agent
glutaminase	[no description available]	medium	3	0
dextromethorphan	[no description available]	medium	2	0	6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthrene	antitussive; environmental contaminant; neurotoxin; NMDA receptor antagonist; oneirogen; prodrug; xenobiotic
diacetyldichlorofluorescein	[no description available]	medium	2	0
trinitrobenzenesulfonic acid	[no description available]	medium	6	0	arenesulfonic acid; C-nitro compound	epitope; explosive; reagent
hypothiocyanite ion	[no description available]	medium	1	0
n-nitrosoiminodiacetic acid	[no description available]	medium	1	0
trimetazidine	[no description available]	medium	1	1	aromatic amine
thymidine	[no description available]	medium	6	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
rc 3095	[no description available]	medium	1	0
dihydro-beta-erythroidine	[no description available]	medium	1	0	delta-lactone; organic heterotetracyclic compound; tertiary amino compound	nicotinic antagonist
anatoxin a	[no description available]	medium	1	0	tropane alkaloid
methyllycaconitine	[no description available]	medium	1	0
pyrrolidine-2,4-dicarboxylic acid	[no description available]	medium	4	0
6-amino-1-hydroxyhexane-1,1-diphosphonate	[no description available]	medium	2	1	1,1-bis(phosphonic acid)
tert-butylhydroperoxide	[no description available]	medium	3	0	alkyl hydroperoxide	antibacterial agent; oxidising agent
molsidomine	[no description available]	high	9	0	ethyl ester; morpholines; oxadiazole; zwitterion	antioxidant; apoptosis inhibitor; cardioprotective agent; nitric oxide donor; vasodilator agent
nitric acid	[no description available]	medium	1	0	nitrogen oxoacid	protic solvent; reagent
neutral red	[no description available]	medium	1	0	hydrochloride	acid-base indicator; dye; two-colour indicator
europium	[no description available]	medium	1	0	f-block element atom; lanthanoid atom
tetracycline	[no description available]	medium	3	1
1-hexadecyl-2-acetyl-glycero-3-phosphocholine	[no description available]	medium	5	0	2-acetyl-1-alkyl-sn-glycero-3-phosphocholine	antihypertensive agent; beta-adrenergic antagonist; bronchoconstrictor agent; hematologic agent; vasodilator agent
betadex	[no description available]	medium	3	0	cyclodextrin
5-methyltetrahydrofolate	[no description available]	medium	1	0
n-acetyl-n-formyl-5-methoxykynurenamine	[no description available]	medium	2	0	aromatic ketone
iodine	[no description available]	medium	17	0	halide anion; monoatomic iodine	human metabolite
kynuramine	[no description available]	medium	2	0	kynurenamines; primary amino compound	metabolite
n-(2-(5-methoxy-2-oxo-2,3-dihydro-1h-indol-3-yl)ethyl)acetamide	[no description available]	medium	1	0	acetamides; hydroxyindoles; tryptamines	antineoplastic agent; apoptosis inducer; plant metabolite
alkenes	[no description available]	medium	2	0
agmatine	[no description available]	medium	2	0	guanidines; primary amino compound	Escherichia coli metabolite; mouse metabolite
phenethylamine	[no description available]	medium	1	0	alkaloid; aralkylamine; phenylethylamine	Escherichia coli metabolite; human metabolite; mouse metabolite
tricine	[no description available]	medium	2	0	tricine
phorbol-12,13-diacetate	[no description available]	medium	1	0
homogentisic acid	[no description available]	medium	1	0	dihydroxyphenylacetic acid; hydroquinones	human metabolite; plant metabolite
ferulic acid	[no description available]	medium	1	0	ferulic acids	anti-inflammatory agent; antioxidant; apoptosis inhibitor; cardioprotective agent; MALDI matrix material; plant metabolite
tarenflurbil	[no description available]	medium	1	0	flurbiprofen
flurbiprofen	[no description available]	medium	3	0	fluorobiphenyl; monocarboxylic acid	antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
eritoran	[no description available]	medium	1	0	lipid As
concanavalin a	[no description available]	medium	3	0
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	[no description available]	medium	14	0	non-proteinogenic alpha-amino acid
8-nitroguanine	[no description available]	medium	2	0	oxopurine
3-methylquercetin	[no description available]	medium	1	0	7-hydroxyflavonol; monomethoxyflavone; tetrahydroxyflavone	anticoagulant; EC 1.14.18.1 (tyrosinase) inhibitor; metabolite
malonic acid	[no description available]	medium	1	0	alpha,omega-dicarboxylic acid	human metabolite
sulfur hexafluoride	[no description available]	medium	1	0	sulfur coordination entity	greenhouse gas; NMR chemical shift reference compound; ultrasound contrast agent
beta carotene	[no description available]	medium	3	0	carotenoid beta-end derivative; cyclic carotene	antioxidant; biological pigment; cofactor; ferroptosis inhibitor; human metabolite; mouse metabolite; plant metabolite; provitamin A
venlafaxine hydrochloride	[no description available]	medium	1	0	hydrochloride
cyclohexanol	[no description available]	medium	1	0	cyclohexanols; secondary alcohol	solvent
dihydroxyphenylalanine	[no description available]	medium	4	0	hydroxyphenylalanine; non-proteinogenic alpha-amino acid; tyrosine derivative	human metabolite
potassium hydroxide	[no description available]	medium	1	1	alkali metal hydroxide
4-aminobenzoic acid	[no description available]	medium	1	0	aminobenzoic acid; aromatic amino-acid zwitterion	allergen; Escherichia coli metabolite; plant metabolite
sulfanilamide	[no description available]	medium	1	0	substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial agent; drug allergen; EC 4.2.1.1 (carbonic anhydrase) inhibitor
4-aminobenzoic acid	[no description available]	medium	1	0	aminobenzoate; aromatic amino-acid anion	Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
salicylates	[no description available]	medium	9	0	monohydroxybenzoate	plant metabolite
taurolithocholic acid	[no description available]	medium	6	0	bile acid taurine conjugate; monocarboxylic acid amide	human metabolite
digitonin	[no description available]	medium	2	0
copper gluconate	[no description available]	medium	5	0	organic molecular entity
2-thiomalic acid	[no description available]	medium	1	0	C4-dicarboxylic acid
gluconic acid	[no description available]	medium	3	0	gluconic acid	chelator; Penicillium metabolite
nap taurine	[no description available]	medium	27	0
anandamide	[no description available]	medium	1	0	endocannabinoid; N-acylethanolamine 20:4	human blood serum metabolite; neurotransmitter; vasodilator agent
benzoylecgonine	[no description available]	medium	1	1	benzoate ester; tropane alkaloid	epitope; human xenobiotic metabolite; marine xenobiotic metabolite; plant metabolite
unithiol	[no description available]	medium	4	0
fluconazole	[no description available]	medium	1	0	conazole antifungal drug; difluorobenzene; tertiary alcohol; triazole antifungal drug	environmental contaminant; P450 inhibitor; xenobiotic
fast green fcf	[no description available]	medium	1	0	organic sodium salt	fluorochrome; food colouring; histological dye
acid fuchsin	[no description available]	medium	1	0
heparitin sulfate	[no description available]	medium	1	0
thallium	[no description available]	medium	1	0	boron group element atom
thallium sulfate	[no description available]	medium	1	0	metal sulfate; thallium molecular entity	insecticide; rodenticide
ethane	[no description available]	medium	1	0	alkane; gas molecular entity	plant metabolite; refrigerant
1,4-dihydropyridine	[no description available]	medium	1	0
vantocil	[no description available]	medium	3	0
biguanides	[no description available]	medium	5	1	guanidines
sodium sulfate	[no description available]	medium	2	0	inorganic sodium salt
tartaric acid	[no description available]	medium	1	0	tartaric acid	Escherichia coli metabolite
1-(3-chlorophenyl)piperazine	[no description available]	medium	1	1	monochlorobenzenes; N-arylpiperazine	drug metabolite; environmental contaminant; serotonergic agonist; xenobiotic
yohimbine	[no description available]	medium	2	1	methyl 17-hydroxy-20xi-yohimban-16-carboxylate	alpha-adrenergic antagonist; dopamine receptor D2 antagonist; serotonergic antagonist
cyanidin 3-galactoside	[no description available]	medium	1	0
taurineamide	[no description available]	medium	4	0
ethidium	[no description available]	medium	1	0	phenanthridines	fluorochrome; intercalator
diacetylfluorescein	[no description available]	medium	1	0
sulfuryl fluoride	[no description available]	medium	1	0	sulfuryl halide	fumigant insecticide
alpha-chymotrypsin	[no description available]	medium	7	0
3,5-diiodosalicylic acid	[no description available]	medium	1	0
2,3-dihydroxybenzoic acid	[no description available]	medium	2	0	dihydroxybenzoic acid	human xenobiotic metabolite; plant metabolite
acetoin	[no description available]	medium	1	0	methyl ketone; secondary alpha-hydroxy ketone	metabolite
s-(2-carboxyethyl)cysteine	[no description available]	medium	1	0
carbocysteine	[no description available]	medium	2	0	L-cysteine thioether; non-proteinogenic L-alpha-amino acid	mucolytic
estrone sulfate	[no description available]	medium	1	0	17-oxo steroid; steroid sulfate	human metabolite; mouse metabolite
isospaglumic acid	[no description available]	medium	5	0	dipeptide	human metabolite
isospaglumic acid	[no description available]	medium	5	1	dipeptide	human metabolite
3-phenyllactic acid	[no description available]	medium	1	0	2-hydroxy monocarboxylic acid	human metabolite
indole-3-lactic acid	[no description available]	medium	1	0	hydroxy monocarboxylic acid; indol-3-yl carboxylic acid	human metabolite
cyanides	[no description available]	medium	20	0	pseudohalide anion	EC 1.9.3.1 (cytochrome c oxidase) inhibitor
anticodon	[no description available]	medium	4	0
pituitrin	[no description available]	medium	12	0
hesperidin	[no description available]	medium	1	0	3'-hydroxyflavanones; 4'-methoxyflavanones; dihydroxyflavanone; disaccharide derivative; flavanone glycoside; monomethoxyflavanone; rutinoside	mutagen
hesperetin	[no description available]	medium	1	0	3'-hydroxyflavanones; 4'-methoxyflavanones; monomethoxyflavanone; trihydroxyflavanone	antineoplastic agent; antioxidant; plant metabolite
naringenin	[no description available]	medium	1	0	(2S)-flavan-4-one; naringenin	expectorant; plant metabolite
naringin	[no description available]	medium	1	0	(2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; neohesperidoside	anti-inflammatory agent; antineoplastic agent; metabolite
fucoxanthin	[no description available]	medium	1	0
linsidomine	[no description available]	medium	8	0	morpholines
sorbinil	[no description available]	medium	4	0	azaspiro compound; chromanes; imidazolidinone; organofluorine compound; oxaspiro compound	antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor
imidazolidines	[no description available]	medium	4	0	azacycloalkane; imidazolidines; saturated organic heteromonocyclic parent
org 24598	[no description available]	medium	1	0
methacycline	[no description available]	medium	1	0	1,2-diglyceride
thioflavin t	[no description available]	medium	1	0	organic chloride salt	fluorochrome; geroprotector; histological dye
clofibric acid	[no description available]	medium	5	0	aromatic ether; monocarboxylic acid; monochlorobenzenes	anticholesteremic drug; antilipemic drug; antineoplastic agent; herbicide; marine xenobiotic metabolite; PPARalpha agonist
benoxaprofen glucuronide	[no description available]	medium	1	0
flunitrazepam	[no description available]	medium	8	0	1,4-benzodiazepinone; C-nitro compound; monofluorobenzenes	anxiolytic drug; GABAA receptor agonist; sedative
11-ketotestosterone	[no description available]	medium	1	0	11-oxo steroid; 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; androstanoid	androgen; human metabolite; marine xenobiotic metabolite
cesium	[no description available]	medium	4	0	alkali metal atom
cesium chloride	[no description available]	medium	2	0	inorganic caesium salt; inorganic chloride	phase-transfer catalyst; vasoconstrictor agent
veratridine	[no description available]	medium	21	0
acetonitrile	[no description available]	medium	4	0	aliphatic nitrile; volatile organic compound	EC 3.5.1.4 (amidase) inhibitor; NMR chemical shift reference compound; polar aprotic solvent
7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole	[no description available]	medium	1	0
carboxyl radical	[no description available]	medium	1	0	carbon oxide; organic radical anion	xenobiotic metabolite
resazurin	[no description available]	medium	1	0	phenoxazine
stearates	[no description available]	medium	1	0
docosanol	[no description available]	medium	1	0	docosanol; long-chain primary fatty alcohol	antiviral drug; plant metabolite
dehydrocholic acid	[no description available]	medium	3	0	12-oxo steroid; 3-oxo-5beta-steroid; 7-oxo steroid; oxo-5beta-cholanic acid	gastrointestinal drug
furoylglycine	[no description available]	medium	1	0	furans; N-acylglycine	human metabolite
sulfuric acid	[no description available]	medium	1	0	sulfur oxoacid	catalyst
phenothiazine	[no description available]	medium	1	0	phenothiazine	ferroptosis inhibitor; plant metabolite; radical scavenger
dithizone	[no description available]	medium	2	0
cytochalasin b	[no description available]	medium	8	0	cytochalasin; lactam; lactone; organic heterotricyclic compound	actin polymerisation inhibitor; metabolite; mycotoxin; platelet aggregation inhibitor
amiodarone	[no description available]	medium	3	0	1-benzofurans; aromatic ketone; organoiodine compound; tertiary amino compound	cardiovascular drug
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene	[no description available]	medium	1	0	BODIPY compound
retapamulin	[no description available]	medium	1	0	carbotricyclic compound; carboxylic ester; cyclic ketone
mupirocin	[no description available]	medium	2	0	alpha,beta-unsaturated carboxylic ester; epoxide; monocarboxylic acid; oxanes; secondary alcohol; triol	antibacterial drug; bacterial metabolite; protein synthesis inhibitor
fusidic acid	[no description available]	medium	3	0	11alpha-hydroxy steroid; 3alpha-hydroxy steroid; alpha,beta-unsaturated monocarboxylic acid; steroid acid; steroid antibiotic; sterol ester	EC 2.7.1.33 (pantothenate kinase) inhibitor; Escherichia coli metabolite; protein synthesis inhibitor
proanthocyanidin	[no description available]	medium	1	0
methamphetamine	[no description available]	medium	6	0	amphetamines; secondary amine	central nervous system stimulant; environmental contaminant; neurotoxin; psychotropic drug; xenobiotic
permethrin	[no description available]	medium	1	0	cyclopropanecarboxylate ester; cyclopropanes	agrochemical; ectoparasiticide; pyrethroid ester acaricide; pyrethroid ester insecticide; scabicide
sm 346	[no description available]	medium	1	0
urobilinogen	[no description available]	medium	1	0	bilanes	human metabolite
dithionitrobenzoic acid	[no description available]	medium	1	0	nitrobenzoic acid; organic disulfide	indicator
3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide	[no description available]	medium	1	0
ecteinascidin 743	[no description available]	medium	1	0	acetate ester; azaspiro compound; bridged compound; hemiaminal; isoquinoline alkaloid; lactone; organic heteropolycyclic compound; organic sulfide; oxaspiro compound; polyphenol; tertiary amino compound	alkylating agent; angiogenesis modulating agent; anti-inflammatory agent; antineoplastic agent; marine metabolite
mafosfamide	[no description available]	medium	1	0
glyceric acid	[no description available]	medium	2	0	trionic acid	fundamental metabolite
aminomalonic acid	[no description available]	medium	1	0	amino dicarboxylic acid	Daphnia magna metabolite; human metabolite
cobalt	[no description available]	medium	18	0	cobalt group element atom; metal allergen	micronutrient
dibutyldichlorotin	[no description available]	medium	2	0
thymidine monophosphate	[no description available]	medium	1	0	thymidine 5'-monophosphate	fundamental metabolite
carboxyethyl-hydroxychroman	[no description available]	medium	1	0
heme	[no description available]	medium	4	0
hypothiocyanite ion	[no description available]	medium	2	0	one-carbon compound; sulfur oxoacid	antibacterial agent; antifungal agent; antiviral agent; human metabolite; oxidising agent; rat metabolite
dibromoacetonitrile	[no description available]	medium	1	0	aliphatic nitrile
p-methoxy-n-methylphenethylamine	[no description available]	medium	3	0	aromatic ether; secondary amino compound	metabolite
potassium iodide	[no description available]	medium	2	0	potassium salt	expectorant; radical scavenger
resorcinol	[no description available]	medium	1	0	benzenediol; phenolic donor; resorcinols	erythropoietin inhibitor; sensitiser
imipramine	[no description available]	medium	5	0	dibenzoazepine	adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
phytosterols	[no description available]	medium	2	0
cyanuric acid	[no description available]	medium	1	0	1,3,5-triazinanes; 1,3,5-triazines; heteroaryl hydroxy compound	xenobiotic
bromine	[no description available]	medium	2	0	diatomic bromine
celecoxib	[no description available]	medium	1	0	organofluorine compound; pyrazoles; sulfonamide; toluenes	cyclooxygenase 2 inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug
lanthionine	[no description available]	medium	2	0	alanine derivative; non-proteinogenic alpha-amino acid; organic sulfide	bacterial metabolite
deoxypyridinoline	[no description available]	medium	2	0
geranylgeraniol	[no description available]	medium	1	0	geranylgeraniol
mevalonic acid	[no description available]	medium	2	0	3,5-dihydroxy-3-methylpentanoic acid
tri-o-cresyl phosphate	[no description available]	medium	1	0
finasteride	[no description available]	medium	1	0	3-oxo steroid; aza-steroid; delta-lactam	androgen antagonist; antihyperplasia drug; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor
astressin b	[no description available]	medium	1	0
endomorphin 1	[no description available]	medium	1	0	oligopeptide
fluo-3	[no description available]	medium	3	0	xanthene dye	fluorochrome
diatrizoic acid	[no description available]	medium	1	0	acetamides; benzoic acids; organoiodine compound	environmental contaminant; radioopaque medium; xenobiotic
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone	[no description available]	medium	4	0
lithocholic acid	[no description available]	medium	43	1	bile acid; C24-steroid; monohydroxy-5beta-cholanic acid	geroprotector; human metabolite; mouse metabolite
arcaine	[no description available]	medium	1	0	guanidines
etomidate	[no description available]	medium	1	0	ethyl ester; imidazoles	intravenous anaesthetic; sedative
omega-n-methylarginine	[no description available]	medium	3	0	amino acid zwitterion; arginine derivative; guanidines; L-arginine derivative; non-proteinogenic L-alpha-amino acid
4-aminobenzhydrazide	[no description available]	medium	2	0
diltiazem	[no description available]	medium	6	1	5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate	antihypertensive agent; calcium channel blocker; vasodilator agent
acetyl phosphate	[no description available]	medium	1	0	acyl monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
formycins	[no description available]	medium	1	0
formycin b	[no description available]	medium	1	0	formycin
bilobalide	[no description available]	medium	1	0	sesquiterpene lactone
noxythiolin	[no description available]	medium	6	0	thioureas
phenobarbital	[no description available]	medium	23	0	barbiturates	anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative
diethyl maleate	[no description available]	medium	5	0	ethyl ester; maleate ester	glutathione depleting agent
dextroamphetamine	[no description available]	medium	4	0	1-phenylpropan-2-amine	adrenergic agent; adrenergic uptake inhibitor; dopamine uptake inhibitor; dopaminergic agent; neurotoxin; sympathomimetic agent
sidnocarb	[no description available]	medium	3	0
oxadiazoles	[no description available]	medium	30	0
z 335	[no description available]	medium	1	0
cycloleucine	[no description available]	medium	2	0	non-proteinogenic alpha-amino acid	EC 2.5.1.6 (methionine adenosyltransferase) inhibitor
ditaurobilirubin	[no description available]	medium	13	0
methylphenazonium methosulfate	[no description available]	medium	1	0	azaheterocycle sulfate salt; phenazines
melitten	[no description available]	medium	4	0
lysophosphatidylcholines	[no description available]	medium	8	0	1-O-acyl-sn-glycero-3-phosphocholine
troxerutin	[no description available]	medium	2	0
rutin	[no description available]	medium	2	0	disaccharide derivative; quercetin O-glucoside; rutinoside; tetrahydroxyflavone	antioxidant; metabolite
azides	[no description available]	medium	15	0	pseudohalide anion	mitochondrial respiratory-chain inhibitor
spiperone	[no description available]	medium	3	0	aromatic ketone; azaspiro compound; organofluorine compound; piperidines; tertiary amino compound	alpha-adrenergic antagonist; antipsychotic agent; dopaminergic antagonist; psychotropic drug; serotonergic antagonist
quinpirole	[no description available]	medium	1	0	pyrazoloquinoline	dopamine agonist
w 7	[no description available]	medium	7	0
magnesium sulfate	[no description available]	medium	4	0	magnesium salt; metal sulfate; organic magnesium salt	anaesthetic; analgesic; anti-arrhythmia drug; anticonvulsant; calcium channel blocker; cardiovascular drug; fertilizer; tocolytic agent
thioinosine	[no description available]	medium	2	0
kaolinite	[no description available]	medium	1	0	aluminosilicate mineral; mixture	antidiarrhoeal drug; excipient
hydrogen carbonate	[no description available]	medium	28	0	carbon oxoanion	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
charybdotoxin	[no description available]	medium	3	0
allyl formate	[no description available]	medium	2	0
ethionine	[no description available]	medium	5	0	S-ethylhomocysteine	antimetabolite; carcinogenic agent
1,4-naphthoquinone	[no description available]	medium	2	0	1,4-naphthoquinones
naphthoquinones	[no description available]	medium	2	0
s-methylisothiopseudouronium	[no description available]	medium	1	0
isothiuronium	[no description available]	medium	1	0
meropenem	[no description available]	medium	1	0	alpha,beta-unsaturated monocarboxylic acid; carbapenemcarboxylic acid; organic sulfide; pyrrolidinecarboxamide	antibacterial agent; antibacterial drug; drug allergen
quinine	[no description available]	medium	6	0	cinchona alkaloid	antimalarial; muscle relaxant; non-narcotic analgesic
naproxen	[no description available]	medium	2	0	methoxynaphthalene; monocarboxylic acid	antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; gout suppressant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
tolmetin	[no description available]	medium	2	0	aromatic ketone; monocarboxylic acid; pyrroles	EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug
n-acetylneuraminic acid	[no description available]	medium	3	0	N-acetylneuraminic acids	antioxidant; bacterial metabolite; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; human metabolite; mouse metabolite
g(m2) ganglioside	[no description available]	medium	1	0	N-acetyl-beta-D-galactosaminyl-(1->4)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-N-acylsphingosine; sialotriaosylceramide	antigen
tolonium chloride	[no description available]	medium	1	0
chelerythrine	[no description available]	medium	9	0	benzophenanthridine alkaloid; organic cation	antibacterial agent; antineoplastic agent; EC 2.7.11.13 (protein kinase C) inhibitor
deposiston	[no description available]	medium	1	0
norethindrone	[no description available]	medium	1	0	17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; terminal acetylenic compound; tertiary alcohol	progestin; synthetic oral contraceptive
cholestyramine resin	[no description available]	medium	21	0
nomifensine	[no description available]	medium	2	0	isoquinolines	dopamine uptake inhibitor
4-n,n-dimethylaminoazobenzene-4'-sulfonyl chloride	[no description available]	medium	4	0
p-dimethylaminoazobenzene	[no description available]	medium	5	0	azobenzenes
mirtazapine	[no description available]	medium	2	0	benzazepine; tetracyclic antidepressant	alpha-adrenergic antagonist; anxiolytic drug; H1-receptor antagonist; histamine antagonist; oneirogen; serotonergic antagonist
mianserin	[no description available]	medium	2	0	dibenzoazepine	adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; H1-receptor antagonist; histamine agonist; sedative; serotonergic antagonist
23-seleno-25-homotaurocholic acid	[no description available]	medium	2	0	corticosteroid hormone
tetramethylrhodamine	[no description available]	medium	1	0	xanthene dye
phosphoglycocyamine	[no description available]	medium	2	0	guanidinoacetic acids; phosphoramide
pantothenic acid	[no description available]	medium	13	0	pantothenic acid; vitamin B5	antidote to curare poisoning; geroprotector; human blood serum metabolite
taurobilirubin	[no description available]	medium	5	0
gamma-sitosterol	[no description available]	medium	1	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; phytosterols	marine metabolite; plant metabolite
cytellin	[no description available]	medium	1	0
potassium cyanide	[no description available]	medium	6	0	cyanide salt; one-carbon compound; potassium salt	EC 1.15.1.1 (superoxide dismutase) inhibitor; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; neurotoxin
digoxin	[no description available]	medium	8	1	cardenolide glycoside; steroid saponin	anti-arrhythmia drug; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; epitope
busulfan	[no description available]	medium	1	0	methanesulfonate ester	alkylating agent; antineoplastic agent; carcinogenic agent; insect sterilant; teratogenic agent
thiotepa	[no description available]	medium	3	0	aziridines
phosphoserine	[no description available]	medium	2	0	non-proteinogenic alpha-amino acid; O-phosphoamino acid; serine derivative	human metabolite
serine ethanolamine phosphate	[no description available]	medium	1	0	amino acid zwitterion; non-proteinogenic alpha-amino acid; O-phosphoamino acid; phosphoethanolamine; serine derivative
nitrous oxide	[no description available]	medium	3	0	gas molecular entity; nitrogen oxide	analgesic; bacterial metabolite; food packaging gas; food propellant; general anaesthetic; greenhouse gas; inhalation anaesthetic; NMDA receptor antagonist; raising agent; refrigerant; vasodilator agent
n-acetyltyrosine, (dl)-isomer	[no description available]	medium	2	0	N-acetyl-amino acid; phenols; tyrosine derivative	human urinary metabolite
2-naphthol	[no description available]	medium	3	0	naphthol	antinematodal drug; genotoxin; human urinary metabolite; human xenobiotic metabolite; mouse metabolite; radical scavenger
naphthyl acetate	[no description available]	medium	1	0
fluprednisolone	[no description available]	medium	1	0	fluorinated steroid
barium sulfate	[no description available]	medium	1	0	barium salt; inorganic barium salt; metal sulfate	radioopaque medium
fludrocortisone	[no description available]	medium	1	0	11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; fluorinated steroid; mineralocorticoid	adrenergic agent; anti-inflammatory drug
procainamide	[no description available]	medium	2	0	benzamides	anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker
chondroitin sulfates	[no description available]	medium	3	0
chondroitin	[no description available]	medium	1	0
chloroform	[no description available]	medium	4	0	chloromethanes; one-carbon compound	carcinogenic agent; central nervous system drug; inhalation anaesthetic; non-polar solvent; refrigerant
quinaldic acid	[no description available]	medium	1	0	quinolinemonocarboxylic acid	human metabolite; Saccharomyces cerevisiae metabolite
mustard gas	[no description available]	medium	3	0	ethyl sulfide; organochlorine compound	alkylating agent; carcinogenic agent; vesicant
ether	[no description available]	medium	2	0	ether; volatile organic compound	inhalation anaesthetic; non-polar solvent; refrigerant
aminopyrine	[no description available]	medium	3	0	pyrazolone; tertiary amino compound	antipyretic; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
glycyrrhizic acid	[no description available]	medium	1	0	enone; glucosiduronic acid; pentacyclic triterpenoid; tricarboxylic acid; triterpenoid saponin	EC 3.4.21.5 (thrombin) inhibitor; plant metabolite
4-hydroxypropiophenone	[no description available]	medium	1	0	acetophenones
methandriol	[no description available]	medium	1	0	3-hydroxy steroid	androgen
carboxin	[no description available]	medium	1	0	anilide fungicide; anilide; enamide; organosulfur heterocyclic compound; oxacycle; secondary carboxamide	antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor
carbonyl cyanide m-chlorophenyl hydrazone	[no description available]	medium	1	0	hydrazone; monochlorobenzenes; nitrile	antibacterial agent; geroprotector; ionophore
sq-23377	[no description available]	medium	13	0	cyclic ether; enol; polyunsaturated fatty acid; very long-chain fatty acid	calcium ionophore; metabolite
(2-(trimethylammonium)ethyl)methanethiosulfonate	[no description available]	medium	3	0
oxytocin	[no description available]	medium	7	0	heterodetic cyclic peptide; peptide hormone	oxytocic; vasodilator agent
formylmethionyl-leucyl-phenylalanine methyl ester	[no description available]	medium	2	0	peptide
n-formylmethionine leucyl-phenylalanine	[no description available]	medium	8	0	tripeptide
glutaurine	[no description available]	medium	54	0	dipeptide zwitterion; dipeptide; L-glutamine derivative; sulfonic acid	anticonvulsant; anxiolytic drug; hormone; human metabolite; mammalian metabolite; mouse metabolite
theanine	[no description available]	medium	1	0	amino acid zwitterion; N(5)-alkyl-L-glutamine	geroprotector; neuroprotective agent; plant metabolite
gamma-glutamylglutamine	[no description available]	medium	3	0	dipeptide	human metabolite
carvedilol	[no description available]	medium	1	0	carbazoles; secondary alcohol; secondary amino compound	alpha-adrenergic antagonist; antihypertensive agent; beta-adrenergic antagonist; cardiovascular drug; vasodilator agent
alpha-naphthyl isocyanate	[no description available]	medium	1	0
cyanates	[no description available]	medium	1	0
desoxycorticosterone	[no description available]	medium	13	0	20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; mineralocorticoid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
pyridoxic acid	[no description available]	medium	1	0	hydroxymethylpyridine; methylpyridines; monohydroxypyridine; vitamin B6	human urinary metabolite; mouse metabolite
zm 241385	[no description available]	medium	1	0	diamino-1,3,5-triazine
s-nitro-n-acetylpenicillamine	[no description available]	medium	3	0
amitrole	[no description available]	medium	3	0	aromatic amine; triazoles	carotenoid biosynthesis inhibitor; EC 1.11.1.6 (catalase) inhibitor; herbicide
phenolsulfonphthalein	[no description available]	medium	2	0	2,1-benzoxathiole; arenesulfonate ester; phenols; sultone	acid-base indicator; diagnostic agent; two-colour indicator
bradykinin	[no description available]	medium	4	0	oligopeptide	human blood serum metabolite; vasodilator agent
icatibant	[no description available]	medium	3	0
thiocyanate	[no description available]	medium	2	0	pseudohalide anion; sulfur molecular entity	human metabolite
framycetin	[no description available]	medium	10	1	aminoglycoside	allergen; antibacterial drug; Escherichia coli metabolite
antalarmin	[no description available]	medium	1	0	pyrrolopyrimidine; tertiary amino compound	corticotropin-releasing factor receptor antagonist
dironyl	[no description available]	medium	1	0	organic molecular entity
1-butanol	[no description available]	medium	2	0	alkyl alcohol; primary alcohol; short-chain primary fatty alcohol	human metabolite; mouse metabolite; protic solvent
neopterin	[no description available]	medium	2	0
ag 1879	[no description available]	medium	2	0	aromatic amine; monochlorobenzenes; pyrazolopyrimidine	beta-adrenergic antagonist; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector
zinc protoporphyrin ix	[no description available]	medium	1	0
rubidium	[no description available]	medium	14	0	alkali metal atom
carbogen	[no description available]	medium	1	0
carbene	[no description available]	medium	2	0	carbene; methanediyl
prazosin	[no description available]	medium	4	0	aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines	alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
saccharin	[no description available]	medium	1	0	1,2-benzisothiazole; N-sulfonylcarboxamide	environmental contaminant; sweetening agent; xenobiotic
phosphotyrosine	[no description available]	medium	3	0	L-tyrosine derivative; non-proteinogenic L-alpha-amino acid; O(4)-phosphotyrosine	Escherichia coli metabolite; immunogen
inositol 1,4,5-trisphosphate	[no description available]	medium	4	0	myo-inositol trisphosphate	mouse metabolite
indole-2-carboxylic acid	[no description available]	medium	1	0	indolyl carboxylic acid
potassium ascorbyl tocopheryl phosphate	[no description available]	medium	1	0
3-chloro-L-tyrosine	[no description available]	medium	1	0	chloroamino acid; L-alpha-amino acid zwitterion; L-tyrosine derivative; monochlorobenzenes; non-proteinogenic L-alpha-amino acid	biomarker; human metabolite
gliclazide	[no description available]	medium	1	0	N-sulfonylurea	hypoglycemic agent; insulin secretagogue; radical scavenger
repaglinide	[no description available]	medium	1	0	piperidines
carbamates	[no description available]	medium	4	0	amino-acid anion
gramicidin a	[no description available]	medium	8	0
enkephalin, ala(2)-mephe(4)-gly(5)-	[no description available]	medium	2	0
tetrachlorodecaoxide	[no description available]	medium	2	0
sorbitol 3-phosphate	[no description available]	medium	1	0	alditol 3-phosphate; glucitol phosphate
neramexane	[no description available]	medium	3	0
tiopronin	[no description available]	medium	1	0	N-acyl-amino acid
acetaminophen sulfate ester	[no description available]	medium	1	0	acetamides; aryl sulfate	drug metabolite
3-(glutathion-s-yl)acetaminophen	[no description available]	medium	1	0	glutathione derivative
acetaminophen glucuronide	[no description available]	medium	1	0	beta-D-glucosiduronic acid	drug metabolite
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid	[no description available]	medium	29	0	stilbenoid
12-o-retinoylphorbol-13-acetate	[no description available]	medium	1	0
luminol	[no description available]	medium	12	0
potassium dichromate	[no description available]	medium	1	0	potassium salt	allergen; oxidising agent; sensitiser
nitroblue tetrazolium	[no description available]	medium	1	0	organic cation
bisindolylmaleimide i	[no description available]	medium	1	0
adipic acid	[no description available]	medium	1	0	alpha,omega-dicarboxylic acid; dicarboxylic fatty acid	food acidity regulator; human xenobiotic metabolite
alpha-asarone	[no description available]	medium	1	0	asarone	anticonvulsant; GABA modulator
4-nitrophenyl acetate	[no description available]	medium	1	0	C-nitro compound; phenyl acetates
pyranine	[no description available]	medium	1	0	organic sodium salt	fluorochrome
docusate	[no description available]	medium	1	0	diester; organosulfonic acid
nitrophenols	[no description available]	medium	7	0
solifenacin succinate	[no description available]	medium	2	0	isoquinolines
dihydro-3-coumaric acid	[no description available]	medium	1	0	monocarboxylic acid	Escherichia coli metabolite; human xenobiotic metabolite
isovaleric acid	[no description available]	medium	1	0	branched-chain saturated fatty acid; methylbutyric acid; short-chain fatty acid	mammalian metabolite; plant metabolite
troclosene	[no description available]	medium	1	0
benoxaprofen	[no description available]	medium	1	0	1,3-benzoxazoles; monocarboxylic acid; monochlorobenzenes	antipsoriatic; antipyretic; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; hepatotoxic agent; nephrotoxin; non-narcotic analgesic; non-steroidal anti-inflammatory drug; protein kinase C agonist
bongkrekic acid	[no description available]	medium	1	0	ether; olefinic compound; tricarboxylic acid	apoptosis inhibitor; ATP/ADP translocase inhibitor; bacterial metabolite; EC 2.5.1.18 (glutathione transferase) inhibitor; toxin
valinomycin	[no description available]	medium	7	0	cyclodepsipeptide; macrocycle	antimicrobial agent; antiviral agent; bacterial metabolite; potassium ionophore
propidium	[no description available]	medium	2	0	phenanthridines; quaternary ammonium ion	fluorochrome; intercalator
argon	[no description available]	medium	1	0	monoatomic argon; noble gas atom; p-block element atom	food packaging gas; neuroprotective agent
lactacystin	[no description available]	medium	1	0	lactam; S-substituted L-cysteine
phosphonoacetaldehyde	[no description available]	medium	1	0	phosphonic acids	mouse metabolite
fura-2	[no description available]	medium	7	0
suramin	[no description available]	medium	5	0	naphthalenesulfonic acid; phenylureas; secondary carboxamide	angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug
prolinedithiocarbamate	[no description available]	medium	1	0
ncs 382	[no description available]	medium	2	0
triphenyltetrazolium	[no description available]	medium	3	0	organic cation
bucladesine	[no description available]	medium	15	0	3',5'-cyclic purine nucleotide
phorbol 12,13-dibutyrate	[no description available]	medium	7	0	butyrate ester; phorbol ester; tertiary alpha-hydroxy ketone
alanylglutamine	[no description available]	medium	4	0	dipeptide zwitterion; dipeptide	metabolite
enkephalin, leucine-2-alanine	[no description available]	medium	1	0
dinoprost	[no description available]	medium	2	0	monocarboxylic acid; prostaglandins Falpha	human metabolite; mouse metabolite
2,5-dihydroxybenzoic acid	[no description available]	medium	1	0	dihydroxybenzoic acid	EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; fungal metabolite; human metabolite; MALDI matrix material; mouse metabolite
2-tert-butylhydroquinone	[no description available]	medium	1	0	hydroquinones	food antioxidant
alphaxalone	[no description available]	medium	3	0	11-oxo steroid
brucine	[no description available]	medium	1	0	monoterpenoid indole alkaloid; organic heteroheptacyclic compound
tocopherols	[no description available]	medium	3	0
amitriptyline	[no description available]	medium	2	0	carbotricyclic compound; tertiary amine	adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic
zomepirac	[no description available]	medium	1	0	aromatic ketone; monocarboxylic acid; monochlorobenzenes; pyrroles	cardiovascular drug; non-steroidal anti-inflammatory drug
taurolithocholic acid 3-sulfate	[no description available]	medium	2	0	steroid sulfate oxoanion	human metabolite
4-hydroxy-2-nonenal	[no description available]	medium	2	0	4-hydroxynon-2-enal; 4-hydroxynonenal
n(6)-carboxymethyllysine	[no description available]	medium	1	0	L-lysine derivative; non-proteinogenic L-alpha-amino acid	antigen
glycine chloramine	[no description available]	medium	2	0
dansyl chloride	[no description available]	medium	2	0	aminonaphthalene; sulfonic acid derivative
propionylcarnitine	[no description available]	medium	2	0	O-acylcarnitine	analgesic; antirheumatic drug; cardiotonic drug; human metabolite; peripheral nervous system drug
sulfasalazine	[no description available]	medium	2	1
clofarabine	[no description available]	medium	1	0	adenosines; organofluorine compound	antimetabolite; antineoplastic agent
zopiclone	[no description available]	medium	2	0	monochloropyridine; pyrrolopyrazine	central nervous system depressant; sedative
entecavir	[no description available]	medium	1	0	2-aminopurines; oxopurine; primary alcohol; secondary alcohol	antiviral drug; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
micafungin	[no description available]	medium	1	0	antibiotic antifungal drug; echinocandin	antiinfective agent
darifenacin	[no description available]	medium	1	0	1-benzofurans; monocarboxylic acid amide; pyrrolidines	antispasmodic drug; muscarinic antagonist
almagate	[no description available]	medium	1	0
ziconotide	[no description available]	medium	1	0
benzofurans	[no description available]	medium	2	0
muraglitazar	[no description available]	medium	1	0	1,3-oxazoles
oxazoles	[no description available]	medium	12	0	1,3-oxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
potassium bicarbonate	[no description available]	medium	1	0	organic salt; potassium salt	antifungal agrochemical; buffer; food acidity regulator; raising agent
sk&f 95654	[no description available]	medium	1	0
aminoethylphosphonic acid	[no description available]	high	6	0	phosphonic acids; primary amino compound; zwitterion	human metabolite; metabolite; mouse metabolite
2-sulfanilic acid	[no description available]	medium	3	0	aminobenzenesulfonic acid
oxcarbazepine	[no description available]	medium	1	1	cyclic ketone; dibenzoazepine	anticonvulsant; drug allergen
thromboxane b2	[no description available]	medium	7	0	thromboxanes B	human metabolite; mouse metabolite
12-hydroxy-5,8,10-heptadecatrienoic acid	[no description available]	medium	1	0	hydroxy polyunsaturated fatty acid; long-chain fatty acid; trienoic fatty acid	metabolite
12-hydroxy-5,8,10,14-eicosatetraenoic acid	[no description available]	medium	1	0
fluticasone	[no description available]	medium	1	0	11beta-hydroxy steroid; 17alpha-hydroxy steroid; 3-oxo-Delta(4) steroid; corticosteroid; fluorinated steroid; thioester	anti-allergic agent; anti-asthmatic drug
cumene hydroperoxide	[no description available]	medium	2	0	peroxol	environmental contaminant; Mycoplasma genitalium metabolite; oxidising agent
cidofovir anhydrous	[no description available]	medium	1	0	phosphonic acids; pyrimidone	anti-HIV agent; antineoplastic agent; antiviral drug; photosensitizing agent
organophosphonates	[no description available]	medium	3	0	divalent inorganic anion; phosphite ion
uracil	[no description available]	medium	2	0	pyrimidine nucleobase; pyrimidone	allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; prodrug; Saccharomyces cerevisiae metabolite
tegafur	[no description available]	medium	1	0	organohalogen compound; pyrimidines
uftoral	[no description available]	medium	1	0
limestone	[no description available]	medium	1	0	calcium salt; carbonate salt; inorganic calcium salt; one-carbon compound	antacid; fertilizer; food colouring; food firming agent
vitamin u	[no description available]	medium	2	0	methyl-L-methionine; sulfonium betaine
cgp 54626	[no description available]	medium	1	0
lanthanum	[no description available]	medium	9	0	f-block element atom; lanthanoid atom; scandium group element atom
lanthanum carbonate	[no description available]	medium	1	0
tiotropium bromide	[no description available]	medium	1	0
daptomycin	[no description available]	medium	1	0
ru 66647	[no description available]	medium	1	0
ibandronic acid	[no description available]	medium	2	0
rifamycins	[no description available]	medium	1	0
2,4-diaminobutyric acid	[no description available]	medium	3	1	diamino acid; gamma-amino acid; non-proteinogenic alpha-amino acid
tetrahydrobenzo-4,6-dimethylangelicin	[no description available]	medium	1	0
tropisetron	[no description available]	medium	1	0	indolyl carboxylic acid
verlukast	[no description available]	medium	1	0
vesamicol	[no description available]	medium	1	0	piperidines
mecamylamine	[no description available]	medium	1	0	primary aliphatic amine
glycochenodeoxycholic acid	[no description available]	medium	6	0	bile acid glycine conjugate	human metabolite
manoalide	[no description available]	medium	2	0	butenolide; lactol; sesterterpenoid	EC 3.1.1.4 (phospholipase A2) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; metabolite
urb 597	[no description available]	medium	1	0	biphenyls
orabase	[no description available]	medium	1	0
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester	[no description available]	medium	1	0
2,4-dinitrophenol	[no description available]	medium	4	0	dinitrophenol	allergen; antiseptic drug; bacterial xenobiotic metabolite; geroprotector; oxidative phosphorylation inhibitor
beta-casomorphin 7	[no description available]	medium	1	0
misoprostol	[no description available]	medium	1	0
gadolinium dtpa	[no description available]	medium	1	0	gadolinium coordination entity	MRI contrast agent
quinoxalines	[no description available]	medium	8	0	mancude organic heterobicyclic parent; naphthyridine; ortho-fused heteroarene
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid	[no description available]	medium	2	0	arenesulfonic acid; azobenzenes; methylpyridines; monohydroxypyridine; organic phosphate; pyridinecarbaldehyde	purinergic receptor P2X antagonist
sulfamic acid	[no description available]	medium	2	0	sulfamic acids
5-hydroxytryptophan	[no description available]	medium	8	0	hydroxytryptophan	human metabolite; neurotransmitter
amantadine	[no description available]	medium	1	0	adamantanes; primary aliphatic amine	analgesic; antiparkinson drug; antiviral drug; dopaminergic agent; NMDA receptor antagonist; non-narcotic analgesic
dimethylarginine	[no description available]	medium	1	0
lutein	[no description available]	medium	1	1	carotenol	food colouring; plant metabolite
diazooxonorleucine	[no description available]	medium	1	0	amino acid zwitterion; diazo compound; ketone; non-proteinogenic L-alpha-amino acid	analgesic; antibacterial agent; antimetabolite; antineoplastic agent; antiviral agent; apoptosis inducer; bacterial metabolite; EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor; EC 3.5.1.2 (glutaminase) inhibitor; EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor; EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor; EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor; EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor; EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor; EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor; glutamine antagonist
eflornithine	[no description available]	medium	2	0	alpha-amino acid; fluoroamino acid	trypanocidal drug
vanadyl sulfate	[no description available]	medium	1	0	metal sulfate; vanadium coordination entity
antamanide	[no description available]	medium	1	0
picrotoxinin	[no description available]	medium	7	0
sb 277011	[no description available]	medium	1	0
thioacetic acid	[no description available]	medium	1	0	thioacetic acid
dicumarol	[no description available]	medium	1	0	hydroxycoumarin	anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; Hsp90 inhibitor; vitamin K antagonist
paraoxon	[no description available]	medium	1	0	aryl dialkyl phosphate; organophosphate insecticide	EC 3.1.1.7 (acetylcholinesterase) inhibitor; mouse metabolite
phenylacetic acid	[no description available]	medium	2	0	benzenes; monocarboxylic acid; phenylacetic acids	allergen; Aspergillus metabolite; auxin; EC 6.4.1.1 (pyruvate carboxylase) inhibitor; Escherichia coli metabolite; human metabolite; plant growth retardant; plant metabolite; Saccharomyces cerevisiae metabolite; toxin
zoledronic acid	[no description available]	medium	1	0	1,1-bis(phosphonic acid); imidazoles	bone density conservation agent
felinine	[no description available]	medium	1	0	L-cysteine thioether; non-proteinogenic L-alpha-amino acid; S-alkyl-L-cysteine zwitterion	mammalian metabolite; pheromone
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	[no description available]	medium	2	0	methylpyridines; phenylpyridine; tetrahydropyridine	neurotoxin
pyrimidine dimers	[no description available]	medium	1	0
tobramycin	[no description available]	medium	1	1	amino cyclitol glycoside	antibacterial agent; antimicrobial agent; toxin
egta acetoxymethyl ester	[no description available]	medium	1	0
rtki cpd	[no description available]	medium	1	0
quinazolines	[no description available]	medium	1	0	azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; quinazolines
dextrothyroxine	[no description available]	medium	3	0
dimercaprol	[no description available]	medium	2	0	dithiol; primary alcohol	chelator
selenic acid	[no description available]	medium	1	0	selenium oxoacid
lipoteichoic acid	[no description available]	medium	1	0
lorazepam	[no description available]	medium	1	0	benzodiazepine
ethylene	[no description available]	medium	1	0	alkene; gas molecular entity	plant hormone; refrigerant
n(6),n(6)-dimethyladenine	[no description available]	medium	1	0	tertiary amine
eicosapentaenoic acid	[no description available]	medium	1	0	icosapentaenoic acid; omega-3 fatty acid	anticholesteremic drug; antidepressant; antineoplastic agent; Daphnia galeata metabolite; fungal metabolite; micronutrient; mouse metabolite; nutraceutical
sodium thiosulfate	[no description available]	medium	1	0	inorganic sodium salt	antidote to cyanide poisoning; antifungal drug; nephroprotective agent
fosfomycin	[no description available]	medium	1	0	epoxide; phosphonic acids	antimicrobial agent; EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor
dihydrorhodamine 123	[no description available]	medium	2	0
go 6976	[no description available]	medium	1	0	indolocarbazole; organic heterohexacyclic compound	EC 2.7.11.13 (protein kinase C) inhibitor
sirolimus	[no description available]	medium	1	0	antibiotic antifungal drug; cyclic acetal; cyclic ketone; ether; macrolide lactam; organic heterotricyclic compound; secondary alcohol	antibacterial drug; anticoronaviral agent; antineoplastic agent; bacterial metabolite; geroprotector; immunosuppressive agent; mTOR inhibitor
butyrylcholine	[no description available]	medium	1	0	acylcholine
cellulose	[no description available]	medium	9	0	glycoside
arabinose	[no description available]	medium	2	0	L-arabinose	Escherichia coli metabolite; mouse metabolite
substance p	[no description available]	medium	15	0	peptide	neurokinin-1 receptor agonist; neurotransmitter; vasodilator agent
guanosine triphosphate	[no description available]	medium	2	0	guanosine 5'-phosphate; purine ribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor
propyl beta-carboline-3-carboxylate	[no description available]	medium	1	0	beta-carbolines
tert-butylbicyclophosphorothionate	[no description available]	medium	3	0	organic thiophosphate
alprenolol	[no description available]	medium	2	0	secondary alcohol; secondary amino compound	anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent
2-aminoadipic acid	[no description available]	medium	4	0	amino dicarboxylic acid; dicarboxylic fatty acid; non-proteinogenic alpha-amino acid	Caenorhabditis elegans metabolite; mammalian metabolite
phytanic acid	[no description available]	medium	1	0	branched-chain saturated fatty acid; long-chain fatty acid; methyl-branched fatty acid
nebacetin	[no description available]	medium	1	0
furazolidone	[no description available]	medium	3	0	nitrofuran antibiotic; oxazolidines	antibacterial drug; antiinfective agent; antitrichomonal drug; EC 1.4.3.4 (monoamine oxidase) inhibitor
protoverin	[no description available]	medium	2	0
enkephalin, methionine	[no description available]	medium	11	0
enkephalin, leucine	[no description available]	medium	8	0	pentapeptide; peptide zwitterion	analgesic; delta-opioid receptor agonist; human metabolite; mu-opioid receptor agonist; neurotransmitter; rat metabolite
gallopamil	[no description available]	medium	3	0	benzenes; organic amino compound
motilin	[no description available]	medium	1	0
vasoactive intestinal peptide	[no description available]	medium	4	0
bis(p-chlorophenyl)acetic acid	[no description available]	medium	1	0	monocarboxylic acid; monochlorobenzenes
2,4-dichlorophenoxyacetic acid	[no description available]	medium	5	0	chlorophenoxyacetic acid; dichlorobenzene	agrochemical; defoliant; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; environmental contaminant; phenoxy herbicide; synthetic auxin
2,4,5-trichlorophenoxyacetic acid	[no description available]	medium	2	0	chlorophenoxyacetic acid; trichlorobenzene	defoliant; phenoxy herbicide; synthetic auxin
ddt	[no description available]	medium	3	0	benzenoid aromatic compound; chlorophenylethane; monochlorobenzenes; organochlorine insecticide	bridged diphenyl acaricide; carcinogenic agent; endocrine disruptor; persistent organic pollutant
4-methoxymethylpyridoxine	[no description available]	medium	2	0	pyridines
prostaglandin d2	[no description available]	medium	4	0	prostaglandins D	human metabolite; mouse metabolite
tubocurarine	[no description available]	medium	2	0	bisbenzylisoquinoline alkaloid	drug allergen; muscle relaxant; nicotinic antagonist
aspartame	[no description available]	medium	1	0	carboxylic acid; dipeptide zwitterion; dipeptide; methyl ester	apoptosis inhibitor; EC 3.1.3.1 (alkaline phosphatase) inhibitor; environmental contaminant; micronutrient; nutraceutical; sweetening agent; xenobiotic
norleucine	[no description available]	medium	2	0	2-aminohexanoic acid; L-alpha-amino acid zwitterion; non-proteinogenic L-alpha-amino acid
allylglycine	[no description available]	medium	3	0
5-aminovaleric acid	[no description available]	medium	8	0	amino acid zwitterion; delta-amino acid; omega-amino fatty acid	human metabolite
hexamethonium	[no description available]	medium	8	0	quaternary ammonium salt
thiourea	[no description available]	medium	5	0	one-carbon compound; thioureas; ureas	antioxidant; chromophore
butaclamol	[no description available]	medium	1	0
homocysteic acid	[no description available]	medium	3	0	homocysteic acid	NMDA receptor agonist
p-aminohippuric acid	[no description available]	medium	4	0	N-acylglycine	Daphnia magna metabolite
dihydroalprenolol	[no description available]	medium	1	0
dibutyryl cyclic gmp	[no description available]	medium	1	0
diazobenzenesulfonic acid	[no description available]	medium	1	0
thiamine pyrophosphate	[no description available]	medium	3	0	organic chloride salt; vitamin B1
amrinone	[no description available]	medium	1	0	bipyridines	EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
alpha-aminopyridine	[no description available]	medium	7	0
bicuculline methochloride	[no description available]	medium	1	0
sodium bicarbonate	[no description available]	medium	2	0	one-carbon compound; organic sodium salt	antacid; food anticaking agent
ethanolamine o-sulfate	[no description available]	medium	1	0
lactose	[no description available]	medium	3	0	lactose
eedq	[no description available]	medium	2	0
ethylenediamine	[no description available]	medium	1	0	alkane-alpha,omega-diamine	GABA agonist
dihydro-dids	[no description available]	medium	1	0
dendrobine	[no description available]	medium	1	0	indoles
bromosuccinimide	[no description available]	medium	1	0	dicarboximide; organobromine compound; pyrrolidinone	reagent
clomipramine	[no description available]	medium	1	0	dibenzoazepine	anticoronaviral agent; antidepressant; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; serotonergic antagonist; serotonergic drug; serotonin uptake inhibitor
methysergide	[no description available]	medium	1	0	ergoline alkaloid
n-acetylmethionine	[no description available]	medium	1	0	L-methionine derivative; N-acetyl-L-amino acid; N-acetylmethionine	nutraceutical
progabide	[no description available]	medium	2	0	diarylmethane
2-naphthylacetic acid	[no description available]	medium	3	0	naphthylacetic acid
3-acetylpyridine adenine dinucleotide	[no description available]	medium	1	0	organic molecular entity
methylnitronitrosoguanidine	[no description available]	medium	3	0	nitroso compound	alkylating agent
iodine	[no description available]	medium	11	0	diatomic iodine	nutrient
ferrous sulfate	[no description available]	medium	1	0	iron molecular entity; metal sulfate	reducing agent
itaconic acid	[no description available]	medium	1	0	dicarboxylic acid; dicarboxylic fatty acid; olefinic compound	fungal metabolite; human metabolite
aminopropionitrile	[no description available]	medium	1	0	aminopropionitrile	antineoplastic agent; antirheumatic drug; collagen cross-linking inhibitor; plant metabolite
veratrine	[no description available]	medium	10	0	alkaloid
lasalocid	[no description available]	medium	3	0	beta-hydroxy ketone; monocarboxylic acid; monohydroxybenzoic acid; oxanes; oxolanes; polyether antibiotic; secondary alcohol; tertiary alcohol	bacterial metabolite; coccidiostat; ionophore
trimethadione	[no description available]	medium	2	0	oxazolidinone	anticonvulsant; geroprotector
monoammonium molybdate	[no description available]	medium	1	0	ammonium salt	poison
molybdenum	[no description available]	medium	4	0	chromium group element atom	micronutrient
potassium phosphate	[no description available]	medium	2	0	inorganic phosphate salt; inorganic potassium salt
sulfolithocholic acid	[no description available]	medium	3	0	steroid sulfate
phlorhizin	[no description available]	medium	3	0	aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative	antioxidant; plant metabolite
(7,7-azo-3,12-dihydroxy-5-cholan-24-oyl)-2-aminoethanesulfonic acid	[no description available]	medium	1	0
2,4-dinitrophenylhydrazine	[no description available]	medium	1	0	C-nitro compound; phenylhydrazines	reagent
dansyl hydrazine	[no description available]	medium	1	0
phosphoadenosine phosphosulfate	[no description available]	medium	1	0	acyl sulfate; adenosine bisphosphate; purine ribonucleoside bisphosphate	Escherichia coli metabolite; mouse metabolite
enkephalinamide-met, ala(2)-	[no description available]	medium	6	0
7-ketodeoxycholic acid	[no description available]	medium	1	0	7-oxo steroid; oxo-5beta-cholanic acid
3,7-dihydroxy-12-oxocholanoic acid	[no description available]	medium	1	0	oxo-5beta-cholanic acid
7-ketolithocholic acid	[no description available]	medium	4	0	3alpha-hydroxy steroid; bile acid; monohydroxy-5beta-cholanic acid; oxo-5beta-cholanic acid	human metabolite
oxalates	[no description available]	medium	14	0
fluorescamine	[no description available]	medium	6	0
salicylamide	[no description available]	medium	1	0	phenols; salicylamides	antirheumatic drug; non-narcotic analgesic
alpha-aminobutyric acid	[no description available]	medium	1	0	alpha-aminobutyric acid; D-alpha-amino acid
triiodothyronine	[no description available]	medium	1	0	tetrahydrothiophenes; thiolactone	human metabolite
oxythiamine	[no description available]	medium	1	0	1,3-thiazolium cation	antimetabolite; vitamin B1 antagonist
3-acetylpyridine	[no description available]	medium	6	0	aromatic ketone
estriol	[no description available]	medium	1	0	16alpha-hydroxy steroid; 17beta-hydroxy steroid; 3-hydroxy steroid	estrogen; human metabolite; human xenobiotic metabolite; mouse metabolite
enkephalin-met, ala(2)-	[no description available]	medium	1	0
ampicillin	[no description available]	medium	3	1	beta-lactam antibiotic; penicillin allergen; penicillin	antibacterial drug
epicillin	[no description available]	medium	1	1	penicillin allergen; penicillin
sulfosalicylic acid	[no description available]	medium	1	0	arenesulfonic acid; benzoic acids; phenols	metabolite
methoxamine	[no description available]	medium	2	0	amphetamines	alpha-adrenergic agonist; antihypotensive agent
4-benzamido-4'-isothiocyanostilbene-2,2'-disulfonate	[no description available]	medium	1	0
iodoacetic acid	[no description available]	medium	4	0	haloacetic acid; organoiodine compound	alkylating agent
sodium cyanide	[no description available]	medium	2	0	cyanide salt; one-carbon compound; sodium salt	EC 1.15.1.1 (superoxide dismutase) inhibitor
cyanogen bromide	[no description available]	medium	2	0
terbutaline	[no description available]	medium	1	0	phenylethanolamines; resorcinols	anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; hypoglycemic agent; sympathomimetic agent; tocolytic agent
ethamsylate	[no description available]	medium	1	0	organosulfur compound; sulfonic acid derivative
4-bromoaniline	[no description available]	medium	1	0
dinitrofluorobenzene	[no description available]	medium	2	0	C-nitro compound; organofluorine compound	agrochemical; allergen; chromatographic reagent; EC 2.7.3.2 (creatine kinase) inhibitor; protein-sequencing agent; spectrophotometric reagent
dactinomycin	[no description available]	medium	7	0	actinomycin	mutagen
trimethyltin	[no description available]	medium	4	0
retrorsine	[no description available]	medium	3	0	macrolide
neferine	[no description available]	medium	1	0
6-ketoprostaglandin f1 alpha	[no description available]	medium	4	0	prostaglandins Falpha	human metabolite; mouse metabolite
septide	[no description available]	medium	1	0
substance p, sar(9)-met(o2)(11)-	[no description available]	medium	1	0
sr 140333	[no description available]	medium	1	0
3-hydroxypyridine	[no description available]	medium	1	0	monohydroxypyridine
5,5'-dihydroxylysylnorleucine	[no description available]	medium	1	0
masoprocol	[no description available]	medium	6	0	nordihydroguaiaretic acid	antineoplastic agent; hypoglycemic agent; lipoxygenase inhibitor; metabolite
trifluoperazine	[no description available]	medium	11	0	N-alkylpiperazine; N-methylpiperazine; organofluorine compound; phenothiazines	antiemetic; calmodulin antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor; phenothiazine antipsychotic drug
indacrinone	[no description available]	medium	4	0
((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1h-fluoren-7-yl)oxy)acetic acid	[no description available]	medium	1	0
dichlobanil	[no description available]	medium	1	0	dichlorobenzene; nitrile	agrochemical; cellulose synthesis inhibitor; environmental contaminant; herbicide; xenobiotic
clenbuterol	[no description available]	medium	4	0	amino alcohol; dichlorobenzene; ethanolamines; primary arylamine; secondary amino compound; substituted aniline	beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent
guanylin	[no description available]	medium	1	0
staurosporine	[no description available]	medium	5	0	ammonium ion derivative
8-bromocyclic gmp	[no description available]	medium	2	0	3',5'-cyclic purine nucleotide; organobromine compound	muscle relaxant; protein kinase G agonist
3,3'-diaminobenzidine	[no description available]	medium	1	0	biphenyls; substituted aniline	histological dye
molybdenum cofactor	[no description available]	medium	3	0	Mo-molybdopterin cofactor; organophosphate oxoanion
pteridines	[no description available]	medium	3	0	azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; pteridines
3-o-methylglucose	[no description available]	medium	2	0	D-aldohexose derivative
bis(sulfosuccinimidyl)suberate	[no description available]	medium	2	0
dipalmitoylphosphatidic acid	[no description available]	medium	1	0	phosphatidic acid
dimyristoylphosphatidylcholine	[no description available]	medium	2	0	1,2-diacyl-sn-glycero-3-phosphocholine; phosphatidylcholine 28:0; tetradecanoate ester	antigen; mouse metabolite
ammonium ferric sulfate	[no description available]	medium	1	0	ammonium salt; iron molecular entity; metal sulfate	ferroptosis inducer
((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1h-inden-5-yl)oxy)acetic acid	[no description available]	medium	1	0
scopolamine hydrobromide	[no description available]	medium	6	0
milacemide	[no description available]	medium	2	0
s-2-aminoethyl cysteine	[no description available]	medium	1	0	L-cysteine thioether; non-proteinogenic L-alpha-amino acid	EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor; metabolite; protein synthesis inhibitor
alpha,beta-methyleneadenosine 5'-triphosphate	[no description available]	medium	1	0	nucleoside triphosphate analogue
metronidazole	[no description available]	medium	2	0	C-nitro compound; imidazoles; primary alcohol	antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic
paromomycin	[no description available]	medium	1	0	amino cyclitol glycoside; aminoglycoside antibiotic	anthelminthic drug; antibacterial drug; antiparasitic agent; antiprotozoal drug
cefuroxime	[no description available]	medium	1	0	carbamate ester; cephalosporin
phalloidine	[no description available]	medium	1	0	homodetic cyclic peptide
3,5-dinitrobenzoyl chloride	[no description available]	medium	1	0
baicalein	[no description available]	medium	1	0	trihydroxyflavone	angiogenesis inhibitor; anti-inflammatory agent; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 4.1.1.17 (ornithine decarboxylase) inhibitor; ferroptosis inhibitor; geroprotector; hormone antagonist; plant metabolite; prostaglandin antagonist; radical scavenger
l 663536	[no description available]	medium	1	0	aryl sulfide; indoles; monocarboxylic acid; monochlorobenzenes	antineoplastic agent; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; leukotriene antagonist
acid phosphatase	[no description available]	medium	4	0
peroxyformic acid	[no description available]	medium	1	0
muscarine	[no description available]	medium	2	0	monosaccharide
carbonyl cyanide p-trifluoromethoxyphenylhydrazone	[no description available]	medium	2	0	aromatic ether; hydrazone; nitrile; organofluorine compound	ATP synthase inhibitor; geroprotector; ionophore
oleoyl-coenzyme a	[no description available]	medium	1	0	octadecenoyl-CoA	Escherichia coli metabolite; mouse metabolite
arachidonyl-coenzyme a	[no description available]	medium	1	0	arachidonoyl bioconjugate; unsaturated fatty acyl-CoA
glycolipids	[no description available]	medium	2	0
peroxynitric acid	[no description available]	medium	3	0	nitrogen oxoacid
methylmercuric chloride	[no description available]	medium	1	0	chlorine molecular entity; mercury coordination entity; one-carbon compound
zy 17617b	[no description available]	medium	3	0
mk 473	[no description available]	medium	1	0
5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate	[no description available]	medium	2	0
okadaic acid	[no description available]	medium	4	0	ketal
3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid	[no description available]	medium	1	0
fluorocitrate	[no description available]	medium	2	0	carbonyl compound
ibopamine	[no description available]	medium	1	0	benzoate ester; phenols
deoxyepinephrine	[no description available]	medium	1	0	catecholamine
pyrithione	[no description available]	medium	1	0	monohydroxypyridine; pyridinethione	ionophore
homoserine	[no description available]	medium	3	0	amino acid zwitterion; homoserine	algal metabolite; Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
diaminopimelic acid	[no description available]	medium	2	0	2,6-diaminopimelic acid; amino acid zwitterion	Escherichia coli metabolite
ifosfamide	[no description available]	medium	3	0	ifosfamides	alkylating agent; antineoplastic agent; environmental contaminant; immunosuppressive agent; xenobiotic
dithionite	[no description available]	medium	1	0	sulfur oxide; sulfur oxoanion
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid	[no description available]	medium	7	0	polyamino carboxylic acid; tetracarboxylic acid	chelator
uridine diphosphate n-acetylgalactosamine	[no description available]	medium	1	0	nucleotide-sugar oxoanion	human metabolite
uridine diphosphate n-acetylglucosamine	[no description available]	medium	1	0
hemicholinium 3	[no description available]	medium	1	0
dodecyltrimethylammonium	[no description available]	medium	1	0	quaternary ammonium ion
deamino arginine vasopressin	[no description available]	medium	1	0	heterodetic cyclic peptide	diagnostic agent; renal agent; vasopressin receptor agonist
racemetirosine	[no description available]	medium	1	0
thymol	[no description available]	medium	1	0	monoterpenoid; phenols	volatile oil component
carbodiimides	[no description available]	medium	4	0	carbodiimide
cysteinolic acid	[no description available]	medium	2	0
iodonaphthylazide	[no description available]	medium	1	0
arginine vasopressin	[no description available]	medium	7	0	vasopressin	cardiovascular drug; hematologic agent; mitogen
aldosterone	[no description available]	medium	1	0	11beta-hydroxy steroid; 18-oxo steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; mineralocorticoid; primary alpha-hydroxy ketone; steroid aldehyde	human metabolite; mouse metabolite
calcitriol	[no description available]	medium	3	0	D3 vitamins; hydroxycalciol; triol	antineoplastic agent; antipsoriatic; bone density conservation agent; calcium channel agonist; calcium channel modulator; hormone; human metabolite; immunomodulator; metabolite; mouse metabolite; nutraceutical
sodium borohydride	[no description available]	medium	2	0	inorganic sodium salt; metal tetrahydridoborate
levoleucovorin	[no description available]	medium	4	1	5-formyltetrahydrofolic acid	antineoplastic agent; metabolite
1,9-dideoxyforskolin	[no description available]	medium	5	0	acetate ester; labdane diterpenoid; organic heterotricyclic compound	plant metabolite
ethyldimethylaminopropyl carbodiimide	[no description available]	medium	1	0
dantrolene	[no description available]	medium	4	0	hydrazone; imidazolidine-2,4-dione	muscle relaxant; neuroprotective agent; ryanodine receptor antagonist
octopamine	[no description available]	medium	4	0	phenylethanolamines; tyramines	neurotransmitter
1-propanol	[no description available]	medium	1	0	propan-1-ols; short-chain primary fatty alcohol	metabolite; protic solvent
ethylnitrosourea	[no description available]	medium	2	0	N-nitrosoureas	alkylating agent; carcinogenic agent; genotoxin; mutagen
n-nitrosobutylurea	[no description available]	medium	1	0
sodium sulfide	[no description available]	medium	3	0
morpholinopropane sulfonic acid	[no description available]	medium	2	0	MOPS; morpholines; organosulfonic acid
1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol	[no description available]	medium	1	0
misonidazole	[no description available]	medium	1	0
anethole trithione	[no description available]	medium	1	0	methoxybenzenes
diallyl disulfide	[no description available]	medium	1	0	organic disulfide	antifungal agent; antineoplastic agent; plant metabolite
clomesone	[no description available]	medium	1	0
5-doxylstearate	[no description available]	medium	1	0	aminoxyls
sulbactam	[no description available]	medium	1	0	penicillanic acids
cellobiose	[no description available]	medium	1	0	cellobiose	epitope
meglumine	[no description available]	medium	4	0	hexosamine; secondary amino compound
chlortetracycline	[no description available]	medium	2	0
strontium	[no description available]	medium	1	0	alkaline earth metal atom
24-norursodeoxycholic acid	[no description available]	medium	1	0
cytochalasin d	[no description available]	medium	2	0
ferri-heme undecapeptide	[no description available]	medium	1	0
2-chloropropionic acid	[no description available]	medium	2	0
pyrilamine	[no description available]	medium	2	0	aromatic ether; ethylenediamine derivative	H1-receptor antagonist
monocrotaline	[no description available]	medium	5	0	pyrrolizidine alkaloid
bidisomide	[no description available]	medium	1	0	acetamides
formiminoglutamic acid	[no description available]	medium	1	0	dicarboxylic acid; L-glutamic acid derivative
deoxyuridine	[no description available]	medium	1	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
methylmalonic acid	[no description available]	medium	2	0	C4-dicarboxylic acid	human metabolite
pelubiprofen	[no description available]	medium	1	0
sanguinarine	[no description available]	medium	1	0	alkaloid antibiotic; benzophenanthridine alkaloid; botanical anti-fungal agent
nalidixic acid	[no description available]	medium	1	0	1,8-naphthyridine derivative; monocarboxylic acid; quinolone antibiotic	antibacterial drug; antimicrobial agent; DNA synthesis inhibitor
kt 5720	[no description available]	medium	1	0	carboxylic ester; gamma-lactam; hemiaminal; indolocarbazole; organic heterooctacyclic compound; semisynthetic derivative; tertiary alcohol	EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor
eth 615	[no description available]	medium	1	0
calyculin a	[no description available]	medium	4	0
lidocaine	[no description available]	medium	2	0	benzenes; monocarboxylic acid amide; tertiary amino compound	anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic
losartan potassium	[no description available]	medium	1	0
clonidine	[no description available]	medium	4	0	clonidine; imidazoline
clonazepam	[no description available]	medium	2	0	1,4-benzodiazepinone; monochlorobenzenes	anticonvulsant; anxiolytic drug; GABA modulator
buspirone	[no description available]	medium	3	0	azaspiro compound; N-alkylpiperazine; N-arylpiperazine; organic heteropolycyclic compound; piperidones; pyrimidines	anxiolytic drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; sedative; serotonergic agonist
s 145	[no description available]	medium	1	0	monoterpenoid
pregnenolone sulfate	[no description available]	medium	2	0	steroid sulfate	EC 2.7.1.33 (pantothenate kinase) inhibitor; human metabolite
pregnenolone	[no description available]	medium	5	0	20-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; C21-steroid	human metabolite; mouse metabolite
pyridyldithioethylamine	[no description available]	medium	1	0
n-(4,4-diphenyl-3-butenyl)nipecotic acid	[no description available]	medium	2	0	diarylmethane
methanesulfonic acid	[no description available]	medium	1	0	alkanesulfonic acid; one-carbon compound	Escherichia coli metabolite
imipenem, anhydrous	[no description available]	medium	2	0	beta-lactam antibiotic allergen; carbapenems; zwitterion	antibacterial drug
cilastatin	[no description available]	medium	2	0	carboxamide; L-cysteine derivative; non-proteinogenic L-alpha-amino acid; organic sulfide	EC 3.4.13.19 (membrane dipeptidase) inhibitor; environmental contaminant; protease inhibitor; xenobiotic
buserelin	[no description available]	medium	1	0	oligopeptide
nystatin a1	[no description available]	medium	4	0	nystatins
ursocholic acid	[no description available]	medium	2	0	12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7beta-hydroxy steroid; bile acid; C24-steroid; trihydroxy-5beta-cholanic acid	EC 1.1.1.159 (7alpha-hydroxysteroid dehydrogenase) inhibitor; human urinary metabolite
phorone	[no description available]	medium	1	0	dialkenyl ketone
4-chloromercuribenzenesulfonate	[no description available]	medium	3	0	arenesulfonic acid; arylmercury compound
guanylyl imidodiphosphate	[no description available]	medium	1	0	nucleoside triphosphate analogue
monensin	[no description available]	medium	5	0	cyclic hemiketal; monocarboxylic acid; polyether antibiotic; spiroketal	antifungal agent; coccidiostat; ionophore
2-phenylsuccinate	[no description available]	medium	1	0
1-oleoyl-2-acetylglycerol	[no description available]	medium	1	0	1,2-diglyceride
proadifen	[no description available]	medium	1	0	diarylmethane
sodium azide	[no description available]	medium	8	0	inorganic sodium salt	antibacterial agent; explosive; mitochondrial respiratory-chain inhibitor; mutagen
aa 861	[no description available]	medium	1	0	1,4-benzoquinones; acetylenic compound; primary alcohol	EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; ferroptosis inhibitor
ta 0910	[no description available]	medium	1	0	oligopeptide	analgesic; neuroprotective agent; nootropic agent
3-hydroxyaspartic acid	[no description available]	medium	2	0	amino dicarboxylic acid; aspartic acid derivative; C4-dicarboxylic acid; hydroxy-amino acid
cgp 35348	[no description available]	medium	3	0
transferrin	[no description available]	medium	2	0
amanitins	[no description available]	medium	1	0
2-bromoacetyl-6-methoxynaphthalene	[no description available]	medium	1	0
4-iodophenol	[no description available]	medium	2	0	iodophenol
6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione	[no description available]	medium	2	0	phthalazines
fura-2-am	[no description available]	medium	1	0
4,4'-dinitro-2,2'-stilbenedisulfonic acid	[no description available]	medium	3	0	4,4'-dinitrostilbene-2,2'-disulfonic acid
1-(5-isoquinolinesulfonyl)-2-methylpiperazine	[no description available]	medium	2	0	isoquinolines; N-sulfonylpiperazine	EC 2.7.11.13 (protein kinase C) inhibitor
leukotriene d4	[no description available]	medium	2	0	dipeptide; leukotriene; organic sulfide	bronchoconstrictor agent; human metabolite; mouse metabolite
sodium acetate, anhydrous	[no description available]	medium	1	0	organic sodium salt	NMR chemical shift reference compound
4-bromophenacyl bromide	[no description available]	medium	3	0
thromboxane a2	[no description available]	medium	4	0	epoxy monocarboxylic acid; thromboxanes A	mouse metabolite
15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid	[no description available]	medium	1	0
thromboxanes	[no description available]	medium	1	0
alpha-linolenic acid	[no description available]	medium	2	0	linolenic acid; omega-3 fatty acid	micronutrient; mouse metabolite; nutraceutical
fenton's reagent	[no description available]	medium	1	0
1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid	[no description available]	medium	1	0	harmala alkaloid
pyrrolidine-3,4-dicarboxylic acid	[no description available]	medium	1	0
4,4'-diaminodiphenylmethane	[no description available]	medium	1	0	aromatic amine	allergen; carcinogenic agent
lubeluzole	[no description available]	medium	3	0	benzothiazoles
2,3-naphthalenedicarboxaldehyde	[no description available]	medium	4	0
hirudin	[no description available]	medium	1	0
arachidonyltrifluoromethane	[no description available]	medium	2	0	fatty acid derivative; ketone; olefinic compound; organofluorine compound	EC 3.1.1.4 (phospholipase A2) inhibitor
chromotropic acid	[no description available]	medium	1	0	naphthalenediols; naphthalenesulfonic acid	indicator
tert-butylthiol	[no description available]	medium	1	0
c.i. direct red 80	[no description available]	medium	1	0	organic sodium salt	fluorochrome; histological dye
gamma-cyclodextrin	[no description available]	medium	1	0	cyclodextrin
pervanadate	[no description available]	medium	1	0
1-methyl-4-phenylpyridinium	[no description available]	medium	2	0	pyridinium ion	apoptosis inducer; herbicide; human xenobiotic metabolite; neurotoxin
ferric chloride	[no description available]	medium	2	0	iron coordination entity	astringent; Lewis acid
phosphorus radioisotopes	[no description available]	medium	2	0
7-hydroxy-2-n,n-dipropylaminotetralin	[no description available]	medium	1	0	tetralins
apraclonidine	[no description available]	medium	1	0	dichlorobenzene; guanidines; imidazolines	alpha-adrenergic agonist; antiglaucoma drug; beta-adrenergic agonist; diagnostic agent; ophthalmology drug
chloroquine	[no description available]	medium	3	0	aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug
2-(4-(3-methyl-2-thienyl)phenyl)propionic acid	[no description available]	medium	2	0
dityrosine	[no description available]	medium	1	0	biphenyls; non-proteinogenic alpha-amino acid; tyrosine derivative	biomarker
kn 93	[no description available]	medium	1	0	monochlorobenzenes; monomethoxybenzene; primary alcohol; sulfonamide; tertiary amino compound	EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor; geroprotector
7-octylindolactam v	[no description available]	medium	1	0
lanthanum chloride	[no description available]	medium	3	0
sodium chromate(vi)	[no description available]	medium	1	0	inorganic sodium salt	carcinogenic agent; diagnostic agent; oxidising agent; poison
chromates	[no description available]	medium	1	0	chromium oxoanion; divalent inorganic anion	oxidising agent
sincalide	[no description available]	medium	2	0	oligopeptide
pd 135158	[no description available]	medium	1	0
2-chloro-n(6)cyclopentyladenosine	[no description available]	medium	1	0
heroin	[no description available]	medium	1	0	morphinane alkaloid	mu-opioid receptor agonist; opioid analgesic; prodrug
2-chloroethyl ethyl sulfide	[no description available]	medium	2	0
huperzine a	[no description available]	medium	1	0	quinolone
sesquiterpenes	[no description available]	medium	1	0
aluminum oxide	[no description available]	medium	2	0
5-(n-4-chlorobenzyl)-n-(2',4'-dimethyl)benzamil	[no description available]	medium	1	0
meglitinide	[no description available]	medium	1	0
beta-glucono-1,5-lactone	[no description available]	medium	1	0	aldono-1,5-lactone; gluconolactone	animal metabolite; mouse metabolite
desipramine	[no description available]	medium	2	0	dibenzoazepine; secondary amino compound	adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; cholinergic antagonist; drug allergen; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; serotonin uptake inhibitor
6-anilino-5,8-quinolinedione	[no description available]	medium	2	0	aminoquinoline; aromatic amine; p-quinones; quinolone	antineoplastic agent; EC 4.6.1.2 (guanylate cyclase) inhibitor
5-dihydrocortisone	[no description available]	medium	1	0	3-oxo-5beta-steroid; 4,5-dihydrocortisone; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone
arginylphenylalaninamide	[no description available]	medium	1	0
hydrochloric acid	[no description available]	medium	6	0	chlorine molecular entity; gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
diethyl pyrocarbonate	[no description available]	medium	1	0	acyclic carboxylic anhydride
methadyl acetate	[no description available]	medium	2	0	diarylmethane
galactose	[no description available]	medium	2	0
tungsten	[no description available]	medium	1	0	chromium group element atom	micronutrient
oleanolic acid	[no description available]	medium	1	0	hydroxy monocarboxylic acid; pentacyclic triterpenoid	plant metabolite
quillaic acid	[no description available]	medium	1	0	aldehyde; hydroxy monocarboxylic acid; pentacyclic triterpenoid	anti-inflammatory agent; metabolite
sapogenins	[no description available]	medium	1	0
cgp 71872	[no description available]	medium	1	0
2-(2,3-dicarboxycyclopropyl)glycine	[no description available]	medium	2	0
alamethicin	[no description available]	medium	1	0
linoleic acid hydroperoxide	[no description available]	medium	1	0
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline	[no description available]	medium	1	0	naphthalenes; sulfonic acid derivative
o-succinylhomoserine	[no description available]	medium	1	0	hemisuccinate; o-succinylhomoserine	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
acivicin	[no description available]	medium	1	0	isoxazoles; non-proteinogenic L-alpha-amino acid; organochlorine compound	antileishmanial agent; antimetabolite; antimicrobial agent; antineoplastic agent; EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor; glutamine antagonist; metabolite
aminooxyacetic acid	[no description available]	medium	9	0	amino acid; hydroxylamines; monocarboxylic acid	anticonvulsant; EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor; EC 4.2.1.22 (cystathionine beta-synthase) inhibitor; nootropic agent
7,7-dimethyl-5,8-eicosadienoic acid	[no description available]	medium	1	0	long-chain fatty acid
3-methylcholanthrene	[no description available]	medium	1	0	ortho- and peri-fused polycyclic arene	aryl hydrocarbon receptor agonist; carcinogenic agent
lisinopril	[no description available]	medium	1	0	dipeptide	EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
gadolinium chloride	[no description available]	medium	1	0	gadolinium coordination entity	TRP channel blocker
gadolinium	[no description available]	medium	2	0	f-block element atom; lanthanoid atom
pravastatin	[no description available]	medium	1	0	3-hydroxy carboxylic acid; carbobicyclic compound; carboxylic ester; hydroxy monocarboxylic acid; secondary alcohol; statin (semi-synthetic)	anticholesteremic drug; environmental contaminant; metabolite; xenobiotic
taurodehydrocholate	[no description available]	medium	1	0
methionine sulfoxide	[no description available]	medium	2	0	amino acid zwitterion; L-methionine S-oxide	Escherichia coli metabolite
methionine sulfoxide	[no description available]	medium	2	1	amino acid zwitterion; L-methionine S-oxide	Escherichia coli metabolite
taltrimide	[no description available]	medium	5	0
cupric glycinate	[no description available]	medium	1	0
dapsone	[no description available]	medium	2	0	substituted aniline; sulfone	anti-inflammatory drug; antiinfective agent; antimalarial; leprostatic drug
deuterium oxide	[no description available]	medium	1	0	deuterated compound; water	NMR solvent
anatibant	[no description available]	medium	1	0	proline derivative
oxacillin	[no description available]	medium	1	0	penicillin	antibacterial agent; antibacterial drug
calcium lactate	[no description available]	medium	1	0
thiopental	[no description available]	medium	1	0	barbiturates	anticonvulsant; drug allergen; environmental contaminant; intravenous anaesthetic; sedative; xenobiotic
lithium citrate	[no description available]	medium	1	0	lithium salt
lysophosphatidylethanolamine	[no description available]	medium	1	0
lysophosphatidylserine	[no description available]	medium	1	0	1-acyl-sn-glycero-3-phosphoserine
lysophosphatidylinositol	[no description available]	medium	1	0
bromcresol green	[no description available]	medium	1	0	benzofurans
mibefradil	[no description available]	medium	1	0	tetralins	T-type calcium channel blocker
n-acetylbenzidine	[no description available]	medium	1	0
phorbol-12-myristate	[no description available]	medium	1	0
benzohydroxamic acid	[no description available]	medium	1	0
salicylhydroxamic acid	[no description available]	medium	2	0	hydroxamic acid; phenols	antibacterial drug; EC 1.11.2.2 (myeloperoxidase) inhibitor; EC 3.5.1.5 (urease) inhibitor; trypanocidal drug
alanylalanine	[no description available]	medium	1	0	dipeptide
alanyl-alanyl-alanine	[no description available]	medium	1	0	tripeptide	metabolite
3,4-dihydroxyphenylglycol	[no description available]	medium	1	0	catechols; tetrol	metabolite; mouse metabolite
methoxyhydroxyphenylglycol	[no description available]	medium	2	0	methoxybenzenes; phenols
fentanyl	[no description available]	medium	1	0	anilide; monocarboxylic acid amide; piperidines	adjuvant; anaesthesia adjuvant; anaesthetic; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic
oxaloacetic acid	[no description available]	medium	1	0	C4-dicarboxylic acid; oxo dicarboxylic acid	geroprotector; metabolite
alpha-ketobutyric acid	[no description available]	medium	1	0	2-oxo monocarboxylic acid; short-chain fatty acid
benzo(a)pyrene 7,8-dihydrodiol	[no description available]	medium	1	0	pyrenes
1,2-dioxetane	[no description available]	medium	1	0
snx 230	[no description available]	medium	1	0
deflazacort	[no description available]	medium	1	0	corticosteroid hormone
ketorolac	[no description available]	medium	1	0	amino acid; aromatic ketone; monocarboxylic acid; pyrrolizines; racemate	analgesic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug
lofexidine	[no description available]	medium	1	0	aromatic ether; carboxamidine; dichlorobenzene; imidazoles	alpha-adrenergic agonist; antihypertensive agent
squalene	[no description available]	medium	1	0	triterpene	human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
ceruletide	[no description available]	medium	1	0	oligopeptide	diagnostic agent; gastrointestinal drug
sodium carbonate	[no description available]	medium	1	1	carbonate salt; organic sodium salt
methohexital	[no description available]	medium	1	1	acetylenic compound; barbiturates	drug allergen; intravenous anaesthetic
isorhamnetin 3-o-glucoside	[no description available]	medium	1	0	beta-D-glucoside; glycosyloxyflavone; monomethoxyflavone; monosaccharide derivative; trihydroxyflavone	metabolite
2',7'-dichlorofluorescein	[no description available]	medium	1	0	2-benzofurans	fluorochrome
levetiracetam	[no description available]	medium	1	0	pyrrolidin-2-ones	anticonvulsant; environmental contaminant; xenobiotic
ethane sulfonate	[no description available]	medium	1	0	alkanesulfonic acid
rivastigmine	[no description available]	medium	1	0	carbamate ester; tertiary amino compound	cholinergic drug; EC 3.1.1.8 (cholinesterase) inhibitor; neuroprotective agent
1-aminocyclopropane-1-carboxylic acid	[no description available]	medium	1	0	amino acid zwitterion; monocarboxylic acid; non-proteinogenic alpha-amino acid	ethylene releasers; plant metabolite
ethylene glycol	[no description available]	medium	2	0	ethanediol; glycol	metabolite; mouse metabolite; solvent; toxin
diethylurea	[no description available]	medium	1	0
cytochalasin e	[no description available]	medium	1	0	cytochalasan alkaloid	metabolite
dehydroascorbic acid	[no description available]	medium	1	0	dehydroascorbic acid; vitamin C	coenzyme; mouse metabolite
tetrachloroethylene	[no description available]	medium	1	0	chlorocarbon; chloroethenes	nephrotoxic agent
(2-sulfonatoethyl)methanethiosulfonate	[no description available]	medium	1	0
acepromazine	[no description available]	medium	1	0	aromatic ketone; methyl ketone; phenothiazines; tertiary amino compound	phenothiazine antipsychotic drug
kn 62	[no description available]	medium	1	0	piperazines
panaxadiol	[no description available]	medium	1	0	triterpenoid saponin
anisodamine	[no description available]	medium	1	0
tetrandrine	[no description available]	medium	1	0	bisbenzylisoquinoline alkaloid; isoquinolines
ginkgolide b	[no description available]	medium	1	0
gypenoside ix	[no description available]	medium	1	0
5-hydroxyuracil	[no description available]	medium	1	0	hydroxypyrimidine
8-hydroxyadenine	[no description available]	medium	1	0	6-aminopurines; heteroaryl hydroxy compound; nucleobase analogue; oxopurine	bacterial metabolite; human metabolite
chlordiazepoxide	[no description available]	medium	3	0	benzodiazepine
cyclohexene	[no description available]	medium	1	0	cycloalkene
chlorosulfonic acid	[no description available]	medium	1	0
sulfur monochloride	[no description available]	medium	1	0
2-aminocyclohexanecarboxylic acid	[no description available]	medium	1	0
phorbol	[no description available]	medium	1	0	cyclic ketone; enone; tertiary alcohol; tertiary alpha-hydroxy ketone; tetracyclic diterpenoid
phorbols	[no description available]	medium	1	0	diterpene; terpenoid fundamental parent
8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate	[no description available]	medium	1	0
n-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide	[no description available]	medium	1	0
phenylhydrazine	[no description available]	medium	3	0	phenylhydrazines	xenobiotic
thymine	[no description available]	medium	1	0	pyrimidine nucleobase; pyrimidone	Escherichia coli metabolite; human metabolite; mouse metabolite
galactitol	[no description available]	medium	3	0	hexitol	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
antibiotic g 418	[no description available]	medium	1	0
propantheline	[no description available]	medium	1	0	xanthenes
platinum	[no description available]	medium	2	0	elemental platinum; nickel group element atom; platinum group metal atom
ninhydrin	[no description available]	medium	3	0	aromatic ketone; beta-diketone; indanones; ketone hydrate	colour indicator; human metabolite
nitrosobis(2-oxopropyl)amine	[no description available]	medium	1	0	ketone; nitrosamine	carcinogenic agent
tempo	[no description available]	medium	1	0	aminoxyls; piperidines	catalyst; ferroptosis inhibitor; radical scavenger
hydroxypropyl-gamma-cyclodextrin	[no description available]	medium	1	0
y 27632	[no description available]	medium	1	0	aromatic amide
daunorubicin	[no description available]	medium	2	0	aminoglycoside antibiotic; anthracycline; p-quinones; tetracenequinones	antineoplastic agent; bacterial metabolite
urethane	[no description available]	medium	4	0	carbamate ester	fungal metabolite; mutagen
puromycin	[no description available]	medium	2	0	puromycins	antiinfective agent; antimicrobial agent; antineoplastic agent; EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor; EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor; nucleoside antibiotic; protein synthesis inhibitor
ethyl methanesulfonate	[no description available]	medium	1	0	methanesulfonate ester	alkylating agent; antineoplastic agent; carcinogenic agent; genotoxin; mutagen; teratogenic agent
sulfobromophthalein	[no description available]	medium	9	1	2-benzofurans; organobromine compound; organosulfonic acid; phenols	dye
vasotocin	[no description available]	medium	1	0
bismuth	[no description available]	medium	1	0	metal atom; pnictogen
silicon	[no description available]	medium	1	0	carbon group element atom; metalloid atom; nonmetal atom
bismuth subsalicylate	[no description available]	medium	1	0
lactulose	[no description available]	medium	1	0
thiamine monophosphate	[no description available]	medium	1	0	organic chloride salt; vitamin B1
thiamine pyrophosphate	[no description available]	medium	1	0	organophosphate oxoanion; vitamin B1	human metabolite; Saccharomyces cerevisiae metabolite
pyrithiamine	[no description available]	medium	1	0
3-phenoxybenzoic acid	[no description available]	medium	1	0	phenoxybenzoic acid	human xenobiotic metabolite; marine xenobiotic metabolite
hexobarbital	[no description available]	medium	1	0	barbiturates
chlordan	[no description available]	medium	1	0	cyclodiene organochlorine insecticide	GABA-gated chloride channel antagonist; persistent organic pollutant
eledoisin	[no description available]	medium	1	0	peptide
benzene	[no description available]	medium	2	0	aromatic annulene; benzenes; volatile organic compound	carcinogenic agent; environmental contaminant; non-polar solvent
sepharose	[no description available]	medium	1	0
elastin	[no description available]	medium	1	0	oligopeptide
xanthinol niacinate	[no description available]	medium	1	0
deslanoside	[no description available]	medium	1	0	12beta-hydroxy steroid; 14beta-hydroxy steroid; cardenolide glycoside; tetrasaccharide derivative	anti-arrhythmia drug; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; metabolite
lanatosides	[no description available]	medium	1	0
digitoxin	[no description available]	medium	2	0	cardenolide glycoside	EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
pantetheine	[no description available]	medium	2	0	pantetheines; thiol	human metabolite; metabolite; mouse metabolite
tricalcium phosphate	[no description available]	medium	3	0	calcium phosphate
durapatite	[no description available]	medium	1	0
calcium phosphate, dibasic, anhydrous	[no description available]	medium	3	0	calcium phosphate
calcium phosphate, monobasic, anhydrous	[no description available]	medium	3	0	calcium phosphate	fertilizer
calcium pyrophosphate	[no description available]	medium	3	0
5-methylnicotinamide	[no description available]	medium	1	0
dynorphins	[no description available]	medium	1	0
dynorphin (1-8)	[no description available]	medium	1	0
3-mercaptopropionic acid	[no description available]	medium	3	0	mercaptopropanoic acid	algal metabolite
demecolcine	[no description available]	medium	1	0	alkaloid; secondary amino compound	antineoplastic agent; microtubule-destabilising agent
ro 15-4513	[no description available]	medium	1	0	organic heterotricyclic compound; organonitrogen heterocyclic compound
4-isopropylbicyclophosphate	[no description available]	medium	1	0
3,4-methylenedioxyamphetamine	[no description available]	medium	1	0	benzodioxoles
n-methyl-3,4-methylenedioxyamphetamine	[no description available]	medium	1	0	amphetamines; benzodioxoles	neurotoxin
ethylcholine aziridinium	[no description available]	medium	1	0
psyllium	[no description available]	medium	1	1	very long-chain fatty acid
methanesulfinic acid	[no description available]	medium	1	0	organosulfinic acid
3-mercaptopyruvic acid	[no description available]	medium	1	0	2-oxo monocarboxylic acid; thiol	antidote to cyanide poisoning; Escherichia coli metabolite; human metabolite; mouse metabolite
phenylpyruvic acid	[no description available]	medium	1	0	2-oxo monocarboxylic acid	chromogenic compound; EC 6.4.1.1 (pyruvate carboxylase) inhibitor; fundamental metabolite
2,3,4,6-tetrachlorophenol	[no description available]	medium	1	0	tetrachlorophenol	xenobiotic metabolite
camphor, (+-)-isomer	[no description available]	medium	1	0	bornane monoterpenoid; cyclic monoterpene ketone	plant metabolite
camphorated parachlorophenol	[no description available]	medium	1	0
cadmium carbonate	[no description available]	medium	1	0
succinylacetone	[no description available]	medium	1	0	beta-diketone; dioxo monocarboxylic acid	human metabolite
1,2-dielaidoylphosphatidylethanolamine	[no description available]	medium	1	0
hydralazine	[no description available]	medium	2	0	azaarene; hydrazines; ortho-fused heteroarene; phthalazines	antihypertensive agent; vasodilator agent
bathocuproine disulfonate	[no description available]	medium	2	0	arenesulfonic acid; phenanthrolines	chelator
taurolipid b	[no description available]	medium	6	0
firefly luciferin	[no description available]	medium	1	0	1,3-thiazolemonocarboxylic acid; benzothiazoles; imidothioate	luciferin
nortriptyline	[no description available]	medium	1	0	organic tricyclic compound; secondary amine	adrenergic uptake inhibitor; analgesic; antidepressant; antineoplastic agent; apoptosis inducer; drug metabolite
leukotriene b4	[no description available]	medium	1	0	dihydroxy monocarboxylic acid; hydroxy polyunsaturated fatty acid; leukotriene; long-chain fatty acid	human metabolite; mouse metabolite; plant metabolite; vasoconstrictor agent
3-amino-3-phenylpropionic acid	[no description available]	medium	1	0	amino acid zwitterion; beta-amino acid
antimycin a	[no description available]	medium	1	0	amidobenzoic acid
g(m1) ganglioside	[no description available]	medium	2	0	alpha-N-acetylneuraminosyl-(2->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine; sialotetraosylceramide
detorubicin	[no description available]	medium	1	0
dacarbazine	[no description available]	medium	1	0	dacarbazine
procarbazine	[no description available]	medium	1	0	benzamides; hydrazines	antineoplastic agent
vindesine	[no description available]	medium	2	0	methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; primary carboxamide; tertiary alcohol; tertiary amino compound; vinca alkaloid	antineoplastic agent
neurokinin a	[no description available]	medium	1	0
4-nitrobenzofurazan	[no description available]	medium	1	0
lucifer yellow	[no description available]	medium	1	0	organic lithium salt	fluorochrome
meperidine	[no description available]	medium	1	0	ethyl ester; piperidinecarboxylate ester; tertiary amino compound	antispasmodic drug; kappa-opioid receptor agonist; mu-opioid receptor agonist; opioid analgesic
n-methylnicotinamide	[no description available]	medium	1	0	pyridinecarboxamide	metabolite
dimethylhydrazines	[no description available]	medium	1	0
glycolithocholic acid	[no description available]	medium	2	0	bile acid glycine conjugate; N-acylglycine
benzoic acid	[no description available]	medium	4	0	benzoic acids	algal metabolite; antimicrobial food preservative; drug allergen; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; human xenobiotic metabolite; plant metabolite
n-methylglucosamine	[no description available]	medium	1	0
n,n'-(1,2-dihydroxyethylene)bisacrylamide	[no description available]	medium	1	0
fotemustine	[no description available]	medium	1	0	N-nitrosoureas; organic phosphonate; organochlorine compound
nimustine	[no description available]	medium	1	0	aminopyrimidine; N-nitrosoureas; organochlorine compound	alkylating agent; antineoplastic agent
ethacrynic acid	[no description available]	medium	1	0	aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid	EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic
kanamycin a	[no description available]	medium	1	0	kanamycins	bacterial metabolite
phencyclidine	[no description available]	medium	1	0	benzenes; piperidines	anaesthetic; neurotoxin; NMDA receptor antagonist; psychotropic drug
methazolamide	[no description available]	medium	1	0	sulfonamide; thiadiazoles
gamma-glu-asp	[no description available]	medium	1	0	dipeptide
nigericin	[no description available]	medium	2	0	polycyclic ether	antibacterial agent; antimicrobial agent; bacterial metabolite; potassium ionophore
enkephalin-met, lys(6)-	[no description available]	medium	1	0
pargyline	[no description available]	medium	4	0	aromatic amine
cysteine thiosulfonate	[no description available]	medium	1	0	S-conjugate
alpha-fluoro-beta-alanine	[no description available]	medium	1	0	organonitrogen compound; organooxygen compound
glutaral	[no description available]	medium	1	0	dialdehyde	cross-linking reagent; disinfectant; fixative
glycine amide	[no description available]	medium	1	0	amino acid amide; glycine derivative
metaperiodate	[no description available]	medium	1	0	iodine oxoacid
metaperiodate	[no description available]	medium	1	0	iodine oxoanion; monovalent inorganic anion
4-bromomethyl-7-methoxycoumarin	[no description available]	medium	1	0
potassium thiocyanate	[no description available]	medium	1	0	potassium salt
copper bis(3,5-diisopropylsalicylate)	[no description available]	medium	1	0
beta-mercaptolactate cysteine disulfide	[no description available]	medium	1	0	organic molecular entity
cholanic acid	[no description available]	medium	1	0	cholanic acids
substance p (4-11), pro(4)-trp(7,9)-	[no description available]	medium	1	0
atractyloside	[no description available]	medium	1	0
oligomycins	[no description available]	medium	2	0
fibrin	[no description available]	medium	1	0	peptide
triethylenephosphoramide	[no description available]	medium	1	0	phosphoramide
2-aminofluorene	[no description available]	medium	1	0
3-amino-1-methyl-5h-pyrido(4,3-b)indole	[no description available]	medium	1	0	pyridoindole
3-chloroperbenzoic acid	[no description available]	medium	1	0	monochlorobenzenes; peroxy acid
potassium fluoride	[no description available]	medium	1	0	fluoride salt; potassium salt	NMR chemical shift reference compound; poison
gabaculine	[no description available]	medium	1	0	5-aminocyclohexa-1,3-diene-1-carboxylic acid	bacterial metabolite; EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor
hydroxyacetylaminofluorene	[no description available]	medium	1	0	2-acetamidofluorenes
guaiacol	[no description available]	medium	4	0	guaiacols	disinfectant; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; expectorant; plant metabolite
cypermethrin	[no description available]	medium	1	0	aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound	agrochemical; molluscicide; pyrethroid ester acaricide; pyrethroid ester insecticide
tetramethrin	[no description available]	medium	1	0	cyclopropanecarboxylate ester; maleimides; phthalimide insecticide	pyrethroid ester insecticide
ecomustine	[no description available]	medium	1	0
6-methyl-2-ethyl-3-hydroxypyridine	[no description available]	medium	1	0
mitozolomide	[no description available]	medium	2	1
iohexol	[no description available]	medium	1	0	benzenedicarboxamide; organoiodine compound	environmental contaminant; radioopaque medium; xenobiotic
nornitrogen mustard	[no description available]	medium	1	0	nitrogen mustard
estramustine	[no description available]	medium	1	0	17beta-hydroxy steroid; carbamate ester; organochlorine compound	alkylating agent; antineoplastic agent; radiation protective agent
tetranitromethane	[no description available]	medium	1	0	organonitrogen compound
n-acetylimidazole	[no description available]	medium	1	0	N-acylimidazole
4-nitrobenzenesulfonyl fluoride	[no description available]	medium	1	0
methyl methanesulfonate	[no description available]	medium	1	0	methanesulfonate ester	alkylating agent; apoptosis inducer; carcinogenic agent; genotoxin; mutagen
mechlorethamine	[no description available]	medium	1	0	nitrogen mustard; organochlorine compound	alkylating agent
metapramine	[no description available]	medium	1	0	dibenzooxazepine
dronabinol	[no description available]	medium	2	0	benzochromene; diterpenoid; phytocannabinoid; polyketide	cannabinoid receptor agonist; epitope; hallucinogen; metabolite; non-narcotic analgesic
tiagabine	[no description available]	medium	1	0	beta-amino acid; piperidinemonocarboxylic acid; tertiary amino compound; thiophenes	anticonvulsant; GABA reuptake inhibitor
flurazepam	[no description available]	medium	2	0	1,4-benzodiazepinone; monofluorobenzenes; organochlorine compound; tertiary amino compound	anticonvulsant; anxiolytic drug; GABAA receptor agonist; sedative
flupenthixol	[no description available]	medium	1	0	thioxanthenes
chlorobenzene	[no description available]	medium	2	0	monochlorobenzenes	solvent
metoprolol	[no description available]	medium	1	0	aromatic ether; propanolamine; secondary alcohol; secondary amino compound	antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; geroprotector; xenobiotic
bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide	[no description available]	medium	1	0
trimoprostil	[no description available]	medium	1	0
promethazine	[no description available]	medium	1	0	phenothiazines; tertiary amine	anti-allergic agent; anticoronaviral agent; antiemetic; antipruritic drug; H1-receptor antagonist; local anaesthetic; sedative
2-acetylaminofluorene	[no description available]	medium	1	0	2-acetamidofluorenes	antimitotic; carcinogenic agent; epitope; mutagen
canaline	[no description available]	medium	1	0	amino acid zwitterion; non-proteinogenic L-alpha-amino acid	antimetabolite; antineoplastic agent; phytogenic insecticide; plant metabolite
pridinol	[no description available]	medium	1	0	piperidines; tertiary alcohol	antiparkinson drug; muscle relaxant
trihexyphenidyl	[no description available]	medium	1	0	amine
2,2'-azobis(2,4-dimethylvaleronitrile)	[no description available]	medium	1	0
nitrefazole	[no description available]	medium	1	0	imidazoles
fenfluramine	[no description available]	medium	1	0	(trifluoromethyl)benzenes; secondary amino compound	appetite depressant; serotonergic agonist; serotonin uptake inhibitor
cyanamide	[no description available]	medium	1	0	nitrile; one-carbon compound	EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor
zimeldine	[no description available]	medium	1	0	styrenes
azomycin	[no description available]	medium	1	0	C-nitro compound; imidazoles	antitubercular agent
1-ethyl-3-(4-azonia-4,4-dimethylpentyl)carbodiimide	[no description available]	medium	1	0
progabide acid	[no description available]	medium	1	0
kojic amine	[no description available]	medium	1	0
2-keto-4-methylthiobutyric acid	[no description available]	medium	1	0	omega-(methylthio)-2-oxocarboxylic acid
suloctidil	[no description available]	medium	2	0
glutamic acid diethyl ester	[no description available]	medium	2	0
pteroic acid	[no description available]	medium	1	0	pteroic acid
metoclopramide	[no description available]	medium	1	0	benzamides; monochlorobenzenes; substituted aniline; tertiary amino compound	antiemetic; dopaminergic antagonist; environmental contaminant; gastrointestinal drug; xenobiotic
stearic acid	[no description available]	medium	1	0	long-chain fatty acid; saturated fatty acid; straight-chain saturated fatty acid	algal metabolite; Daphnia magna metabolite; human metabolite; plant metabolite
thiazolidine-4-carboxylic acid	[no description available]	medium	1	0	alpha-amino acid zwitterion; non-proteinogenic alpha-amino acid; sulfur-containing amino acid; thiazolidinemonocarboxylic acid	antidote; antioxidant; hepatoprotective agent
picibanil	[no description available]	medium	1	0	penicillinate anion
trigonelline	[no description available]	medium	1	0	alkaloid; iminium betaine	food component; human urinary metabolite; plant metabolite
phenylisothiocyanate	[no description available]	medium	1	0	isothiocyanate	allergen; reagent
pamidronate	[no description available]	medium	1	0	phosphonoacetic acid
strophanthidin	[no description available]	medium	1	0	14beta-hydroxy steroid; 19-oxo steroid; 3beta-hydroxy steroid; 5beta-hydroxy steroid; cardenolides; steroid aldehyde
cetylpyridinium	[no description available]	medium	1	0	pyridinium ion
leupeptin	[no description available]	medium	1	0	aldehyde; tripeptide	bacterial metabolite; calpain inhibitor; cathepsin B inhibitor; EC 3.4.21.4 (trypsin) inhibitor; serine protease inhibitor
leupeptins	[no description available]	medium	1	0
d-ala(2),mephe(4),met(0)-ol-enkephalin	[no description available]	medium	1	0
flunarizine	[no description available]	medium	1	0	diarylmethane
diphenylhexatriene	[no description available]	medium	1	0	alkatriene	fluorochrome
guanylthiourea	[no description available]	medium	1	0
doxepin	[no description available]	medium	1	0	dibenzooxepine; tertiary amino compound	antidepressant
barium chloride	[no description available]	medium	1	0	barium salt; inorganic chloride	potassium channel blocker
pantethine	[no description available]	medium	1	0	organic disulfide	coenzyme; nutraceutical
1-naphthaleneacetic acid	[no description available]	medium	1	0	naphthylacetic acid	synthetic auxin
dodecylcyclohexane	[no description available]	medium	1	0
piperacillin	[no description available]	medium	1	0	penicillin allergen; penicillin	antibacterial drug
halothane	[no description available]	medium	2	0	haloalkane; organobromine compound; organochlorine compound; organofluorine compound	inhalation anaesthetic
3-aminocyclohexanecarboxylic acid	[no description available]	medium	1	0
serine o-sulfate	[no description available]	medium	1	0	L-serine derivative; non-proteinogenic L-alpha-amino acid; O-sulfoamino acid
2-aminoethylmethyl sulfone	[no description available]	medium	1	0
p-chloromercuribenzoic acid	[no description available]	medium	1	0	chlorine molecular entity; mercuribenzoic acid
bis(4-nitrophenyl)phosphate	[no description available]	medium	1	0	aryl phosphate
cadaverine	[no description available]	medium	1	0	alkane-alpha,omega-diamine	Daphnia magna metabolite; Escherichia coli metabolite; mouse metabolite; plant metabolite
c.i. 42510	[no description available]	medium	1	0
agar	[no description available]	medium	2	0
sulfisoxazole	[no description available]	medium	1	0	isoxazoles; sulfonamide antibiotic; sulfonamide	antibacterial drug; drug allergen
prednisone	[no description available]	medium	1	0	11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	adrenergic agent; anti-inflammatory drug; antineoplastic agent; immunosuppressive agent; prodrug
pyrophosphate	[no description available]	medium	1	0	diphosphate ion
codeine	[no description available]	medium	1	0	morphinane alkaloid; organic heteropentacyclic compound	antitussive; drug allergen; environmental contaminant; opioid analgesic; opioid receptor agonist; prodrug; xenobiotic
beta-aminoethyl isothiourea	[no description available]	medium	1	0
iproniazid	[no description available]	medium	2	0	carbohydrazide; pyridines
17-ketosteroids	[no description available]	medium	2	0
vanadium	[no description available]	medium	1	0	elemental vanadium; vanadium group element atom	micronutrient
sulfaguanidine	[no description available]	medium	1	0	sulfonamide antibiotic	antiinfective agent
osmium	[no description available]	medium	1	0	iron group element atom; platinum group metal atom
phenetidine	[no description available]	medium	1	0	aromatic ether; primary amino compound; substituted aniline	drug metabolite
methoxyflurane	[no description available]	medium	1	0	ether; organochlorine compound; organofluorine compound	hepatotoxic agent; inhalation anaesthetic; nephrotoxic agent; non-narcotic analgesic
ammonium sulfate	[no description available]	medium	3	0	ammonium salt; inorganic sulfate salt	fertilizer
phenelzine	[no description available]	medium	1	0	primary amine
chloral hydrate	[no description available]	medium	2	0	aldehyde hydrate; ethanediol; organochlorine compound	general anaesthetic; mouse metabolite; sedative; xenobiotic
cholestanol	[no description available]	medium	1	0	cholestanoid
plutonium	[no description available]	medium	3	0	actinoid atom; f-block element atom
tolazoline	[no description available]	medium	1	0	imidazoles	alpha-adrenergic antagonist; antihypertensive agent; vasodilator agent
zoxazolamine	[no description available]	medium	1	0	benzoxazole
phenacetin	[no description available]	medium	1	0	acetamides; aromatic ether	cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug
triamcinolone acetonide	[no description available]	medium	1	0	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; cyclic ketal; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone	anti-allergic agent; anti-inflammatory drug
lignin	[no description available]	medium	1	0
iodipamide	[no description available]	medium	1	0	benzoic acids; organoiodine compound; secondary carboxamide	radioopaque medium
indocyanine green	[no description available]	medium	1	0	1,1-diunsubstituted alkanesulfonate; benzoindole; cyanine dye
gastrins	[no description available]	medium	1	0
humulene	[no description available]	medium	2	0	alpha-humulene
fusarium	[no description available]	medium	2	0
ants	[no description available]	medium	2	0
egg white	[no description available]	medium	2	0
bassianolide	[no description available]	medium	7	1	cyclodepsipeptide; cyclooctadepsipeptide	antineoplastic agent; fungal metabolite; insecticide
isomethyleugenol	[no description available]	medium	16	0	isomethyleugenol
vendex	[no description available]	medium	1	1	organotin acaricide
octachloronaphthalene	[no description available]	medium	2	0
s,n,n'-tripropylthiocarbamate	[no description available]	medium	2	1	tertiary amine
eye	[no description available]	medium	19	1
fomesafen	[no description available]	medium	10	1	aromatic ether; C-nitro compound; monochlorobenzenes; N-sulfonylcarboxamide; organofluorine compound; phenols	agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
cetylpyridinium chloride anhydrous	[no description available]	medium	3	1	chloride salt; organic chloride salt	antiseptic drug; surfactant
jaw	[no description available]	medium	1	0	indolecarboxamide
hypericum	[no description available]	medium	1	0	penicillanic acids
tridemorph	[no description available]	medium	1	1	morpholines; tertiary amino compound	antifungal agrochemical
astemizole	[no description available]	medium	1	0	benzimidazoles; piperidines	anti-allergic agent; anticoronaviral agent; H1-receptor antagonist
2-propanol	[no description available]	medium	4	0	secondary alcohol; secondary fatty alcohol	protic solvent
benzothiazide	[no description available]	medium	1	0	benzothiadiazine; sulfonamide	antihypertensive agent; diuretic
iodinated glycerol	[no description available]	medium	1	0	dioxolane
nociceptin	[no description available]	medium	1	0	organic molecular entity; polypeptide	human metabolite; rat metabolite
trolamine salicylate	[no description available]	medium	1	0
foxes	[no description available]	medium	1	0
torpedo	[no description available]	medium	1	0
sodium ethylxanthate	[no description available]	medium	1	0
apnea	[no description available]	medium	1	0	purine nucleoside
2-oxo-3-methylvalerate	[no description available]	low	0	0	2-oxo monocarboxylic acid; branched-chain keto acid	human metabolite
alpha-ketoisovalerate	[no description available]	low	0	0	2-oxo monocarboxylic acid; branched-chain keto acid	human metabolite; Saccharomyces cerevisiae metabolite
2-keto-4-methylvalerate	[no description available]	low	0	0	2-oxo monocarboxylic acid; branched-chain keto acid	algal metabolite; human metabolite
3-hydroxyanthranilic acid	[no description available]	low	0	0	aminobenzoic acid; monohydroxybenzoic acid	human metabolite; mouse metabolite
3-hydroxykynurenine	[no description available]	low	0	0	hydroxykynurenine	human metabolite
3-oxoadipic acid	[no description available]	low	0	0	dicarboxylic fatty acid; oxo dicarboxylic acid	bacterial xenobiotic metabolite; human metabolite
3-phenylpropionic acid	[no description available]	low	0	0	benzenes; monocarboxylic acid	antifungal agent; human metabolite; plant metabolite
isocaproaldehyde	[no description available]	low	0	0	alpha-CH2-containing aldehyde	human metabolite; mouse metabolite
anthranilic acid	[no description available]	low	0	0	aminobenzoic acid	human metabolite; mouse metabolite
betaine aldehyde	[no description available]	low	0	0	quaternary ammonium ion	Aspergillus metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite
ureidosuccinic acid	[no description available]	low	0	0	aspartic acid derivative; C4-dicarboxylic acid; N-carbamoyl-amino acid	Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
dihydrolipoic acid	[no description available]	low	0	0	thio-fatty acid	antioxidant; human metabolite; neuroprotective agent
trimethylenediamine	[no description available]	low	0	0	alkane-alpha,omega-diamine	human metabolite; mouse metabolite; reagent
pyrrolidonecarboxylic acid	[no description available]	low	0	0	oxoproline; pyrrolidin-2-ones; pyrrolidinemonocarboxylic acid	human metabolite
alpha-keto-delta-guanidinovaleric acid	[no description available]	medium	0	0	2-oxo monocarboxylic acid; zwitterion	human metabolite; mouse metabolite
dihydrouracil	[no description available]	low	0	0	pyrimidone	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
dihydrolipoamide	[no description available]	low	0	0	dithiol; monocarboxylic acid amide	cofactor; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
dihydroxyacetone phosphate	[no description available]	low	0	0	glycerone phosphates; primary alpha-hydroxy ketone	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
dihydroxyacetone	[no description available]	low	0	0	ketotriose; primary alpha-hydroxy ketone	antifungal agent; Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
5,6-dimethylbenzimidazole	[no description available]	low	0	0	dimethylbenzimidazole	Escherichia coli metabolite; human metabolite
gamma-butyrobetaine	[no description available]	low	0	0	amino-acid betaine	Escherichia coli metabolite; human metabolite
glutaric acid	[no description available]	low	0	0	alpha,omega-dicarboxylic acid; dicarboxylic fatty acid	Daphnia magna metabolite; human metabolite
glycolaldehyde	[no description available]	low	0	0	glycolaldehydes	fundamental metabolite; human metabolite
hydrogen cyanide	[no description available]	low	0	0	hydracid; one-carbon compound	Escherichia coli metabolite; human metabolite; poison
indole-3-acetaldehyde	[no description available]	low	0	0	indoleacetaldehyde	bacterial metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
potassium	[no description available]	low	0	0	alkali metal cation; elemental potassium; monoatomic monocation; monovalent inorganic cation	cofactor; human metabolite
lipoamide	[no description available]	low	0	0	dithiolanes; monocarboxylic acid amide	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
methylmercaptan	[no description available]	low	0	0	alkanethiol	human metabolite; Saccharomyces cerevisiae metabolite
n-methylphenylethanolamine	[no description available]	low	0	0	alkaloid; phenylethanolamines	human metabolite; plant metabolite
n'-acetylspermine	[no description available]	low	0	0	acetamides; acetylspermine	human metabolite
hydroxypyruvic acid	[no description available]	low	0	0	2-oxo monocarboxylic acid; 3-hydroxy monocarboxylic acid; primary alpha-hydroxy ketone	Escherichia coli metabolite; human metabolite
oxalic acid	[no description available]	low	0	0	alpha,omega-dicarboxylic acid	algal metabolite; human metabolite; plant metabolite
4-hydroxyphenylpyruvic acid	[no description available]	low	0	0	2-oxo monocarboxylic acid; phenols	human metabolite
hexadecanal	[no description available]	low	0	0	2,3-saturated fatty aldehyde; long-chain fatty aldehyde	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
phenylacetaldehyde	[no description available]	low	0	0	alpha-CH2-containing aldehyde; phenylacetaldehydes	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
2-hydroxyphenethylamine	[no description available]	low	0	0	phenylethanolamines	human metabolite
phosphoric acid	[no description available]	low	0	0	phosphoric acids	algal metabolite; fertilizer; human metabolite; NMR chemical shift reference compound; solvent
2-(4-methyl-1,3-thiazol-5-yl)ethanol	[no description available]	low	0	0	1,3-thiazoles; primary alcohol	Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
tryptamine	[no description available]	low	0	0	aminoalkylindole; aralkylamino compound; indole alkaloid; tryptamines	human metabolite; mouse metabolite; plant metabolite
perillic acid	[no description available]	low	0	0	alpha,beta-unsaturated monocarboxylic acid; cyclohexenecarboxylic acid	antineoplastic agent; human metabolite; mouse metabolite
meglutol	[no description available]	low	0	0	3-hydroxy carboxylic acid; dicarboxylic acid; tertiary alcohol	anticholesteremic drug; antimetabolite; EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor; human metabolite; plant metabolite
3-hydroxy-4-methoxyphenethylamine	[no description available]	low	0	0	monomethoxybenzene; phenols; phenylethylamine; primary amino compound	human metabolite; rat metabolite
5-methoxytryptamine	[no description available]	low	0	0	aromatic ether; primary amino compound; tryptamines	5-hydroxytryptamine 2A receptor agonist; 5-hydroxytryptamine 2B receptor agonist; 5-hydroxytryptamine 2C receptor agonist; antioxidant; cardioprotective agent; human metabolite; mouse metabolite; neuroprotective agent; radiation protective agent; serotonergic agonist
cetyl alcohol	[no description available]	low	0	0	hexadecanol; long-chain primary fatty alcohol	algal metabolite; flavouring agent; human metabolite; plant metabolite
4-cresol	[no description available]	low	0	0	cresol	Escherichia coli metabolite; human metabolite; uremic toxin
debrisoquin	[no description available]	low	0	0	carboxamidine; isoquinolines	adrenergic agent; antihypertensive agent; human metabolite; sympatholytic agent
decanoic acid	[no description available]	low	0	0	medium-chain fatty acid; straight-chain saturated fatty acid	algal metabolite; anti-inflammatory agent; antibacterial agent; human metabolite; plant metabolite; volatile oil component
nordazepam	[no description available]	low	0	0	1,4-benzodiazepinone; organochlorine compound	anticonvulsant; anxiolytic drug; GABA modulator; human metabolite; sedative
tele-methylhistamine	[no description available]	low	0	0	imidazoles; primary amino compound	human metabolite; mouse metabolite
indolepropionic acid	[no description available]	low	0	0	indol-3-yl carboxylic acid	auxin; human metabolite; plant metabolite
2-phenylglycine	[no description available]	low	0	0	non-proteinogenic alpha-amino acid	human metabolite
sebacic acid	[no description available]	low	0	0	alpha,omega-dicarboxylic acid; dicarboxylic fatty acid	human metabolite; plant metabolite
retinoic acid	[no description available]	low	0	0	alpha,beta-unsaturated monocarboxylic acid; retinoid	human metabolite
isonicotinic acid	[no description available]	low	0	0	pyridinemonocarboxylic acid	algal metabolite; human metabolite
cytidine monophosphate	[no description available]	low	0	0	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
n-pentanol	[no description available]	low	0	0	pentanol; short-chain primary fatty alcohol	human metabolite; plant metabolite
ethylamine	[no description available]	low	0	0	primary aliphatic amine	human metabolite
skatole	[no description available]	low	0	0	methylindole	human metabolite; mammalian metabolite
3-methylpentane	[no description available]	low	0	0	alkane; volatile organic compound	allelochemical; human metabolite; non-polar solvent
methylcyclopentane	[no description available]	low	0	0	cycloalkane; volatile organic compound	human metabolite; plant metabolite
phosphoribosyl pyrophosphate	[no description available]	low	0	0	5-O-phosphono-D-ribofuranosyl diphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite
1-phenethylamine	[no description available]	low	0	0	phenylethylamine	human metabolite
methylcyclohexane	[no description available]	low	0	0	cycloalkane; volatile organic compound	aprotic solvent; human metabolite; plant metabolite
undecanoic acid	[no description available]	low	0	0	medium-chain fatty acid; straight-chain saturated fatty acid	antifungal agent; human metabolite
1-tridecanol	[no description available]	low	0	0	long-chain primary fatty alcohol; tridecanol	bacterial metabolite; human metabolite; plant metabolite
stearyl alcohol	[no description available]	low	0	0	long-chain primary fatty alcohol; octadecanol	algal metabolite; human metabolite; plant metabolite
acetol	[no description available]	low	0	0	methyl ketone; primary alcohol; primary alpha-hydroxy ketone; propanones	Escherichia coli metabolite; human metabolite; mouse metabolite
2-methylbutanoic acid	[no description available]	low	0	0	methylbutyric acid	bacterial metabolite; human metabolite
isopropyl palmitate	[no description available]	low	0	0	fatty acid ester; isopropyl ester	human metabolite
20-alpha-dihydroprogesterone	[no description available]	low	0	0	20-hydroxypregn-4-en-3-one	human metabolite; mouse metabolite
homoarginine	[no description available]	low	0	0	homoarginine; L-lysine derivative; non-proteinogenic L-alpha-amino acid	biomarker; EC 3.1.3.1 (alkaline phosphatase) inhibitor; human metabolite; rat metabolite; xenobiotic metabolite
dibenzo(a,l)pyrene	[no description available]	low	0	0	ortho- and peri-fused polycyclic arene	human metabolite; mutagen
diiodotyrosine	[no description available]	low	0	0	diiodotyrosine; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite
3-methoxytyrosine	[no description available]	low	0	0	aromatic L-alpha-amino acid zwitterion; L-tyrosine derivative; monomethoxybenzene; non-proteinogenic L-alpha-amino acid	human metabolite
4-hydroxyphenyllactic acid	[no description available]	low	0	0	2-hydroxy carboxylic acid; phenols	bacterial metabolite; human metabolite
4-methylcatechol	[no description available]	low	0	0	methylcatechol	antioxidant; carcinogenic agent; hapten; human metabolite; plant metabolite
epitestosterone	[no description available]	low	0	0	17alpha-hydroxy steroid; 3-oxo-Delta(4) steroid; androstanoid	androgen antagonist; human metabolite
indican	[no description available]	low	0	0	aryl sulfate; indoles	human metabolite
suberic acid	[no description available]	low	0	0	alpha,omega-dicarboxylic acid; dicarboxylic fatty acid	human metabolite
hexadecanedioic acid	[no description available]	low	0	0	alpha,omega-dicarboxylic acid; dicarboxylic fatty acid	human metabolite
androstenediol	[no description available]	low	0	0	17beta-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid	androgen; human metabolite; mouse metabolite; radiation protective agent
dihydrotestosterone	[no description available]	low	0	0	17beta-hydroxy steroid; 17beta-hydroxyandrostan-3-one; 3-oxo-5alpha-steroid	androgen; Daphnia magna metabolite; human metabolite; mouse metabolite
aceturic acid	[no description available]	low	0	0	N-acetyl-amino acid; N-acylglycine	human metabolite
myristic acid	[no description available]	low	0	0	long-chain fatty acid; straight-chain saturated fatty acid	algal metabolite; Daphnia magna metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite
lignoceric acid	[no description available]	low	0	0	straight-chain saturated fatty acid; very long-chain fatty acid	Daphnia tenebrosa metabolite; human metabolite; plant metabolite; volatile oil component
18-hydroxycorticosterone	[no description available]	low	0	0	11beta-hydroxy steroid; 18-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo steroid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
2-hydroxybutyric acid	[no description available]	low	0	0	2-hydroxy monocarboxylic acid; hydroxybutyric acid	algal metabolite; human metabolite
3-methylhexane	[no description available]	low	0	0	alkane; volatile organic compound	human metabolite
2-hydroxyphenylacetic acid	[no description available]	low	0	0	hydroxy monocarboxylic acid; phenols	human metabolite; mouse metabolite
5-methyl-2-furfural	[no description available]	low	0	0	aldehyde; furans	EC 2.2.1.6 (acetolactate synthase) inhibitor; flavouring agent; human metabolite; Maillard reaction product
2-hexanol	[no description available]	low	0	0	hexanol; secondary alcohol	human metabolite; plant metabolite; semiochemical
1,1,3,3-tetramethylurea	[no description available]	low	0	0	ureas	human metabolite
dodecanedioic acid	[no description available]	low	0	0	alpha,omega-dicarboxylic acid; dicarboxylic fatty acid	EC 1.1.1.1 (alcohol dehydrogenase) inhibitor; human metabolite
2'-deoxyadenosine	[no description available]	low	0	0	purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
1-pentene-3-one	[no description available]	low	0	0	enone	flavouring agent; genotoxin; human metabolite; plant metabolite
9,10-epoxystearic acid	[no description available]	low	0	0	epoxystearic acid	human metabolite
5-hydroxyindole	[no description available]	low	0	0	hydroxyindoles	human metabolite
beta-hydroxymyristic acid	[no description available]	low	0	0	3-hydroxy fatty acid; 3-hydroxy monocarboxylic acid; long-chain fatty acid	bacterial metabolite; human metabolite
perillaldehyde	[no description available]	low	0	0	aldehyde; olefinic compound	human metabolite; mouse metabolite; volatile oil component
tricosanoic acid	[no description available]	low	0	0	straight-chain saturated fatty acid; very long-chain fatty acid	Daphnia magna metabolite; human metabolite; plant metabolite
uridine diphosphate glucuronic acid	[no description available]	low	0	0	UDP-D-glucuronic acid	Escherichia coli metabolite; human metabolite; mouse metabolite
tetrahydropapaveroline	[no description available]	low	0	0	benzylisoquinoline alkaloid; benzyltetrahydroisoquinoline; isoquinolinol	human metabolite
cyclic cmp	[no description available]	low	0	0	3',5'-cyclic pyrimidine nucleotide	human metabolite
3,3',5'-triiodothyronine	[no description available]	low	0	0	iodothyronine	human metabolite
limonene	[no description available]	low	0	0	cycloalkene; p-menthadiene	human metabolite
estetrol	[no description available]	low	0	0	15alpha-hydroxy steroid; 16alpha-hydroxy steroid; 17beta-hydroxy steroid; 3-hydroxy steroid; steroid hormone	estrogen receptor agonist; estrogen; human metabolite; human xenobiotic metabolite; oral contraceptive
iron	[no description available]	low	0	0	divalent metal cation; iron cation; monoatomic dication	cofactor; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
1-methyladenosine	[no description available]	low	0	0	methyladenosine	human metabolite
nonanal	[no description available]	low	0	0	medium-chain fatty aldehyde; n-alkanal; saturated fatty aldehyde	human metabolite; plant metabolite
dimethylacetamide	[no description available]	low	0	0	acetamides; monocarboxylic acid amide	human metabolite
norsalsolinol	[no description available]	low	0	0	isoquinolinol	animal metabolite; apoptosis inducer; human metabolite; marine metabolite
2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline	[no description available]	low	0	0	isoquinolinol; tertiary amino compound	human metabolite; neurotoxin; rat metabolite
d-lactic acid	[no description available]	low	0	0	2-hydroxypropanoic acid	Escherichia coli metabolite; human metabolite
xanthosine	[no description available]	low	0	0	purines D-ribonucleoside; xanthosines	Escherichia coli metabolite; human metabolite; mouse metabolite
5-methylcytosine	[no description available]	low	0	0	methylcytosine; pyrimidines	human metabolite
deoxyuridine triphosphate	[no description available]	low	0	0	deoxyuridine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-triphosphate	Arabidopsis thaliana metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite
homocitrulline	[no description available]	low	0	0	amino acid zwitterion; L-lysine derivative; non-proteinogenic L-alpha-amino acid; ureas	human metabolite; mouse metabolite
cholesteryl sulfate	[no description available]	low	0	0	steroid sulfate	human metabolite
2'-deoxycytidine 5'-triphosphate	[no description available]	low	0	0	2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-triphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
25-hydroxycholesterol	[no description available]	low	0	0	25-hydroxy steroid; oxysterol	human metabolite
aica ribonucleotide	[no description available]	low	0	0	1-(phosphoribosyl)imidazolecarboxamide; aminoimidazole	cardiovascular drug; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
n-acetylserine	[no description available]	low	0	0	acetyl-L-serine; N-acetyl-L-amino acid	human metabolite
o-4-methylthymine	[no description available]	low	0	0	aromatic ether; methylthymine	human metabolite
tetraiodothyroacetic acid	[no description available]	low	0	0	2-halophenol; aromatic ether; iodophenol; monocarboxylic acid	apoptosis inducer; human metabolite; thyroid hormone
omega-aminocaprylic acid	[no description available]	low	0	0	medium-chain fatty acid; omega-amino fatty acid	human metabolite
parabanic acid	[no description available]	low	0	0	hydracid; imidazolidinone	human metabolite
n-acetyl-l-arginine	[no description available]	low	0	0	N-acetyl-L-amino acid	human metabolite
cystine	[no description available]	low	0	0	cystine zwitterion; cystine; L-cysteine derivative; non-proteinogenic L-alpha-amino acid	EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
6-methyladenine	[no description available]	low	0	0	6-alkylaminopurine; methyladenine	human metabolite
hydracrylic acid	[no description available]	low	0	0	3-hydroxy monocarboxylic acid; omega-hydroxy-short-chain fatty acid	Escherichia coli metabolite; human metabolite
hordenine	[no description available]	low	0	0	phenethylamine alkaloid	human metabolite; mouse metabolite
4-methoxyestradiol	[no description available]	low	0	0	17beta-hydroxy steroid; 3-hydroxy steroid; aromatic ether; phenols	estrogen; human metabolite; rat metabolite
ubiquinone-o	[no description available]	low	0	0	ubiquinones	Escherichia coli metabolite; human metabolite
n-acetylhistamine	[no description available]	low	0	0	acetamides; imidazoles	human metabolite
indole-3-carboxylic acid	[no description available]	low	0	0	indol-3-yl carboxylic acid	bacterial metabolite; human metabolite
5-hydroxymethylcytosine	[no description available]	low	0	0	aminopyrimidine; aromatic primary alcohol; nucleobase analogue; pyrimidone	human metabolite; mouse metabolite
n-acetylglutamic acid	[no description available]	low	0	0	N-acetyl-L-amino acid; N-acyl-L-glutamic acid	human metabolite; Saccharomyces cerevisiae metabolite
2,5-dihydroxybenzaldehyde	[no description available]	low	0	0	dihydroxybenzaldehyde	human metabolite; mouse metabolite; Penicillium metabolite
2-ketopentanoic acid	[no description available]	low	0	0	2-oxo monocarboxylic acid; oxopentanoic acid	human metabolite
hydroxyindoleacetaldehyde	[no description available]	low	0	0	hydroxyindoles; indoleacetaldehyde	human metabolite; mouse metabolite
5-hydroxymethyluracil	[no description available]	low	0	0	primary alcohol; pyrimidone	human metabolite
12-hydroxydodecanoic acid	[no description available]	low	0	0	omega-hydroxy-medium-chain fatty acid	human metabolite
decane-1,2-diol	[no description available]	low	0	0	glycol; volatile organic compound	anti-inflammatory agent; antioxidant; human metabolite
4-nitrophenyl sulfate	[no description available]	low	0	0	aryl sulfate; C-nitro compound	human metabolite
glucose-1,6-bisphosphate	[no description available]	low	0	0	D-glucose 1,6-bisphosphate	Escherichia coli metabolite; human metabolite
biotinamide	[no description available]	low	0	0	biotins; monocarboxylic acid amide	human metabolite
3,4-dihydroxymandelic acid	[no description available]	low	0	0	2-hydroxy monocarboxylic acid; catechols	antioxidant; drug metabolite; human metabolite; mouse metabolite
3-hydroxymandelic acid	[no description available]	low	0	0	2-hydroxy monocarboxylic acid; phenols	human metabolite
17-alpha-hydroxypregnenolone	[no description available]	low	0	0	17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; hydroxypregnenolone; tertiary alpha-hydroxy ketone	human metabolite; mouse metabolite
cholest-4-en-3-one	[no description available]	low	0	0	3-oxo-Delta(4) steroid; cholestanoid	human metabolite; plant metabolite
2-pinene oxide	[no description available]	low	0	0	epoxide; pinane monoterpenoid	bacterial xenobiotic metabolite; fragrance; human metabolite
1-methylhistidine	[no description available]	medium	0	0	L-histidine derivative; non-proteinogenic L-alpha-amino acid; zwitterion	human metabolite
3-hydroxybutyric acid	[no description available]	low	0	0	3-hydroxybutyric acid; ketone body	fungal metabolite; human metabolite; pheromone
testosterone acetate	[no description available]	low	0	0	3-oxo-Delta(4) steroid; androstanoid; sterol ester	human metabolite
phenylacetylglutamine	[no description available]	low	0	0	N(2)-phenylacetylglutamine	human metabolite
5beta-pregnane-3,20-dione	[no description available]	low	0	0	20-oxo steroid; 3-oxo-5beta-steroid; C21-steroid	human metabolite; mouse metabolite
zymosterol	[no description available]	low	0	0	3beta-sterol; cholestanoid	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
5-alpha-dihydroprogesterone	[no description available]	low	0	0	20-oxo steroid; 3-oxo-5alpha-steroid; C21-steroid hormone	human metabolite; progestogen
n-epsilon-acetyllysine	[no description available]	low	0	0	acetyl-L-lysine; amino acid zwitterion; N(6)-acyl-L-lysine	human metabolite
2-hydroxyhexadecanoic acid	[no description available]	low	0	0	2-hydroxy fatty acid; hydroxypalmitic acid	human metabolite
19-oxo-delta(4) androstene-3,17-dione	[no description available]	low	0	0	17-oxo steroid; 19-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid; steroid aldehyde	human metabolite
gamma-glutamylglutamate	[no description available]	low	0	0	dipeptide	human metabolite
n(alpha)-acetyllysine	[no description available]	low	0	0	acetyl-L-lysine; amino acid zwitterion	human metabolite
5,6-dihydrothymine	[no description available]	low	0	0	pyrimidone	human metabolite; metabolite; mouse metabolite
gamma-glutamyltyrosine	[no description available]	low	0	0	dicarboxylic acid; dipeptide; phenols; primary amino compound; secondary carboxamide	human metabolite
cholest-5-ene-3 beta,26-diol	[no description available]	low	0	0	26-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; oxysterol	EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite
2-hydroxyisovaleric acid	[no description available]	low	0	0	2-hydroxy monocarboxylic acid	human metabolite
zymostenol	[no description available]	low	0	0	3beta-sterol; cholestanoid	human metabolite; mouse metabolite
16-hydroxydehydroepiandrosterone	[no description available]	low	0	0	16alpha-hydroxy steroid; 17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid; secondary alpha-hydroxy ketone	human metabolite; mouse metabolite
cortisol 21-sulfate	[no description available]	low	0	0	11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 3-oxo-Delta(4) steroid; cortisol ester; steroid sulfate; tertiary alpha-hydroxy ketone	human metabolite
1,2-distearoylphosphatidylethanolamine	[no description available]	low	0	0	phosphatidylethanolamine zwitterion; phosphatidylethanolamine	human metabolite
hydrogen sulfite	[no description available]	low	0	0	sulfur oxoanion	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
aflatoxin b1-2,3-oxide	[no description available]	low	0	0	aflatoxin	human metabolite
fructose 2,6-diphosphate	[no description available]	low	0	0	D-fructofuranose 2,6-bisphosphate	human metabolite; mouse metabolite
3,3'-diiodothyronine	[no description available]	low	0	0	3,3'-diiodothyronine; amino acid zwitterion	human metabolite
l-lactic acid	[no description available]	low	0	0	(2S)-2-hydroxy monocarboxylic acid; 2-hydroxypropanoic acid	Escherichia coli metabolite; human metabolite
testosterone 17-glucosiduronate	[no description available]	low	0	0	3-oxo steroid; beta-D-glucosiduronic acid; enone; steroid glucosiduronic acid	human metabolite
androsterone glucuronide	[no description available]	low	0	0	beta-D-glucosiduronic acid; steroid glucosiduronic acid	human metabolite; metabolite; mouse metabolite
selenomethylselenocysteine	[no description available]	low	0	0	non-proteinogenic alpha-amino acid; selenocysteines	antineoplastic agent; human metabolite
1,5(10)-estradiene-3,4,17-trione	[no description available]	low	0	0	17-oxo steroid; 3-oxo-Delta(1) steroid; orthoquinones	human metabolite
estrone-3-glucuronide	[no description available]	low	0	0	17-oxo steroid; beta-D-glucosiduronic acid; steroid glucosiduronic acid	human metabolite; mouse metabolite
3,4-dihydroxyphenylacetaldehyde	[no description available]	low	0	0	alpha-CH2-containing aldehyde; catechols; phenylacetaldehydes	Escherichia coli metabolite; human metabolite; mouse metabolite
1-hydroxyethyl radical	[no description available]	low	0	0	organic anion	human metabolite; Saccharomyces cerevisiae metabolite
(20s)-20-hydroxycholesterol	[no description available]	low	0	0	20-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; oxysterol	human metabolite; mouse metabolite
deoxyhypusine	[no description available]	low	0	0	L-lysine derivative; non-proteinogenic L-alpha-amino acid	human metabolite
3,7,12-trihydroxycoprostanic acid	[no description available]	low	0	0	12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; cholestanoic acid; hydroxy monocarboxylic acid	human metabolite
triiodothyronine sulfate	[no description available]	low	0	0	aryl sulfate; O-sulfoamino acid	human metabolite
3,7,12-trihydroxycholestan-26-oic acid	[no description available]	low	0	0	12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; hydroxy monocarboxylic acid; steroid acid	human metabolite
erythrose 4-phosphate	[no description available]	low	0	0	erythrose phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
n(8)-acetylspermidine	[no description available]	low	0	0	acetylspermidine	Escherichia coli metabolite; human metabolite
7 alpha-hydroxy-4-cholesten-3-one	[no description available]	low	0	0	3-oxo-Delta(4) steroid; 7alpha-hydroxy steroid; cholestanoid	human metabolite; mouse metabolite
pristanic acid	[no description available]	low	0	0	branched-chain saturated fatty acid; long-chain fatty acid; methyl-branched fatty acid	human metabolite
27-hydroxycholesterol	[no description available]	low	0	0	26-hydroxycholesterol	apoptosis inducer; human metabolite; mouse metabolite; neuroprotective agent
3-carboxy-4-methyl-5-propyl-2-furanpropionic acid	[no description available]	low	0	0	dicarboxylic acid; furoic acid	human metabolite; uremic toxin
dehydroalanine	[no description available]	low	0	0	2,3-dehydroamino acid; alpha,beta-unsaturated monocarboxylic acid; amino acid zwitterion; enamine; non-proteinogenic alpha-amino acid	alkylating agent; human metabolite; mouse metabolite
3-c-methylerythritol	[no description available]	low	0	0	tetritol	human metabolite
succinylacetoacetate	[no description available]	low	0	0	alpha,omega-dicarboxylic acid; beta-diketone	human metabolite
isoursodeoxycholic acid	[no description available]	low	0	0	dihydroxy-5beta-cholanic acid	human metabolite
mannitol-1-phosphate	[no description available]	low	0	0	alditol 1-phosphate; hexitol phosphate	Escherichia coli metabolite; human metabolite
kinetensin	[no description available]	low	0	0	oligopeptide	histamine releasing agent; human metabolite
estra-1(10),4-diene-2,3,17-trione	[no description available]	low	0	0	17-oxo steroid; 3-oxo-Delta(4) steroid; orthoquinones	human metabolite
2'-deoxycytidine diphosphate	[no description available]	low	0	0	2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-diphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite
n-methylserotonin	[no description available]	low	0	0	phenols; tryptamines	human metabolite; plant metabolite
3,4-dihydroxybutanoic acid	[no description available]	low	0	0	3-hydroxy fatty acid; omega-hydroxy-short-chain fatty acid	human metabolite
n-palmitoylglycine	[no description available]	low	0	0	fatty amide; N-acylglycine 16:0	human metabolite; marine metabolite
gamma-glutamyl-leucine	[no description available]	low	0	0	glutamyl-L-amino acid	human metabolite
ribulose	[no description available]	low	0	0	ribulose	Escherichia coli metabolite; human metabolite
3,4-dihydroxyphenylglycolaldehyde	[no description available]	low	0	0	catechols; hydroxyaldehyde	human metabolite; mouse metabolite; neurotoxin
androsterone sulfate	[no description available]	low	0	0	17-oxo steroid; androstanoid; steroid sulfate	human metabolite; mouse metabolite
3,7,12-trihydroxycoprostane	[no description available]	low	0	0	12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid	human metabolite; mouse metabolite
saccharopine	[no description available]	low	0	0	amino acid opine; L-lysine derivative	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
allysine	[no description available]	low	0	0	allysine; amino acid zwitterion; aminoadipate semialdehyde; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
orotidylic acid	[no description available]	low	0	0	pyrimidine ribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
allocholic acid	[no description available]	low	0	0	12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; allo-bile acid; C24-steroid	human metabolite; marine metabolite; rat metabolite
beta-ureidoisobutyric acid	[no description available]	low	0	0	ureidocarboxylic acid	human metabolite; mouse metabolite
kynurenine	[no description available]	low	0	0	amino acid zwitterion; kynurenine; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
nicotinate ribonucleoside	[no description available]	low	0	0	ammonium betaine	human metabolite
n(6)-(n-threonylcarbonyl)adenosine	[no description available]	low	0	0	L-threonine derivative; N-(adenosin-N(6)-ylcarbonyl)threonine	Escherichia coli metabolite; human metabolite
sedoheptulose 7-phosphate	[no description available]	low	0	0	ketoheptose phosphate; sedoheptulose derivative	Escherichia coli metabolite; human metabolite; mouse metabolite
histidinol	[no description available]	low	0	0	amino alcohol; imidazoles	EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitor; Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
thiocysteine	[no description available]	low	0	0	amino acid zwitterion; S-substituted L-cysteine	human metabolite; mouse metabolite
nicotinic acid adenine dinucleotide	[no description available]	low	0	0	nicotinic acid dinucleotide	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol	[no description available]	low	0	0	3beta-sterol	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
bradykinin, des-phe(8)-des-arg(9)-	[no description available]	low	0	0	oligopeptide	human metabolite; rat metabolite
isobutyryl-1-carnitine	[no description available]	low	0	0	methyl-branched fatty acyl-L-carnitine; O-isobutyrylcarnitine; saturated fatty acyl-L-carnitine	human metabolite
threitol	[no description available]	low	0	0	threitol	human metabolite
aceglutamide	[no description available]	low	0	0	N-acetyl-L-amino acid; N(2)-acetylglutamine; N(2)-acyl-L-glutamine	human metabolite
2'-deoxyadenosine triphosphate	[no description available]	low	0	0	2'-deoxyadenosine 5'-phosphate; purine 2'-deoxyribonucleoside 5'-diphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
2-ethylhydracrylic acid	[no description available]	low	0	0	branched-chain saturated fatty acid; hydroxy fatty acid; short-chain fatty acid	human metabolite
2-methyl-3-oxovaleric acid	[no description available]	low	0	0	3-oxo monocarboxylic acid	human metabolite
monoacetylcadaverine	[no description available]	low	0	0	acetamides; N-substituted cadaverine; primary amino compound; secondary carboxamide	human metabolite
beta-citrylglutamic acid	[no description available]	low	0	0	N-acyl-L-glutamic acid; tetracarboxylic acid	human metabolite; iron chelator
maltotriose	[no description available]	low	0	0	maltotriose trisaccharide	human metabolite
cholestane-3,7,12,26-tetrol	[no description available]	low	0	0	12alpha-hydroxy steroid; 26-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid	human metabolite; mouse metabolite
beta-leucine	[no description available]	low	0	0	beta-amino acid	human metabolite
2-methylbutyrylglycine	[no description available]	low	0	0	N-acylglycine	human metabolite
neurotensin (1-8)	[no description available]	low	0	0	peptide zwitterion; peptide	human metabolite
erythritol	[no description available]	low	0	0	butane-1,2,3,4-tetrol	antioxidant; human metabolite; plant metabolite
5 alpha-androstane-3 beta,17 beta-diol	[no description available]	low	0	0	17beta-hydroxy steroid; 3beta-hydroxy steroid; androstane-3,17-diol	Daphnia magna metabolite; human metabolite
cholesteryl palmitate	[no description available]	low	0	0	cholesteryl ester	human metabolite; mouse metabolite
lanosterol	[no description available]	low	0	0	14alpha-methyl steroid; 3beta-sterol; tetracyclic triterpenoid	bacterial metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
2-hydroxyestradiol	[no description available]	low	0	0	17beta-hydroxy steroid; 2-hydroxy steroid	carcinogenic agent; human metabolite; metabolite; mouse metabolite; prodrug
5-hydroxyisourate	[no description available]	low	0	0	oxopurine	human metabolite; mouse metabolite
5-formyluracil	[no description available]	low	0	0	aldehyde; nucleobase analogue; pyrimidone	human metabolite; mutagen
5'-methylthioadenosine	[no description available]	low	0	0	thioadenosine	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
5'-deoxyadenosine	[no description available]	low	0	0	5'-deoxyribonucleoside; adenosines	Escherichia coli metabolite; human metabolite; mouse metabolite
isomaltose	[no description available]	low	0	0	glycosylglucose	human metabolite; metabolite; mouse metabolite
glucosamine 6-phosphate	[no description available]	low	0	0	2-amino-2-deoxy-D-glucopyranose 6-phosphate	human metabolite; Saccharomyces cerevisiae metabolite
dopaquinone	[no description available]	low	0	0	1,2-benzoquinones; amino acid zwitterion; L-phenylalanine derivative	human metabolite; mouse metabolite
tryptophanamide	[no description available]	low	0	0	amino acid amide; tryptophan derivative	human metabolite
5-diphosphomevalonic acid	[no description available]	low	0	0	carboxyalkyl phosphate	human metabolite; mouse metabolite
7-dehydrocholesterol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; cholestanoid; Delta(5),Delta(7)-sterol	human metabolite; mouse metabolite
desmosterol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C27-steroid; cholestanoid	human metabolite; mouse metabolite
n'-formylkynurenine	[no description available]	low	0	0	amino acid zwitterion; N-formylkynurenine; non-proteinogenic amino acid derivative; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
fuculose 1-phosphate	[no description available]	low	0	0	deoxyaldohexose phosphate	human metabolite
nicotinamide-beta-riboside	[no description available]	low	0	0	N-glycosylnicotinamide; pyridine nucleoside	geroprotector; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
4-hydroxyphenylacetaldehyde	[no description available]	low	0	0	alpha-CH2-containing aldehyde; phenylacetaldehydes	Escherichia coli metabolite; human metabolite; mouse metabolite
trimethyllysine	[no description available]	low	0	0	alpha-amino-acid cation	human metabolite; mouse metabolite
inositol 3,4-bisphosphate	[no description available]	low	0	0	myo-inositol bisphosphate	human metabolite; mouse metabolite
n-acetylglucosamine-1-phosphate	[no description available]	low	0	0	N-acetyl-D-glucosamine 1-phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
24,25-dihydrolanosterol	[no description available]	low	0	0	3beta-sterol; tetracyclic triterpenoid	human metabolite; mouse metabolite
2-hydroxyestrone	[no description available]	low	0	0	2-hydroxy steroid; catechols	human metabolite
2-methoxyestrone	[no description available]	low	0	0	17-oxo steroid; 3-hydroxy steroid; alicyclic ketone; aromatic ether; phenolic steroid; phenols	human metabolite; mouse metabolite
estradiol-3-glucuronide	[no description available]	low	0	0	17beta-hydroxy steroid; beta-D-glucosiduronic acid; steroid glucosiduronic acid	human metabolite; mouse metabolite
acetyl adenylate	[no description available]	low	0	0	5'-acylphosphoadenosin	human metabolite; mouse metabolite
epiandrosterone	[no description available]	low	0	0	17-oxo steroid; 3beta-hydroxy steroid; androstanoid	androgen; human metabolite
4,4-dimethylcholesta-8,14,24-trienol	[no description available]	low	0	0	3beta-sterol; Delta(14) steroid	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
enkephalin, methionine	[no description available]	low	0	0	pentapeptide; peptide zwitterion	analgesic; antineoplastic agent; delta-opioid receptor agonist; human metabolite; mu-opioid receptor agonist
dephosphocoenzyme a	[no description available]	low	0	0	adenosine 5'-phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
3-hydroxy-3-methylglutaryl-coenzyme a	[no description available]	low	0	0	3-hydroxy-3-methylglutaryl-CoA; 3-hydroxy fatty acyl-CoA	human metabolite; mouse metabolite
ribothymidine	[no description available]	low	0	0	methyluridine	antigen; Escherichia coli metabolite; human metabolite
docosahexaenoate	[no description available]	low	0	0	docosahexaenoic acid; omega-3 fatty acid	algal metabolite; antineoplastic agent; Daphnia tenebrosa metabolite; human metabolite; mouse metabolite; nutraceutical
tetragastrin	[no description available]	low	0	0	peptidyl amide; tetrapeptide	anxiogenic; human metabolite
hexanoyl-coenzyme a	[no description available]	low	0	0	medium-chain fatty acyl-CoA	Escherichia coli metabolite; human metabolite; mouse metabolite
tyrosine o-sulfate	[no description available]	low	0	0	aryl sulfate; L-tyrosine derivative; O-sulfoamino acid	human metabolite
thyrotropin-releasing hormone	[no description available]	low	0	0	peptide hormone; tripeptide	human metabolite
n-methylproline	[no description available]	low	0	0	L-alpha-amino acid zwitterion; L-proline derivative; tertiary amino compound	human metabolite; plant metabolite
citraconic acid	[no description available]	low	0	0	dicarboxylic acid; dicarboxylic fatty acid	human metabolite
flavin mononucleotide	[no description available]	low	0	0	flavin mononucleotide; vitamin B2	bacterial metabolite; coenzyme; cofactor; human metabolite; mouse metabolite
mannose 1-phosphate	[no description available]	low	0	0	mannose phosphate	fundamental metabolite; human metabolite
glycerylphosphorylcholine	[no description available]	low	0	0	phosphocholines; sn-glycerol 3-phosphates	Escherichia coli metabolite; human metabolite; mouse metabolite; neuroprotective agent; parasympatholytic; Saccharomyces cerevisiae metabolite
cholesterol acetate	[no description available]	low	0	0	acetate ester; cholesteryl ester	human metabolite
1,6-anhydro-beta-glucopyranose	[no description available]	low	0	0	anhydrohexose	Arabidopsis thaliana metabolite; biomarker; human metabolite
hydroxylysine	[no description available]	low	0	0	5-hydroxylysine; hydroxy-L-lysine	human metabolite
isobutyryl-coenzyme a	[no description available]	low	0	0	methyl-branched fatty acyl-CoA; short-chain fatty acyl-CoA	human metabolite; mouse metabolite
galactaric acid	[no description available]	low	0	0	hexaric acid	human metabolite
dihydroxycoprostane	[no description available]	low	0	0	3alpha-hydroxy steroid; 7alpha-hydroxy steroid	human metabolite; mouse metabolite
angiotensin i, ile(5)-	[no description available]	low	0	0	angiotensin; peptide zwitterion	human metabolite; neurotransmitter agent
fructosyl-glycine	[no description available]	low	0	0	fructosamine; glycine derivative; glyco-amino acid	human metabolite
arachidoyl-coenzyme a	[no description available]	low	0	0	11,12-saturated fatty acyl-CoA; long-chain fatty acyl-CoA	human metabolite
lignoceroyl-coenzyme a	[no description available]	low	0	0	very long-chain fatty acyl-CoA	human metabolite; Saccharomyces cerevisiae metabolite
5-hydroxybenzimidazole	[no description available]	low	0	0	benzimidazoles; phenols	bacterial metabolite; human metabolite; rat metabolite
n-carbamylglutamate	[no description available]	low	0	0	glutamic acid derivative; ureas	human metabolite
citramalate	[no description available]	low	0	0	dicarboxylic acid dianion	human metabolite; plant metabolite
leukotriene a4	[no description available]	low	0	0	epoxy fatty acid; leukotriene; long-chain fatty acid; oxylipin; polyunsaturated fatty acid	human metabolite; mouse metabolite; plant metabolite
prostaglandin b1	[no description available]	low	0	0	prostaglandins B	human metabolite
psychosine	[no description available]	low	0	0	glycosylsphingoid	human metabolite
ubiquinone 9	[no description available]	low	0	0	ubiquinones	antioxidant; human metabolite
prostaglandin f2beta	[no description available]	low	0	0	prostaglandins Fbeta	human metabolite
8,11,14-eicosatrienoic acid	[no description available]	low	0	0	fatty acid 20:3; long-chain fatty acid	fungal metabolite; human metabolite; nutraceutical
15-keto-5,8,11,13-eicosatetraenoic acid	[no description available]	low	0	0	oxoicosatetraenoic acid	human metabolite
15-hydroxy-5,8,11,13-eicosatetraenoic acid	[no description available]	low	0	0	(5Z,8Z,11Z,13E)-15-HETE	human metabolite; mouse metabolite
prostaglandin a2	[no description available]	low	0	0	prostaglandins A	human metabolite
prostaglandin b2	[no description available]	low	0	0	prostaglandins B	human metabolite
prostaglandin g2	[no description available]	low	0	0	prostaglandins G	human metabolite; mouse metabolite
9-deoxy-delta-9-prostaglandin d2	[no description available]	low	0	0	prostaglandins J	human metabolite
11-dehydro-thromboxane b2	[no description available]	low	0	0	thromboxane	human metabolite
lipoxin a4	[no description available]	low	0	0	hydroxy polyunsaturated fatty acid; lipoxin; long-chain fatty acid	human metabolite; metabolite
gamma-linolenic acid	[no description available]	low	0	0	linolenic acid; omega-6 fatty acid	human metabolite; mouse metabolite; plant metabolite
prostaglandin e3	[no description available]	low	0	0	prostaglandins E	human metabolite
leukotriene f-4	[no description available]	low	0	0	dipeptide; leukotriene; organic sulfide	human metabolite
prostaglandin f1	[no description available]	low	0	0	prostaglandins Falpha	human metabolite
previtamin d(3)	[no description available]	low	0	0	D3 vitamins; hydroxy seco-steroid; seco-cholestane; secondary alcohol	human metabolite
brassicasterol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; ergostanoid; phytosterols	algal metabolite; animal metabolite; biomarker; EC 1.3.1.72 (Delta(24)-sterol reductase) inhibitor; human metabolite; marine metabolite; plant metabolite; sterol biosynthesis inhibitor
retinoyl beta-glucuronide	[no description available]	low	0	0	glucuronic acids; retinoid	human metabolite
prostaglandin d3	[no description available]	low	0	0	prostaglandins D	human metabolite
tocotrienol, alpha	[no description available]	low	0	0	tocotrienol; vitamin E	ferroptosis inhibitor; human metabolite; neuroprotective agent; plant metabolite
menatetrenone	[no description available]	low	0	0	menaquinone	anti-inflammatory agent; antioxidant; bone density conservation agent; human metabolite; neuroprotective agent
phthioic acid	[no description available]	low	0	0	branched-chain saturated fatty acid; fatty acid 26:0; methyl-branched fatty acid; very long-chain fatty acid	Aspergillus metabolite; human metabolite
2-decenoic acid	[no description available]	low	0	0	2-decenoic acid	human metabolite
9,11-linoleic acid	[no description available]	low	0	0	octadeca-9,11-dienoic acid	anti-inflammatory agent; antiatherogenic agent; antineoplastic agent; apoptosis inducer; bacterial xenobiotic metabolite; human metabolite
9-hydroxy-10,12-octadecadienoic acid	[no description available]	low	0	0	HODE; octadecadienoic acid	human metabolite; metabolite; mouse metabolite; plant metabolite
17-phenyltrinorprostaglandin e2	[no description available]	low	0	0	alicyclic ketone; beta-hydroxy ketone; hydroxy monocarboxylic acid; olefinic compound; oxo monocarboxylic acid; prostanoid; secondary alcohol	human metabolite; prostaglandin receptor agonist
thromboxane b3	[no description available]	low	0	0	thromboxanes B	human metabolite; mouse metabolite
12-hydroxy-5,8,10,14-eicosatetraenoic acid	[no description available]	low	0	0	(5Z,8Z,10E,14Z)-12-hydroxyicosatetraenoic acid; HETE	human metabolite; pro-angiogenic agent
20-hydroxy-5,8,11,14-eicosatetraenoic acid	[no description available]	low	0	0	HETE; hydroxy monocarboxylic acid	human metabolite; mouse metabolite
5-oxo-6,8,11,14-eicosatetraenoic acid	[no description available]	low	0	0	oxoicosatetraenoic acid	human metabolite; immunomodulator; mouse metabolite
8-isoprostaglandin e2	[no description available]	low	0	0	cyclic ketone; diol; prostanoid; secondary alcohol	bronchoconstrictor agent; human metabolite; rat metabolite; vasoconstrictor agent
oleylamide	[no description available]	low	0	0	primary fatty amide	human metabolite; plant metabolite
monolinolein	[no description available]	low	0	0	1-acylglycerol 18:2; rac-1-monoacylglycerol	antiviral agent; human metabolite; plant metabolite
1,25-dihydroxy-24-oxo-vitamin d3	[no description available]	low	0	0	hydroxycalciol; oxocalciol; tertiary alpha-hydroxy ketone	human metabolite
calcifediol	[no description available]	low	0	0	D3 vitamins; diol; hydroxycalciol	bone density conservation agent; human metabolite; metabolite; mouse metabolite; nutraceutical
vitamin k 1	[no description available]	low	0	0	phylloquinones; vitamin K	cofactor; human metabolite; plant metabolite
cerium	[no description available]	low	0	0	CE(18:2); cholesteryl octadeca-9,12-dienoate	human metabolite; mouse metabolite
xylulose	[no description available]	low	0	0	xylulose	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
11-dehydrocorticosterone	[no description available]	low	0	0	11-oxo steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; corticosteroid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
1-butyl oleate	[no description available]	low	0	0	fatty acid ester	human metabolite
erucyl amide	[no description available]	low	0	0	13-docosenamide	EC 3.1.1.7 (acetylcholinesterase) inhibitor; human metabolite; mammalian metabolite; plant metabolite; rat metabolite
vitamin mk 8	[no description available]	low	0	0	menaquinone	Escherichia coli metabolite; human metabolite
2,3-oxidosqualene	[no description available]	low	0	0	2,3-epoxysqualene	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
2-keto-4-hydroxyglutarate	[no description available]	low	0	0	oxo dicarboxylate	human metabolite; Saccharomyces cerevisiae metabolite
deoxyribose	[no description available]	low	0	0	deoxypentose	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
iditol	[no description available]	low	0	0	iditol	fungal metabolite; human metabolite
glutamate	[no description available]	low	0	0	glutamate(1-); polar amino acid zwitterion	EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor; human metabolite; Saccharomyces cerevisiae metabolite
cerotate	[no description available]	low	0	0	fatty acid anion 26:0; omega-methyl fatty acid anion; very long-chain fatty acid anion	human metabolite; Saccharomyces cerevisiae metabolite
adenosine triphosphate	[no description available]	low	0	0	nucleoside 5'-triphoshate(4-)	cofactor; fundamental metabolite; human metabolite
docosapentaenoic acid	[no description available]	low	0	0	docosapentaenoic acid; omega-3 fatty acid	algal metabolite; human metabolite
3-methylbutyrylcarnitine	[no description available]	low	0	0	C5-acylcarnitine	human metabolite
hexanoylcarnitine	[no description available]	low	0	0	hexanoate ester; O-acylcarnitine	human metabolite
linoleamide	[no description available]	low	0	0	primary fatty amide	human metabolite
13-cis-retinal	[no description available]	low	0	0	retinal	human metabolite
4-hydroxyretinoic acid	[no description available]	low	0	0	retinoid; secondary allylic alcohol	human metabolite
4-oxo-2-nonenal	[no description available]	low	0	0	enal; enone	human metabolite
20,22-dihydroxycholesterol	[no description available]	low	0	0	20-hydroxy steroid; 22-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; cholestanoid; oxysterol	human metabolite; mouse metabolite
biotinate	[no description available]	low	0	0	monocarboxylic acid anion; vitamin B7	cofactor; human metabolite; Saccharomyces cerevisiae metabolite
fuculose	[no description available]	low	0	0	deoxyketohexose	Escherichia coli metabolite; human metabolite
gamma-glutamylvaline	[no description available]	low	0	0	glutamyl-L-amino acid	human metabolite
ophthalmic acid	[no description available]	low	0	0	L-glutamine derivative	biomarker; human metabolite
acetylcarnitine	[no description available]	low	0	0	O-acetylcarnitine; saturated fatty acyl-L-carnitine	human metabolite; Saccharomyces cerevisiae metabolite
adenosine diphosphate	[no description available]	low	0	0	nucleoside 5'-diphosphate(3-)	fundamental metabolite; human metabolite
cyclic amp	[no description available]	low	0	0	organophosphate oxoanion	human metabolite; Saccharomyces cerevisiae metabolite
1,23,25-trihydroxyvitamin d3	[no description available]	low	0	0	D3 vitamins; hydroxy seco-steroid; hydroxycalciol; tetrol	human metabolite
arachidonoylserotonin	[no description available]	low	0	0	N-acylserotonin; phenols	anti-inflammatory agent; anticonvulsant; antioxidant; capsaicin receptor antagonist; EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor; human metabolite; signalling molecule
3-hydroxyproline	[no description available]	low	0	0	3-hydroxyproline; amino acid zwitterion; D-proline derivative	bacterial metabolite; human metabolite
cytidine diphosphate choline	[no description available]	low	0	0	nucleotide-(amino alcohol)s; phosphocholines	human metabolite; mouse metabolite; neuroprotective agent; psychotropic drug; Saccharomyces cerevisiae metabolite
octanoylcarnitine	[no description available]	low	0	0	O-octanoylcarnitine; saturated fatty acyl-L-carnitine	human metabolite
palmitoylcarnitine	[no description available]	low	0	0	O-palmitoylcarnitine; saturated fatty acyl-L-carnitine	EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; human metabolite; mouse metabolite
cyclic 3',5'-thymidine monophosphate	[no description available]	low	0	0	3',5'-cyclic pyrimidine nucleotide	human metabolite
pristanal	[no description available]	low	0	0	2-methyl-branched fatty aldehyde; saturated fatty aldehyde	human metabolite
lanosten-3-ol-32-al	[no description available]	low	0	0	14alpha-formyl steroid; 3beta-sterol; tetracyclic triterpenoid	human metabolite
adenosine monophosphate	[no description available]	low	0	0	nucleoside 5'-monophosphate(2-)	cofactor; fundamental metabolite; human metabolite
cob(ii)alamin	[no description available]	low	0	0	cobalamin	cofactor; human metabolite
3-hydroxy-3-methyl-hexanoic acid	[no description available]	low	0	0	3-hydroxy monocarboxylic acid; volatile organic compound	human metabolite
uridine diphosphate	[no description available]	low	0	0	nucleoside 5'-diphosphate(3-)	human metabolite; Saccharomyces cerevisiae metabolite
n-acetylgalactosamine-1-phosphate	[no description available]	low	0	0	D-galactosamine 1-phosphate	human metabolite
1-phospho-5-s-methylthioribulose	[no description available]	low	0	0	organophosphate oxoanion	human metabolite; Saccharomyces cerevisiae metabolite
10-nitro-oleic acid	[no description available]	low	0	0	long-chain fatty acid; monounsaturated fatty acid; nitro fatty acid	human metabolite
ticrynafen	[no description available]	low	0	0	monocarboxylic acid anion; organophosphate oxoanion	human metabolite
s-(1,2-dicarboxyethyl)cysteine	[no description available]	low	0	0	L-cysteine thioether; tricarboxylic acid	human metabolite; Maillard reaction product
apelin-13 peptide	[no description available]	low	0	0	oligopeptide	antihypertensive agent; autophagy inhibitor; biomarker; human metabolite; neuroprotective agent
p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe	[no description available]	low	0	0	polypeptide	apoptosis inhibitor; human metabolite; neuroprotective agent
inositol 1,3,4-trisphosphate	[no description available]	low	0	0	inositol phosphate oxoanion	human metabolite
diadenosine tetraphosphate	[no description available]	low	0	0	organophosphate oxoanion	human metabolite; Saccharomyces cerevisiae metabolite
2-ketoarginine	[no description available]	medium	0	0	2-oxo monocarboxylic acid; zwitterion	human metabolite; mouse metabolite
adenosine diphosphate glucose	[no description available]	low	0	0	NDP-alpha-D-glucose(2-); ribonucleoside 5'-diphosphate-alpha-D-glucose(2-)	human metabolite
nicotinate mononucleotide	[no description available]	low	0	0	organophosphate oxoanion	human metabolite; Saccharomyces cerevisiae metabolite
oleoylcarnitine	[no description available]	low	0	0	monounsaturated fatty acyl-L-carnitine	glycine transporter 2 inhibitor; human metabolite
6-phosphogluconolactone	[no description available]	low	0	0	organophosphate oxoanion	human metabolite; Saccharomyces cerevisiae metabolite
3-hydroxyisovalerylcarnitine	[no description available]	low	0	0	O-acylcarnitine	human metabolite
angiotensin i	[no description available]	low	0	0	angiotensin; peptide zwitterion	antihypertensive agent; cardioprotective agent; human metabolite; rat metabolite
9-PAHSA	[no description available]	low	0	0	FAHFA; long-chain fatty acid	anti-inflammatory agent; human metabolite; hypoglycemic agent
lugdunin	[no description available]	low	0	0	homodetic cyclic peptide; indoles; macrocycle; peptide antibiotic; thiazolidines	human metabolite; rat metabolite
deoxyinosine	[no description available]	low	0	0	purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
deoxyguanosine triphosphate	[no description available]	low	0	0	deoxyguanosine phosphate; guanyl deoxyribonucleotide; purine 2'-deoxyribonucleoside 5'-triphosphate	Arabidopsis thaliana metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
7,8-dihydroneopterin	[no description available]	low	0	0	dihydropterin; neopterins	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
deoxyinosine monophosphate	[no description available]	low	0	0	deoxyinosine phosphate; purine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite
guanosine diphosphate mannose	[no description available]	low	0	0	GDP-D-mannose	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite
inosine triphosphate	[no description available]	low	0	0	inosine phosphate; purine ribonucleoside 5'-triphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
sapropterin	[no description available]	low	0	0	5,6,7,8-tetrahydrobiopterin	coenzyme; cofactor; diagnostic agent; human metabolite
dyspropterin	[no description available]	low	0	0	biopterins; tetrahydropterin	human metabolite; metabolite; mouse metabolite
8-nitroguanosine 3',5'-cyclic monophosphate	[no description available]	low	0	0	3',5'-cyclic purine nucleotide; C-nitro compound	biomarker; Brassica napus metabolite; human metabolite; signalling molecule
n(2),n(2)-dimethylguanosine	[no description available]	low	0	0	methylguanosine	human metabolite
creatinine	[no description available]	low	0	0	imidazolidinone; lactam	diagnostic agent; human metabolite
apelin-12 peptide	[no description available]	low	0	0	oligopeptide	biomarker; human blood serum metabolite; human metabolite; neuroprotective agent
benzyl alcohol	[no description available]	low	0	0	benzyl alcohols	antioxidant; fragrance; metabolite; solvent
pqq cofactor	[no description available]	low	0	0	orthoquinones; pyrroloquinoline cofactor; tricarboxylic acid	anti-inflammatory agent; antioxidant; cofactor; water-soluble vitamin (role)
vanillin	[no description available]	low	0	0	benzaldehydes; monomethoxybenzene; phenols	anti-inflammatory agent; anticonvulsant; antioxidant; flavouring agent; plant metabolite
isopentenyl pyrophosphate	[no description available]	low	0	0	prenol phosphate	antigen; antioxidant; epitope; Escherichia coli metabolite; mouse metabolite; phosphoantigen
7,8-dihydroxyflavone	[no description available]	low	0	0	dihydroxyflavone	antidepressant; antineoplastic agent; antioxidant; plant metabolite; tropomyosin-related kinase B receptor agonist
benphothiamine	[no description available]	low	0	0	aminopyrimidine; formamides; organic phosphate; thioester	antioxidant; immunological adjuvant; nutraceutical; protective agent; provitamin B1
caffeic acid	[no description available]	low	0	0	catechols; hydroxycinnamic acid	antioxidant; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; plant metabolite
carcinine	[no description available]	low	0	0	beta-alanine derivative; imidazoles; monocarboxylic acid amide; organonitrogen compound; organooxygen compound	antioxidant; crustacean metabolite
resveratrol	[no description available]	low	0	0	polyphenol; resorcinols; stilbenol	antioxidant; geroprotector; glioma-associated oncogene inhibitor; phytoalexin
sulforaphane	[no description available]	low	0	0	isothiocyanate; sulfoxide	antineoplastic agent; antioxidant; EC 3.5.1.98 (histone deacetylase) inhibitor; plant metabolite
2,2'-thiodiethanol	[no description available]	low	0	0	aliphatic sulfide; diol	antineoplastic agent; antioxidant; metabolite; solvent
troglitazone	[no description available]	low	0	0	chromanes; thiazolidinone	anticoagulant; anticonvulsant; antineoplastic agent; antioxidant; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; hypoglycemic agent; platelet aggregation inhibitor; vasodilator agent
zonisamide	[no description available]	low	0	0	1,2-benzoxazoles; sulfonamide	anticonvulsant; antioxidant; central nervous system drug; protective agent; T-type calcium channel blocker
medroxyprogesterone acetate	[no description available]	low	0	0	20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; corticosteroid; steroid ester	adjuvant; androgen; antineoplastic agent; antioxidant; female contraceptive drug; inhibitor; progestin; synthetic oral contraceptive
n,n'-diphenyl-4-phenylenediamine	[no description available]	low	0	0	N-substituted diamine; secondary amino compound	antioxidant
2,4-di-tert-butylphenol	[no description available]	low	0	0	alkylbenzene; phenols	antioxidant; bacterial metabolite; marine metabolite
lactobionic acid	[no description available]	low	0	0	disaccharide	antioxidant
methyl gallate	[no description available]	low	0	0	gallate ester	anti-inflammatory agent; antioxidant; plant metabolite
gamma-terpinene	[no description available]	low	0	0	cyclohexadiene; monoterpene	antioxidant; human xenobiotic metabolite; plant metabolite; volatile oil component
n-isopropyl-n-phenyl-4-phenylenediamine	[no description available]	low	0	0	N-substituted diamine	allergen; antioxidant
3-tert-butyl-4-hydroxyanisole	[no description available]	low	0	0	aromatic ether; phenols	antioxidant; human xenobiotic metabolite
ethyl vanillin	[no description available]	low	0	0	aromatic ether; benzaldehydes; phenols	antioxidant; flavouring agent
triethylenediamine	[no description available]	low	0	0	bridged compound; diamine; saturated organic heterobicyclic parent; tertiary amino compound	antioxidant; catalyst; reagent
thymoquinone	[no description available]	low	0	0	1,4-benzoquinones	adjuvant; anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; cardioprotective agent; plant metabolite
4-hydroxyphenylethanol	[no description available]	low	0	0	phenols	anti-arrhythmia drug; antioxidant; cardiovascular drug; fungal metabolite; geroprotector; plant metabolite; protective agent
4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol	[no description available]	low	0	0	terpineol; tertiary alcohol	anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; antiparasitic agent; apoptosis inducer; plant metabolite; volatile oil component
diphenylamine	[no description available]	low	0	0	aromatic amine; bridged diphenyl fungicide; secondary amino compound	antifungal agrochemical; antioxidant; carotogenesis inhibitor; EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor; ferroptosis inhibitor; radical scavenger
dihydroferulic acid	[no description available]	low	0	0	guaiacols; monocarboxylic acid; phenylpropanoid	antioxidant; human xenobiotic metabolite; mouse metabolite; plant metabolite
diallyl trisulfide	[no description available]	low	0	0	organic trisulfide	anti-inflammatory agent; antilipemic drug; antineoplastic agent; antioxidant; antiprotozoal drug; apoptosis inducer; estrogen receptor antagonist; insecticide; platelet aggregation inhibitor; vasodilator agent
methyl vanillate	[no description available]	low	0	0	aromatic ether; benzoate ester; phenols	antioxidant; plant metabolite
zingerone	[no description available]	low	0	0	methyl ketone; monomethoxybenzene; phenols	anti-inflammatory agent; antiemetic; antioxidant; flavouring agent; fragrance; plant metabolite; radiation protective agent
butylated hydroxytoluene	[no description available]	low	0	0	phenols	antioxidant; ferroptosis inhibitor; food additive; geroprotector
2,6-di-tert-butylphenol	[no description available]	low	0	0	alkylbenzene; phenols	antioxidant
silybin	[no description available]	low	0	0	aromatic ether; benzodioxine; flavonolignan; polyphenol; secondary alpha-hydroxy ketone	antineoplastic agent; antioxidant; hepatoprotective agent; plant metabolite
oltipraz	[no description available]	low	0	0	1,2-dithiole; pyrazines	angiogenesis modulating agent; antimutagen; antineoplastic agent; antioxidant; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; neurotoxin; protective agent; schistosomicide drug
gallocatechol	[no description available]	low	0	0	gallocatechin	antioxidant; metabolite; radical scavenger
salvin	[no description available]	low	0	0	abietane diterpenoid; carbotricyclic compound; catechols; monocarboxylic acid	angiogenesis modulating agent; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; food preservative; HIV protease inhibitor; plant metabolite
7-hydroxydehydroepiandrosterone	[no description available]	low	0	0	17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; 7alpha-hydroxy steroid; androstanoid	anti-inflammatory agent; antioxidant; estrogen; human xenobiotic metabolite; rat metabolite
pinocembrin	[no description available]	low	0	0	(2S)-flavan-4-one; dihydroxyflavanone	antineoplastic agent; antioxidant; metabolite; neuroprotective agent; vasodilator agent
epicatechin	[no description available]	low	0	0	catechin; polyphenol	antioxidant
gallocatechol	[no description available]	low	0	0	catechin; flavan-3,3',4',5,5',7-hexol	antioxidant; food component; plant metabolite
vexibinol	[no description available]	low	0	0	(2S)-flavan-4-one; 4'-hydroxyflavanones; tetrahydroxyflavanone	antimalarial; antimicrobial agent; antioxidant; plant metabolite
pinobanksin	[no description available]	low	0	0	secondary alpha-hydroxy ketone; trihydroxyflavanone	antimutagen; antioxidant; metabolite
brazilin	[no description available]	low	0	0	catechols; organic heterotetracyclic compound; tertiary alcohol	anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; apoptosis inducer; biological pigment; hepatoprotective agent; histological dye; NF-kappaB inhibitor; plant metabolite
madecassic acid	[no description available]	low	0	0	monocarboxylic acid; pentacyclic triterpenoid; tetrol	antioxidant; plant metabolite
fangchinoline	[no description available]	low	0	0	aromatic ether; bisbenzylisoquinoline alkaloid; macrocycle	anti-HIV-1 agent; anti-inflammatory agent; antineoplastic agent; antioxidant; neuroprotective agent; plant metabolite
corilagin	[no description available]	low	0	0	ellagitannin; gallate ester	antihypertensive agent; antioxidant; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; non-steroidal anti-inflammatory drug
arjunolic acid	[no description available]	low	0	0	hydroxy monocarboxylic acid; pentacyclic triterpenoid	antibacterial agent; antifungal agent; antioxidant; metabolite
maslinic acid	[no description available]	low	0	0	dihydroxy monocarboxylic acid; pentacyclic triterpenoid	anti-inflammatory agent; antineoplastic agent; antioxidant; plant metabolite
ethyl protocatechuate	[no description available]	low	0	0	catechols; ethyl ester	antibacterial agent; antioxidant; apoptosis inducer; EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; plant metabolite
3,4-dihydroxyphenylethanol	[no description available]	low	0	0	catechols; primary alcohol	antineoplastic agent; antioxidant; metabolite
eriocitrin	[no description available]	low	0	0	3'-hydroxyflavanones; 4'-hydroxyflavanones; disaccharide derivative; flavanone glycoside; rutinoside; trihydroxyflavanone	antioxidant
sugiol	[no description available]	low	0	0	abietane diterpenoid; carbotricyclic compound; cyclic terpene ketone; meroterpenoid; phenols	antineoplastic agent; antioxidant; antiviral agent; plant metabolite; radical scavenger
sesaminol	[no description available]	low	0	0	benzodioxoles; furofuran; organic hydroxy compound	antioxidant; plant metabolite
wr 1065	[no description available]	low	0	0	alkanethiol; diamine	antioxidant; drug metabolite; radiation protective agent
cafestol	[no description available]	low	0	0	diterpenoid; furans; organic heteropentacyclic compound; primary alcohol; tertiary alcohol	angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; hypoglycemic agent; plant metabolite
kahweol	[no description available]	low	0	0	diterpenoid; furans; organic heteropentacyclic compound; primary alcohol; tertiary alcohol	angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; plant metabolite
procyanidin b2	[no description available]	low	0	0	biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin	antioxidant; metabolite
proanthocyanidin a2	[no description available]	low	0	0	hydroxyflavan; proanthocyanidin	angiogenesis modulating agent; anti-HIV agent; antioxidant; metabolite
swertisin	[no description available]	low	0	0	dihydroxyflavone; flavone C-glycoside; monomethoxyflavone; monosaccharide derivative; polyphenol	adenosine A1 receptor antagonist; anti-inflammatory agent; antioxidant; hypoglycemic agent; plant metabolite
rubiadin	[no description available]	low	0	0	dihydroxyanthraquinone	antibacterial agent; antioxidant; hepatoprotective agent; plant metabolite
cyanidin	[no description available]	low	0	0	5-hydroxyanthocyanidin	antioxidant; metabolite; neuroprotective agent
ovothiol c	[no description available]	low	0	0	aryl thiol; L-alpha-amino acid zwitterion; L-histidine derivative	antioxidant; marine metabolite; radical scavenger
ovothiol a	[no description available]	low	0	0	aryl thiol; L-alpha-amino acid zwitterion; L-histidine derivative; non-proteinogenic L-alpha-amino acid	antioxidant; marine metabolite; radical scavenger
2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman	[no description available]	low	0	0	benzopyran	antioxidant
eckol	[no description available]	low	0	0	phlorotannin	antioxidant; metabolite
procyanidin b3	[no description available]	low	0	0	biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin	anti-inflammatory agent; antioxidant; EC 2.3.1.48 (histone acetyltransferase) inhibitor; metabolite
schizandrin b	[no description available]	low	0	0	aromatic ether; cyclic acetal; organic heterotetracyclic compound; oxacycle; tannin	anti-asthmatic agent; anti-inflammatory agent; antilipemic drug; antioxidant; apoptosis inhibitor; hepatoprotective agent; nephroprotective agent; neuroprotective agent; plant metabolite
acrovestone	[no description available]	low	0	0	acetophenones; aromatic ether; olefinic compound; polyphenol	antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite
4'-demethyldesoxypodophyllotoxin	[no description available]	low	0	0	furonaphthodioxole; gamma-lactone; lignan; methoxybenzenes; phenols	antineoplastic agent; antioxidant; immunosuppressive agent; plant metabolite
ampelopsin	[no description available]	low	0	0	dihydromyricetin; secondary alpha-hydroxy ketone	antineoplastic agent; antioxidant; metabolite
secoxyloganin	[no description available]	low	0	0	beta-D-glucoside; dicarboxylic acid monoester; enoate ester; methyl ester; monosaccharide derivative; pyrans; secoiridoid glycoside	anti-allergic agent; antioxidant; plant metabolite
pectolinarin	[no description available]	low	0	0	dimethoxyflavone; disaccharide derivative; glycosyloxyflavone; monohydroxyflavanone; rutinoside	anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; plant metabolite
procyanidin C1	[no description available]	low	0	0	hydroxyflavan; polyphenol; proanthocyanidin	anti-inflammatory agent; antioxidant; EC 1.17.3.2 (xanthine oxidase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; lipoxygenase inhibitor; metabolite
2,5-dihydroxybenzyl alcohol	[no description available]	low	0	0	aromatic primary alcohol; phenols	antineoplastic agent; antioxidant; apoptosis inhibitor; fungal metabolite
sitosterol, (3beta)-isomer	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C29-steroid; phytosterols; stigmastane sterol	anticholesteremic drug; antioxidant; mouse metabolite; plant metabolite; sterol methyltransferase inhibitor
methyl 3,4-dihydroxybenzoate	[no description available]	low	0	0	catechols; methyl ester	antioxidant; neuroprotective agent; plant metabolite
3,4-dihydroxyphenylpropionic acid	[no description available]	low	0	0	(dihydroxyphenyl)propanoic acid	antioxidant; human xenobiotic metabolite
allose	[no description available]	low	0	0	allopyranose; D-allose	antioxidant
peonidin	[no description available]	low	0	0	5-hydroxyanthocyanidin	antineoplastic agent; antioxidant; apoptosis inducer; metabolite
ginsenoside re	[no description available]	low	0	0	12beta-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid	anti-inflammatory agent; antineoplastic agent; antioxidant; nephroprotective agent; neuroprotective agent; plant metabolite
notoginsenoside r1	[no description available]	low	0	0	12beta-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid	antioxidant; apoptosis inducer; neuroprotective agent; phytoestrogen; plant metabolite
stevioside	[no description available]	low	0	0	beta-D-glucoside; bridged compound; diterpene glycoside; ent-kaurane diterpenoid; tetracyclic diterpenoid	anti-inflammatory agent; antineoplastic agent; antioxidant; hypoglycemic agent; plant metabolite; sweetening agent
davidigenin	[no description available]	low	0	0	dihydrochalcones; polyphenol	anti-allergic agent; anti-asthmatic agent; antioxidant; metabolite
genipin	[no description available]	low	0	0	iridoid monoterpenoid	anti-inflammatory agent; antioxidant; apoptosis inhibitor; cross-linking reagent; hepatotoxic agent; uncoupling protein inhibitor
isonaringin	[no description available]	low	0	0	(2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; rutinoside	anti-inflammatory agent; antioxidant; metabolite
knipholone	[no description available]	low	0	0	aromatic ketone; dihydroxyanthraquinone; methoxybenzenes; methyl ketone; polyphenol; resorcinols	antineoplastic agent; antioxidant; antiplasmodial drug; leukotriene antagonist; metabolite
alpha bitter acid	[no description available]	low	0	0	aromatic ketone; cyclic ketone; diketone; tertiary alpha-hydroxy ketone; triol	antibacterial drug; antioxidant; cyclooxygenase 2 inhibitor; metabolite
solasodine	[no description available]	low	0	0	alkaloid antibiotic; azaspiro compound; hemiaminal ether; oxaspiro compound; sapogenin; steroid alkaloid	anticonvulsant; antifungal agent; antiinfective agent; antioxidant; antipyretic; antispermatogenic agent; apoptosis inducer; cardiotonic drug; central nervous system depressant; diuretic; immunomodulator; plant metabolite; teratogenic agent
petunidin-3-glucoside	[no description available]	low	0	0	anthocyanin cation; aromatic ether; beta-D-glucoside	antioxidant; metabolite
equilenin	[no description available]	low	0	0	17-oxo steroid; 3-hydroxy steroid	antioxidant; mammalian metabolite
lycopene	[no description available]	low	0	0	acyclic carotene	antioxidant; plant metabolite
pallidol	[no description available]	low	0	0	carbopolycyclic compound; polyphenol; stilbenoid	antifungal agent; antioxidant; plant metabolite
piperlactam s	[no description available]	low	0	0	alkaloid; aromatic ether; gamma-lactam; organic heterotetracyclic compound; phenols	anti-inflammatory agent; antioxidant; plant metabolite
2-hydroxycinnamic acid	[no description available]	low	0	0	2-coumaric acid; phenols	antioxidant; metabolite
beta-ionone	[no description available]	low	0	0	ionone	antioxidant; fragrance
isoferulic acid	[no description available]	low	0	0	ferulic acids	antioxidant; biomarker; metabolite
aurapten	[no description available]	low	0	0	coumarins; monoterpenoid	antihypertensive agent; antineoplastic agent; antioxidant; apoptosis inducer; dopaminergic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; gamma-secretase modulator; gastrointestinal drug; hepatoprotective agent; matrix metalloproteinase inhibitor; neuroprotective agent; plant metabolite; PPARalpha agonist; vulnerary
ferrostatin-1	[no description available]	low	0	0	ethyl ester; primary arylamine; substituted aniline	antifungal agent; antioxidant; ferroptosis inhibitor; neuroprotective agent; radiation protective agent; radical scavenger
fraxetin	[no description available]	low	0	0	aromatic ether; hydroxycoumarin	anti-inflammatory agent; antibacterial agent; antimicrobial agent; antioxidant; apoptosis inducer; apoptosis inhibitor; Arabidopsis thaliana metabolite; hepatoprotective agent; hypoglycemic agent
quercetin 3-o-glucuronide	[no description available]	low	0	0	beta-D-glucosiduronic acid; quercetin O-glycoside	antidepressant; antioxidant; metabolite
sinapine	[no description available]	low	0	0	acylcholine	antioxidant; photosynthetic electron-transport chain inhibitor; plant metabolite
7,3'-dihydroxy-4'-methoxyisoflavone	[no description available]	low	0	0	4'-methoxyisoflavones; 7-hydroxyisoflavones	antioxidant; metabolite
quercitrin	[no description available]	low	0	0	alpha-L-rhamnoside; monosaccharide derivative; quercetin O-glycoside; tetrahydroxyflavone	antileishmanial agent; antioxidant; EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite
retinol palmitate	[no description available]	low	0	0	all-trans-retinyl ester; retinyl palmitate	antioxidant; Escherichia coli metabolite; human xenobiotic metabolite
luteolin-7-glucoside	[no description available]	low	0	0	beta-D-glucoside; glycosyloxyflavone; monosaccharide derivative; trihydroxyflavone	antioxidant; plant metabolite
chrysoeriol	[no description available]	low	0	0	monomethoxyflavone; trihydroxyflavone	antineoplastic agent; antioxidant; metabolite
quercetin 3-o-glucopyranoside	[no description available]	low	0	0	beta-D-glucoside; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone	antineoplastic agent; antioxidant; antipruritic drug; bone density conservation agent; geroprotector; histamine antagonist; osteogenesis regulator; plant metabolite
zeaxanthin	[no description available]	low	0	0	carotenol	antioxidant; bacterial metabolite; cofactor
butein	[no description available]	low	0	0	chalcones; polyphenol	antineoplastic agent; antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; geroprotector; hypoglycemic agent; plant metabolite; radiosensitizing agent; tyrosine kinase inhibitor
gardenia yellow	[no description available]	low	0	0	diester; disaccharide derivative; diterpenoid	antioxidant; food colouring; histological dye; plant metabolite
cryptoxanthins	[no description available]	low	0	0	carotenol	antioxidant; biomarker; plant metabolite; provitamin A
esculetin	[no description available]	low	0	0	hydroxycoumarin	antioxidant; plant metabolite; ultraviolet filter
esculin	[no description available]	low	0	0	beta-D-glucoside; hydroxycoumarin	antioxidant; metabolite
oleuropein	[no description available]	low	0	0	beta-D-glucoside; catechols; diester; methyl ester; pyrans; secoiridoid glycoside	anti-inflammatory agent; antihypertensive agent; antineoplastic agent; antioxidant; apoptosis inducer; NF-kappaB inhibitor; nutraceutical; plant metabolite; radical scavenger
chrysin	[no description available]	low	0	0	7-hydroxyflavonol; dihydroxyflavone	anti-inflammatory agent; antineoplastic agent; antioxidant; EC 2.7.11.18 (myosin-light-chain kinase) inhibitor; hepatoprotective agent; plant metabolite
diosmetin	[no description available]	low	0	0	3'-hydroxyflavonoid; monomethoxyflavone; trihydroxyflavone	angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; bone density conservation agent; cardioprotective agent; plant metabolite; tropomyosin-related kinase B receptor agonist; vasodilator agent
diosmin	[no description available]	low	0	0	dihydroxyflavanone; disaccharide derivative; glycosyloxyflavone; monomethoxyflavone; rutinoside	anti-inflammatory agent; antioxidant
fisetin	[no description available]	low	0	0	3'-hydroxyflavonoid; 7-hydroxyflavonol; tetrahydroxyflavone	anti-inflammatory agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; metabolite; plant metabolite
demethylbellidifolin	[no description available]	low	0	0	tetrol; xanthones	antioxidant; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite; mutagen; radical scavenger
hispidulin	[no description available]	low	0	0	monomethoxyflavone; trihydroxyflavone	anti-inflammatory agent; anticonvulsant; antineoplastic agent; antioxidant; apoptosis inducer; plant metabolite
mangostin	[no description available]	low	0	0	aromatic ether; phenols; xanthones	antimicrobial agent; antineoplastic agent; antioxidant; plant metabolite
1,2,8-trihydroxy-6-methoxyxanthone	[no description available]	low	0	0	aromatic ether; polyphenol; xanthones	antioxidant; plant metabolite
norwogonin	[no description available]	low	0	0	trihydroxyflavone	antioxidant; metabolite
orientin	[no description available]	low	0	0	3'-hydroxyflavonoid; C-glycosyl compound; tetrahydroxyflavone	antioxidant; metabolite
patuletin	[no description available]	low	0	0	flavonols; monomethoxyflavone; pentahydroxyflavone	analgesic; antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; metabolite
quercetagetin	[no description available]	low	0	0	flavonols; hexahydroxyflavone	antioxidant; antiviral agent; plant metabolite
rhamnetin	[no description available]	low	0	0	monomethoxyflavone; tetrahydroxyflavone	anti-inflammatory agent; antioxidant; metabolite
robustaflavone	[no description available]	low	0	0	biflavonoid; hydroxyflavone; ring assembly	anti-HBV agent; antineoplastic agent; antioxidant; metabolite
tamarixetin	[no description available]	low	0	0	7-hydroxyflavonol; monomethoxyflavone; tetrahydroxyflavone	antioxidant; metabolite
coumestrol	[no description available]	low	0	0	coumestans; delta-lactone; polyphenol	anti-inflammatory agent; antioxidant; plant metabolite
astringin	[no description available]	low	0	0	beta-D-glucoside; monosaccharide derivative; polyphenol; stilbenoid	antineoplastic agent; antioxidant; metabolite
polydatin	[no description available]	low	0	0	beta-D-glucoside; monosaccharide derivative; polyphenol; stilbenoid	anti-arrhythmia drug; antioxidant; geroprotector; hepatoprotective agent; metabolite; nephroprotective agent; potassium channel modulator
pterostilbene	[no description available]	low	0	0	diether; methoxybenzenes; stilbenol	anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; hypoglycemic agent; neuroprotective agent; neurotransmitter; plant metabolite; radical scavenger
quercimeritrin	[no description available]	low	0	0	beta-D-glucoside; flavonols; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone	antioxidant; metabolite
quercetin-3-o-sophoroside	[no description available]	low	0	0	sophoroside; tetrahydroxyflavone	antioxidant; plant metabolite
gamma-tocotrienol	[no description available]	low	0	0	tocotrienol; vitamin E	antineoplastic agent; antioxidant; apoptosis inducer; hepatoprotective agent; plant metabolite; radiation protective agent
nk 104	[no description available]	low	0	0	calcium salt; statin (synthetic)	antioxidant
pitavastatin	[no description available]	low	0	0	cyclopropanes; dihydroxy monocarboxylic acid; monofluorobenzenes; quinolines; statin (synthetic)	antioxidant
rosmarinic acid	[no description available]	low	0	0	carboxylic ester; monocarboxylic acid; phenylpropanoid; polyphenol	antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; non-steroidal anti-inflammatory drug; peripheral nervous system drug; plant metabolite; serine proteinase inhibitor
cannabigerol	[no description available]	low	0	0	phytocannabinoid; resorcinols	anti-inflammatory agent; antibacterial agent; antioxidant; appetite enhancer; cannabinoid receptor agonist; neuroprotective agent; plant metabolite
quadrangularin a	[no description available]	low	0	0	indanes; polyphenol; stilbenoid	antioxidant; plant metabolite
isosalipurposide	[no description available]	low	0	0	beta-D-glucoside; chalcones; monosaccharide derivative; resorcinols	antioxidant; plant metabolite
icariin	[no description available]	low	0	0	flavonols; glycosyloxyflavone	antioxidant; bone density conservation agent; EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; phytoestrogen
sappanchalcone	[no description available]	low	0	0	catechols; chalcones; monomethoxybenzene	anti-allergic agent; anti-inflammatory agent; antioxidant; metabolite
4-methylesculetin	[no description available]	low	0	0	hydroxycoumarin	anti-inflammatory agent; antioxidant; hyaluronan synthesis inhibitor
spiraeoside	[no description available]	low	0	0	beta-D-glucoside; flavonols; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone	antineoplastic agent; antioxidant; plant metabolite
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside	[no description available]	low	0	0	beta-D-glucoside; resorcinols; stilbenoid	anti-inflammatory agent; antioxidant; apoptosis inhibitor; cardioprotective agent; cyclooxygenase 2 inhibitor; platelet aggregation inhibitor
monomethyl fumarate	[no description available]	low	0	0	dicarboxylic acid monoester; enoate ester; methyl ester	antioxidant; drug metabolite; immunomodulator
5,4'-dihydroxy-7,3'-dimethoxyflavone	[no description available]	low	0	0	dihydroxyflavone; dimethoxyflavone	anti-allergic agent; anti-inflammatory agent; antibacterial agent; antioxidant; melanin synthesis inhibitor; plant metabolite
quercetin 3-sambubioside	[no description available]	low	0	0	disaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone	antioxidant; plant metabolite
germacrone	[no description available]	low	0	0	germacrane sesquiterpenoid; olefinic compound	androgen antagonist; anti-inflammatory agent; antifeedant; antifungal agent; antimicrobial agent; antineoplastic agent; antioxidant; antitussive; antiviral agent; apoptosis inducer; autophagy inducer; hepatoprotective agent; insecticide; neuroprotective agent; plant metabolite; volatile oil component
meso-zeaxanthin	[no description available]	low	0	0	carotenol	anti-inflammatory agent; antioxidant; human xenobiotic metabolite; marine metabolite
salvianolic acid B	[no description available]	low	0	0	1-benzofurans; catechols; dicarboxylic acid; enoate ester; polyphenol	anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; apoptosis inducer; autophagy inhibitor; cardioprotective agent; hepatoprotective agent; hypoglycemic agent; neuroprotective agent; osteogenesis regulator; plant metabolite
trilobatin	[no description available]	low	0	0	aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative	anti-inflammatory agent; antioxidant; plant metabolite; sweetening agent
capsiate	[no description available]	low	0	0	carboxylic ester; monomethoxybenzene; phenols	angiogenesis inhibitor; anti-allergic agent; anti-inflammatory agent; antioxidant; capsaicin receptor agonist; hypoglycemic agent; plant metabolite
tln 4601	[no description available]	low	0	0	dibenzodiazepine; farnesane sesquiterpenoid; olefinic compound; secondary amine; triol	antineoplastic agent; antioxidant; cathepsin L (EC 3.4.22.15) inhibitor
nigerloxin	[no description available]	low	0	0	aromatic ether; benzamides; benzoic acids; phenols; styrenes	antioxidant; Aspergillus metabolite; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; radical scavenger
7-phloroeckol	[no description available]	low	0	0	aromatic ether; phlorotannin	antioxidant; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; metabolite
aspalathin	[no description available]	low	0	0	C-glycosyl compound; catechols; dihydrochalcones; polyketide; polyphenol	antioxidant; EC 1.17.3.2 (xanthine oxidase) inhibitor; hypoglycemic agent; plant metabolite
glyceryl ferulate	[no description available]	low	0	0	1-monoglyceride; aromatic ether; enoate ester; phenols	antioxidant; plant metabolite; ultraviolet filter
(+)-dehydrodiconiferyl alcohol	[no description available]	low	0	0	dehydrodiconiferyl alcohol	antioxidant; plant metabolite
ginsenoside rb3	[no description available]	low	0	0	12beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid	antidepressant; antioxidant; cardioprotective agent; neuroprotective agent; NMDA receptor antagonist; plant metabolite
astragaloside IV	[no description available]	low	0	0	pentacyclic triterpenoid; triterpenoid saponin	anti-inflammatory agent; antioxidant; EC 4.2.1.1 (carbonic anhydrase) inhibitor; neuroprotective agent; plant metabolite; pro-angiogenic agent
1-O-feruloyl-beta-D-glucose	[no description available]	low	0	0	aromatic ether; beta-D-glucoside; cinnamate ester; phenols	antioxidant; plant metabolite
alx-0600	[no description available]	low	0	0	polypeptide	antioxidant; glucagon-like peptide-2 receptor agonist; metabolite; protective agent
pyranonigrin a	[no description available]	low	0	0	cyclic ketone; enol; gamma-lactam; pyranopyrrole; secondary alcohol	antioxidant; Aspergillus metabolite; marine metabolite
madecassoside	[no description available]	low	0	0	carboxylic ester; pentacyclic triterpenoid; trisaccharide derivative; triterpenoid saponin	anti-inflammatory agent; antioxidant; antirheumatic drug; plant metabolite; vulnerary
bacillithiol	[no description available]	low	0	0	glycoside; monosaccharide derivative; thiol	antioxidant; bacterial metabolite; cofactor
kurarinol	[no description available]	low	0	0	4'-hydroxyflavanones; monomethoxyflavanone; trihydroxyflavanone	anti-inflammatory agent; antioxidant; plant metabolite
(20R)-ginsenoside Rg3	[no description available]	low	0	0	ginsenoside; glycoside; tetracyclic triterpenoid	antioxidant; plant metabolite
oleuropein aglycone	[no description available]	low	0	0	catechols; diester; lactol; methyl ester; pyrans; secoiridoid	anti-inflammatory agent; antioxidant; mTOR inhibitor; neuroprotective agent; plant metabolite; TRPA1 channel agonist
staphyloxanthin	[no description available]	low	0	0	apo carotenoid triterpenoid; D-aldohexose derivative; fatty acid ester; triol; xanthophyll	antioxidant; biological pigment; metabolite; virulence factor
6-hydroxy-2,4,5-triaminopyrimidine	[no description available]	low	0	0	aminopyrimidine; hydroxypyrimidine	antioxidant; chromophore
liproxstatin-1	[no description available]	low	0	0	azaspiro compound; monochlorobenzenes; organic heterotricyclic compound; secondary amino compound	antioxidant; cardioprotective agent; ferroptosis inhibitor; radical scavenger
alpha-hydroxyglutarate	[no description available]	low	0	0	2-hydroxydicarboxylic acid; dicarboxylic fatty acid	metabolite; mouse metabolite
alpha-ketoadipic acid	[no description available]	low	0	0	oxo dicarboxylic acid	human urinary metabolite; mouse metabolite
n-carbamoyl-beta-alanine	[no description available]	low	0	0	beta-alanine derivative	metabolite; mouse metabolite
4-aminobutyraldehyde	[no description available]	low	0	0	aminobutanal; omega-aminoaldehyde	Escherichia coli metabolite; mouse metabolite
4-hydroxybenzaldehyde	[no description available]	low	0	0	hydroxybenzaldehyde	EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor; mouse metabolite; plant metabolite
allantoic acid	[no description available]	low	0	0	ureas	mouse metabolite; plant metabolite
aminoacetone	[no description available]	low	0	0	methyl ketone; propanones	Escherichia coli metabolite; mouse metabolite
hydrobromic acid	[no description available]	low	0	0	gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
butyraldehyde	[no description available]	low	0	0	butanals	biomarker; Escherichia coli metabolite; mouse metabolite
carbamyl phosphate	[no description available]	low	0	0	acyl monophosphate; one-carbon compound	Escherichia coli metabolite; mouse metabolite
coproporphyrinogen iii	[no description available]	low	0	0	coproporphyrinogen	Escherichia coli metabolite; mouse metabolite
1,2-dihydroxy-1,2-dihydronaphthalene	[no description available]	low	0	0	dihydronaphthalenes; naphthalenediols	bacterial xenobiotic metabolite; mouse metabolite
4-nitrophenylphosphate	[no description available]	low	0	0	aryl phosphate	mouse metabolite
n(1)-methylnicotinamide	[no description available]	low	0	0	pyridinium ion	algal metabolite; anti-inflammatory agent; human urinary metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
gamma-guanidinobutyric acid	[no description available]	medium	0	0	guanidines; monocarboxylic acid; zwitterion	fungal metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
phosphoglycolate	[no description available]	low	0	0	carboxyalkyl phosphate	Escherichia coli metabolite; mouse metabolite
hydrogen selenide	[no description available]	low	0	0	mononuclear parent hydride; selenium hydride	Escherichia coli metabolite; mouse metabolite
3,3-dimethylallyl pyrophosphate	[no description available]	low	0	0	prenol phosphate	epitope; Escherichia coli metabolite; mouse metabolite; phosphoantigen
diethyl phosphate	[no description available]	low	0	0	dialkyl phosphate	human xenobiotic metabolite; mouse metabolite
o,o-diethyl phosphorothionate	[no description available]	low	0	0	organic thiophosphate	human xenobiotic metabolite; mouse metabolite
carbonic acid	[no description available]	low	0	0	carbon oxoacid; chalcocarbonic acid	mouse metabolite
hydantoin-5-propionic acid	[no description available]	low	0	0	imidazolidine-2,4-dione; monocarboxylic acid	metabolite; mouse metabolite
hydroxymethylbilane	[no description available]	low	0	0	bilanes	Escherichia coli metabolite; mouse metabolite
lactaldehyde	[no description available]	low	0	0	hydroxyaldehyde; propanals	mouse metabolite
naphthalene	[no description available]	low	0	0	naphthalenes; ortho-fused bicyclic arene	apoptosis inhibitor; carcinogenic agent; environmental contaminant; mouse metabolite; plant metabolite; volatile oil component
hydroxide ion	[no description available]	low	0	0	oxygen hydride	mouse metabolite
4-nitrophenol	[no description available]	low	0	0	4-nitrophenols	human xenobiotic metabolite; mouse metabolite
parathion	[no description available]	low	0	0	C-nitro compound; organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; mouse metabolite
phenol	[no description available]	low	0	0	phenols	antiseptic drug; disinfectant; human xenobiotic metabolite; mouse metabolite
porphobilinogen	[no description available]	low	0	0	aralkylamino compound; dicarboxylic acid; pyrroles	Escherichia coli metabolite; metabolite; mouse metabolite
propylene glycol	[no description available]	low	0	0	glycol; propane-1,2-diols	allergen; human xenobiotic metabolite; mouse metabolite; protic solvent
pyridoxine 5-phosphate	[no description available]	low	0	0	vitamin B6 phosphate	Escherichia coli metabolite; mouse metabolite
succinic semialdehyde	[no description available]	low	0	0	aldehydic acid	Escherichia coli metabolite; mouse metabolite
tartronate semialdehyde	[no description available]	low	0	0	2-hydroxy monocarboxylic acid; 3-oxo monocarboxylic acid; aldehyde	Escherichia coli metabolite; mouse metabolite
uroporphyrinogen iii	[no description available]	low	0	0	uroporphyrinogen	Escherichia coli metabolite; mouse metabolite
adrenic acid	[no description available]	low	0	0	docosatetraenoic acid	mouse metabolite
uridine diphosphate	[no description available]	low	0	0	pyrimidine ribonucleoside 5'-diphosphate; uridine 5'-phosphate	Escherichia coli metabolite; mouse metabolite
cytidine diphosphate	[no description available]	low	0	0	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-diphosphate	Escherichia coli metabolite; mouse metabolite
uridine triphosphate	[no description available]	low	0	0	pyrimidine ribonucleoside 5'-triphosphate; uridine 5'-phosphate	Escherichia coli metabolite; mouse metabolite
cytidine triphosphate	[no description available]	low	0	0	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite
1-naphthaldehyde	[no description available]	low	0	0	naphthaldehyde	mouse metabolite
2-naphthaldehyde	[no description available]	low	0	0	naphthaldehyde	mouse metabolite
ethylene oxide	[no description available]	low	0	0	gas molecular entity; oxacycle; saturated organic heteromonocyclic parent	allergen; mouse metabolite; mutagen
vinylidene chloride	[no description available]	low	0	0	chloroethenes	carcinogenic agent; mouse metabolite; mutagen
trichloroacetaldehyde	[no description available]	low	0	0	aldehyde; organochlorine compound	mouse metabolite
trichloroacetic acid	[no description available]	low	0	0	monocarboxylic acid; organochlorine compound	carcinogenic agent; metabolite; mouse metabolite
gibberellic acid	[no description available]	low	0	0	C19-gibberellin; gibberellin monocarboxylic acid; lactone; organic heteropentacyclic compound	mouse metabolite; plant metabolite
trichloroethylene	[no description available]	low	0	0	chloroethenes	inhalation anaesthetic; mouse metabolite
1-nitronaphthalene	[no description available]	low	0	0	mononitronaphthalene	environmental contaminant; mouse metabolite
2-naphthoic acid	[no description available]	low	0	0	naphthoic acid	mouse metabolite; xenobiotic metabolite
methylphenyl carbinol	[no description available]	low	0	0	aromatic alcohol	mouse metabolite
4-hydroxyacetophenone	[no description available]	low	0	0	monohydroxyacetophenone	fungal metabolite; mouse metabolite; plant metabolite
styrene	[no description available]	low	0	0	styrenes; vinylarene; volatile organic compound	mouse metabolite; mutagen; plant metabolite
2-phenylacetamide	[no description available]	low	0	0	monocarboxylic acid amide	mouse metabolite
4-bromophenol	[no description available]	low	0	0	bromophenol	human urinary metabolite; human xenobiotic metabolite; marine metabolite; mouse metabolite; persistent organic pollutant; rat metabolite
ethylene dibromide	[no description available]	low	0	0	bromoalkane; bromohydrocarbon	algal metabolite; carcinogenic agent; fumigant; marine metabolite; mouse metabolite; mutagen
bromobenzene	[no description available]	low	0	0	bromoarene; bromobenzenes; volatile organic compound	hepatotoxic agent; mouse metabolite; non-polar solvent
2-heptanone	[no description available]	low	0	0	dialkyl ketone; methyl ketone	mouse metabolite; pheromone
2,2,2-trichloroethanol	[no description available]	low	0	0	chloroethanol	mouse metabolite
aminoimidazole carboxamide	[no description available]	low	0	0	aminoimidazole; monocarboxylic acid amide	mouse metabolite
adenosine phosphosulfate	[no description available]	low	0	0	acyl monophosphate; acyl sulfate; adenosine 5'-phosphate	Escherichia coli metabolite; mouse metabolite
fructose-1,6-diphosphate	[no description available]	low	0	0	D-fructofuranose 1,6-bisphosphate	mouse metabolite
hydroxyhydroquinone	[no description available]	low	0	0	benzenetriol	mouse metabolite
1,2-dihydroxynaphthalene	[no description available]	low	0	0	naphthalenediol	mouse metabolite
propiolaldehyde	[no description available]	low	0	0	terminal acetylenic compound; ynal	mouse metabolite
phenylphosphate	[no description available]	low	0	0	aryl phosphate	mouse metabolite
n-cyclohexylformamide	[no description available]	low	0	0	alicyclic compound; formamides	mouse metabolite
deoxycytidine monophosphate	[no description available]	low	0	0	2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; mouse metabolite
nicotinamide mononucleotide	[no description available]	low	0	0	nicotinamide mononucleotide	Escherichia coli metabolite; mouse metabolite
2'-deoxyadenosine triphosphate	[no description available]	low	0	0	2'-deoxyadenosine 5'-phosphate; purine 2'-deoxyribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite
uridine diphosphate galactose	[no description available]	low	0	0	UDP-D-galactose	mouse metabolite
1-naphthalenemethanol	[no description available]	low	0	0	naphthylmethanol	mouse metabolite
diadenosine tetraphosphate	[no description available]	low	0	0	diadenosyl tetraphosphate	Escherichia coli metabolite; mouse metabolite
d-glutamate	[no description available]	low	0	0	D-alpha-amino acid; glutamic acid	Escherichia coli metabolite; mouse metabolite
hydroiodic acid	[no description available]	low	0	0	gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
trichloroepoxyethane	[no description available]	low	0	0	epoxide	mouse metabolite
adenosine diphosphate ribose	[no description available]	low	0	0	ADP-sugar	Escherichia coli metabolite; mouse metabolite
phosphopantothenic acid	[no description available]	low	0	0	amidoalkyl phosphate	Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
cyromazine	[no description available]	low	0	0	triamino-1,3,5-triazine	mouse metabolite; triazine insecticide
thymidine 5'-triphosphate	[no description available]	low	0	0	pyrimidine 2'-deoxyribonucleoside 5'-triphosphate; thymidine phosphate	Escherichia coli metabolite; mouse metabolite
2'-deoxyuridylic acid	[no description available]	low	0	0	deoxyuridine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; metabolite; mouse metabolite
obtusifoliol	[no description available]	low	0	0	14alpha-methyl steroid; 3beta-sterol	mouse metabolite; plant metabolite
3'-cmp	[no description available]	low	0	0	cytidine 3'-phosphate; pyrimidine ribonucleoside 3'-monophosphate	Escherichia coli metabolite; metabolite; mouse metabolite
7-methylxanthine	[no description available]	low	0	0	oxopurine; purine alkaloid	human xenobiotic metabolite; mouse metabolite; plant metabolite
cifostodine	[no description available]	low	0	0	2',3'-cyclic pyrimidine nucleotide	Escherichia coli metabolite; mouse metabolite; Mycoplasma genitalium metabolite
n'-methyl-2-pyridone-5-carboxamide	[no description available]	low	0	0	methylpyridines; pyridinecarboxamide; pyridone	metabolite; mouse metabolite
1-methyluric acid	[no description available]	low	0	0	oxopurine	human xenobiotic metabolite; mouse metabolite
cyclopropylamine	[no description available]	low	0	0	primary aliphatic amine	mouse metabolite
6-hydroxynicotinic acid	[no description available]	low	0	0	monohydroxypyridine	Arabidopsis thaliana metabolite; human urinary metabolite; mouse metabolite
xanthosine 5'-triphosphate	[no description available]	low	0	0	purine ribonucleoside 5'-monophosphate; xanthosine 5'-phosphate	Escherichia coli metabolite; metabolite; mouse metabolite
2-naphthalenemethanol	[no description available]	low	0	0	naphthylmethanol	mouse metabolite; xenobiotic metabolite
xanthurenic acid 8-methyl ether	[no description available]	low	0	0	aromatic ether; monohydroxyquinoline; quinolinemonocarboxylic acid	carcinogenic agent; metabolite; mouse metabolite
glucose	[no description available]	low	0	0	D-glucopyranose	mouse metabolite
1,3,7-trimethylurate	[no description available]	low	0	0	oxopurine	human blood serum metabolite; human urinary metabolite; human xenobiotic metabolite; mouse metabolite
1-methylxanthine	[no description available]	low	0	0	1-methylxanthine	mouse metabolite
3,7-dimethyluric acid	[no description available]	low	0	0	oxopurine	metabolite; mouse metabolite
biocytin	[no description available]	low	0	0	azabicycloalkane; L-alpha-amino acid zwitterion; L-lysine derivative; monocarboxylic acid amide; non-proteinogenic L-alpha-amino acid; thiabicycloalkane; ureas	mouse metabolite
1,7-dimethyluric acid	[no description available]	low	0	0	oxopurine	human xenobiotic metabolite; mouse metabolite
24-methylenecholesterol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol	mouse metabolite
succinyl-coenzyme a	[no description available]	low	0	0	omega-carboxyacyl-CoA	Escherichia coli metabolite; inhibitor; mouse metabolite
acetoacetyl coa	[no description available]	low	0	0	3-oxo-fatty acyl-CoA	Escherichia coli metabolite; mouse metabolite
2,8-dihydroxyadenine	[no description available]	low	0	0	6-aminopurines; diol; heteroaryl hydroxy compound; oxopurine	human urinary metabolite; mammalian metabolite; mouse metabolite; nephrotoxic agent
propionyl-coenzyme a	[no description available]	low	0	0	acyl-CoA	Escherichia coli metabolite; metabolite; mouse metabolite
21-deoxycortisol	[no description available]	low	0	0	11beta-hydroxy steroid; 17alpha-hydroxy-C21-steroid; deoxycortisol; tertiary alpha-hydroxy ketone	human blood serum metabolite; mouse metabolite
stearoyl-coenzyme a	[no description available]	low	0	0	11,12-saturated fatty acyl-CoA; long-chain fatty acyl-CoA	Escherichia coli metabolite; mouse metabolite
1-hydroxyphenanthrene	[no description available]	low	0	0	phenanthrol	mouse metabolite
2,5-dihydroxypyridine	[no description available]	low	0	0	dihydroxypyridine	mouse metabolite
cerium	[no description available]	low	0	0	cholesteryl ester	mouse metabolite
6,6-dimethyl-2-methylenebicyclo(3.1.1)heptan-3-ol	[no description available]	low	0	0	carbobicyclic compound; pinane monoterpenoid; secondary alcohol	GABA modulator; mouse metabolite; plant metabolite; volatile oil component
ecgonine methyl ester	[no description available]	low	0	0	methyl ester; tertiary amino compound; tropane alkaloid	analgesic; central nervous system depressant; metabolite; mouse metabolite; opioid analgesic; peripheral nervous system drug
2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine	[no description available]	low	0	0	hydroxylamine; imidazopyridine	carcinogenic agent; genotoxin; human xenobiotic metabolite; mouse metabolite; mutagen; neurotoxin; rat metabolite
cholest-5-en-3 beta,7 alpha-diol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 7alpha-hydroxy steroid; oxysterol	mouse metabolite
s-chloromethylglutathione	[no description available]	low	0	0	organochlorine compound; S-substituted glutathione	alkylating agent; bacterial xenobiotic metabolite; mouse metabolite
5-acetylamino-6-formylamino-3-methyluracil	[no description available]	low	0	0	formamidopyrimidine	mouse metabolite
5,6-dihydroxyindole	[no description available]	low	0	0	dihydroxyindole	mouse metabolite
5,6-dihydroxy-2-indolylcarboxylic acid	[no description available]	low	0	0	dihydroxyindole	mouse metabolite
protoporphyrinogen	[no description available]	low	0	0	porphyrinogens	Escherichia coli metabolite; mouse metabolite
inositol-3,4,5,6-tetrakisphosphate	[no description available]	low	0	0	myo-inositol tetrakisphosphate	mouse metabolite
24-hydroxycholesterol	[no description available]	low	0	0	24-hydroxycholesterol	biomarker; human blood serum metabolite; mouse metabolite
phytosphingosine	[no description available]	low	0	0	amino alcohol; sphingoid; triol	mouse metabolite; Saccharomyces cerevisiae metabolite
butyryl-coenzyme a	[no description available]	low	0	0	butanoyl-CoAs	Escherichia coli metabolite; mouse metabolite
n-acetylputrescine	[no description available]	low	0	0	N-monoacetylalkane-alpha,omega-diamine; N-substituted putrescine	metabolite; mouse metabolite
cdp ethanolamine	[no description available]	low	0	0	nucleotide-(amino alcohol)s; phosphoethanolamine	mouse metabolite
galactose-1-phosphate	[no description available]	low	0	0	alpha-D-hexose 1-phosphate; D-galactopyranose 1-phosphate	Escherichia coli metabolite; mouse metabolite
1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine	[no description available]	low	0	0	1-acyl-2-hexadecanoyl-sn-glycero-3-phosphocholine; phosphatidylcholine 30:0; tetradecanoate ester	mouse metabolite
d-glutamine	[no description available]	low	0	0	amino acid zwitterion; D-alpha-amino acid; glutamine	mouse metabolite
diquafosol	[no description available]	low	0	0	pyrimidine ribonucleoside 5'-tetraphosphate; uridine 5'-phosphate	mouse metabolite; P2Y2 receptor agonist
19-hydroxytestosterone	[no description available]	low	0	0	17beta-hydroxy steroid; 19-hydroxy steroid; 3-oxo-Delta(4) steroid	mouse metabolite
2-hydroxy-1,4-benzoquinone	[no description available]	low	0	0	monohydroxy-1,4-benzoquinones	mouse metabolite
sorbitol 6-phosphate	[no description available]	low	0	0	alditol 6-phosphate; glucitol phosphate	Escherichia coli metabolite; mouse metabolite
adenosine 3'-phosphate-5'-phosphate	[no description available]	low	0	0	adenosine bisphosphate	Escherichia coli metabolite; mouse metabolite
alpha-ribazole	[no description available]	low	0	0	1-ribosylbenzimidazole; dimethylbenzimidazole	Escherichia coli metabolite; mouse metabolite
saicar	[no description available]	low	0	0	1-(phosphoribosyl)imidazolecarboxamide	Escherichia coli metabolite; mouse metabolite
thymidine 5'-diphosphate	[no description available]	low	0	0	pyrimidine 2'-deoxyribonucleoside 5'-diphosphate; thymidine phosphate	Escherichia coli metabolite; mouse metabolite
hydromethylthionine	[no description available]	low	0	0	aromatic amine; phenothiazines; tertiary amino compound	bacterial xenobiotic metabolite; fluorochrome; mouse metabolite; rat metabolite
5-hydroxykynuramine	[no description available]	low	0	0	hydroxykynurenamine; primary amino compound	mouse metabolite
sedoheptulose 1,7-bisphosphate	[no description available]	low	0	0	ketoheptose phosphate; sedoheptulose derivative	Escherichia coli metabolite; mouse metabolite
diadenosine triphosphate	[no description available]	low	0	0	diadenosyl triphosphate	mouse metabolite
carboxyaminoimidazole ribotide	[no description available]	low	0	0	1-(phosphoribosyl)imidazole; aminoimidazole; imidazole-4-carboxylic acid	Escherichia coli metabolite; mouse metabolite
isovaleryl-coenzyme a	[no description available]	low	0	0	methylbutanoyl-CoA; short-chain fatty acyl-CoA	mouse metabolite
lauroyl-coenzyme a	[no description available]	low	0	0	medium-chain fatty acyl-CoA	Escherichia coli metabolite; mouse metabolite
phenylacetyl-coenzyme a	[no description available]	low	0	0	acyl-CoA	Escherichia coli metabolite; metabolite; mouse metabolite
5-formamidoimidazole-4-carboxamide ribotide	[no description available]	low	0	0	1-(phosphoribosyl)imidazolecarboxamide	Escherichia coli metabolite; mouse metabolite
campesterol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C28-steroid; phytosterols	mouse metabolite
gamma-glutamyl phosphate	[no description available]	low	0	0	gamma-glutamyl phosphate	Escherichia coli metabolite; mouse metabolite
5-amino-6-ribitylamino-2,4-(1h,3h)pyrimidinedione	[no description available]	low	0	0	aminouracil; hydroxypyrimidine	Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
androstane-3,17-dione, (5alpha)-isomer	[no description available]	low	0	0	3-oxo-5alpha-steroid; androstane-3,17-dione	mouse metabolite
21-hydroxypregnenolone	[no description available]	low	0	0	21-hydroxy steroid; hydroxypregnenolone; primary alpha-hydroxy ketone	mouse metabolite
epietiocholanolone	[no description available]	low	0	0	17-oxo steroid; 3beta-hydroxy steroid; androstanoid	androgen; animal metabolite; human blood serum metabolite; mouse metabolite; rat metabolite
19-hydroxy-4-androstene-3,17-dione	[no description available]	low	0	0	17-oxo steroid; 19-hydroxy steroid; 3-oxo steroid; androstanoid	mouse metabolite
glyceraldehyde 3-phosphate	[no description available]	low	0	0	glyceraldehyde 3-phosphate	mouse metabolite
ribulose 5-phosphate	[no description available]	low	0	0	ribulose 5-phosphate	mouse metabolite
xylulose-5-phosphate, (d)-isomer	[no description available]	low	0	0	xylulose 5-phosphate	Escherichia coli metabolite; mouse metabolite
glycerate 1,3-biphosphate	[no description available]	low	0	0	2,3-bisphosphoglyceric acid; acyl monophosphate	Escherichia coli metabolite; mouse metabolite
xanthosine 5'-triphosphate	[no description available]	low	0	0	purine ribonucleoside 5'-triphosphate; xanthosine 5'-phosphate	Escherichia coli metabolite; mouse metabolite
galactose	[no description available]	low	0	0	D-galactopyranose	epitope; mouse metabolite
galactose	[no description available]	low	0	0	D-galactopyranose	mouse metabolite
s-adenosyl-3-methylthiopropylamine	[no description available]	low	0	0	adenosines; sulfonium compound	Escherichia coli metabolite; human urinary metabolite; mouse metabolite; rat metabolite
6-phosphonoglucono-delta-lactone	[no description available]	low	0	0	aldonolactone phosphate	Escherichia coli metabolite; mouse metabolite
stachyose	[no description available]	low	0	0	raffinose family oligosaccharide; tetrasaccharide	mouse metabolite; plant metabolite
ketodihydrosphingosine	[no description available]	low	0	0	2-amino-1-hydroxyoctadecan-3-one	mouse metabolite
androstane-3,17-dione, (5beta)-isomer	[no description available]	low	0	0	3-oxo-5beta-steroid; androstane-3,17-dione	mouse metabolite
pantothenylcysteine 4'-phosphate	[no description available]	low	0	0	L-cysteine derivative	Escherichia coli metabolite; mouse metabolite
beta-sulfopyruvic acid	[no description available]	low	0	0	carboxyalkanesulfonic acid	mouse metabolite
2-hydroxypropylphosphonic acid	[no description available]	low	0	0	phosphonic acids; secondary alcohol	mouse metabolite
inositol-1,4,5,6-tetrakisphosphate	[no description available]	low	0	0	myo-inositol tetrakisphosphate	mouse metabolite
maleic acid	[no description available]	low	0	0	butenedioic acid	algal metabolite; mouse metabolite; plant metabolite
n(1)-(5-phosphoribosyl)-5,6-dimethylbenzimidazole	[no description available]	low	0	0	1-ribosylbenzimidazole; dimethylbenzimidazole; ribose monophosphate	Escherichia coli metabolite; mouse metabolite
prostaglandin h2	[no description available]	low	0	0	olefinic compound; oxylipin; prostaglandins H; secondary alcohol	mouse metabolite
farnesyl pyrophosphate	[no description available]	low	0	0	farnesyl diphosphate	Escherichia coli metabolite; mouse metabolite
geranyl pyrophosphate	[no description available]	low	0	0	polyprenyl diphosphate	Escherichia coli metabolite; mouse metabolite
1,5-dihydro-fad	[no description available]	low	0	0	flavin adenine dinucleotide	Escherichia coli metabolite; mouse metabolite
s-hydroxymethylglutathione	[no description available]	low	0	0	S-substituted glutathione	Escherichia coli metabolite; mouse metabolite
geranylgeranyl pyrophosphate	[no description available]	low	0	0	geranylgeranyl diphosphate	mouse metabolite
cytidine monophosphate n-acetylneuraminic acid	[no description available]	low	0	0	CMP-N-acyl-beta-neuraminic acid	mouse metabolite
4-phosphoerythronate	[no description available]	low	0	0	4-phosphoerythronic acid	Escherichia coli metabolite; mouse metabolite
colfosceril palmitate	[no description available]	low	0	0	1-acyl-2-hexadecanoyl-sn-glycero-3-phosphocholine; phosphatidylcholine 32:0	mouse metabolite; surfactant
lyso-pc	[no description available]	low	0	0	1-O-acyl-sn-glycero-3-phosphocholine; lysophosphatidylcholine 16:0	mouse metabolite
trans-4-coumaric acid	[no description available]	low	0	0	4-coumaric acid	food component; mouse metabolite; plant metabolite
3-hydroxybutyryl-coenzyme a	[no description available]	low	0	0	3-hydroxyacyl-CoA; hydroxybutanoyl-CoA	mouse metabolite
malonyl coenzyme a	[no description available]	low	0	0	malonyl-CoAs	EC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor; Escherichia coli metabolite; metabolite; mouse metabolite
palmitoyl coenzyme a	[no description available]	low	0	0	11,12-saturated fatty acyl-CoA; 3-substituted propionyl-CoA; long-chain fatty acyl-CoA; palmitoyl bioconjugate	Escherichia coli metabolite; mouse metabolite
dihydrosphingosine 1-phosphate	[no description available]	low	0	0	sphingoid 1-phosphate	mouse metabolite
coniferyl alcohol	[no description available]	low	0	0	guaiacols; phenylpropanoid	animal metabolite; monolignol; mouse metabolite; pheromone; plant metabolite; volatile oil component
raphanusamic acid	[no description available]	low	0	0	thiazolidinemonocarboxylic acid	Arabidopsis thaliana metabolite; mouse metabolite; xenobiotic metabolite
glutaryl-coenzyme a	[no description available]	low	0	0	glutaryl-CoAs	mouse metabolite
arachidonic acid 5-hydroperoxide	[no description available]	low	0	0	5-HPETE	mouse metabolite
arachidonic acid omega-9 hydroperoxide	[no description available]	low	0	0	HPETE	mouse metabolite
15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, (s)-(e,z,z,z)-isomer	[no description available]	low	0	0	15-HPETE	mouse metabolite
1-palmitoyl-2-oleoyl-sn-glycerol	[no description available]	low	0	0	1,2-diacyl-sn-glycerol; 1-palmitoyl-2-oleoylglycerol	mouse metabolite
epoprostenol	[no description available]	low	0	0	prostaglandins I	mouse metabolite
11,12-dihydroxyeicosatrienoic acid	[no description available]	low	0	0	DHET	mouse metabolite
14,15-dihydroxyeicosatrienoic acid	[no description available]	low	0	0	DHET; diol; secondary allylic alcohol	mouse metabolite
5,6-epoxy-8,11,14-eicosatrienoic acid	[no description available]	low	0	0	EET	mouse metabolite
8,9-epoxyeicosatrienoic acid	[no description available]	low	0	0	EET	mouse metabolite
1-palmitoyl-2-oleoylphosphatidylethanolamine, (z & r)-isomer	[no description available]	low	0	0	1,2-diacyl-sn-glycero-3-phosphoethanolamine; phosphatidylethanolamine 34:1 zwitterion; phosphatidylethanolamine	mouse metabolite
cholesteryl oleate	[no description available]	low	0	0	CE(18:1); cholesteryl octadec-9-enoate	mouse metabolite
stearidonic acid	[no description available]	low	0	0	long-chain fatty acid; octadecatetraenoic acid; omega-3 fatty acid	Daphnia galeata metabolite; mouse metabolite; plant metabolite
trilinolein	[no description available]	low	0	0	1,2-diacyl-3-linoleoylglycerol; 1,3-diacyl-2-linoleoylglycerol; linoleoyl containing 1,2,3-triacyl-sn-glycerol; TG(18:2/18:2/18:2); triglyceride	mouse metabolite
monodehydroascorbate	[no description available]	low	0	0	organic radical	mouse metabolite
vitamin a2	[no description available]	low	0	0	retinoid; vitamin A	human xenobiotic metabolite; marine xenobiotic metabolite; mouse metabolite
1,2-dioleoylphosphatidylserine	[no description available]	low	0	0	phosphatidylserine(18:1/18:1)	mouse metabolite
5-hydroxy-6,8,11,14,17-eicosapentaenoic acid	[no description available]	low	0	0	HEPE	mouse metabolite
1-stearoyl-2-linoleoylphosphatidylcholine	[no description available]	low	0	0	phosphatidylcholine 36:2	mouse metabolite
1-stearoyl-2-linoleoyl-sn-glycerol	[no description available]	low	0	0	1,2-diacyl-sn-glycerol; diacylglycerol 36:2	mouse metabolite
1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine	[no description available]	low	0	0	phosphatidylcholine 38:6	mouse metabolite
13(S)-HODE	[no description available]	low	0	0	HODE	antineoplastic agent; human xenobiotic metabolite; mouse metabolite
1-stearoyl-2-oleoyl-sn-glycerol	[no description available]	low	0	0	1,2-diacyl-sn-glycerol; 1-stearoyl-2-oleoylglycerol; diacylglycerol 36:1	mouse metabolite
1-palmitoyl-2-palmitoleoyl-sn-glycero-3-phosphocholine	[no description available]	low	0	0	1-acyl-2-palmitoleoyl-sn-glycero-3-phosphocholine; phosphatidylcholine 32:1	mouse metabolite
13-oxo-9,11-octadecadienoic acid	[no description available]	low	0	0	13-oxo-9,11-octadecadienoic acid	metabolite; mouse metabolite
n-stearoylsphingomyelin	[no description available]	low	0	0	sphingomyelin 36:1; sphingomyelin d18:1	mouse metabolite
cholesteryl arachidonate	[no description available]	low	0	0	cholesteryl icosatetraenoate	antibacterial agent; mouse metabolite
acryloyl-coenzyme a	[no description available]	low	0	0	2-enoyl-CoA; monounsaturated fatty acyl-CoA	mouse metabolite
samarium	[no description available]	low	0	0	sphingomyelin d18:1/16:0	mouse metabolite
n-palmitoylgalactosylsphingosine	[no description available]	low	0	0	HexCer(d18:1/16:0); N-acyl-beta-D-galactosylsphingosine	mouse metabolite
s-tetradecanoyl-coenzyme a	[no description available]	low	0	0	11,12-saturated fatty acyl-CoA; long-chain fatty acyl-CoA	Escherichia coli metabolite; mouse metabolite
prosomatostatin	[no description available]	low	0	0	heterodetic cyclic peptide; peptide hormone	fungal metabolite; mouse metabolite; rat metabolite
phosphatidylcholines	[no description available]	low	0	0	phosphatidylcholine 40:6	mouse metabolite
cyclosporine	[no description available]	low	0	0	keto-disaccharide	mouse metabolite
g(m3) ganglioside	[no description available]	low	0	0	alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide; sialodiosylceramide; sialotriaosylceramide	mouse metabolite
diguanosine tetraphosphate	[no description available]	low	0	0	guanosine 5'-phosphate; purine ribonucleoside 5'-tetraphosphate	Escherichia coli metabolite; mouse metabolite
2'-deoxyguanosine 5'-phosphate	[no description available]	low	0	0	deoxyguanosine phosphate; guanyl deoxyribonucleotide; purine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; mouse metabolite
dihydrofolate	[no description available]	low	0	0	dihydrofolic acids	Escherichia coli metabolite; mouse metabolite
dihydroneopterin triphosphate	[no description available]	low	0	0	dihydropterin; neopterins; pterin phosphate	Escherichia coli metabolite; mouse metabolite
2'-deoxyinosine triphosphate	[no description available]	low	0	0	deoxyinosine phosphate; purine 2'-deoxyribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite
guanosine diphosphate	[no description available]	low	0	0	guanosine 5'-phosphate; purine ribonucleoside 5'-diphosphate	Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor
gdp-4-keto-6-deoxymannose	[no description available]	low	0	0	GDP-sugar	Escherichia coli metabolite; mouse metabolite
guanosine pentaphosphate	[no description available]	low	0	0	guanosine 5'-phosphate; guanosine bisphosphate	Escherichia coli metabolite; mouse metabolite
guanosine tetraphosphate	[no description available]	low	0	0	guanosine bisphosphate	Escherichia coli metabolite; mouse metabolite
leucovorin	[no description available]	low	0	0	formyltetrahydrofolic acid	Escherichia coli metabolite; mouse metabolite
5,10-methenyltetrahydrofolate	[no description available]	low	0	0	methylenetetrahydrofolic acid	Escherichia coli metabolite; mouse metabolite
10-formyltetrahydrofolate	[no description available]	low	0	0	formyltetrahydrofolic acid	Escherichia coli metabolite; mouse metabolite
7-keto-8-aminopelargonic acid	[no description available]	low	0	0	7-oxo monocarboxylic acid; amino acid zwitterion; amino acid	Saccharomyces cerevisiae metabolite
toxopyrimidine	[no description available]	low	0	0	aminopyrimidine; aromatic primary alcohol	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
indol-3-yl pyruvic acid	[no description available]	low	0	0	2-oxo monocarboxylic acid; indol-3-yl carboxylic acid	plant metabolite; Saccharomyces cerevisiae metabolite
phenylethyl alcohol	[no description available]	low	0	0	benzenes; primary alcohol	Aspergillus metabolite; fragrance; plant growth retardant; plant metabolite; Saccharomyces cerevisiae metabolite
isobutyl alcohol	[no description available]	low	0	0	alkyl alcohol; primary alcohol	Saccharomyces cerevisiae metabolite
isobutyraldehyde	[no description available]	low	0	0	2-methyl-branched fatty aldehyde; propanals	Saccharomyces cerevisiae metabolite
2-furoic acid	[no description available]	low	0	0	furoic acid	bacterial xenobiotic metabolite; human xenobiotic metabolite; inhibitor; plant metabolite; Saccharomyces cerevisiae metabolite
2-methylbutanal	[no description available]	low	0	0	2-methyl-branched fatty aldehyde; methylbutanal	plant metabolite; Saccharomyces cerevisiae metabolite; volatile oil component
2-phenylethyl acetate	[no description available]	low	0	0	acetate ester	metabolite; Saccharomyces cerevisiae metabolite
propargyl alcohol	[no description available]	low	0	0	propynol; terminal acetylenic compound; volatile organic compound	antifungal agent; Saccharomyces cerevisiae metabolite
isobutyl acetate	[no description available]	low	0	0	acetate ester	Saccharomyces cerevisiae metabolite
2-methylbutanol	[no description available]	low	0	0	alkyl alcohol; primary alcohol	Saccharomyces cerevisiae metabolite
shikimic acid	[no description available]	low	0	0	alpha,beta-unsaturated monocarboxylic acid; cyclohexenecarboxylic acid; hydroxy monocarboxylic acid	Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
ethyl acetate	[no description available]	low	0	0	acetate ester; ethyl ester; volatile organic compound	EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor; metabolite; polar aprotic solvent; Saccharomyces cerevisiae metabolite
methionol	[no description available]	low	0	0	aliphatic sulfide; methyl sulfide	Saccharomyces cerevisiae metabolite
tryptophol	[no description available]	low	0	0	indolyl alcohol	auxin; plant metabolite; Saccharomyces cerevisiae metabolite
levocarnitine	[no description available]	low	0	0	carnitine	antilipemic drug; nootropic agent; nutraceutical; Saccharomyces cerevisiae metabolite; water-soluble vitamin (role)
isovalerylaldehyde	[no description available]	low	0	0	methylbutanal	flavouring agent; plant metabolite; Saccharomyces cerevisiae metabolite; volatile oil component
chorismic acid	[no description available]	low	0	0	5-[(1-carboxyethenyl)oxy]-6-hydroxycyclohexa-1,3-diene-1-carboxylic acid	Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
isopentyl alcohol	[no description available]	low	0	0	alkyl alcohol; primary alcohol; volatile organic compound	antifungal agent; Saccharomyces cerevisiae metabolite; xenobiotic metabolite
isoamyl acetate	[no description available]	low	0	0	acetate ester	metabolite; Saccharomyces cerevisiae metabolite
4-hydroxy-2-ethyl-5-methyl-3(2h)-furanone	[no description available]	low	0	0	cyclic ketone; enol; furans	Saccharomyces cerevisiae metabolite
copper histidine	[no description available]	low	0	0	D-alpha-amino acid; histidine; polar amino acid zwitterion	Saccharomyces cerevisiae metabolite
4-methyl-4-sulfanylpentan-2-one	[no description available]	low	0	0	alkanethiol; methyl ketone	plant metabolite; Saccharomyces cerevisiae metabolite
poly-o-acetylserine	[no description available]	low	0	0	acetate ester; acetyl-L-serine; amino acid zwitterion	bacterial metabolite; Saccharomyces cerevisiae metabolite
2'-deoxy cyclic amp	[no description available]	low	0	0	3',5'-cyclic purine nucleotide	Saccharomyces cerevisiae metabolite
hydroxythreonine	[no description available]	low	0	0	amino acid zwitterion; hydroxy-amino acid; L-threonine derivative; non-proteinogenic L-alpha-amino acid	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
pantolactone	[no description available]	low	0	0	butan-4-olide	Saccharomyces cerevisiae metabolite
D-leucine	[no description available]	low	0	0	D-alpha-amino acid zwitterion; D-alpha-amino acid; leucine	bacterial metabolite; Saccharomyces cerevisiae metabolite
fecosterol	[no description available]	low	0	0	3beta-sterol	Saccharomyces cerevisiae metabolite
ergosterol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; ergostanoid; phytosterols	fungal metabolite; Saccharomyces cerevisiae metabolite
3-mercaptohexyl acetate	[no description available]	low	0	0	acetate ester; alkanethiol	Saccharomyces cerevisiae metabolite
3-mercaptohexanol	[no description available]	low	0	0	alkanethiol; primary alcohol	flavouring agent; plant metabolite; Saccharomyces cerevisiae metabolite
tocotrienol, delta	[no description available]	low	0	0	tocotrienol; vitamin E	anti-inflammatory agent; antineoplastic agent; apoptosis inducer; bone density conservation agent; NF-kappaB inhibitor; plant metabolite; radiation protective agent; Saccharomyces cerevisiae metabolite
ubiquinone 6	[no description available]	low	0	0	ubiquinones	Saccharomyces cerevisiae metabolite
3-dehydroshikimate	[no description available]	low	0	0	monocarboxylic acid anion	Saccharomyces cerevisiae metabolite
d-ribo-phytosphingosine-1-phosphate	[no description available]	low	0	0	sphingoid 1-phosphate	Saccharomyces cerevisiae metabolite
6-hydroxymethyl-7,8-dihydropterin	[no description available]	low	0	0	dihydropterin	Saccharomyces cerevisiae metabolite
cyclic imp	[no description available]	low	0	0	3',5'-cyclic purine nucleotide; nucleoside 3',5'-cyclic phosphate	mammalian metabolite; Saccharomyces cerevisiae metabolite
5,6,7,8-tetrahydrofolic acid	[no description available]	low	0	0	tetrahydrofolic acid	Saccharomyces cerevisiae metabolite
monoisopropanolamine	[no description available]	low	0	0	amino alcohol; secondary alcohol	Escherichia coli metabolite
5,6,7,8-tetrahydropteridine	[no description available]	low	0	0	pteridines	cofactor; Escherichia coli metabolite
arsenic acid	[no description available]	low	0	0	arsenic oxoacid	Escherichia coli metabolite
carbamic acid	[no description available]	low	0	0	carbon oxoacid; one-carbon compound; organonitrogen compound	Escherichia coli metabolite
2-aminoacetaldehyde	[no description available]	low	0	0	amino aldehyde; omega-aminoaldehyde	Escherichia coli metabolite
2,3-diaminopropionic acid	[no description available]	low	0	0	alanine derivative; amino acid zwitterion; beta-amino acid; diamino acid; non-proteinogenic alpha-amino acid	Escherichia coli metabolite
oxaluric acid	[no description available]	low	0	0	2-oxo monocarboxylic acid; ureas	Escherichia coli metabolite
n(1)-acetylspermidine	[no description available]	low	0	0	acetylspermidine	Escherichia coli metabolite; metabolite
propionaldehyde	[no description available]	low	0	0	alpha-CH2-containing aldehyde; propanals	Escherichia coli metabolite
1,4-dihydroxy-2-naphthoic acid	[no description available]	low	0	0	dihydroxy monocarboxylic acid; naphthalenediols; naphthohydroquinone; naphthoic acid	Escherichia coli metabolite
thiocyanic acid	[no description available]	low	0	0	hydracid; one-carbon compound; organosulfur compound	Escherichia coli metabolite
iminoaspartic acid	[no description available]	low	0	0	aspartic acid derivative; C4-dicarboxylic acid; ketimine	Escherichia coli metabolite
indole	[no description available]	low	0	0	indole; polycyclic heteroarene	Escherichia coli metabolite
oxamic acid	[no description available]	low	0	0	dicarboxylic acid monoamide	Escherichia coli metabolite
diphosphoric acid	[no description available]	low	0	0	acyclic phosphorus acid anhydride; phosphorus oxoacid	Escherichia coli metabolite
prephenic acid	[no description available]	low	0	0	oxo dicarboxylic acid	Escherichia coli metabolite; plant metabolite
dimethyl sulfide	[no description available]	low	0	0	aliphatic sulfide	algal metabolite; bacterial xenobiotic metabolite; EC 3.5.1.4 (amidase) inhibitor; Escherichia coli metabolite; marine metabolite
sulfur dioxide	[no description available]	low	0	0	sulfur oxide	Escherichia coli metabolite; food bleaching agent; refrigerant
1,3,4-butanetriol	[no description available]	low	0	0	triol	bacterial xenobiotic metabolite; Escherichia coli metabolite
molybdate ion	[no description available]	low	0	0	divalent inorganic anion; molybdenum oxoanion	Escherichia coli metabolite
myrmicacin	[no description available]	low	0	0	3-hydroxy fatty acid; medium-chain fatty acid	antimitotic; Escherichia coli metabolite
n-(3-aminopropyl)cadaverine	[no description available]	low	0	0	polyazaalkane; triamine	Escherichia coli metabolite
D-tyrosine	[no description available]	low	0	0	D-alpha-amino acid zwitterion; D-alpha-amino acid; tyrosine	Escherichia coli metabolite
3'-uridylic acid	[no description available]	low	0	0	pyrimidine ribonucleoside 3'-monophosphate; uridine phosphate	Escherichia coli metabolite
2',3'-cyclic amp	[no description available]	low	0	0	2',3'-cyclic purine nucleotide	Escherichia coli metabolite
2,5-diketogluconic acid	[no description available]	low	0	0	diketoaldonic acid	Escherichia coli metabolite
selenodiglutathione	[no description available]	low	0	0	glutathione derivative; thioselenide	Escherichia coli metabolite; metabolite
2-deoxyglucose-6-phosphate	[no description available]	low	0	0	deoxyaldohexose phosphate	Escherichia coli metabolite; Mycoplasma genitalium metabolite
thymidine diphosphate-l-rhamnose	[no description available]	low	0	0	dTDP-L-rhamnose	Escherichia coli metabolite
trehalose-6-phosphate	[no description available]	low	0	0	trehalose phosphate	Escherichia coli metabolite
ribulose-1,5 diphosphate	[no description available]	low	0	0	ribulose phosphate	Escherichia coli metabolite; plant metabolite
aerobactin	[no description available]	low	0	0	L-lysine derivative	Escherichia coli metabolite; siderophore; virulence factor
lipid x	[no description available]	low	0	0	N-acyl-D-glucosamine 1-phosphate	Escherichia coli metabolite
glutamate-1-semialdehyde	[no description available]	low	0	0	5-oxo monocarboxylic acid; amino acid zwitterion; gamma-amino acid; glutamic semialdehyde	Escherichia coli metabolite
o-phosphohomoserine	[no description available]	low	0	0	O-phosphorylhomoserine	Escherichia coli metabolite
2,3-dihydroxybenzoylserine	[no description available]	low	0	0	L-serine derivative	Escherichia coli metabolite
beta-aspartyl phosphate	[no description available]	low	0	0	aminoacyl phosphate; L-aspartic acid derivative; non-proteinogenic L-alpha-amino acid	Escherichia coli metabolite
abrine	[no description available]	low	0	0	L-tryptophan derivative; N-methyl-L-alpha-amino acid zwitterion; N-methyl-L-alpha-amino acid	Escherichia coli metabolite
3-deoxy-d-arabino-heptulosonate-7-phosphate	[no description available]	low	0	0	ketoaldonic acid phosphate	Escherichia coli metabolite
6,7-dimethyl-8-ribityllumazine, (d)-isomer	[no description available]	low	0	0	pteridines	cofactor; Escherichia coli metabolite
glucosamine 1-phosphate	[no description available]	low	0	0	glucosamine phosphate	Escherichia coli metabolite
9-mercaptodethiobiotin	[no description available]	low	0	0	imidazolidinone; monocarboxylic acid; thiol; ureas	Escherichia coli metabolite
idonic acid	[no description available]	low	0	0	idonic acid	Escherichia coli metabolite
n(1)-((5'-phosphoribulosyl)formimino)-5-aminoimidazo-4-carboxamide ribonucleotide	[no description available]	low	0	0	1-(phosphoribosyl)imidazolecarboxamide	Escherichia coli metabolite
2-oxo-3-deoxygalactonic acid	[no description available]	low	0	0	hexonic acid; ketoaldonic acid	Escherichia coli metabolite
ribose 1-phosphate	[no description available]	low	0	0	D-ribose 1-phosphate	Escherichia coli metabolite
3-dehydroquinic acid	[no description available]	low	0	0	2-hydroxy monocarboxylic acid; 4-hydroxy monocarboxylic acid; 4-oxo monocarboxylic acid; 5-hydroxy monocarboxylic acid; secondary alpha-hydroxy ketone	Escherichia coli metabolite
s-ribosyl-l-homocysteine	[no description available]	low	0	0	S-(5-deoxy-D-ribos-5-yl)-L-homocysteine	Escherichia coli metabolite
nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii)	[no description available]	low	0	0	diadenosyl pentaphosphate	Escherichia coli metabolite; vasoconstrictor agent
glutathionylspermidine	[no description available]	low	0	0	glutathione derivative	Escherichia coli metabolite
arbutin	[no description available]	low	0	0	beta-D-glucoside; monosaccharide derivative	Escherichia coli metabolite; plant metabolite
2-c-methylerythritol 4-phosphate	[no description available]	low	0	0	tetritol phosphate	Escherichia coli metabolite
1-deoxy-d-xylulose 5-phosphate	[no description available]	low	0	0	xylulose phosphate	Escherichia coli metabolite
c(alpha)-formylglycine	[no description available]	low	0	0	3-oxoalanine; amino acid zwitterion; L-alanine derivative; non-proteinogenic L-alpha-amino acid	Escherichia coli metabolite
palmitoleic acid	[no description available]	low	0	0	hexadec-9-enoic acid	algal metabolite; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; human blood serum metabolite
sucrose-6-phosphate	[no description available]	low	0	0	disaccharide phosphate	Escherichia coli metabolite
iminoglycine	[no description available]	medium	0	0	dehydroamino acid; imine; zwitterion	Escherichia coli metabolite
2-keto-3-deoxy-6-phosphogluconate	[no description available]	low	0	0	ketoaldonic acid phosphate	Escherichia coli metabolite
formyl-coenzyme a	[no description available]	low	0	0	acyl-CoA	Escherichia coli metabolite
3-deoxy-2-octulosonic acid(2)-lipid iv(a)	[no description available]	low	0	0	lipid As	Escherichia coli metabolite
phosphothreonine	[no description available]	low	0	0	L-threonine derivative; non-proteinogenic L-alpha-amino acid; O-phosphoamino acid	Escherichia coli metabolite
maleamic acid	[no description available]	low	0	0	alpha,beta-unsaturated monocarboxylic acid; dicarboxylic acid monoamide	bacterial xenobiotic metabolite; Escherichia coli metabolite
canthaxanthin	[no description available]	low	0	0	carotenone	biological pigment; Escherichia coli metabolite; food colouring; fungal metabolite
(e)-4-hydroxy-3-methylbut-2-enyl diphosphate	[no description available]	low	0	0	prenol phosphate	epitope; Escherichia coli metabolite; phosphoantigen
menaquinone 7	[no description available]	low	0	0	menaquinone	bone density conservation agent; cofactor; Escherichia coli metabolite; human blood serum metabolite; Mycoplasma genitalium metabolite
5-ketogluconic acid	[no description available]	low	0	0	hexonic acid; ketoaldonic acid	Escherichia coli metabolite
menaquinone 9	[no description available]	low	0	0	menaquinone	Escherichia coli metabolite
allolactose	[no description available]	low	0	0	glycosylglucose	Escherichia coli metabolite
1-deoxy-2-pentulose	[no description available]	low	0	0	deoxypentose	Escherichia coli metabolite
fructosyl-lysine	[no description available]	low	0	0	fructosamine; glyco-amino acid	Escherichia coli metabolite
lipid a	[no description available]	low	0	0	dodecanoate ester; lipid A; tetradecanoate ester	Escherichia coli metabolite
(S)-4,5-dihydroxypentane-2,3-dione	[no description available]	low	0	0	alpha-diketone; secondary alpha-hydroxy ketone	Escherichia coli metabolite
kdo2-lipid a	[no description available]	low	0	0	dodecanoate ester; lipid As; tetradecanoate ester	Escherichia coli metabolite
oxalyl-coenzyme a	[no description available]	low	0	0	omega-carboxyacyl-CoA	Escherichia coli metabolite
novobiocin	[no description available]	low	0	0	carbamate ester; ether; hexoside; hydroxycoumarin; monocarboxylic acid amide; monosaccharide derivative; phenols	antibacterial agent; antimicrobial agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Escherichia coli metabolite; hepatoprotective agent
queuine	[no description available]	low	0	0	pyrrolopyrimidine	Escherichia coli metabolite
3'-guanylic acid	[no description available]	low	0	0	guanosine 3'-phosphate; purine ribonucleoside 3'-monophosphate	Escherichia coli metabolite
2',3'-cyclic gmp	[no description available]	low	0	0	2',3'-cyclic purine nucleotide	Escherichia coli metabolite
colibactin	[no description available]	low	0	0	1,3-thiazoles; azaspiro compound; polyketide; pyrroline; secondary carboxamide	alkylating agent; carcinogenic agent; Escherichia coli metabolite; genotoxin
bendazac	[no description available]	low	0	0	indazoles; monocarboxylic acid	non-steroidal anti-inflammatory drug; radical scavenger
anthrone	[no description available]	low	0	0	anthracenone	radical scavenger
deanol	[no description available]	low	0	0	ethanolamines; tertiary amine	curing agent; radical scavenger
1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose	[no description available]	low	0	0	gallate ester; galloyl beta-D-glucose	anti-inflammatory agent; antineoplastic agent; geroprotector; hepatoprotective agent; plant metabolite; radiation protective agent; radical scavenger
pyrrolidine dithiocarbamate	[no description available]	low	0	0	dithiocarbamic acids; pyrrolidines	anticonvulsant; antineoplastic agent; geroprotector; neuroprotective agent; NF-kappaB inhibitor; radical scavenger
phenoxazine	[no description available]	low	0	0	phenoxazine	ferroptosis inhibitor; radical scavenger
sigmoidin a	[no description available]	low	0	0	4'-hydroxyflavanones; tetrahydroxyflavanone	anti-inflammatory agent; anti-obesity agent; antibacterial agent; metabolite; radical scavenger
proxyl nitroxide	[no description available]	low	0	0	aminoxyls; pyrrolidines	radical scavenger
homoorientin	[no description available]	low	0	0	flavone C-glycoside; tetrahydroxyflavone	antineoplastic agent; radical scavenger
astilbin	[no description available]	low	0	0	3'-hydroxyflavanones; 4'-hydroxyflavanones; alpha-L-rhamnoside; flavanone glycoside; monosaccharide derivative; tetrahydroxyflavanone	anti-inflammatory agent; plant metabolite; radical scavenger
pramipexole	[no description available]	low	0	0	benzothiazoles; diamine	antidyskinesia agent; antiparkinson drug; dopamine agonist; radical scavenger
6,6'-bieckol	[no description available]	low	0	0	aromatic ether; oxacycle; phlorotannin	anti-HIV-1 agent; metabolite; radical scavenger
tempol	[no description available]	low	0	0	aminoxyls; hydroxypiperidine	anti-inflammatory agent; antineoplastic agent; apoptosis inducer; catalyst; hepatoprotective agent; nephroprotective agent; neuroprotective agent; radical scavenger
matteucinol	[no description available]	low	0	0	4'-methoxyflavanones; dihydroxyflavanone; monomethoxyflavanone	plant metabolite; radical scavenger
2',6'-dihydroxy-4'-methoxydihydrochalcone	[no description available]	low	0	0	dihydrochalcones; monomethoxybenzene; polyphenol	antiplasmodial drug; radical scavenger
rosiglitazone	[no description available]	low	0	0	acetate ester; coumarins; diester	pro-angiogenic agent; radical scavenger
silychristin	[no description available]	low	0	0	1-benzofurans; aromatic ether; flavonolignan; polyphenol; secondary alpha-hydroxy ketone	lipoxygenase inhibitor; metabolite; prostaglandin antagonist; radical scavenger
tempace	[no description available]	low	0	0	aminoxyls; piperidinecarboxamide; secondary carboxamide	radiation protective agent; radical scavenger
triacetoneamine-n-oxyl	[no description available]	low	0	0	aminoxyls; piperidones	radical scavenger
propolin c	[no description available]	low	0	0	4'-hydroxyflavanones; tetrahydroxyflavanone	metabolite; radical scavenger
4-maleimido-2,2,6,6-tetramethylpiperidinooxyl	[no description available]	low	0	0	aminoxyls; dicarboximide; maleimides; piperidines	radical scavenger; spin label
n-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl)iodoacetamide	[no description available]	low	0	0	aminoxyls; organoiodine compound; piperidinecarboxamide; secondary carboxamide	radical scavenger; spin label
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole	[no description available]	low	0	0	benzoic acid; imidazolines; organic radical	apoptosis inhibitor; radical scavenger
dieckol	[no description available]	low	0	0	aromatic ether; oxacycle; phlorotannin	anticoagulant; EC 3.2.1.20 (alpha-glucosidase) inhibitor; hepatoprotective agent; metabolite; radical scavenger
tempo carboxylic acid	[no description available]	low	0	0	aminoxyls; piperidinemonocarboxylic acid	MRI contrast agent; radical scavenger; spin label
ladanein	[no description available]	low	0	0	dihydroxyflavone; dimethoxyflavone	antiviral agent; plant metabolite; radical scavenger
cupressuflavone	[no description available]	low	0	0	biflavonoid; hydroxyflavone; ring assembly	EC 3.4.21.37 (leukocyte elastase) inhibitor; metabolite; radical scavenger
orobol	[no description available]	low	0	0	7-hydroxyisoflavones	anti-inflammatory agent; fungal metabolite; plant metabolite; radical scavenger
kaempferol-3-o-rutinoside	[no description available]	low	0	0	disaccharide derivative; kaempferol O-glucoside; rutinoside; trihydroxyflavone	metabolite; plant metabolite; radical scavenger
methyl brevifolincarboxylate	[no description available]	low	0	0	cyclic ketone; delta-lactone; organic heterotricyclic compound; phenols	EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; metabolite; platelet aggregation inhibitor; radical scavenger; vasodilator agent
ginsenoside rb1	[no description available]	low	0	0	ginsenoside; glycoside; tetracyclic triterpenoid	anti-inflammatory drug; anti-obesity agent; apoptosis inhibitor; neuroprotective agent; plant metabolite; radical scavenger
kaempferol 7-o-glucoside	[no description available]	low	0	0	beta-D-glucoside; flavonols; kaempferol O-glucoside; monosaccharide derivative; trihydroxyflavone	metabolite; plant metabolite; radical scavenger
nymphaeol c	[no description available]	low	0	0	4'-hydroxyflavanones; tetrahydroxyflavanone	metabolite; radical scavenger
eckstolonol	[no description available]	low	0	0	organic heteropentacyclic compound; oxacycle; phlorotannin	metabolite; radical scavenger
eriodictyol 7-O-beta-D-glucopyranoside	[no description available]	low	0	0	beta-D-glucoside; flavanone glycoside; monosaccharide derivative; trihydroxyflavanone	plant metabolite; radical scavenger
(E)-5-hydroxy-6-(3-methylbut-2-enyl)-2-(pent-1-enyl)benzofuran-4-carbaldehyde	[no description available]	low	0	0	1-benzofurans; aldehyde; phenols	Aspergillus metabolite; Chaetomium metabolite; radical scavenger
dipyrone	[no description available]	low	0	0	amino sulfonic acid; pyrazoles	anti-inflammatory agent; antipyretic; antirheumatic drug; cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug; prodrug
bes	[no description available]	low	0	0	1,1-diunsubstituted alkanesulfonate; amino sulfonic acid; BES
tes	[no description available]	low	0	0	amino sulfonic acid; ethanolamines; TES
delta(1)-piperidine-2-carboxylic acid	[no description available]	low	0	0	piperidinemonocarboxylic acid; zwitterion
serpentine (alkaloid)	[no description available]	low	0	0	carboxylic ester; iminium betaine; indole alkaloid; quinolizines; zwitterion
s-methyl glutathione	[no description available]	low	0	0	methyl sulfide; S-substituted glutathione; zwitterion
dopamine 3-o-sulfate	[no description available]	low	0	0	aryl sulfate; phenols; primary amino compound; zwitterion	human blood serum metabolite; human urinary metabolite
dopamine 4-o-sulfate	[no description available]	low	0	0	aryl sulfate; phenols; primary amino compound; zwitterion	human blood serum metabolite; human urinary metabolite
aclacinomycin	[no description available]	low	0	0	aminoglycoside; anthracycline; deoxy hexoside; methyl ester; monosaccharide derivative; phenols; polyketide; tertiary alcohol; tetracenequinones; zwitterion	antimicrobial agent; antineoplastic agent; metabolite
tyramine o-sulfate	[no description available]	low	0	0	aryl sulfate; primary amino compound; zwitterion	human urinary metabolite; human xenobiotic metabolite
3,4-dihydro-2h-pyrrole-5-carboxylic acid	[no description available]	low	0	0	1-pyrrolinecarboxylic acid; zwitterion
aclarubicin	[no description available]	low	0	0	aminoglycoside; anthracycline; methyl ester; phenols; polyketide; tetracenequinones; trisaccharide derivative; zwitterion	antimicrobial agent; antineoplastic agent; apoptosis inducer; bacterial metabolite; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
ly 163892	[no description available]	low	0	0	carbacephem; zwitterion	antibacterial drug; antimicrobial agent
alanyllactate	[no description available]	low	0	0	D-alanyl ester; depsipeptide; zwitterion
baci-im	[no description available]	low	0	0	homodetic cyclic peptide; polypeptide; zwitterion	antibacterial agent; antimicrobial agent
cysteinyldopa	[no description available]	low	0	0	catecholamine; zwitterion
aszonalenin	[no description available]	low	0	0	benzodiazepine; zwitterion
muraymycin d2	[no description available]	low	0	0	zwitterion	antimicrobial agent
boromycin	[no description available]	low	0	0	macrodiolide; macrolide antibiotic; organoboron compound; oxaspiro compound; zwitterion	anti-HIV agent; antibacterial agent; bacterial metabolite

taurine

Cross-References

Synonyms (161)

Research Excerpts

Overview

Effects

Actions

Treatment

Roles (8)

Drug Classes (2)

Pathways (30)

Protein Targets (34)

Potency Measurements

Inhibition Measurements

Biological Processes (142)

Molecular Functions (46)

Ceullar Components (32)

Bioassays (73)

Research

Studies (9,708)

Study Types

Research Highlights

Safety/Toxicity (179)

Long-term Use (39)

Pharmacokinetics (183)

Bioavailability (40)

Dosage (156)

Interactions (10)

Natural Sources (1)

Article	Year
The protective effect of taurine on cyclophosphamide-induced testicular toxicity in rats. Pakistan journal of pharmaceutical sciences, Volume: 36, Issue: 5(Special)	2023
[Toxicity comparison of raw and vinegar-processed Bupleuri Radix based on ~1H-NMR metabolomics]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 47, Issue: 19	2022
Taurolidine-related adverse events in patients on home parenteral nutrition frequently indicate catheter-related problems. Clinical nutrition (Edinburgh, Scotland), Volume: 41, Issue: 10	2022
Protective role of ellagic acid and taurine against fluoxetine induced hepatotoxic effects on biochemical and oxidative stress parameters, histopathological changes, and gene expressions of IL-1β, NF-κB, and TNF-α in male Wistar rats. Life sciences, Sep-01, Volume: 304	2022
The renoprotective effects of gallic acid on cisplatin-induced nephrotoxicity through anti-apoptosis, anti-inflammatory effects, and downregulation of lncRNA TUG1. Naunyn-Schmiedeberg's archives of pharmacology, Volume: 395, Issue: 6	2022
Taurine modulates dynamics of oxidative defense, secondary metabolism, and nutrient relation to mitigate boron and chromium toxicity in Triticum aestivum L. plants. Environmental science and pollution research international, Volume: 29, Issue: 30	2022
Taurine Has Potential Protective Effects against the Chronic Cardiotoxicity Induced by Doxorubicin in Mice. Biological & pharmaceutical bulletin, Volume: 44, Issue: 11	2021
Taurine ameliorates cytotoxic effects of Di(2-ethylhexyl) phthalate on Leydig cells. Andrologia, Volume: 53, Issue: 8	2021
On the mechanisms of taurine in alleviating electrocardiographic, hemodynamic, and biochemical parameters following aluminum phosphide cardiotoxicity. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 154	2021
Developmental toxicity of lead in rats after gestational exposure and the protective role of taurine. Journal of biochemical and molecular toxicology, Volume: 35, Issue: 8	2021
Taurine attenuates valproic acid-induced hepatotoxicity via modulation of RIPK1/RIPK3/MLKL-mediated necroptosis signaling in mice. Molecular biology reports, Volume: 48, Issue: 5	2021
[Protective effect of taurine against formaldehyde-induced male reproductive toxicity in adult male rats]. Zhonghua nan ke xue = National journal of andrology, Volume: 26, Issue: 9	2020
The protective function of taurine on pesticide-induced permanent neurodevelopmental toxicity in juvenile rats. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Volume: 35, Issue: 1	2021
The role of taurine on chemotherapy-induced cardiotoxicity: A systematic review of non-clinical study. Life sciences, Jan-15, Volume: 265	2021
Protective potential of curcumin or taurine on nephrotoxicity caused by bisphenol A. Environmental science and pollution research international, Volume: 27, Issue: 19	2020
Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings. Amino acids, Volume: 51, Issue: 10-12	2019
Safety and efficacy of taurine as an add-on treatment for tics in youngsters. European journal of neurology, Volume: 27, Issue: 3	2020
Protection of Taurine Against Neurotoxicity Induced by Arsenic in Primary Cortical Neurons. Advances in experimental medicine and biology, Volume: 1155	2019
Perinatal Taurine Supplementation Prevents the Adverse Effects of Maternal Dyslipidemia on Growth and Cardiovascular Control in Adult Rat Offspring. Advances in experimental medicine and biology, Volume: 1155	2019
The defensive role of taurine against gonadotoxicity and testicular apoptosis effects induced by cisplatin in rats. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, Volume: 26, Issue: 1	2020
Testicular toxicity of orally administrated bisphenol A in rats and protective role of taurine and curcumin. Pakistan journal of pharmaceutical sciences, Volume: 32, Issue: 3	2019
Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC). World journal of surgical oncology, Jun-03, Volume: 17, Issue: 1	2019
Contributions of Mass Spectrometry to the Identification of Low Molecular Weight Molecules Able to Reduce the Toxicity of Amyloid-β Peptide to Cell Cultures and Transgenic Mouse Models of Alzheimer's Disease. Molecules (Basel, Switzerland), Mar-24, Volume: 24, Issue: 6	2019
Histopathological and biochemical studies on the effect of curcumin and taurine against bisphenol A toxicity in male rats. Environmental science and pollution research international, Volume: 26, Issue: 12	2019
Homotaurine, a safe blood-brain barrier permeable GABA Scientific reports, 11-08, Volume: 8, Issue: 1	2018
Antiapoptotic effect of taurine against NMDA-induced retinal excitotoxicity in rats. Neurotoxicology, Volume: 70	2019
Effects of acute ammonia toxicity on oxidative stress, immune response and apoptosis of juvenile yellow catfish Pelteobagrus fulvidraco and the mitigation of exogenous taurine. Fish & shellfish immunology, Volume: 79	2018
Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 04-01, Volume: 33, Issue: 4	2018
Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease. Clinical pharmacokinetics, Volume: 57, Issue: 3	2018
Molecular mechanisms of nickel induced neurotoxicity and chemoprevention. Toxicology, 12-01, Volume: 392	2017
Taurine counteracts the neurotoxic effects of streptozotocin-induced diabetes in rats. Amino acids, Volume: 50, Issue: 1	2018
The potential protective role of taurine against 5-fluorouracil-induced nephrotoxicity in adult male rats. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, Jun-14, Volume: 69, Issue: 5	2017
The Vigabatrin Induced Retinal Toxicity is Associated with Photopic Exposure and Taurine Deficiency: An In Vivo Study. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Volume: 40, Issue: 5	2016
Potential urinary biomarkers of nephrotoxicity in cyclophosphamide-treated rats investigated by NMR-based metabolic profiling. Journal of biochemical and molecular toxicology, Volume: 31, Issue: 3	2017
Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina. Neurotoxicity research, Volume: 31, Issue: 1	2017
Effect of taurine supplementation on hepatic metabolism and alleviation of cadmium toxicity and bioaccumulation in a marine teleost, red sea bream, Pagrus major. Fish physiology and biochemistry, Volume: 43, Issue: 1	2017
The protective effects of taurine on acute ammonia toxicity in grass carp Ctenopharynodon idellus. Fish & shellfish immunology, Volume: 56	2016
Acute ammonia toxicity in crucian carp Carassius auratus and effects of taurine on hyperammonemia. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, Volume: 190	2016
Mitochondrial defects associated with β-alanine toxicity: relevance to hyper-beta-alaninemia. Molecular and cellular biochemistry, Volume: 416, Issue: 1-2	2016
Metabolomic Characterizations of Liver Injury Caused by Acute Arsenic Toxicity in Zebrafish. PloS one, Volume: 11, Issue: 3	2016
Efficacy and Safety of "URSA Complex" in Subjects with Physical Fatigue: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. Chinese medical journal, Jan-20, Volume: 129, Issue: 2	2016
Protective effects of taurine on doxorubicin-induced acute hepatotoxicity through suppression of oxidative stress and apoptotic responses. Anti-cancer drugs, Volume: 27, Issue: 1	2016
Hydrogen sulfide modulates cadmium-induced physiological and biochemical responses to alleviate cadmium toxicity in rice. Scientific reports, Sep-11, Volume: 5	2015
Taurine zinc solid dispersions attenuate doxorubicin-induced hepatotoxicity and cardiotoxicity in rats. Toxicology and applied pharmacology, Nov-15, Volume: 289, Issue: 1	2015
Taurine: the appeal of a safe amino acid for skeletal muscle disorders. Journal of translational medicine, Jul-25, Volume: 13	2015
Attenuation of rotenone toxicity in SY5Y cells by taurine and N-acetyl cysteine alone or in combination. Brain research, Oct-05, Volume: 1622	2015
(1)H NMR-Based Metabolomics and Neurotoxicity Study of Cerebrum and Cerebellum in Rats Treated with Cinnabar, a Traditional Chinese Medicine. Omics : a journal of integrative biology, Volume: 19, Issue: 8	2015
Neurodevelopment in children with intrauterine growth restriction: adverse effects and interventions. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, Volume: 29, Issue: 4	2016
Amelioration of nandrolone decanoate-induced testicular and sperm toxicity in rats by taurine: effects on steroidogenesis, redox and inflammatory cascades, and intrinsic apoptotic pathway. Toxicology and applied pharmacology, Feb-01, Volume: 282, Issue: 3	2015
The effects of taurine on vigabatrin, high light intensity and mydriasis induced retinal toxicity in the pigmented rat. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, Volume: 67, Issue: 1	2015
Taurine protects HK-2 cells from oxidized LDL-induced cytotoxicity via the ROS-mediated mitochondrial and p53-related apoptotic pathways. Toxicology and applied pharmacology, Sep-15, Volume: 279, Issue: 3	2014
Protection of differentiated neuronal NG108-15 cells from P2X7 receptor-mediated toxicity by taurine. Pharmacological reports : PR, Volume: 66, Issue: 4	2014
Determination of 12 potential nephrotoxicity biomarkers in rat serum and urine by liquid chromatography with mass spectrometry and its application to renal failure induced by Semen Strychni. Journal of separation science, Volume: 37, Issue: 9-10	2014
Activation of PI3K-Akt through taurine is critical for propofol to protect rat cardiomyocytes from doxorubicin-induced toxicity. Canadian journal of physiology and pharmacology, Volume: 92, Issue: 2	2014
Mechanisms of phenytoin-induced toxicity in freshly isolated rat hepatocytes and the protective effects of taurine and/or melatonin. Journal of biochemical and molecular toxicology, Volume: 28, Issue: 3	2014
Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma. Journal of experimental & clinical cancer research : CR, Oct-11, Volume: 32	2013
Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates. Toxicology in vitro : an international journal published in association with BIBRA, Volume: 28, Issue: 2	2014
Mechanisms of trazodone-induced cytotoxicity and the protective effects of melatonin and/or taurine toward freshly isolated rat hepatocytes. Journal of biochemical and molecular toxicology, Volume: 27, Issue: 10	2013
Acamprosate {monocalcium bis(3-acetamidopropane-1-sulfonate)} reduces ethanol-drinking behavior in rats and glutamate-induced toxicity in ethanol-exposed primary rat cortical neuronal cultures. European journal of pharmacology, Oct-15, Volume: 718, Issue: 1-3	2013
Mechanisms underlying taurine protection against glutamate-induced neurotoxicity. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, Volume: 40, Issue: 5	2013
Cytoprotective effects of taurine against toxicity induced by isoniazid and hydrazine in isolated rat hepatocytes. Arhiv za higijenu rada i toksikologiju, Volume: 64, Issue: 2	2013
Major components of energy drinks (caffeine, taurine, and guarana) exert cytotoxic effects on human neuronal SH-SY5Y cells by decreasing reactive oxygen species production. Oxidative medicine and cellular longevity, Volume: 2013	2013
The influence of taurine pretreatment on aluminum chloride induced nephrotoxicity in Swiss albino mice. Histology and histopathology, Volume: 29, Issue: 1	2014
Protective effect of taurine on triorthocresyl phosphate (TOCP)-induced cytotoxicity in C6 glioma cells. Advances in experimental medicine and biology, Volume: 776	2013
The cysteine dioxgenase knockout mouse: altered cysteine metabolism in nonhepatic tissues leads to excess H2S/HS(-) production and evidence of pancreatic and lung toxicity. Antioxidants & redox signaling, Oct-20, Volume: 19, Issue: 12	2013
Taurine attenuates bilirubin-induced neurotoxicity in the auditory system in neonatal guinea pigs. International journal of pediatric otorhinolaryngology, Volume: 77, Issue: 5	2013
Enhancement of acetaminophen-induced chronic hepatotoxicity in restricted fed rats: a nonclinical approach to acetaminophen-induced chronic hepatotoxicity in susceptible patients. The Journal of toxicological sciences, Volume: 37, Issue: 5	2012
Potential protective effect of taurine against dibromoacetonitrile-induced neurotoxicity in rats. Environmental toxicology and pharmacology, Volume: 34, Issue: 3	2012
N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models. Acta ophthalmologica, Volume: 90, Issue: 8	2012
Dietary taurine reduces zinc-induced toxicity in male Wistar rats. Journal of food science, Volume: 76, Issue: 4	2011
Protective effect of taurine on cardiotoxicity of the bufadienolides derived from toad (Bufo bufo gargarizans Canto) venom in guinea-pigs in vivo and in vitro. Toxicology mechanisms and methods, Volume: 22, Issue: 1	2012
The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity. International journal of cancer, Sep-01, Volume: 131, Issue: 5	2012
Understanding and interpreting vision safety issues with vigabatrin therapy. Acta neurologica Scandinavica. Supplementum, Issue: 192	2011
Risk of caffeine toxicity associated with the use of 'legal highs' (novel psychoactive substances). European journal of clinical pharmacology, Volume: 68, Issue: 4	2012
Inhibition of amyloid peptide fragment Aβ25-35 fibrillogenesis and toxicity by N-terminal β-amino acid-containing esapeptides: is taurine moiety essential for in vivo effects? Chemical biology & drug design, Volume: 79, Issue: 1	2012
Prophylactic and therapeutic effects of taurine against aluminum-induced acute hepatotoxicity in mice. Journal of hazardous materials, Aug-30, Volume: 192, Issue: 2	2011
[The cytotoxicity and expression changes of endoplasmic reticulum related genes induced by MWCNTs with different surface modifications]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, Jun-18, Volume: 43, Issue: 3	2011
Protective role of taurine against morphine-induced neurotoxicity in C6 cells via inhibition of oxidative stress. Neurotoxicity research, Volume: 20, Issue: 4	2011
Toxicity of antiseptics against chondrocytes: what is best for the cartilage in septic joint surgery? International orthopaedics, Volume: 35, Issue: 11	2011
Study of acute biochemical effects of thallium toxicity in mouse urine by NMR spectroscopy. Journal of applied toxicology : JAT, Volume: 31, Issue: 7	2011
Pulmonary toxicity in mice exposed to low and medium doses of water-soluble multi-walled carbon nanotubes. Journal of nanoscience and nanotechnology, Volume: 10, Issue: 12	2010
Protection of taurine and granulocyte colony-stimulating factor against excitotoxicity induced by glutamate in primary cortical neurons. Journal of biomedical science, Aug-24, Volume: 17 Suppl 1	2010
Energy drinks: a review of use and safety for athletes. The Physician and sportsmedicine, Volume: 38, Issue: 2	2010
Contrast-induced nephrotoxicity: possible synergistic effect of stress hyperglycemia. AJR. American journal of roentgenology, Volume: 195, Issue: 1	2010
Taurine protects against bilirubin-induced neurotoxicity in vitro. Brain research, Mar-12, Volume: 1320	2010
Effects of MK-801, taurine and dextromethorphan on neurotoxicity caused by manganese in rats. Toxicology and industrial health, Volume: 26, Issue: 1	2010
The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence. Expert opinion on drug safety, Volume: 9, Issue: 1	2010
Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. American journal of physiology. Gastrointestinal and liver physiology, Volume: 297, Issue: 3	2009
[Intervention effect of taurine on neurotoxicity of manganese in rat's prefrontal cortex]. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases, Volume: 26, Issue: 10	2008
Taurine depletion by beta-alanine inhibits induction of hepatotoxicity in mice treated acutely with carbon tetrachloride. Advances in experimental medicine and biology, Volume: 643	2009
Beneficial effect of taurine treatment against doxorubicin-induced cardiotoxicity in mice. Advances in experimental medicine and biology, Volume: 643	2009
Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity. Annals of neurology, Volume: 65, Issue: 1	2009
Evaluations of the trans-sulfuration pathway in multiple liver toxicity studies. Toxicology and applied pharmacology, Feb-15, Volume: 235, Issue: 1	2009
Contribution of methylmercury, polychlorinated biphenyls and organochlorine pesticides to the toxicity of a contaminant mixture based on Canadian Arctic population blood profiles. Toxicology letters, Feb-10, Volume: 184, Issue: 3	2009
Hypotaurine and sulfhydryl-containing antioxidants reduce H2S toxicity in erythrocytes from a marine invertebrate. The Journal of experimental biology, Volume: 211, Issue: Pt 24	2008
Distinct influence of atypical 1,4-dihydropyridine compounds in azidothymidine-induced neuro- and cardiotoxicity in mice ex vivo. Basic & clinical pharmacology & toxicology, Volume: 103, Issue: 5	2008
Hepatoprotective effects of taurine against mercury induced toxicity in rats. Journal of environmental biology, Volume: 28, Issue: 4	2007
Selection of agents for prevention of cisplatin-induced hepatotoxicity. Pharmacological research, Volume: 57, Issue: 2	2008
Taurine attenuates aminoglycoside ototoxicity by inhibiting inducible nitric oxide synthase expression in the cochlea. Neuroreport, Jan-08, Volume: 19, Issue: 1	2008
Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats. Neurochemical research, Volume: 33, Issue: 3	2008
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Metabolomics analysis of the potential mechanism of Yi-Guan-Jian decoction to reverse bone loss in glucocorticoid-induced osteoporosis. Journal of orthopaedic surgery and research, Jun-05, Volume: 18, Issue: 1	2023
LC-MS-based metabolomics reveals metabolic changes in short- and long-term administration of Compound Danshen Dripping Pills against acute myocardial infarction in rats. Phytomedicine : international journal of phytotherapy and phytopharmacology, Volume: 104	2022
Supplementation of taurine improves ionic homeostasis and mitochondrial function in the rats exhibiting post-traumatic stress disorder-like symptoms. European journal of pharmacology, Oct-05, Volume: 908	2021
Taurine enhances voluntary alcohol intake and promotes anxiolytic-like behaviors in rats. Alcohol (Fayetteville, N.Y.), Volume: 88	2020
Differential Metabolomic Analysis of Liver Tissues from Rat Models of Parenteral Nutrition-Associated Liver Disease. BioMed research international, Volume: 2020	2020
Sub-chronic taurine administration induces behavioral sensitization but does not influence ethanol-induced dopamine release in the nucleus accumbens. Pharmacology, biochemistry, and behavior, Volume: 188	2020
Effects of Chronic Intake of a Low Concentration of Taurine on Physical Strength and Body Composition in Mice. Advances in experimental medicine and biology, Volume: 1155	2019
Lipid Profile Changes Induced by Chronic Administration of Anabolic Androgenic Steroids and Taurine in Rats. Medicina (Kaunas, Lithuania), Aug-27, Volume: 55, Issue: 9	2019
Long term treatment of metformin impedes development of chemoresistance by regulating cancer stem cell differentiation through taurine generation in ovarian cancer cells. The international journal of biochemistry & cell biology, Volume: 107	2019
Neuro-metabolite profiles of rodent models of psychiatric dysfunctions characterised by MR spectroscopy. Neuropharmacology, 03-01, Volume: 146	2019
RP-HPLC method for simultaneous estimation of vigabatrin, gamma-aminobutyric acid and taurine in biological samples. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Feb-15, Volume: 1076	2018
Short-term treatment with taurolidine is associated with liver injury. BMC pharmacology & toxicology, 08-11, Volume: 18, Issue: 1	2017
Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation. Neurochemistry international, Volume: 108	2017
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, Volume: 49, Issue: 6	2016
Taurine content in different brain structures during ageing: effect on hippocampal synaptic plasticity. Amino acids, Volume: 48, Issue: 5	2016
Irrigation with N,N-dichloro-2,2-dimethyltaurine (NVC-422) in a citrate buffer maintains urinary catheter patency in vitro and prevents encrustation by Proteus mirabilis. Urolithiasis, Volume: 44, Issue: 3	2016
Taurine is a crucial factor to preserve retinal ganglion cell survival. Advances in experimental medicine and biology, Volume: 775	2013
Neuropsychopharmacological actions of taurine. Advances in experimental medicine and biology, Volume: 775	2013
Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks. Clinical nutrition (Edinburgh, Scotland), Volume: 32, Issue: 4	2013
Influence of chronic administration of anabolic androgenic steroids and taurine on haemostasis profile in rats: a thrombelastographic study. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, Volume: 24, Issue: 3	2013
Pharmacological characterization of GABAA receptors in taurine-fed mice. Journal of biomedical science, Aug-24, Volume: 17 Suppl 1	2010
Taurine trials in animal models offer no support for anxiolytic, antidepressant or stimulant effects. The Israel journal of psychiatry and related sciences, Volume: 45, Issue: 1	2008
[Central hypotensive effect involving neurotransmitters of long-term administration of taurine to stroke-prone spontaneously hypertensive rat]. Masui. The Japanese journal of anesthesiology, Volume: 56, Issue: 2	2007
A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease. Neurology, Nov-28, Volume: 67, Issue: 10	2006
Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone. Addiction biology, Volume: 11, Issue: 1	2006
Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Volume: 28, Issue: 8	2003
Effects of chronic administration of bilobalide on amino acid levels in mouse brain. Cellular and molecular biology (Noisy-le-Grand, France), Volume: 48, Issue: 6	2002
Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free radical biology & medicine, Volume: 26, Issue: 7-8	1999
Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers. The Journal of pharmacology and experimental therapeutics, Volume: 286, Issue: 3	1998
Effects of muscimol or homotaurine on sleep-wake states in alcohol-dependent rats during withdrawal. Pharmacology, biochemistry, and behavior, Volume: 59, Issue: 4	1998
Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Volume: 18, Issue: 2	1998
Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine. European journal of pharmacology, May-06, Volume: 303, Issue: 1-2	1996
Reduced taurine contents and modification of anticonvulsive effects of phenobarbital and phenytoin by guanidinoethane sulfonate in mice. Progress in clinical and biological research, Volume: 179	1985
Modification of the antiepileptic actions of phenobarbital and phenytoin by the taurine transport inhibitor, guanidinoethane sulfonate. European journal of pharmacology, Apr-02, Volume: 110, Issue: 2	1985
Effects of long term alcohol ingestion on glutathione metabolising enzymes and taurine contents in the myocardium of rats. Cardiovascular research, Volume: 20, Issue: 12	1986
Valproate doubles the anoxic survival time of normal developing mice: possible relevance to valproate-induced decreases in cerebral levels of glutamate and aspartate, and increases in taurine. Life sciences, Volume: 45, Issue: 1	1989
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Effects of Zinc, Manganese, and Taurine on Egg Shell Microstructure in Commercial Laying Hens After Peak Production. Biological trace element research, Volume: 201, Issue: 6	2023
Two high-performance liquid chromatography-tandem mass spectrometry methods for determination of edaravone and taurine in human plasma: Application to drug-drug interaction and pharmacokinetic studies. Journal of separation science, Volume: 43, Issue: 12	2020
RNAi screening of subtracted transcriptomes reveals tumor suppression by taurine-activated GABAA receptors involved in volume regulation. PloS one, Volume: 13, Issue: 5	2018
Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease. Clinical pharmacokinetics, Volume: 57, Issue: 3	2018
Oral and intravenous pharmacokinetics of taurine in sprague-dawley rats: the influence of dose and the possible involvement of the proton-coupled amino acid transporter, PAT1, in oral taurine absorption. Physiological reports, Volume: 5, Issue: 19	2017
Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data. CNS drugs, Volume: 31, Issue: 6	2017
Investigation of LRRC8-Mediated Volume-Regulated Anion Currents in Xenopus Oocytes. Biophysical journal, Oct-04, Volume: 111, Issue: 7	2016
Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment. Journal of Alzheimer's disease : JAD, Volume: 50, Issue: 3	2016
Protolichesterinic Acid, Isolated from the Lichen Cetraria islandica, Reduces LRRC8A Expression and Volume-Sensitive Release of Organic Osmolytes in Human Lung Epithelial Cancer Cells. Phytotherapy research : PTR, Volume: 30, Issue: 1	2016
Pharmacokinetics and bioequivalence evaluation of acamprosate calcium tablets in healthy Chinese volunteers. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Nov-15, Volume: 79	2015
Amino Acid Correction of Regulatory Volume Decrease Evoked by Hypotonic Stress in Mouse Oocytes In Vitro. Bulletin of experimental biology and medicine, Volume: 159, Issue: 1	2015
Regulatory volume decrease in neural precursor cells: taurine efflux and gene microarray analysis. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Volume: 34, Issue: 6	2014
Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker. Journal of psychiatric research, Volume: 59	2014
Acquired cisplatin resistance in human ovarian A2780 cancer cells correlates with shift in taurine homeostasis and ability to volume regulate. American journal of physiology. Cell physiology, Dec-15, Volume: 307, Issue: 12	2014
Characteristics and roles of the volume-sensitive outwardly rectifying (VSOR) anion channel in the central nervous system. Neuroscience, Sep-05, Volume: 275	2014
Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC. Science (New York, N.Y.), May-09, Volume: 344, Issue: 6184	2014
Glycine modulates membrane potential, cell volume, and phagocytosis in murine microglia. Amino acids, Volume: 46, Issue: 8	2014
LC-MS/MS methods for the determination of edaravone and/or taurine in rat plasma and its application to a pharmacokinetic study. Biomedical chromatography : BMC, Volume: 28, Issue: 9	2014
Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma. Journal of experimental & clinical cancer research : CR, Oct-11, Volume: 32	2013
Anoctamin 6 differs from VRAC and VSOAC but is involved in apoptosis and supports volume regulation in the presence of Ca2+. Pflugers Archiv : European journal of physiology, Volume: 466, Issue: 10	2014
Volume-sensitive release of organic osmolytes in the human lung epithelial cell line A549: role of the 5-lipoxygenase. American journal of physiology. Cell physiology, Jul-01, Volume: 305, Issue: 1	2013
Digestive cells from Mytilus galloprovincialis show a partial regulatory volume decrease following acute hypotonic stress through mechanisms involving inorganic ions. Cell biochemistry and function, Volume: 31, Issue: 6	2013
Influence of WNK3 on intracellular chloride concentration and volume regulation in HEK293 cells. Pflugers Archiv : European journal of physiology, Volume: 464, Issue: 3	2012
Fetal and neonatal iron deficiency causes volume loss and alters the neurochemical profile of the adult rat hippocampus. Nutritional neuroscience, Volume: 14, Issue: 2	2011
Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration. British journal of pharmacology, Volume: 164, Issue: 7	2011
Specificity of the volume-activated amino acid efflux pathway in cultured human breast cancer cells. General physiology and biophysics, Volume: 30, Issue: 1	2011
Regulatory volume response following hypotonic stress in Atlantic salmon erythrocytes. Fish physiology and biochemistry, Volume: 37, Issue: 4	2011
Precolumn derivatization followed by liquid chromatographic separation and determination of tramiprosate in rat plasma by fluorescence detector: application to pharmacokinetics. Journal of pharmaceutical and biomedical analysis, May-15, Volume: 55, Issue: 2	2011
A LC-MS analysis of acamprosate from human plasma: pharmacokinetic application. Drug testing and analysis, Volume: 3, Issue: 10	2011
Regulatory volume decrease and P receptor signaling in fish cells: mechanisms, physiology, and modeling approaches. Journal of experimental zoology. Part A, Ecological genetics and physiology, Apr-01, Volume: 315, Issue: 4	2011
Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography-mass spectroscopy: a pharmacokinetic study in healthy volunteers. Therapeutic drug monitoring, Volume: 32, Issue: 4	2010
Pharmacokinetics of acamprosate calcium in healthy Chinese subjects after oral administration of three dosage levels. Arzneimittel-Forschung, Volume: 59, Issue: 12	2009
Cell volume control in phospholemman (PLM) knockout mice: do cardiac myocytes demonstrate a regulatory volume decrease and is this influenced by deletion of PLM? Experimental physiology, Volume: 94, Issue: 3	2009
Cell volume regulation: physiology and pathophysiology. Acta physiologica (Oxford, England), Volume: 194, Issue: 4	2008
Quantification of astrocyte volume changes during ischemia in situ reveals two populations of astrocytes in the cortex of GFAP/EGFP mice. Journal of neuroscience research, Volume: 87, Issue: 1	2009
Volume-sensitive NADPH oxidase activity and taurine efflux in NIH3T3 mouse fibroblasts. American journal of physiology. Cell physiology, Volume: 294, Issue: 6	2008
Volume expansion stimulates monoubiquitination and endocytosis of surface-expressed skate anion-exchanger isoform. American journal of physiology. Regulatory, integrative and comparative physiology, Volume: 294, Issue: 5	2008
Cholesterol regulates volume-sensitive osmolyte efflux from human SH-SY5Y neuroblastoma cells following receptor activation. The Journal of pharmacology and experimental therapeutics, Volume: 324, Issue: 2	2008
Regulatory volume decrease after swelling induced by urea in fibroblasts: prominent role of organic osmolytes. Molecular and cellular biochemistry, Volume: 306, Issue: 1-2	2007
Activation and inactivation of the volume-sensitive taurine leak pathway in NIH3T3 fibroblasts and Ehrlich Lettre ascites cells. American journal of physiology. Cell physiology, Volume: 293, Issue: 1	2007
Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients. Clinical pharmacokinetics, Volume: 46, Issue: 6	2007
The pharmacokinetics of taurolidine metabolites in healthy volunteers. Journal of clinical pharmacology, Volume: 47, Issue: 6	2007
Cell volume regulation in the perfused liver of a freshwater air-breathing cat fish Clarias batrachus under aniso-osmotic conditions: roles of inorganic ions and taurine. Journal of biosciences, Volume: 31, Issue: 5	2006
Receptor regulation of the volume-sensitive efflux of taurine and iodide from human SH-SY5Y neuroblastoma cells: differential requirements for Ca(2+) and protein kinase C. The Journal of pharmacology and experimental therapeutics, Volume: 320, Issue: 3	2007
Aquaporin expression and cell volume regulation in the SV40 immortalized rat submandibular acinar cell line. Pflugers Archiv : European journal of physiology, Volume: 453, Issue: 6	2007
Prostanoid receptors regulate the volume-sensitive efflux of osmolytes from murine fibroblasts via a cyclic AMP-dependent mechanism. The Journal of pharmacology and experimental therapeutics, Volume: 319, Issue: 2	2006
Osmoregulation of taurine efflux from cultured human breast cancer cells: comparison with volume activated Cl- efflux and regulation by extracellular ATP. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Volume: 18, Issue: 1-3	2006
Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats. Biopharmaceutics & drug disposition, Volume: 27, Issue: 7	2006
Regulation of volume-sensitive osmolyte efflux from human SH-SY5Y neuroblastoma cells following activation of lysophospholipid receptors. The Journal of pharmacology and experimental therapeutics, Volume: 317, Issue: 2	2006
Subnanomolar concentrations of thrombin enhance the volume-sensitive efflux of taurine from human 1321N1 astrocytoma cells. The Journal of pharmacology and experimental therapeutics, Volume: 315, Issue: 2	2005
Differences in the metabolism and pharmacokinetics of two structurally similar PPAR agonists in dogs: involvement of taurine conjugation. Xenobiotica; the fate of foreign compounds in biological systems, Volume: 34, Issue: 7	2004
Tyrosine kinase inhibition affects skate anion exchanger isoform I alterations after volume expansion. American journal of physiology. Regulatory, integrative and comparative physiology, Volume: 288, Issue: 4	2005
Activation and inactivation of volume-sensitive taurine efflux from rat mammary gland. Molecular and cellular biochemistry, Volume: 262, Issue: 1-2	2004
Role of volume-stimulated osmolyte and anion channels in volume regulation by mammalian sperm. Molecular human reproduction, Volume: 10, Issue: 11	2004
Synthesis and assessment of [11C]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography. Nuclear medicine and biology, Volume: 31, Issue: 5	2004
Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra. Stroke, Volume: 35, Issue: 5	2004
Differential effects of pyrethroids on volume-sensitive anion and organic osmolyte pathways. Clinical and experimental pharmacology & physiology, Volume: 31, Issue: 3	2004
Volume changes and whole cell membrane currents activated during gradual osmolarity decrease in C6 glioma cells: contribution of two types of K+ channels. American journal of physiology. Cell physiology, Volume: 286, Issue: 6	2004
Potentiation of the osmosensitive taurine release and cell volume regulation by cytosolic Ca2+ rise in cultured cerebellar astrocytes. Glia, Volume: 44, Issue: 2	2003
Activation of muscarinic cholinergic receptors enhances the volume-sensitive efflux of myo-inositol from SH-SY5Y neuroblastoma cells. Journal of neurochemistry, Volume: 87, Issue: 2	2003
Taurine enhances volume regulation in hippocampal slices swollen osmotically. Neuroscience, Volume: 120, Issue: 3	2003
Influence of protein tyrosine kinases on cell volume change-induced taurine release. Cerebellum (London, England), Volume: 1, Issue: 2	2002
Human sperm volume regulation. Response to physiological changes in osmolality, channel blockers and potential sperm osmolytes. Human reproduction (Oxford, England), Volume: 18, Issue: 5	2003
Fast U-FLARE-based correlation-peak imaging with complete effective homonuclear decoupling. Magnetic resonance in medicine, Volume: 49, Issue: 5	2003
Proton MR spectroscopy demonstration of taurine peaks in megalencephalic leukoencephalopathy with cysts. Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society, Volume: 27, Issue: 1	2003
Mechanism of the reduced elimination clearance of benzylpenicillin from cerebrospinal fluid in rats with intracisternal administration of lipopolysaccharide. Drug metabolism and disposition: the biological fate of chemicals, Volume: 30, Issue: 11	2002
A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Volume: 27, Issue: 4	2002
Rho family GTP binding proteins are involved in the regulatory volume decrease process in NIH3T3 mouse fibroblasts. The Journal of physiology, Jun-15, Volume: 541, Issue: Pt 3	2002
Effects of calcium, calmodulin, protein kinase C and protein tyrosine kinases on volume-activated taurine efflux in human erythroleukemia cells. Journal of cellular physiology, Volume: 189, Issue: 3	2001
S-adenosyl-L-methionine N-ole-1-oyltaurate: pharmacokinetic of the orally administered salt in rats. International journal of pharmaceutics, Nov-06, Volume: 230, Issue: 1-2	2001
Isovolumetric regulation mechanisms in cultured cerebellar granule neurons. Journal of neurochemistry, Volume: 79, Issue: 1	2001
The role of a swelling-activated taurine transport pathway in the regulation of articular chondrocyte volume. Pflugers Archiv : European journal of physiology, Volume: 442, Issue: 5	2001
Volume-activated trimethylamine oxide efflux in red blood cells of spiny dogfish (Squalus acanthias). American journal of physiology. Regulatory, integrative and comparative physiology, Volume: 281, Issue: 3	2001
High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer research, Jul-15, Volume: 61, Issue: 14	2001
Riluzole reduces brain swelling and contusion volume in rats following controlled cortical impact injury. Journal of neurotrauma, Volume: 17, Issue: 12	2000
Different physiological mechanisms control isovolumetric regulation and regulatory volume decrease in chick embryo cardiomyocytes. Cell biology international, Volume: 24, Issue: 10	2000
Pharmacological characterization of volume-sensitive, taurine permeable anion channels in rat supraoptic glial cells. British journal of pharmacology, Volume: 130, Issue: 8	2000
Fast echo planar based correlation-peak imaging: demonstration on the rat brain in vivo. Magnetic resonance in medicine, Volume: 44, Issue: 1	2000
Inhibition of volume-stimulated taurine efflux and tyrosine kinase activity in the skate red blood cell. Pflugers Archiv : European journal of physiology, Volume: 440, Issue: 1	2000
Volume-sensitive amino acid efflux from a pancreatic beta-cell line. Molecular and cellular endocrinology, Apr-25, Volume: 162, Issue: 1-2	2000
Volume sensitive efflux of taurine in HEK293 cells overexpressing phospholemman. Biochimica et biophysica acta, Apr-17, Volume: 1496, Issue: 2-3	2000
Further evidence for the existence of a volume-activated taurine efflux pathway in rat mammary tissue independent from volume-sensitive Cl- channels. Acta physiologica Scandinavica, Volume: 168, Issue: 2	2000
Tyrosine phosphorylation modulates the osmosensitivity of volume-dependent taurine efflux from glial cells in the rat supraoptic nucleus. The Journal of physiology, Mar-01, Volume: 523 Pt 2	2000
Cell volume regulation: the role of taurine loss in maintaining membrane potential and cell pH. The Journal of physiology, Feb-15, Volume: 523 Pt 1	2000
Volume-dependent taurine release from cultured astrocytes requires permissive [Ca(2+)](i) and calmodulin. The American journal of physiology, Volume: 277, Issue: 4	1999
Separate taurine and chloride efflux pathways activated during regulatory volume decrease. The American journal of physiology, Volume: 277, Issue: 3	1999
Cell volume regulatory mechanisms in apoptotic cell death. Herz, Volume: 24, Issue: 3	1999
Activation and inactivation of taurine efflux in hyposmotic and isosmotic swelling in cortical astrocytes: role of ionic strength and cell volume decrease. Journal of neuroscience research, Jun-15, Volume: 56, Issue: 6	1999
Effects of ammonia in vitro on endogenous taurine efflux and cell volume in rat cerebrocortical minislices: influence of inhibitors of volume-sensitive amino acid transport. Neuroscience, Volume: 91, Issue: 2	1999
Regulatory volume response of erythrocytes exposed to a gradual and slow decrease in medium osmolality. Pflugers Archiv : European journal of physiology, Volume: 437, Issue: 5	1999
Volume-regulated anion and organic osmolyte channels in mouse zygotes. Biology of reproduction, Volume: 60, Issue: 4	1999
Volume expansion stimulates p72(syk) and p56(lyn) in skate erythrocytes. The Journal of biological chemistry, Mar-19, Volume: 274, Issue: 12	1999
Swelling activation of transport pathways in erythrocytes: effects of Cl-, ionic strength, and volume changes. The American journal of physiology, Volume: 276, Issue: 1	1999
The role of taurine in the regulation of brain cell volume in chronically hyponatraemic rats. Neurochemistry international, Volume: 33, Issue: 5	1998
Clinical pharmacokinetics of acamprosate. Clinical pharmacokinetics, Volume: 35, Issue: 5	1998
Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells. British journal of pharmacology, Volume: 125, Issue: 4	1998
Methylmercury-induced inhibition of regulatory volume decrease in astrocytes: characterization of osmoregulator efflux and its reversal by amiloride. Brain research, Nov-16, Volume: 811, Issue: 1-2	1998
Corticosterone peak is responsible for stress-induced elevation of glutamate in the hippocampus. Stress (Amsterdam, Netherlands), Volume: 2, Issue: 3	1998
Effects of NaCl removal on osmolyte fluxes and regulatory volume decrease in cultured astrocytes. Journal of neuroscience research, Jul-15, Volume: 53, Issue: 2	1998
Taurine efflux and intracellular pH during astrocyte volume regulation. Advances in experimental medicine and biology, Volume: 442	1998
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
The Impact of Taurine on Obesity-Induced Diabetes Mellitus: Mechanisms Underlying Its Effect. Endocrinology and metabolism (Seoul, Korea), Volume: 38, Issue: 5	2023
Combination of resveratrol and luteolin ameliorates α-naphthylisothiocyanate-induced cholestasis by regulating the bile acid homeostasis and suppressing oxidative stress. Food & function, Jul-04, Volume: 13, Issue: 13	2022
Modulation of endothelium-derived nitric oxide production and activity by taurine and taurine-conjugated bile acids. Nitric oxide : biology and chemistry, 01-01, Volume: 94	2020
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology, Volume: 96, Issue: 5	2019
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. The Journal of biological chemistry, 11-15, Volume: 294, Issue: 46	2019
Taurine Regulation of Neuroendocrine Function. Advances in experimental medicine and biology, Volume: 1155	2019
Special topic: The association between pulse ingredients and canine dilated cardiomyopathy: addressing the knowledge gaps before establishing causation. Journal of animal science, 03-01, Volume: 97, Issue: 3	2019
Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain. CNS drugs, Volume: 32, Issue: 9	2018
Improvement of the Solubility and Intestinal Absorption of Curcumin by N-Acyl Taurates and Elucidation of the Absorption-Enhancing Mechanisms. Biological & pharmaceutical bulletin, Volume: 40, Issue: 12	2017
Regional dysregulation of taurine and related amino acids in the fetal rat brain following gestational alcohol exposure. Alcohol (Fayetteville, N.Y.), Volume: 66	2018
Arachidonic acid with taurine enhances pulmonary absorption of macromolecules without any serious histopathological damages. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, Volume: 114	2017
FRET-based dual-emission and pH-responsive nanocarriers for enhanced delivery of protein across intestinal epithelial cell barrier. ACS applied materials & interfaces, Oct-22, Volume: 6, Issue: 20	2014
Taurine supplementation reduces blood pressure and prevents endothelial dysfunction and oxidative stress in post-weaning protein-restricted rats. PloS one, Volume: 9, Issue: 8	2014
Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release. British journal of pharmacology, Volume: 169, Issue: 3	2013
Novel metabolites and roles for α-tocopherol in humans and mice discovered by mass spectrometry-based metabolomics. The American journal of clinical nutrition, Volume: 96, Issue: 4	2012
Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration. British journal of pharmacology, Volume: 164, Issue: 7	2011
Comparative study of taurine and tauropyrone: GABA receptor binding, mitochondrial processes and behaviour. The Journal of pharmacy and pharmacology, Volume: 63, Issue: 2	2011
Copper-taurine (CT): a potential organic compound to facilitate infected wound healing. Medical hypotheses, Volume: 73, Issue: 6	2009
Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets. Archives of pharmacal research, Volume: 31, Issue: 6	2008
Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats. Biopharmaceutics & drug disposition, Volume: 27, Issue: 7	2006
Comparative species utilization and toxicity of sulfur amino acids. The Journal of nutrition, Volume: 136, Issue: 6 Suppl	2006
Optimization of suppository preparation containing sodium laurate and taurine that can safely improve rectal absorption of rebamipide. Biological & pharmaceutical bulletin, Volume: 29, Issue: 2	2006
Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine. Journal of controlled release : official journal of the Controlled Release Society, Sep-14, Volume: 99, Issue: 1	2004
Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Volume: 22, Issue: 5	2004
Taurine status in normal dogs fed a commercial diet associated with taurine deficiency and dilated cardiomyopathy. Journal of animal physiology and animal nutrition, Volume: 87, Issue: 9-10	2003
Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages. Journal of pharmaceutical sciences, Volume: 92, Issue: 4	2003
S-adenosyl-L-methionine N-ole-1-oyltaurate: pharmacokinetic of the orally administered salt in rats. International journal of pharmaceutics, Nov-06, Volume: 230, Issue: 1-2	2001
Taurine as a universal carrier of lipid soluble vitamins: a hypothesis. Amino acids, Volume: 19, Issue: 2	2000
Influence of oral beta-alanine and L-histidine supplementation on the carnosine content of the gluteus medius. Equine veterinary journal. Supplement, Issue: 30	1999
Interaction of taurine on baclofen intestinal absorption: a nonlinear mathematical treatment using differential equations to describe kinetic inhibition models. Journal of pharmaceutical sciences, Volume: 85, Issue: 11	1996
Carrier-mediated jejunal absorption of conjugated bile acids in the guinea pig. Gastroenterology, Volume: 110, Issue: 4	1996
Effect of taurine, L-glutamine and L-histidine addition in an amino acid glucose solution on the cellular bioavailability of zinc. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, Volume: 7, Issue: 3	1994
Assessment of the nutritional adequacy of pet foods through the life cycle. The Journal of nutrition, Volume: 124, Issue: 12 Suppl	1994
Bioavailability of orally administered zinc, using Taurizine. Pharmaceutisch weekblad. Scientific edition, Feb-21, Volume: 8, Issue: 1	1986
Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations. European journal of cancer & clinical oncology, Volume: 24, Issue: 8	1988
Urinary taurine excretion as a function of taurine intake in adult cats. The Journal of nutrition, Volume: 122, Issue: 5	1992
Urinary excretion of taurine as a function of taurine intake: potential for estimating taurine bioavailability in the adult cat. Advances in experimental medicine and biology, Volume: 315	1992
Metabolism of [35S]taurine in man. The Journal of nutrition, Volume: 105, Issue: 9	1975
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Exploring the physiological plasticity of giant grouper (Epinephelus lanceolatus) to dietary sulfur amino acids and taurine to measure dietary requirements and essentiality. Fish physiology and biochemistry, Volume: 49, Issue: 5	2023
Exploring the potential of taurolidine in inducing mobilization and detachment of colon cancer cells: a preliminary in-vitro study. BMC pharmacology & toxicology, 06-13, Volume: 23, Issue: 1	2022
Urinary Metabolomics From a Dose-Fractionated Polymyxin B Rat Model of Acute Kidney Injury. International journal of antimicrobial agents, Volume: 60, Issue: 1	2022
Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials. European journal of clinical nutrition, Volume: 76, Issue: 5	2022
Taurine upregulates insulin signaling and mitochondrial metabolism in vitro but not in adipocytes of obese women. Nutrition (Burbank, Los Angeles County, Calif.), Volume: 93	2022
Taurine in sports and exercise. Journal of the International Society of Sports Nutrition, May-26, Volume: 18, Issue: 1	2021
9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model. Neuropharmacology, 12-15, Volume: 181	2020
The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials. European journal of pharmacology, Oct-15, Volume: 885	2020
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval. Alzheimer's research & therapy, 08-12, Volume: 12, Issue: 1	2020
The Production of a Rat Model That Inhibits Phosphoenolpyruvate Carboxykinase (PEPCK), a Rate-Limiting Enzyme of Hepatic Gluconeogenesis. Advances in experimental medicine and biology, Volume: 1155	2019
Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC). World journal of surgical oncology, Jun-03, Volume: 17, Issue: 1	2019
Biomarkers of oxidative stress, inflammation, and vascular dysfunction in inherited cystathionine β-synthase deficient homocystinuria and the impact of taurine treatment in a phase 1/2 human clinical trial. Journal of inherited metabolic disease, Volume: 42, Issue: 3	2019
Common Ingredient Profiles of Multi-Ingredient Pre-Workout Supplements. Nutrients, Jan-24, Volume: 11, Issue: 2	2019
Multi-Omics Study on the Impact of Cysteine Feed Level on Cell Viability and mAb Production in a CHO Bioprocess. Biotechnology journal, Volume: 14, Issue: 4	2019
Taurine-magnesium coordination compound, a potential anti-arrhythmic complex, improves aconitine-induced arrhythmias through regulation of multiple ion channels. Toxicology and applied pharmacology, 10-01, Volume: 356	2018
One step preparation of polymeric maltitol particles, from a sugar molecule, maltitol for biomedical applications. Materials science & engineering. C, Materials for biological applications, Aug-01, Volume: 89	2018
Effects of taurine on striatal dopamine transporter expression and dopamine uptake in SHR rats. Behavioural brain research, 08-01, Volume: 348	2018
Antigonadal and endocrine-disrupting activities of lambda cyhalothrin in female rats and its attenuation by taurine. Toxicology and industrial health, Volume: 34, Issue: 3	2018
Taurine as a protective agent for 5-fluorouracil-induced hepatic damage related to oxidative stress. Die Pharmazie, Sep-01, Volume: 71, Issue: 9	2016
Acamprosate rescues neuronal defects in the Drosophila model of Fragile X Syndrome. Life sciences, Feb-15, Volume: 195	2018
Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction. PloS one, Volume: 12, Issue: 11	2017
In-vitro examination of the positive inotropic effect of caffeine and taurine, the two most frequent active ingredients of energy drinks. BMC cardiovascular disorders, 08-10, Volume: 17, Issue: 1	2017
Taurine promotes cognitive function in prenatally stressed juvenile rats via activating the Akt-CREB-PGC1α pathway. Redox biology, Volume: 10	2016
Pharmacokinetics and bioequivalence evaluation of acamprosate calcium tablets in healthy Chinese volunteers. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Nov-15, Volume: 79	2015
(1)H NMR-Based Metabolomics and Neurotoxicity Study of Cerebrum and Cerebellum in Rats Treated with Cinnabar, a Traditional Chinese Medicine. Omics : a journal of integrative biology, Volume: 19, Issue: 8	2015
Acamprosate: A Review of Its Use in Alcohol Dependence. Drugs, Volume: 75, Issue: 11	2015
Reduced plasma taurine level in Parkinson's disease: association with motor severity and levodopa treatment. The International journal of neuroscience, Volume: 126, Issue: 7	2016
Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA, May-14, Volume: 311, Issue: 18	2014
Metabolic characterization of all-trans-retinoic acid (ATRA)-induced craniofacial development of murine embryos using in vivo proton magnetic resonance spectroscopy. PloS one, Volume: 9, Issue: 5	2014
Alterations in sulfur amino acid metabolism in mice treated with silymarin: a novel mechanism of its action involved in enhancement of the antioxidant defense in liver. Planta medica, Volume: 79, Issue: 12	2013
Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction (Abingdon, England), Volume: 108, Issue: 2	2013
Enhancement of acetaminophen-induced chronic hepatotoxicity in restricted fed rats: a nonclinical approach to acetaminophen-induced chronic hepatotoxicity in susceptible patients. The Journal of toxicological sciences, Volume: 37, Issue: 5	2012
Potential protective effect of taurine against dibromoacetonitrile-induced neurotoxicity in rats. Environmental toxicology and pharmacology, Volume: 34, Issue: 3	2012
Novel metabolites and roles for α-tocopherol in humans and mice discovered by mass spectrometry-based metabolomics. The American journal of clinical nutrition, Volume: 96, Issue: 4	2012
Behavioral effects of taurine pretreatment in zebrafish acutely exposed to ethanol. Neuropharmacology, Volume: 63, Issue: 4	2012
Acute effects of methiocarb on oxidative damage and the protective effects of vitamin E and taurine in the liver and kidney of Wistar rats. Toxicology and industrial health, Volume: 29, Issue: 1	2013
Prophylactic and therapeutic effects of taurine against aluminum-induced acute hepatotoxicity in mice. Journal of hazardous materials, Aug-30, Volume: 192, Issue: 2	2011
Pulmonary toxicity in mice exposed to low and medium doses of water-soluble multi-walled carbon nanotubes. Journal of nanoscience and nanotechnology, Volume: 10, Issue: 12	2010
Acamprosate calcium as augmentation therapy for anxiety disorders. The Annals of pharmacotherapy, Volume: 44, Issue: 12	2010
Investigation of toxicological effects of Shuanghuanglian injection in Beagle dogs by metabonomic and traditional approaches. Experimental biology and medicine (Maywood, N.J.), Volume: 235, Issue: 11	2010
Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide. Journal of biomedical science, Aug-24, Volume: 17 Suppl 1	2010
Intracisternal or intrathecal glycine, taurine, or muscimol inhibit bicuculline-induced allodynia and thermal hyperalgesia in mice. Acta pharmacologica Sinica, Volume: 31, Issue: 8	2010
Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography-mass spectroscopy: a pharmacokinetic study in healthy volunteers. Therapeutic drug monitoring, Volume: 32, Issue: 4	2010
Reduced de novo synthesis of 5-methyltetrahydrofolate and reduced taurine levels in ethanol-treated chick brains. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, Volume: 152, Issue: 3	2010
The role of small molecular weight compounds to increase vacuolation induced by VacA toxin in vitro. Toxicology in vitro : an international journal published in association with BIBRA, Volume: 24, Issue: 5	2010
Hypoglycemic and hypolipidemic effects of an aqueous extract of Chamaerops humilis leaves in obese, hyperglycemic and hyperlipidemic Meriones shawi rats. Pakistan journal of pharmaceutical sciences, Volume: 23, Issue: 2	2010
Pharmacokinetics of acamprosate calcium in healthy Chinese subjects after oral administration of three dosage levels. Arzneimittel-Forschung, Volume: 59, Issue: 12	2009
Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study. The journal of nutrition, health & aging, Volume: 13, Issue: 6	2009
[Antagonism for different doses of taurine on calcium overload in myocardial cells of diastole heart failure rat model]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 34, Issue: 3	2009
Exogenous folate ameliorates ethanol-induced brain hyperhomocysteinemia and exogenous ethanol reduces taurine levels in chick embryos. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, Volume: 150, Issue: 1	2009
Evaluations of the trans-sulfuration pathway in multiple liver toxicity studies. Toxicology and applied pharmacology, Feb-15, Volume: 235, Issue: 1	2009
Contribution of methylmercury, polychlorinated biphenyls and organochlorine pesticides to the toxicity of a contaminant mixture based on Canadian Arctic population blood profiles. Toxicology letters, Feb-10, Volume: 184, Issue: 3	2009
Prevention of epilepsy by taurine treatments in mice experimental model. Journal of neuroscience research, May-01, Volume: 87, Issue: 6	2009
Taurine supplementation modulates glucose homeostasis and islet function. The Journal of nutritional biochemistry, Volume: 20, Issue: 7	2009
Tolerability of N-chlorotaurine plus ammonium chloride in the rabbit and human eye--a phase 1 clinical study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, Volume: 246, Issue: 12	2008
[Metabonomics profile of urine from rats administrated with different treatment period of isoniazid]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, Volume: 29, Issue: 6	2007
Tolerability of N-chlorotaurine in the bovine mammary gland. The Journal of dairy research, Volume: 75, Issue: 2	2008
Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics. Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine,Fall, Volume: 20, Issue: 3	2007
Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia. Cellular and molecular neurobiology, Volume: 28, Issue: 4	2008
Application of metabonomics in a comparative profiling study reveals N-acetylfelinine excretion as a biomarker for inhibition of the farnesyl pathway by bisphosphonates. Chemical research in toxicology, Volume: 20, Issue: 9	2007
The effect of taurine on polymorphonuclear leukocyte functions in endotoxemia. Amino acids, Volume: 33, Issue: 4	2007
Absorption, tissue distribution, metabolism and elimination of taurine given orally to rats. Amino acids, Volume: 32, Issue: 4	2007
Natural approaches to epilepsy. Alternative medicine review : a journal of clinical therapeutic, Volume: 12, Issue: 1	2007
Comparative species utilization and toxicity of sulfur amino acids. The Journal of nutrition, Volume: 136, Issue: 6 Suppl	2006
Modulation of inhibitory glycine receptors in cultured embryonic mouse hippocampal neurons by zinc, thiol containing redox agents and carnosine. Neuroscience, Volume: 139, Issue: 4	2006
Involvement of taurine in penicillin-induced epilepsy and anti-convulsion of acupuncture: a preliminary report. Acupuncture & electro-therapeutics research, Volume: 30, Issue: 1-2	2005
Rationale for combining acamprosate and naltrexone for treating alcohol dependence. Journal of studies on alcohol. Supplement, Issue: 15	2005
Enhancing effect of taurine on CYP7A1 mRNA expression in Hep G2 cells. Amino acids, Volume: 30, Issue: 1	2006
[Inhibition of proliferation of hepatic stellate cells by taurine is mediated via regulating cell cycle proteins]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, Volume: 13, Issue: 8	2005
Differences in the metabolism and pharmacokinetics of two structurally similar PPAR agonists in dogs: involvement of taurine conjugation. Xenobiotica; the fate of foreign compounds in biological systems, Volume: 34, Issue: 7	2004
[Effects of tianma gouteng fang on transmitter amino acids in the hippocampus extracellular liquids in freely moving rats subjected to brain ischemia]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 29, Issue: 11	2004
The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research, Nov-15, Volume: 10, Issue: 22	2004
Discriminative stimulus effects of ethanol: lack of interaction with taurine. Behavioural pharmacology, Volume: 15, Issue: 7	2004
Taurine restores ethanol-induced depletion of antioxidants and attenuates oxidative stress in rat tissues. Amino acids, Volume: 27, Issue: 1	2004
Alcohol effects during acamprosate treatment: a dose-response study in humans. Alcoholism, clinical and experimental research, Volume: 28, Issue: 7	2004
Spectral editing and pattern recognition methods applied to high-resolution magic-angle spinning 1H nuclear magnetic resonance spectroscopy of liver tissues. Analytical biochemistry, Dec-01, Volume: 323, Issue: 1	2003
Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods. Alcoholism, clinical and experimental research, Volume: 27, Issue: 7	2003
An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria. Archives of toxicology, Volume: 77, Issue: 4	2003
Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementations. Free radical research, Volume: 37, Issue: 3	2003
Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages. Journal of pharmaceutical sciences, Volume: 92, Issue: 4	2003
Guanidinoethyl sulphonate is a glycine receptor antagonist in striatum. British journal of pharmacology, Volume: 137, Issue: 6	2002
Taurine modulates antioxidant potential and controls lipid peroxidation in the aorta of high fructose-fed rats. Journal of biochemistry, molecular biology, and biophysics : JBMBB : the official journal of the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB), Volume: 6, Issue: 2	2002
[Effects of aluminum on amino acid neurotransmitters in hippocampus of rats]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], Volume: 35, Issue: 6	2001
Taurine selectively modulates the secretory activity of vasopressin neurons in conscious rats. The European journal of neuroscience, Volume: 14, Issue: 7	2001
Taurine protects against carbon tetrachloride toxicity in the cultured neurons and in vivo. Archives of physiology and biochemistry, Volume: 109, Issue: 1	2001
[Pharmacological effects of zhenzhu jingmu oral liquid]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 22, Issue: 7	1997
Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology, Volume: 149, Issue: 4	2000
Taurine blocks ATP-sensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor. British journal of pharmacology, Volume: 130, Issue: 4	2000
The role of taurine in neuronal protection following transient global forebrain ischemia. Neurochemical research, Volume: 25, Issue: 2	2000
Monochloramine-induced cytolysis to cultured rat gastric mucosal cells: role of glutathione and iron in protection and injury. The Journal of laboratory and clinical medicine, Volume: 134, Issue: 4	1999
In vivo studies on chiral inversion and amino acid conjugation of 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid in rats and dogs. Drug metabolism and disposition: the biological fate of chemicals, Volume: 27, Issue: 1	1999
Is there a correlation between taurine levels and xenobiotic-induced perturbations in protein synthesis?: a study with tetracycline in rats. Amino acids, Volume: 15, Issue: 1-2	1998
The effects of the beta 2-agonist drug clenbuterol on taurine levels in heart and other tissues in the rat. Amino acids, Volume: 15, Issue: 1-2	1998
Clinical pharmacokinetics of acamprosate. Clinical pharmacokinetics, Volume: 35, Issue: 5	1998
Advances in development of medications for alcoholism treatment. Psychopharmacology, Volume: 139, Issue: 1-2	1998
Stereoselective determination of R,S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid and its taurine conjugates in dog urine by high-performance liquid chromatography. Journal of chromatography. B, Biomedical sciences and applications, May-08, Volume: 709, Issue: 1	1998
GABA(B) receptors and opioid mechanisms involved in homotaurine-induced analgesia. General pharmacology, Volume: 30, Issue: 3	1998
Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study. The British journal of psychiatry : the journal of mental science, Volume: 171	1997
Abnormal expressions of hepatocellular proteins and extracellular matrix in CCL4-induced liver injury in rats. Chinese medical journal, Volume: 109, Issue: 5	1996
Urinary taurine as a non-invasive marker of aflatoxin B1-induced hepatotoxicity: success and failure. Toxicology, Mar-28, Volume: 118, Issue: 2-3	1997
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
The Effects of TRX Suspension Training Combined with Taurine Supplementation on Body Composition, Glycemic and Lipid Markers in Women with Type 2 Diabetes. Nutrients, Nov-05, Volume: 13, Issue: 11	2021
Two high-performance liquid chromatography-tandem mass spectrometry methods for determination of edaravone and taurine in human plasma: Application to drug-drug interaction and pharmacokinetic studies. Journal of separation science, Volume: 43, Issue: 12	2020
Taurine ameliorated thyroid function in rats co-administered with chlorpyrifos and lead. Veterinary research communications, Volume: 40, Issue: 3-4	2016
The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro. BMC veterinary research, Jan-18, Volume: 9	2013
Cardioprotective effects of cysteine alone or in combination with taurine in diabetes. Physiological research, Volume: 62, Issue: 2	2013
[Antiviral activity of recombinant interferon-alpha-2b in combination with certain antioxidant]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], Volume: 56, Issue: 9-10	2011
Attenuating action of taurine and labetalol on cardiovascular alterations by pyridoxal-isoproterenol, a vitamin-drug interaction with cardiopathologic significance. Advances in experimental medicine and biology, Volume: 643	2009
High-resolution magic angle spinning 1H NMR spectroscopy of metabolic changes in rabbit lens after treatment with dexamethasone combined with UVB exposure. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, Volume: 242, Issue: 12	2004
A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Volume: 27, Issue: 4	2002
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

taurine

Cross-References

Synonyms (161)

Research Excerpts

Overview

Effects

Actions

Treatment

Roles (8)

Drug Classes (2)

Pathways (30)

Protein Targets (34)

Potency Measurements

Inhibition Measurements

Biological Processes (142)

Molecular Functions (46)

Ceullar Components (32)

Bioassays (73)

Research

Studies (9,708)

Study Types

Related Drugs (3,874)

Related Conditions (5,652)

Research Highlights

Safety/Toxicity (179)

Long-term Use (39)

Pharmacokinetics (183)

Bioavailability (40)

Dosage (156)

Interactions (10)

Natural Sources (1)